WorldWideScience

Sample records for trasplante renal abo

  1. Perfil antiinflamatorio del paricalcitol en el receptor de trasplante renal

    Directory of Open Access Journals (Sweden)

    Javier Donate-Correa

    2017-11-01

    Conclusiones: La administración del paricalcitol a receptores de trasplante renal se asocia con efectos beneficiosos sobre su estado inflamatorio, lo que podría asociarse a un potencial beneficio clínico.

  2. Trasplante renal en bloque de donantes pediátricos

    Directory of Open Access Journals (Sweden)

    Pedro Méndez-Chacón

    2005-03-01

    Full Text Available Objetivo: Determinar la aceptación de ambos riñones de donantes pediátricos para utilizarlos como trasplante renal en bloque. Material y Métodos: La edad de los seis donantes varió entre 14 meses y 10 años. La causa de muerte fue el traumatismo encefalocraneano. La edad de los seis receptores osciló entre 15 y 48 años con peso menor de 50 kg. Ambos riñones fueron removidos en bloque. La técnica operatoria de los trasplantes consistió en la anastomosis término lateral del segmento aórtico y vena cava inferior del donante a los vasos ilíacos del receptor; ambos uréteres fueron anastomosados por separado a la vejiga. El implante fue localizado en una de las fosas ilíacas. Resultados: Los injertos en bloque funcionaron inmediatamente. Cuatro de los seis receptores cursaron con función renal adecuada a cuatro años promedio de seguimiento. Uno de los injertos en bloque se perdió por rechazo vascular severo y otro por indisciplina a la medicación inmunosupresora. Las series ecográficas de los riñones revelaron incremento de tamaño hasta en 55% de su dimensión original al tercer mes del trasplante. Conclusión: Se recomienda que los riñones procedentes de donantes menores de tres años de edad sean utilizados como trasplante en bloque y riñones de donantes mayores de tres años como trasplante renal simple. Se demuestra que es posible trasplantar exitosamente riñones en bloque de niños muy pequeños en receptores mayores, según experiencia inédita en nuestro medio.

  3. Inmunidad humoral y trasplante renal posibilidades terapéuticas

    OpenAIRE

    P. Jacqueline Pefaur, Dra.; M. Susana Elgueta, Dra.

    2010-01-01

    El trasplante renal es el tratamiento de elección para los pacientes con falla renal terminal. Las principales causas de pérdida de injertos son la muerte del paciente con injerto funcionante, especialmente de causa cardiovascular y la nefropatía crónica del injerto, con una pérdida crónica de injertos que resulta en un problema relevante. Dentro de las causas de nefropatía crónica destaca la causa inmunológica. Una de las causas de pérdida de injertos de origen inmunológico son los rechazos ...

  4. Trasplante renal en bloque de donantes pediátricos

    OpenAIRE

    Pedro Méndez-Chacón; Armando Vidalón; Carmen Berríos; Miguel Camacho

    2005-01-01

    Objetivo: Determinar la aceptación de ambos riñones de donantes pediátricos para utilizarlos como trasplante renal en bloque. Material y Métodos: La edad de los seis donantes varió entre 14 meses y 10 años. La causa de muerte fue el traumatismo encefalocraneano. La edad de los seis receptores osciló entre 15 y 48 años con peso menor de 50 kg. Ambos riñones fueron removidos en bloque. La técnica operatoria de los trasplantes consistió en la anastomosis término lateral del segmento aórtico y ve...

  5. Trasplante renal doble (TRD de donantes añosos

    Directory of Open Access Journals (Sweden)

    Pedro Méndez-Chacón

    2005-06-01

    Full Text Available Objetivo: Utilizar ambos riñones del donante añoso en un mismo receptor y resaltar la importancia de la histología renal como método seleccionador. Materiales y Métodos: Se evalúa la elección y seguimiento de 11 pacientes quienes recibieron riñones dobles de donantes cadavéricos añosos. La creatinina sérica promedio de los 11 donantes fue de 1,3 mg%, cursando con edades promedio de 63 años (56 a 73 y de 53 años en los receptores. Ambos riñones fueron sometidos a biopsia en cuña por congelación. La cuantificación del tejido dañado se basó en metodología ya definida. Riñones con lesiones microscópicas moderadas (puntaje 4 a 6/12 fueron seleccionados para trasplante renal doble. Estos fueron implantados extraperitonealmente en cada fosa ilíaca con anastomosis a vasos ilíacos externos y ambos uréteres por separado a la vejiga. Esteroides y micofenolato de mofetil conformaron el esquema inmunosupresor de primera línea. Resultados: Ningún receptor requirió hemodiálisis postrasplante. Nueve de los once receptores cursan con función renal aceptable a dos años promedio de seguimiento. Un receptor falleció por accidente cerebrovascular (ACV hemorrágico a los 36 meses del trasplante con injerto funcionante y otro presentó enfermedad neoplásica a 38 meses del postimplante. Conclusiones: El trasplante renal doble de donante añoso constituye opción inédita en nuestro medio para receptores añosos. Resaltamos la histología renal como método en la elección del donante. Futuras investigaciones mostrarán si el trasplante renal doble, incrementando la masa nefronal, sirva para demorar o prevenir la disfunción crónica del injerto a largo plazo.

  6. Diarrea aguda en trasplantes renales y reno-pancreáticos

    OpenAIRE

    Alberto A Carena; Santiago Boughen; María Inés Gagliardi; Mariana Galante

    2015-01-01

    La diarrea es una complicación frecuente y potencialmente grave del trasplante renal. Se describen aquí, en un estudio de corte transversal, las características epidemiológicas y microbiológicas de la diarrea aguda y persistente en pacientes internados con trasplante renal o reno-páncreas. Se incluyeron 52 pacientes internados en un hospital de la Ciudad de Buenos Aires, 42 (80.8%) habían recibido un trasplante renal y 10 (19.2%) reno-páncreas. La diarrea fue el motivo de ingreso en 34 casos ...

  7. Trasplante renal en pacientes con anticuerpos dirigidos contra donante

    Directory of Open Access Journals (Sweden)

    Federico Cicora

    2014-10-01

    Full Text Available En trasplante renal, los anticuerpos donante-específicos por ensayos de fase sólida predicen el rechazo temprano mediado por anticuerpos, incluso con resultados negativos de citometría de flujo o citotoxicidad dependiente del complemento. Aquí se describen los protocolos de inmunosupresión y los resultados a diez meses de cuatro pacientes en los que se detectó anticuerpos donante-específicos anti-antígenos leucocitarios humanos (HLA por Luminex®, pero no detectados por el método de citotoxicidad dependiente de complemento (CDC ni por citometría de flujo. Los cuatro pacientes recibieron tratamiento de inducción con 5 dosis de timoglobulina de 1.25 mg/kg y 5 dosis de inmunoglobulina intravenosa (IVIG de 400 mg/kg. Además, uno recibió 20 mg de basiliximab el mismo día del trasplante y el día 4 postrasplante; otro recibió 3 sesiones de plasmaféresis en los días -5, -3, y -1 y eculizumab en dosis de 1200 mg antes del trasplante, 900 mg el día 1, and 600 mg por semana durante un mes. En todos los casos, la inmunosupresión de mantenimiento consistió en tacrolimus, micofenolato y deltisona. Todos presentaron buenos resultados en el corto plazo. Nuestra experiencia sugiere que los pacientes con anticuerpos donante-específicos anti-HLA detectados solo por Luminex® deben recibir un seguimiento estricto y que en esta población se pueden obtener buenos resultados a partir del uso de terapia de inducción con timoglobulina e IVIG.

  8. Aplasia pura de serie roja post-trasplante alogeneico de células progenitoras hematopoyeticas ABO incompatible Pure red cell aplasia after ABO incompatible bone marrow transplantation

    OpenAIRE

    E. Bulliorsky; C. Shanley; G. Stemmelin; J. Ceresetto; O. Rabinovich

    2002-01-01

    El trasplante alogeneico de células progenitoras hematopoyéticas (TCPH) con incompatibilidad ABO entre el donante y el receptor puede en ocasiones asociarse a trastornos en la progenie eritroide desarrollada a partir de la médula ósea trasplantada, caracterizado por un funcionamiento tardío, inadecuado e incompleto de la misma. En este contexto, la aplasia pura de serie roja es la complicación más severa. Se han intentado tratamientos para la aplasia pura de serie roja post-TCPH con eritropoy...

  9. Trasplante renal de donante vivo entre gemelos monocigotos sin inmunosupresión de mantenimiento

    Directory of Open Access Journals (Sweden)

    Ana Sánchez-Escuredo

    2015-07-01

    Conclusión: El trasplante renal entre gemelos monocigotos ofrece excelentes resultados clínicos. Probablemente el tratamiento inmunosupresor para inhibir la respuesta aloinmune es innecesario en estos casos cuando se haya comprobado la cigosidad.

  10. Aplasia pura de serie roja post-trasplante alogeneico de células progenitoras hematopoyeticas ABO incompatible

    OpenAIRE

    E. Bulliorsky; C. Shanley; G. Stemmelin; J. Ceresetto; O. Rabinovich

    2002-01-01

    El trasplante alogeneico de células progenitoras hematopoyéticas (TCPH) con incompatibilidad ABO entre el donante y el receptor puede en ocasiones asociarse a trastornos en la progenie eritroide desarrollada a partir de la médula ósea trasplantada, caracterizado por un funcionamiento tardío, inadecuado e incompleto de la misma. En este contexto, la aplasia pura de serie roja es la complicación más severa. Se han intentado tratamientos para la aplasia pura de serie roja post-TCPH con eritropoy...

  11. Factores asociados a complicaciones infecciosas en trasplante renal Centro Médico Naval 2006 - 2015

    OpenAIRE

    Ayvar Fuentes, Aldo Enrique

    2016-01-01

    El trasplante renal es la terapia de elección para la insuficiencia renal crónica terminal. Al ser un campo interdisciplinario, es importante que las especialidades involucradas conozcan la importancia que tienen las complicaciones infecciosas en dichos pacientes. Objetivo: Identificar los factores asociados a la incidencia o prevalencia de complicaciones infeccionas en trasplante renal en el Centro Médico Naval “Cirujano Mayor Santiago Távara” entre los años 2006 y 2015. Métodos: Se tomó dat...

  12. Factores asociados y consecuencias clínicas de la anemia post trasplante renal

    Directory of Open Access Journals (Sweden)

    Mónica Freiberg

    2013-04-01

    Full Text Available Un porcentaje considerable de pacientes presentan anemia post trasplante renal. Su origen es multifactorial y sus principales etiologías dependen de la etapa post trasplante que se considere. Estudiamos en un grupo de 134 pacientes los factores asociados con anemia tardía (6 meses post trasplante y sus implicaciones clínicas a mediano plazo. En el análisis de regresión múltiple, la duración de la oliguria post trasplante y el número de episodios de rechazo fueron las variables significativamente asociadas con esta complicación. La supervivencia del órgano mostró una diferencia significativa a los 36 meses entre los grupos (83% en los anémicos versus 96% de los no anémicos p < 0.01. No observamos diferencias en mortalidad o eventos cardiovasculares. Concluimos que la presencia de anemia al sexto mes post trasplante renal está independiente y significativamente asociada con factores que condicionan la masa renal funcionante que explicarían además la menor supervivencia del injerto renal observada en estos pacientes.

  13. Aplasia pura de serie roja post-trasplante alogeneico de células progenitoras hematopoyeticas ABO incompatible

    Directory of Open Access Journals (Sweden)

    E. Bulliorsky

    2002-12-01

    Full Text Available El trasplante alogeneico de células progenitoras hematopoyéticas (TCPH con incompatibilidad ABO entre el donante y el receptor puede en ocasiones asociarse a trastornos en la progenie eritroide desarrollada a partir de la médula ósea trasplantada, caracterizado por un funcionamiento tardío, inadecuado e incompleto de la misma. En este contexto, la aplasia pura de serie roja es la complicación más severa. Se han intentado tratamientos para la aplasia pura de serie roja post-TCPH con eritropoyetina o plasmaféresis, con relativo éxito. Algunos autores han informado también la utilización de globulina antilinfocitaria, asumiendo que dicha aplasia selectiva de la serie roja en la médula ósea trasplantada es mediada por un mecanismo inmune. En este trabajo se describe un paciente portador de una leucemia aguda en quien se realizó un TCPH alogeneico (ABO incompatible con su donante. Teniendo niveles bajos de aglutininas contra el grupo sanguíneo de la donante, desarrolló una aplasia pura de serie roja post - TCPH. La misma no mejoró con tratamiento con eritropoyetina o con un refuerzo de progenitores hematopoyéticos de sangre periférica de la misma donante (boost, resolviéndose totalmente luego de un tratamiento exitoso con globulina antilinfocitaria de origen equino.

  14. Discontinuation of steroids in ABO-incompatible renal transplantation

    DEFF Research Database (Denmark)

    Novosel, Marija Kristina; Bistrup, C.

    2016-01-01

    A steroid-free protocol for ABO-compatible renal transplantation has been used at our center since 1983. To minimize the adverse effects of steroids, we also developed a steroid sparing protocol for ABO-incompatible renal transplantation in 2008. The present study is a report of our results. A re...... transplantations with a steroid sparing protocol. However, a longer follow-up of a lager cohort is needed before firm conclusions can be made....

  15. Aplasia pura de serie roja post-trasplante alogeneico de células progenitoras hematopoyeticas ABO incompatible Pure red cell aplasia after ABO incompatible bone marrow transplantation

    Directory of Open Access Journals (Sweden)

    E. Bulliorsky

    2002-12-01

    Full Text Available El trasplante alogeneico de células progenitoras hematopoyéticas (TCPH con incompatibilidad ABO entre el donante y el receptor puede en ocasiones asociarse a trastornos en la progenie eritroide desarrollada a partir de la médula ósea trasplantada, caracterizado por un funcionamiento tardío, inadecuado e incompleto de la misma. En este contexto, la aplasia pura de serie roja es la complicación más severa. Se han intentado tratamientos para la aplasia pura de serie roja post-TCPH con eritropoyetina o plasmaféresis, con relativo éxito. Algunos autores han informado también la utilización de globulina antilinfocitaria, asumiendo que dicha aplasia selectiva de la serie roja en la médula ósea trasplantada es mediada por un mecanismo inmune. En este trabajo se describe un paciente portador de una leucemia aguda en quien se realizó un TCPH alogeneico (ABO incompatible con su donante. Teniendo niveles bajos de aglutininas contra el grupo sanguíneo de la donante, desarrolló una aplasia pura de serie roja post - TCPH. La misma no mejoró con tratamiento con eritropoyetina o con un refuerzo de progenitores hematopoyéticos de sangre periférica de la misma donante (boost, resolviéndose totalmente luego de un tratamiento exitoso con globulina antilinfocitaria de origen equino.ABO incompatibility in allogeneic bone marrow transplantation may be associated with incomplete or delayed erythroid engraftment, being pure red cell aplasia (PRCA the most severe complication in this setting. Attempts for the treatment of PRCA have been made with erythropoietin or with plasmapheresis with relative success, and some authors have reported the reversibility of PRCA with antilymphocyte globulin (ALG or ATG, based on the assumption that PRCA might be immunologically mediated. We report herewith a patient with acute leukemia who developed post - BMT pure red cell aplasia. His sibling donor (sister was HLA identical and ABO incompatible, having low agglutinin

  16. Inmunidad humoral y trasplante renal posibilidades terapéuticas

    Directory of Open Access Journals (Sweden)

    P. Jacqueline Pefaur, Dra.

    2010-03-01

    Por otra parte y basado en el exitoso tratamiento del RAH, se ha planteado mejorar las expectativas de llegar a realizar un trasplante a los pacientes sensibilizados. Esto es posible conseguir aplicando protocolos de desensibilización que se basan en la utilización de las mismas drogas para tratar RAH, consiguiendo ampliar las posibilidades de trasplante. El éxito de éstas es relativo al tipo de protocolos y a la intensidad de la sensibilización. La sobrevida del injerto en esta situación es plausible en la gran mayoría de los casos, sin embargo existe riesgo de presentar rechazo agudo humoral, y más complejo aún es el hecho que la sobrevida a largo plazo de los injertos sigue siendo todavía desconocida.

  17. Initial Experience with ABO-incompatible Live Donor Renal Transplantation

    Directory of Open Access Journals (Sweden)

    Meng-Kun Tsai

    2006-01-01

    Full Text Available The serious shortage of cadaveric organs has prompted the development of ABO-incompatible live donor renal transplantation. We report our experience of the initial two live donor ABO incompatible renal transplants at our hospital. The first patient was a 55-year-old type A female who received a kidney from her AB type husband. The second patient was a 27-year-old type O male who received renal transplantation from his type A father. Preconditioning immunosuppressive therapy in the two patients with tacrolimus, mycophenolate mofetil and methylprednisolone was started 7 days before transplantation. During the period of preconditioning, double filtration plasmapheresis (DFPP was employed to remove anti-A and -B antibodies. Laparoscopic splenectomy and renal transplantation were performed after the anti-donor ABO antibodies were reduced to a titer of 1:4. Rituximab, a humanized monoclonal anti-CD20 antibody, was administered to the second patient due to a rebound in the anti-A antibody titer during the preconditioning period. Under a tacrolimus-based immunosuppressive regimen, both patients recovered very well without any evidence of rejection. Serum creatinine levels were 1.0 and 1.4 mg/dL at 6 and 3 months after transplantation, respectively. These cases illustrate that with new immunosuppressive agents, DFPP and splenectomy, ABO-incompatible renal transplantation can be successfully conducted in end-stage renal disease patients whose only available live donors are blood group incompatible.

  18. Elección de fluidos en el periodo perioperatorio del trasplante renal

    Directory of Open Access Journals (Sweden)

    Alejandro Gonzalez-Castro

    2017-11-01

    Full Text Available El suero salino normal (SSN ha sido clásicamente el fluido de resucitación elegido en el periodo perioperatorio del trasplante renal frente a aquellas soluciones balanceadas con potasio. Sin embargo, los problemas derivados de la hipercloremia desencadenada por la infusión de SSN han llevado a la realización de estudios que comparaban esta solución con los fluidos equilibrados. Mediante la presente revisión narrativa se deduce que el uso de cristaloides balanceados con contenido de potasio en su formulación, en el perioperatorio de trasplante renal, puede considerarse seguro. Estas soluciones no provocan una alteración del potasio sérico mayor que la provocada por el SSN y mantienen mejor el equilibrio ácido-base en estos enfermos.

  19. Ascitis posterior a trasplante renal pediátrico. Reporte de un caso

    Directory of Open Access Journals (Sweden)

    Samuel Zaltzman Girshevich

    2016-10-01

    Full Text Available La ascitis posterior a un trasplante renal es poco común y generalmente es causada por complicaciones en la técnica quirúrgica. Presentamos el caso de un niño de 5 años de edad con diagnóstico de glomerulonefritis crónica que recibió un trasplante renal de donador vivo relacionado con función adecuada del injerto durante las primeras horas de evolución; 72 horas después de la cirugía, desarrolló ascitis con un gradiente albúmina sérica-ascitis de 0.92 g/ dL. Debido a esto fue necesaria la exploración quirúrgica durante la cual se encontró ascitis en gran cantidad en la cavidad peritoneal con infiltración de líquido entre la cápsula y la superficie del parénquima del riñón nativo; se practicó nefrectomía de este riñón. En el examen histopatológico se observó dilatación acentuada de los vasos linfáticos. La evolución postquirúrgica del paciente fue satisfactoria. La ascitis quilosa se debe al drenaje de linfa hacia la cavidad peritoneal. En la literatura encontramos algunos casos de ascitis de origen linfático después de un trasplante renal. De acuerdo con los hallazgos descritos consideramos que en nuestro caso la ascitis se debió a trasudado de linfa desde la cápsula del riñón nativo, secundario a obstrucción de los vasos linfáticos por manipulación aórtica excesiva durante la cirugía. En pacientes pediátricos sometidos a trasplante renal intraperitoneal que desarrollan ascitis el origen linfático de ésta debe ser considerado.

  20. Therapeutic apheresis therapy for ABO-incompatible renal transplantations.

    Science.gov (United States)

    Ishida, Hideki; Tanabe, Kazunari; Toma, Hiroshi; Akiba, Takashi

    2003-12-01

    The most important transplantation antigen system for organ transplantation is the ABO blood group system. Crossing the blood barrier is usually not done except in emergency cases such as liver transplantations for fulminant hepatitis. Early experiences of allograft transplantations across the blood barriers were discouraging. In the 1970s, clinical trials were started transplanting kidneys of subgroup A2 into blood group O recipients because the tissues of the A2 subgroup express a lower amount of A antigens compared with subgroup A1. The recipients required no special treatment and received the standard immunosuppressive regimen as used in blood group identical cases. Many early graft loses immediately after transplantations were experienced, but these trials resulted in an excellent graft survival rate. A few centers have adapted the concept of A2 kidneys to non-A recipient transplantations with successful results by reducing anti-A blood type titers prior to transplantations. In the early 1980s, the possibility of bridging the ABO barrier was tested by several groups. A1 and B kidneys from living donors were also successfully transplanted across the blood barrier using quadruple immunosuppressive drugs and splenectomy. Since 1989, the largest number of ABO-incompatible renal transplantations have been performed in Japan because of the limited numbers of cadaveric donors. Approximately 400 cases have been successfully transplanted across the blood barrier at many centers in Japan. Owing to novel immunosuppressive drugs, the ABO-incompatible allografts exhibited a level of function comparable with that of ABO-matched allografts even though anti-A or anti-B antibodies had returned to the circulation of the recipients. In this article, we describe the historical background, the current therapeutic strategies including apheresis therapy for the ABO-incompatible transplantations, and the experiences at our institution.

  1. Trasplante renal doble (TRD) de donantes añosos

    OpenAIRE

    Pedro Méndez-Chacón; Armando Vidalón; Mario Medina; Miguel Camacho; José Somocurcio

    2005-01-01

    Objetivo: Utilizar ambos riñones del donante añoso en un mismo receptor y resaltar la importancia de la histología renal como método seleccionador. Materiales y Métodos: Se evalúa la elección y seguimiento de 11 pacientes quienes recibieron riñones dobles de donantes cadavéricos añosos. La creatinina sérica promedio de los 11 donantes fue de 1,3 mg%, cursando con edades promedio de 63 años (56 a 73) y de 53 años en los receptores. Ambos riñones fueron sometidos a biopsia en cuña por congelaci...

  2. Diarrea aguda en trasplantes renales y reno-pancreáticos

    Directory of Open Access Journals (Sweden)

    Alberto A Carena

    2015-02-01

    Full Text Available La diarrea es una complicación frecuente y potencialmente grave del trasplante renal. Se describen aquí, en un estudio de corte transversal, las características epidemiológicas y microbiológicas de la diarrea aguda y persistente en pacientes internados con trasplante renal o reno-páncreas. Se incluyeron 52 pacientes internados en un hospital de la Ciudad de Buenos Aires, 42 (80.8% habían recibido un trasplante renal y 10 (19.2% reno-páncreas. La diarrea fue el motivo de ingreso en 34 casos (65.4%. La etiología de la diarrea pudo estudiarse en 50 pacientes: en 25 (50% no se arribó a un diagnóstico etiológico y en 18 (36% se constató diarrea con causa microbiológica específica: 3 (6% enfermedad por citomegalovirus, 6 (12% diarrea atribuida a citomegalovirus, 5 (10% a rotavirus y 4 (8% a Clostridium difficile. En 7 (14% la diarrea fue atribuida a fármacos (mofetil micofenolato y sirolimus. Aquellos con diarrea con causa microbiológica habían recibido recientemente inmunosupresores a altas dosis con mayor frecuencia que el resto (p = 0.048. Los pacientes con diarrea atribuida a fármacos recibían más frecuentemente mofetil micofenolato (p = 0.039. En 16 (30.8% se realizaron modificaciones de los inmunosupresores como medida terapéutica, y a 47 (90.4% se les indicó antibioticoterapia empírica. La mediana de duración de internación fue de 6 días y 7 pacientes (14.6% persistieron con diarrea al quinto día. Todos tuvieron resolución de la diarrea al alta y un tercio persistió con insuficiencia renal. La información de este estudio puede servir para mejorar las medidas preventivas, diagnósticas y terapéuticas en estos pacientes.

  3. ¿Que nos señala la literatura en relación al trasplante renal y embarazo?

    OpenAIRE

    Barrios Araya,Silvia; Ximena Concha,Miriam

    2014-01-01

    Antecedentes: La enfermedad renal crónica terminal es una patología asociada a condiciones de vida y hábitos de las personas que aumentará su incidencia a nivel mundial en toda la población incluso en mujeres en edad fértil. El trasplante renal considerado como terapia de sustitución renal, ha permitido a mujeres en edad fértil llevar a buen término la gestación. Chile, cuenta con reportes históricos publicados de embarazos en mujeres trasplantadas, Estados Unidos reporta al 2010 un total de ...

  4. Valor pronóstico de la biopsia renal preimplante en donantes fallecidos de edad avanzada en la función renal al año del trasplante

    Directory of Open Access Journals (Sweden)

    Juan J. Amenábar

    2016-01-01

    Conclusiones: Los riñones con mayor afectación histológica presentaron un menor FGe al año del trasplante. La función renal retrasada del injerto y el rechazo fueron factores de riesgo significativos de un bajo FGe al año del trasplante.

  5. Estudio broncoscópico en pacientes con trasplante renal y sepsis respiratoria baja

    Directory of Open Access Journals (Sweden)

    Victoriano Machín González

    1997-08-01

    Full Text Available La infección respiratoria baja constituye uno de los problemas fundamentales que con frecuencia es necesario enfrentar en aquellos pacientes que reciben trasplante renal. Se hace un estudio de 47 enfermos trasplantados, los cuales presentaron como complicación una infección respiratoria baja (IRB evolutivamente en el período comprendido entre enero de 1993 y julio de 1995. Considerando que el éxito del trasplante depende en gran medida de factores inmunológicos y que la sobrevida se debe en parte a la presencia o no de infecciones, y que del total de receptores el 75 % desarrolla algún tipo de infección, se realizó este trabajo apoyándose en el estudio broncoscópico como vía de obtención de muestra microbiológica en estos enfermos. Se hallaron como gérmenes más frecuentes los gramnegativos, y se aislaron microorganismos oportunistas; se demostró la ausencia de complicaciones del proceder en manos expertas y hubo gran correlación clínico-radiológica-broncoscópicaLower respiratory infection constitutes one of the main problems which should frequently be faced in those patients who had undergone a renal transplantation. A study of 47 transplantated patients was performed. Patients presented with a lower respiratory infection as a complication during January 1993 July, 1995. This work was carried out after making a bronchoscopic study as a way to obtain a microbiological sample of these patients taking into account that the sucess of the renal transplantation depends mostly upon immunologic factors and that the survival rate relies mainly on the presence or absence of infections since the total number of recipients may develop some kind of infection. Gramnegative germs were found to be the most frequently and opportunistic microorganisms were isolated. Absence of complications due to this procedure performed by experts was proved, and there was a great clinical, radiologic, and bronchoscopic correlation

  6. Protocolos de selección y estudio del donante y receptor, aplicables a la práctica chilena, en trasplante renal

    Directory of Open Access Journals (Sweden)

    B. Jorge Morales, Dr.

    2010-03-01

    Full Text Available En el trasplante de órganos siempre hay un donante y receptor cuyas voluntades deben ser respetadas y que deben ser estrictamente evaluados desde el punto de vista médico, social, psicológico y moral para determinar la idoneidad de cada uno para recibir la acción médica. En el presente artículo se describen las pautas para estudiar a un potencial donante renal vivo o cadavérico y a los potenciales receptores de un trasplante renal para evitar yerros que compliquen el trasplante o atenten contra normas éticas y científicas básicas universalmente aceptadas que se aplican al trasplante de órganos sólidos en general y de riñón en particular.

  7. Evolución del peso en pacientes durante el primer año del trasplante renal

    Directory of Open Access Journals (Sweden)

    Pilar López Garrigós

    Full Text Available Durante el primer año de trasplante renal es frecuente una ganancia de peso, debido, entre otros a la dieta, sedentarismo, e inmunosupresores, pudiendo aumentar los factores de riesgo del síndrome metabólico. Objetivos: Conocer la evolución del peso de nuestros pacientes durante el primer año del trasplante, y analizar la influencia con las distintas variables asociadas al paciente, sexo, edad, IMC, tratamiento inmunosupresor entre otras. Determinar la asociación entre la ganancia de peso y la aparición de factores de riesgo, como hipertensión arterial, diabetes y dislipidemia. Material y Método: Estudio retrospectivo y analítico. Se estudiaron 100 pacientes con un año de evolución en el trasplante, del Hospital Virgen de la Salud de Toledo. Sé analizaron datos antropométricos, demográficos y clínicos. La ganancia de peso se distribuyo según a las variables del estudio. Resultados: La ganancia de peso al año del trasplante afecto a 93 pacientes, con una media de 7,21 kg ±5,87. El 44,1% aumento su peso por encima de la media, y el 23,7% gano > 10 kg. La prevalencia de sobrepeso y obesidad antes del trasplante fue 57% y 76% después del trasplante. Los hombres ganaron ligeramente más peso que las mujeres. Los más jóvenes < 49 años ganaron más peso, media 9,3 kg. Mayor incidencia de diabetes, hipertensión y dislipemias en los pacientes con sobrepeso y obesidad. Conclusiones: La mayoría de los pacientes aumentaron significativamente de peso al año del trasplante, asociándose con varios de los factores del síndrome metabólico. - Importante la educación, por parte de la enfermería, del paciente para fomentar hábitos de vida saludable.

  8. CALIDAD DE VIDA Y ESTRATEGIAS DE AFRONTAMIENTO EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA SOMETIDOS A HEMODIÁLISIS, DIÁLISIS PERITONEAL Y TRASPLANTE RENAL

    Directory of Open Access Journals (Sweden)

    Cesar Armando Rey Anacona

    2008-07-01

    Full Text Available Se comparó la calidad de vida y las estrategias de afrontamiento en 120 pacientes con Insuficiencia Renal Crónica sometidos a hemodiálisis, diálisis peritoneal o trasplante renal, teniendo en cuenta la edad, sexo, escolaridad, estado civil y ocupación. Los instrumentos utilizados fueron una ficha sociodemográfica, la prueba de calidad de vida WHOQOL-100 (Organización Mundial de la Salud, 1998 y el Cuestionario de Estrategias de Afrontamiento (Lazarus & Folkman, 1985. Se encontró que los pacientes en tratamiento de trasplante reportaban mayor calidad de vida y mejores estrategias de afrontamiento en comparación con los otros tratamientos, siendo mayores las puntuaciones en personas con edad de transición entre adultez media y tardía, mujeres, con estudios universitarios, casados y empleados. Se discuten las implicaciones de estos hallazgos.

  9. Resultados clínicos de trasplantes de riñón en pacientes con enfermedad renal en etapa terminal secundaria a nefritis lupus, enfermedad poliquística renal y nefropatía diabética

    OpenAIRE

    John Fredy Nieto-Ríos; Lina María Serna-Higuita; Sheila Alexandra Builes-Rodriguez; Ricardo Cesar Restrepo-Correa; Arbey Aristizabal-Alzate; Catalina Ocampo-Kohn; Angelica Serna-Campuzano; Natalia Cardona-Díaz; Nelson Dario Giraldo-Ramirez; Gustavo Adolfo Zuluaga-Valencia

    2016-01-01

    Antecedentes:Pacientes con nefritis lúpica pueden progresar a enfermedad renal crónica terminal (10-22%); en estos pacientes el trasplante renal debe ser considerado como la terapia de elección. Objetivo: Evaluar los desenlaces clínicos de un grupo de pacientes con enfermedad renal crónica terminal por nefropatía lúpica, enfermedad renal poliquística y nefropatía diabética que fueron sometidos a trasplante renal en el Hospital Pablo Tobón Uribe.Métodos:Estudio retrospectivo, descriptivo, real...

  10. Fenestración videolaparoscópica de un linfocele sintomático posterior a un trasplante renal

    Directory of Open Access Journals (Sweden)

    Miguel Ángel Martín González

    2003-09-01

    Full Text Available Este trabajo tiene el objetivo de describir un caso tratado por videolaparoscopia, de un linfocele sintomático posterior a trasplante renal. Se refiere a una mujer de 54 años con insuficiencia renal crónica terminal, secundaria a hipertensión arterial severa, la cual se le realizó en el 2001 un trasplante renal de donante cadáver. Presenta, 3 meses después, molestias en la zona del trasplante, sin síntomas urinarios por la presencia de un catéter ureteral utilizado como férula y en tiempo para ser retirado. Se diagnostica un linfocele sintomático. Posterior al chequeo preoperatorio se efectúa drenaje interno por vía videolaparoscópica sin accidentes ni complicaciones quirúrgicas inmediatas y el retirado del catéter ureteral y el alta a las 24 y 48 h de la operación, respectivamente. Después de 10 meses de evolución no se ha encontrado ninguna complicación. El abordaje videolaparoscópico del linfocele sintomático posterior al trasplante renal constituye la terapéutica de elecciónThis paper is aimed at describing a case of symptomatic lymphocele after kidney transplantation, which was treated with videolaparoscopy. It was a 54 years-old woman with terminal chronic renal failure secondary to several blood hypertension, who was transplanted a kidney from a dead donor in 2001. She presented with some discomfort in the transplant area, without urinary symptoms, owing to a urethral catheter used as rod and due to be withdrawn. The diagnosis was symptomatic lymphocele. After pre-operative checking, internal drainage by videolaparoscopy was performed, with no accidents or immediate surgical complications; the urethral catheter was withdrawn at 24 hours and the patient was discharged at 48 hours. Ten months later, no complication was found. The videolaparoscopic treatment of symptomatic lymphocele after kidney transplantation is the therapy of choice

  11. Immunobiology of renal transplant Inmunología del trasplante renal historia de los trasplantes y del complejo mayor de histocompatibilidad

    Directory of Open Access Journals (Sweden)

    Jorge Eliécer Ossa Londoño

    1990-02-01

    Full Text Available

    This article reviews the development of organ transplantation from the early beginning when fiction and superstition prevailed, to the current times when, with the participation of surgeons, oncologists, geneticists and immunologists, the concept of the Major Histocompatibility Complex was developed and later on the complexity of these markers was worked out and was used to match Donors and Recipients thus making transplants feasible. Hopefully molecular biology will help to open a new era in transplantation to make this form of therapy more reliable and safely applicable to other organs.

    En este artículo se revisa el desarrollo de los trasplantes de órganos desde los primeros tiempos cuando prevalecían la ficción y la superstición, hasta la actualidad cuando, con la participación secuencial y sistemática de cirujanos, oncólogos, geneticistas e inmunólogos se descubrió el Complejo Mayor de Histocompatibilidad y más tarde se redujo la complejidad de estos marcadores hasta poderlos utilizar para el apareamiento Donador/Receptor y aumentar el éxito del trasplante. Se espera que la biología molecular ayude a abrir una nueva era en esta área para mejorar la eficiencia de esta forma de terapia y ampliar su uso a otros órganos.

  12. ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report.

    Science.gov (United States)

    Ray, Deepak Shankar; Thukral, Sharmila

    2017-10-06

    BACKGROUND Even though renal transplantation across blood groups is not uncommonly practiced nowadays, there is still hesitation regarding ABO-incompatible transplantation with very high baseline antibody titer. In this case report, the outcome of an ABO-incompatible kidney transplant recipient with a high baseline isoagglutinin titer is reported. CASE REPORT The patient was a non-diabetic, 33-year-old man with end-stage renal disease secondary to chronic glomerulonephritis. The only kidney donor available was his mother, who was blood-group incompatible. The patient's blood group was O positive, whereas his mother was B positive. We evaluated him for an ABO-incompatible renal transplant. The baseline anti-B isoagglutinin titer was >1:8196.  With a desensitization protocol of low-dose Rituximab, plasmapheresis, and IVIG, this titer was brought down to 1:32 before transplantation. He successfully underwent renal transplantation across the ABO barrier, and maintains good graft function after 1 year of follow-up.  CONCLUSIONS In the present era, a high baseline isoagglutinin titer is no longer a contraindication for successful kidney transplantation in ABO-incompatible recipient-donor pairs.

  13. Reanálisis del estudio ESHOL: mortalidad por todas las causas considerando riesgos de competición y tiempo-dependientes para trasplante renal

    Directory of Open Access Journals (Sweden)

    Francisco Maduell

    2016-03-01

    Conclusiones: Los resultados del reanálisis del estudio ESHOL se confirman cuando se aplica el análisis en la población por intención de tratar sin censurar ninguna observación y considerando la mortalidad por todas las causas dependiente del tiempo y del riesgo competitivo del trasplante renal.

  14. El cuidado en un programa de trasplante renal: un acompañamiento de vida

    Directory of Open Access Journals (Sweden)

    Ana Julia Carrillo-Algarra

    2015-01-01

    Full Text Available Objetivo: comprender las experiencias de cuidado de enfermeras integrantes de grupos de trasplante de la ciudad de Bogotá. Materiales y métodos: investigación cualitativa, utilizó la estrategia de grupos focales; la organización y el análisis de datos siguieron la propuesta de codificación de Janice M. Morse; participaron, previo consentimiento informado, 10 de 20 enfermeras de unidades de trasplante. Se realizó triangulación entre las integrantes del equipo investigador y la literatura relevante. Resultados: emergieron 6 ca- tegorías: 1 los múltiples significados del trasplante: cambio, pasión, satisfacción, esperanza, libertad, mayor cercanía, responsabilidad, compromiso, complejidad; 2 las redes de apoyo: familia, asociación de enfermeras, grupo de trabajo interdisciplinario, empresas pro- motoras de salud, industria farmacéutica; 3 implicaciones del día a día: relación cercana con el paciente y la familia, fortalecimiento de la autoestima profesional, estatus dentro del grupo de trasplante, manejo de las cargas; 4 trayectorias del cuidado profesiona l: acom- pañamiento de la enfermera a través del ciclo vital del paciente y posibilidad de identificar necesidades por la estrecha relac ión con él; 5 el perfil de la enfermera: carácter, conocimiento, compromiso, disponibilidad permanente y capacidad de gestión; 6 contradi cciones del trasplante: rechazo al injerto, sufrimiento, desesperanza, sistema de salud; para enfermería, las agotadoras jornadas de tr abajo.

  15. Trasplante renal procedente de donante vivo HLA incompatible: Eficacia y pronóstico en 32 pacientes tras desensibilización

    Directory of Open Access Journals (Sweden)

    Constantino Fernández

    2017-11-01

    Conclusiones: El trasplante renal de donante vivo HLA incompatible tras la desensibilización fue posible en el 71,9% de los pacientes. MFI de clase I y RIS predicen ineficacia de la desensibilización. La supervivencia renal (86% al 5.° año es aceptable con baja incidencia de rechazo agudo (17,4%, aunque con una mayor tendencia al sangrado postoperatorio.

  16. Recidiva de vasculitis asociada a anticuerpos anticitoplasma de neutrófilos en un paciente con trasplante renal

    Directory of Open Access Journals (Sweden)

    Pedro García Cosmes

    2016-03-01

    Full Text Available La afectación renal de las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilos (ANCA puede conducir a enfermedad renal crónica con necesidad de tratamiento renal sustitutivo. En estos enfermos el trasplante renal ofrece excelentes tasas de supervivencia del injerto y del receptor a largo plazo, por lo que pueden ser trasplantados cuando la enfermedad está en remisión. Sin embargo, la amenaza de recidivas de la enfermedad en el injerto se mantiene, aunque, con las modernas pautas de inmunosupresión, su incidencia es menor. Presentamos el caso de un varón diagnosticado de glomerulonefritis extracapilar tipo III C-ANCA (+ que desarrolló una recidiva de la enfermedad en el injerto renal 8 años después de ser trasplantado. La intensificación de la inmunosupresión con plasmaféresis consiguió controlar la enfermedad.

  17. Impacto de la Inmunidad Humoral en la Disfunción del Injerto en el Trasplante Renal.

    OpenAIRE

    Ruiz Esteban, Pedro

    2016-01-01

    La causa principal de pérdida del injerto renal a largo plazo es el daño tisular provocado por anticuerpos anti-HLA donante específico (DSA). El estudio parte del desconocimiento actual sobre aspectos tan importantes en el trasplante de órganos sólidos como el análisis de los factores de riesgo, que provocan la formación de DSA, así cómo el papel que juegan en la formación de DSA y en el rechazo humoral (RH) la dosis y variabilidad de los niveles plasmáticos de los inhibidores de la calcineur...

  18. Obesidad, diabetes y trasplante

    Directory of Open Access Journals (Sweden)

    Anna Bach Pascual

    Full Text Available El trasplante renal es la mejor opción terapéutica en términos de supervivencia y calidad de vida para los pacientes con enfermedad renal crónica. Los pacientes trasplantados son cada vez más mayores y con más pluripatologia asociada. Los avances en inmunosupresión y en el tratamiento han hecho que los pacientes trasplantados fallezcan con el injerto renal funcionante. Existe un incremento de peso del 10% durante el primer año del trasplante, la obesidad se relaciona con la aparición de diabetes mellitus postrasplante. Con el objetivo de analizar la incidencia de obesidad y los factores de riesgo relacionados, en una cohorte de pacientes trasplantados renales realizamos un estudio observacional y prospectivo de estos pacientes, desde enero del 2014 hasta marzo del 2015, con seguimiento de 1 año. Obteniendo como resultado, que los grupos son homogéneos en sexo, tiempo en terapia renal sustitutiva pero distintos en edad. A partir de los 3 meses los pacientes con índice de masa corporal mayor a 25 presentaron mayor incidencia de diabetes mellitus post trasplante respecto al grupo de pacientes con índice de masa corporal inferior a 25.

  19. Validación de marcadores de pronóstico en la evolución inicial de trasplante renal

    OpenAIRE

    Tabernero Fernández, Guadalupe

    2015-01-01

    [ES] El trasplante de órganos, y en especial el Trasplante Renal (TR), ha supuesto un gran avance en los últimos 50 años, siendo quizá uno de los mayores ¨hitos¨ del siglo XX. Desde que se realizó el primer TR en Boston, (EE.UU.), entre dos gemelos idénticos en el año 1954 ha mejorado mucho la técnica quirúrgica, el tratamiento médico posterior a la cirugía, se han desarrollado mejores fármacos inmunosupresores, y ha disminuido la incidencia de infecciones entre estos enfermos. El TR es el tr...

  20. Calidad de vida y estrategias de afrontamiento en pacientes con insuficiencia renal crónica sometidos a hemodiálisis, diálisis peritoneal o trasplante renal

    Directory of Open Access Journals (Sweden)

    Paola Andrea Acosta Hernández

    2008-01-01

    Full Text Available Se comparó la calidad de vida y las estrategias de afrontamiento en 120 pacientes con Insuficiencia Renal Crónica sometidos a hemodiálisis, diálisis peritoneal o trasplante renal, teniendo en cuenta la edad, sexo, escolaridad, estado civil y ocupación. Los instrumentos utilizados fueron una ficha sociodemográfica, la prueba de calidad de vida WHOQOL-100 (Organización Mundial de la Salud, 1998 y el Cuestionario de Estrategias de Afrontamiento (Lazarus & Folkman, 1985. Se encontró que los pacientes en tratamiento de trasplante reportaban mayor calidad de vida y mejores estrategias de afrontamiento en comparación con los otros tratamientos, siendo mayoreslas puntuaciones en personas con edad de transición entre adultez media y tardía, mujeres, con estudios universitarios, casados y empleados. Se discuten las implicaciones de estos hallazgos.

  1. Mieloma múltiple de novo post-trasplante renal manifestado inicialmente con disfunción del injerto. Reporte de 3 casos y revisión de la literatura

    Directory of Open Access Journals (Sweden)

    John Fredy Nieto

    2016-12-01

    Full Text Available El compromiso renal por cadenas ligeras es frecuente en el contexto de las gammapatías monoclonales, afectando los glomérulos o los túbulos renales y siendo el mieloma múltiple la causa más común; puede desarrollarse posterior a un trasplante renal por recurrencia de un mieloma múltiple ya existente, o su presentación puede ser de novo, manifestándose con deterioro de la función renal y presencia de proteinuria. Siempre se requiere una biopsia renal para confirmar el diagnóstico. Se describen tres casos de disfunción del injerto renal debido a compromiso por mieloma múltiple, en pacientes sin una historia previa de ésta condición antes del trasplante.

  2. Short-tem Post Renal Trasplant Follow-up at Madinah Al Munawarah

    Directory of Open Access Journals (Sweden)

    Bernieh Bassam

    1999-01-01

    Full Text Available We reviewed the records of the renal transplant patients followed at our hospital to determine short-term outcome and complications. Sixty-five renal transplant patients, follow-up for two years were included in this study. Of these patients 40 (61.5% were males, 33 (50.7% were Saudis with mean age of 37.2 ± 11.7 years. Donors were living related (LRD in 23 (35%, living non-related (LNRD in 27 (42% and cadaveric (CAD in 15 (23%. Thirty-two transplants were carried out at Medinah, 21 in India and the rest in other centers inside Saudi Arabia. Immunosuppression was based on a triple therapy (Cyclosporin, Azathioprine, and Prednisone. At two years, 52 (80% patients were alive, with functioning graft in 31 (58%. Causes of death among 13 patients (11 LNRD & 2 CAD were infections in 7 (54%, immediate post transplant in three (22.7%, acute myocardial infarction in two (15.7%, CVA in one (7.6%. Complications encountered were acute rejection (23 episodes in 18 923.6% patients, infections in 19 (25%, chronic rejection in 16 (21.5%, surgical in 13 917.1%, diabetes mellitus in 5 (6.5% primary non-function in three (3.8% and Kaposi Sarcoma in two (2.4%. Twenty-six (81.25% out of 32 transplants performed in Madinah were functioning, four (12.5% patients returned to dialysis and two (6.25% patients died. Among the 21 transplants done in India 11 (52% patients died, six (28.6% returned to dialysis, and four (19.4% had function deteriorated in all patients. We conclude that despite limitations, results of renal transplantation carried out at Madinah are encouraging on short-term basis. Live related transplant has a very good outcome, while commercial transplantation carries poor prognosis.

  3. Seroprevalencia de citomegalovirus en donantes de órganos y receptores de trasplante renal, Colombia, 2010-2014

    Directory of Open Access Journals (Sweden)

    Yazmín Rocío Arias-Murillo

    2016-08-01

    Conclusiones. Los resultados del presente estudio evidenciaron que las tasas de infección por citomegalovirus fueron altas y que la categorización del riesgo de los receptores de trasplante señala la necesidad de que los equipos médicos tratantes tomen medidas para minimizar los riesgos.

  4. Estudio prospectivo, aleatorizado, controlado para evaluar la eficacia de la utilización precoz de losartán y/o espironolactona en pacientes con trasplante renal sobre la reducción de tgf-ß1 en plasma y su papel en la regresión de hipertrofia ventricular izquierda y la prevención de nefropatía crónica del trasplante renal

    OpenAIRE

    Luna Huerta, Enrique

    2016-01-01

    La hipertrofia ventricular izquierda es una patología muy prevalente en la población con insuficiencia renal y diálisis, provocando importante morbimortalidad. La principal causa de muerte en el trasplante es la cardiovascular, siendo la hipertrofia ventricular izquierda un factor de riesgo para la misma, así como para la muerte súbita. No existen evidencias de una clara mejoría de esta patología tras el trasplante. La nefropatía crónica del injerto es la principal causa en la actualidad de p...

  5. Trasplante renal y disminución de la mortalidad en los programas de diálisis crónica

    Directory of Open Access Journals (Sweden)

    Walter G. Douthat

    2014-02-01

    Full Text Available El trasplante renal (TR presenta mejor supervivencia, calidad de vida y costos que la diálisis en la insuficiencia renal crónica (IRC. Estudiamos pacientes en diálisis que recibieron TR durante 2010, las causas de finalización del tratamiento y la supervivencia en diálisis. Evaluamos si criterios más amplios para la aceptación de trasplantes hubieran afectado los resultados del procedimiento en ese período. Incluimos 118 pacientes en diálisis, edad media 56.9 ± 18.4 años, tiempo en diálisis 45.5 ± 59.6 meses, 35 (30% presentaban diabetes como causa de IRC, y 58 (49% estaban en espera del TR. Treinta y cuatro finalizaron diálisis, 18 por TR y 12 por fallecimiento. Las principales causas de muerte fueron cardiovasculares, 6 (50% e infecciones, 2 (17%. La supervivencia al año fue 85% para el grupo total, 98% para los pacientes inscriptos en lista de espera y 72% para no inscriptos. Durante 2010 se realizaron 88 TR (62 con donantes cadavéricos [DC], 18 donantes vivos y 8 dobles trasplantes páncreas-riñón. Los receptores de DC tenían en promedio 50.7 años, 67 meses en diálisis, 8 (13% eran diabéticos, 12 (20% con TR previos y 3 cross match contra panel de anticuerpos > 20%. Los donantes tenían edad media 45 años, 28 (45% con criterios expandidos y 27.7 h de isquemia fría. A los 11.4 meses de seguimiento, 13 (21% presentó rechazo agudo, la supervivencia para injerto fue de 88% y 93% para pacientes. La principal causa de finalización de diálisis fue TR, sin detectarse que el empleo de DC afectara la supervivencia del TR.

  6. Temporary discontinuation of immunosuppressive treatment and renal graft rejection: experience of a center in Venezuela Interrupción temporal del tratamiento inmunosupresor y rechazo del trasplante renal: experiencia de un centro en Venezuela

    Directory of Open Access Journals (Sweden)

    José Herrera

    2006-11-01

    Full Text Available In some Latin American countries, discontinuation of treatment when immunosuppressive drugs are unavailable can cause late renal graft loss. This retrospective study reports the frequency and consequences of interrupted treatment at a single center in Venezuela. In 2005 and 2006, we evaluated the medical records of and interviewed 303 patients (181 males followed for more than one year after renal transplantation done between 1973 and 2005. Noncompliance for > 1 week was reported by 124 patients; 107 (86.3% instances were due to unavailability of immunosuppressive drugs at the institution (institutional noncompliance, and the remainder were due to voluntary noncompliance. Acute rejection episodes were about three times as frequent among voluntary noncompliers as institutional noncompliers, probably because voluntary noncompliance lasted longer (mean 42.7 ± standard deviation of 14.1 days than institutional noncompliance (18.5 ± 11.2 days, P En algunos países de América Latina, la interrupción del tratamiento cuando no se dispone de los medicamentos inmunosupresores puede causar la pérdida tardía del trasplante renal. Este estudio retrospectivo informa la frecuencia y las consecuencias de la interrupción del tratamiento en un centro en Venezuela. Se entrevistaron 303 pacientes (181 de ellos del sexo masculino que tenían un seguimiento de más de un año después del trasplante renal y se evaluaron sus historias clínicas. Ciento veinticuatro pacientes informaron haber interrumpido el tratamiento por más de 1 semana; en 107 (86,3% casos el motivo fue no disponer de los medicamentos inmunosupresores en la institución (incumplimiento institucional y el resto se debió a incumplimientos voluntarios. Los episodios de rechazo agudo fueron cerca de tres veces más frecuente en los incumplidores voluntarios que en los incumplidores institucionales, probablemente porque el incumplimiento voluntario duró más (42,7 ± 14,1 días [desviaci

  7. Percepción de la calidad de vida referida por el paciente adulto con trasplante renal

    Directory of Open Access Journals (Sweden)

    María Isabel Durán Muñoz

    2014-03-01

    Full Text Available La percepción personal de un individuo de su situación de vida, dentro del contexto cultural y de valores en el que vive, y en relación con sus objetivos, expectativas, valores e intereses, se denomina, calidad de vida. Como en estudios de pacientes crónicos, los factores más influyentes en la percepción de la calidad de vida, se clasifican en: paciente, medicamento, enfermedad y calidad de la interacción entre paciente y sistema sanitario. Objetivos: Describir la percepción que tienen los pacientes sobre su calidad de vida, e identificar factores que influyen en esta percepción. Material y métodos: Estudio descriptivo transversal en pacientes adultos, con trasplante renal, que acuden a nuestra consulta hospitalaria y son autosuficientes en el tratamiento. Todos los pacientes han recibido charlas grupales sobre el manejo de su tratamiento antes del alta. Recogida de datos con cuestionario anónimo autoadministrado: Escala validada: cuestionario de salud SF-12 (versión 2, durante 4 meses. Se excluyeron pacientes que rechazaron participar y que necesitaban ayuda en el manejo del tratamiento. Se estimó un tamaño muestral de 222 pacientes. Variables dependientes: Calidad de vida. Variables independientes: Factores socio-demográficos, tipo inmunosupresores, educación sanitaria recibida por profesionales de la salud. Se solicitó consentimiento informado y se obtuvo informe favorable del Comité Ético de Investigación Clínica. Resultados: Participaron 209 pacientes. Edad media 55,2(±12,15 rango 21-80 años, siendo el 61,8 % hombres. El 42% eran jubilados, el 38,2% tenían estudios secundarios, el 71% convivían en pareja. El inmunosupresor más utilizado: Micofenolato de sodio (MYFORTIC® (65,5% y el 46,7% tomaban dos inmunosupresores. La información sanitaria sobre efectos secundarios la consideran insuficiente un 20,5%. La media de la percepción de la calidad de vida es de 44,72±8,11 para el componente físico y 47,47±8,8 para

  8. al trasplante de órganos

    Directory of Open Access Journals (Sweden)

    María Ángeles Pérez San Gregorio

    2005-01-01

    Full Text Available El trasplante de órganos es una alternativa terapéutica para aquellos pacientes que tienen problemas graves en el funcionamiento de un órgano vital: corazón, hígado, pulmón, etc. Dada la relevancia de este tema, en el presente estudio teórico analizamos los principales problemas psicológicos asociados al trasplante de órganos. Concretamente, hemos tenido en cuenta los siguientes apartados: 1 Repercusiones psicológicas del trasplante de órganos en los pacientes: delirium, trastornos sexuales, trastornos del estado de ánimo, trastornos de ansiedad, fantasías sobre el donante, insatisfacción con la imagen corporal y otros trastornos; 2 variables psicosociales que influyen en las repercusiones psicológicas asociadas al trasplante de órganos: apoyo familiar, trastornos psicológicos en los familiares, hospitalización, expectativas pre y post-trasplante, estrategias de afrontamiento, duración de la enfermedad, etiología del trasplante, procedencia del órgano implantado y otras variables; 3 fases psicológicas en los trasplantados renales, hepáticos y cardíacos en función de diferentes periodos temporales de comparación; 4 calidad de vida en los trasplantados y variables que la predicen: adherencia terapéutica, hospitalización, apoyo familiar, expectativas hacia el trasplante y etiología del trasplante; y 5 repercusiones psicológicas del trasplante de órganos en los familiares, teniendo en cuenta la influencia que ejerce el apoyo social sobre la salud mental de estos familiares.

  9. Viviendo con trasplante renal, sin protección social en salud: ¿Qué dicen los enfermos sobre las dificultades económicas que enfrentan y sus efectos?

    Directory of Open Access Journals (Sweden)

    Francisco Javier Mercado-Martínez

    2014-10-01

    Full Text Available El trasplante es el mejor tratamiento para la insuficiencia renal, de acuerdo con la biomedicina; sin embargo, es una tecnología cara. Este artículo examina las dificultades económicas y sus efectos en personas con trasplante renal, pero sin protección social en salud. Para el estudio se desarrolló una investigación cualitativa en México. Participaron 21 pacientes trasplantados; se aplicaron entrevistas semiestructuradas, y se realizó un análisis de contenido. Los resultados muestran que las personas enfermas enfrentan dificultades económicas, debido a los costes de las terapias renales, particularmente, de las medicinas. Todo ello tiene efectos negativos: las personas con pocos recursos dejan el tratamiento con medicamentos, abandonan el protocolo, no asisten a las consultas médicas y disminuyen los gastos domésticos, incluyendo el de alimentación; además de suponer una merma en los ingresos familiares. En conclusión, el trasplante renal empobrece a las personas enfermas sin protección social en salud; es urgente la implementación de un sistema de protección social para esta población.

  10. Living donor transplant options in end-stage renal disease patients with ABO incompatibility.

    Science.gov (United States)

    Waigankar, Santosh S; Kamat, Madhav H; Joshi, Shriram; Gandhi, Bhupendra V; Bahadur, Madan; Deshpande, Rushi V

    2013-04-01

    The options available to CKD 5 patients with donor shortage due to incompatibilities is to either get enlisted in cadaver transplant program or opt for three other alternatives viz; ABO-incompatible transplant (ABO-I), ABO-incompatible transplant with Rituximab (ABO-R) or paired-kidney exchange transplant (PKE). At our institute we have performed ABO-I, ABO-R and PKE transplants and we are presenting the results of these transplants performed at our institution. Here, we report our experiences of living donor kidney transplantation in highly sensitized patients. To review the options available to CKD 5 patients with incompatible donor. Between January 2008 and June 2011, 7 PKE, 26 ABO-I and 7 ABO-R transplants were carried out at our institute. Evaluation of both the recipients and donors involved biochemical, serological and radiological investigations. In case of PKE, recipients were operated simultaneously in different operation theaters. In ABO-I splenectomy was done while in ABO-R was given. Post-transplant the recipient management protocol remained the same. Expenditure following each transplant was calculated. The graft and patient survival of ABO-I, ABO-R and PKE transplants 12-18 months after transplant were 78.9%:80%, 85.7%:85.7% and 100%:100%, respectively. The inclusion of Rituximab in the transplant protocol appears promising. The existing donor shortage could be addressed by encouraging other options like PKE. The limiting factor for ABO-R and PKE transplants is time and cost, respectively. The decision depends on the informed consent between the patient and the nephrologists.

  11. Adaptación psicosocial de los adolescentes pos-trasplante renal, según la teoría de Roy Adaptação psicossocial do adolescente pós-trasplante renal segundo a teoria de Roy Psicosocial adaptation of post-renal transplanted adolescents according to Roy Theory

    Directory of Open Access Journals (Sweden)

    Ana Luisa Brandão de Carvalho Lirax

    2005-03-01

    Full Text Available El objetivo de este trabajo fue conocer las repercusiones psicosociales del adolescente después del trasplante renal y los mecanismos de adaptación utilizados en su nueva condición de vida. Es un estudio cualitativo, mediante entrevistas estructuradas. Fueron entrevistados diecinueve adolescentes que estaban en acompañamiento en dos hospitales públicos de Ceará-Brasil, después de la aprobación del proyecto por parte del Comité de Ética de las Instituciones y obtención del consentimiento libre e informado. Los resultados fueron analizados conforme a la teoría de la adaptación de Roy. Se identificaron problemas de adaptación, como: limitación física, vergüenza, miedo al rechazo e impotencia. Sin embargo, esos adolescentes pudieron superar tal situación y mejorar la adaptación a su nueva condición. Concluimos que la teoría de Roy permitió un análisis más profundo de los adolescentes, permitiéndoles un tratamiento más eficaz y, consecuentemente, una mejor calidad de vida.É um estudo descritivo, com análise qualitativo. O objetivo deste trabalho foi conhecer as repercussões psicossociais do adolescente após o trasplante renal e os mecanismos adaptativos utilizados por estes na sua nova condição de vida. Foram entrevistados dezenove adolescentes que estavam em acompanhamento ambulatorial em dois hospitais públicos do Ceará-Brasil, após aprovação do projeto pelo Comitê de Ética das Instituições e obtenção do consentimento livre e esclarecido. Os resultados foram analisados conforme a teoria da adaptação de Roy. Foram identificados problemas de adaptação, como: limitação física, vergonha, medo de rejeição e impotência. Contudo, esses adolescentes puderam superar tal situação e melhorar a adaptação à sua nova condição. Concluímos que a teoria de Roy permitiu uma análise mais aprofundada desses adolescentes, permitindo lhes um tratamento mais eficaz e, conseqüentemente, uma melhor qualidade de

  12. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.

    Science.gov (United States)

    Fadeyi, Emmanuel A; Stratta, Robert J; Farney, Alan C; Pomper, Gregory J

    2014-05-01

    To report a successful unintentional transplantation of a deceased donor kidney from an "incompatible" A1B donor into a recipient who was blood group A2B with unsuspected preformed anti-A1 antibodies. The donor and recipient were both typed for ABO antigens. The recipient was tested for ABO and non-ABO antibodies. The recipient was typed for HLA class I and class II antigens, including HLA antibody screen. The T-and B-flow cytometry crossmatch test was performed using standard protocol. The donor-recipient pair was a complete six-antigen human leukocyte antigen mismatch, but final T- and B-flow cytometry cross-match tests were compatible. The recipient was a 65-year-old woman with a medical history of end-stage renal disease secondary to diabetic nephropathy who underwent kidney transplantation from a 46-year-old brain-dead standard criteria donor. The recipient's RBCs were negative with A1 lectin, and the recipient was thus typed as an A2 subgroup. Anti-A1 could be demonstrated in the recipient's plasma. The donor's RBCs were positive with A1 lectin, thereby conferring an A1 blood type. It is safe to transplant across the A1/A2 blood group barrier provided that the preformed antibodies are not reactive at 37°C and with anti-human globulin.

  13. Vocabulario de negocio para trasplante renal con enfoque ontológico para un modelo de hechos genérico

    Directory of Open Access Journals (Sweden)

    María Elena Martínez del Busto

    2010-01-01

    Full Text Available La modelación orientada a hechos es un enfoque conceptual que permite modelar dominios de negocios en términos de los hechos fundamentales de interés, donde todos los hechos pueden ser verbalizados en un lenguaje fácilmente comprensible por usuarios no técnicos de un dominio de negocio. Dicho enfoque es usado en la construcción de sistemas de reglas de negocio puesto que estas son construidas tomando como base un vocabulario que está formado por las palabras y frases establecidas por la comunidad de usuarios de un negocio particular. Este vocabulario, denominado Modelo de Hechos, se debe establecer en la etapa inicial del ciclo de vida de las reglas. En el presente trabajo se muestra el proceso de creación de una ontología que contiene un Modelo de Hechos genérico haciendo uso de la herramienta Protégé. Este Modelo de Hechos se instancia con el vocabulario perteneciente al domino específico de Trasplante Renal para su integración a un Sistema de Salud que utiliza un enfoque de reglas de negocio.

  14. Uso de medicamentos inmunosupresores en pacientes con trasplante renal, hepático y de médula ósea, en una clínica de nivel III de Bogotá.

    Directory of Open Access Journals (Sweden)

    Jorge J. López G.

    2009-07-01

    Full Text Available Antecedentes. El trasplante de órganos en la actualidad es una opción terapéutica para los pacientes que cursan estadíos terminales de ciertas patologías; el uso de inmunosupresores contribuye en gran medida a la efectividad de este tipo de tratamientos, ya que es fundamental para evitar el rechazo. El no seguimiento del consumo de medicamentos nuevos, como es el caso de los inmunosupresores que suelen tener precios relativamente elevados, junto con la ampliación injustificada de indicaciones, puede ocasionar un aumento de los costos de la terapia farmacológica y, lo más importante, causar riesgos en el paciente trasplantado. Objetivos. Describir y caracterizar el uso de medicamentos inmunosupresores en pacientes con trasplante renal, de médula ósea alogénico y hepático. Material y métodos. Estudio observacional-descriptivo de corte transversal con recolección retrospectiva de la información a un año. Se trata de un estudio de utilización de medicamentos sobre hábitos de prescripción. Resultados. El desenlace global de la terapia del trasplante produce resultados satisfactorios en un 92,5 por ciento (49 pacientes, 5,7 por ciento (3 pacientes presentan rechazo con retiro del injerto, mientras que un paciente fallece después de ser sometido al trasplante. El medicamento más prescrito es el micofenolato de mofetil, con 41 prescripciones (28%, mientras que el más consumido es la prednisona con 2,38 dosis diaria definidas /100 pacientes/día. Conclusiones. Se evidencia la presencia de micofenolato, ciclosporina y corticoides en la mayoría de los esquemas con algunas prescripciones de anticuerpos monoclonales y globulina antitimocítica.

  15. [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors].

    Science.gov (United States)

    Peces, R; Díaz Corte, C; Navascués, R A

    2001-01-01

    Acute hemolytic anemia is one of the side effects associated with cyclosporin and tacrolimus therapy, and three mechanisms have been described to account for hemolytic anemia in patients receiving these drugs: drug induced hemolysis, autoimmune hemolysis and alloimmune hemolysis resulting from donor lymphocytes derived from the allograft (passenger lymphocyte syndrome). We report four cases of renal transplant recipients who developed alloimmune hemolytic anemia due to minor ABO incompatibility while under treatment with cyclosporin (two) and tacrolimus (two). The anti-erythrocyte antibodies responsible for hemolysis were of the IgG isotype and showed anti-A or anti-B specificity. These findings suggest that the hemolysis could be related to alloantibodies derived from the clonal development of donor B lymphocytes in the recipients (microchimerism). In summary, hemolytic anemia due to ABO-minor incompatibility occurs infrequently after renal transplantation. Risks are higher for patients A, B or AB blood group receiving an O blood group graft under treatment with cyclosporin or tacrolimus. Follow-up of these patients is warranted for the early detection and optimal management may be achieved by reduction of immunosuppression and change to mycophenolate mofetil.

  16. ABO desensitization affects cellular immunity and infection control after renal transplantation.

    Science.gov (United States)

    Schachtner, Thomas; Stein, Maik; Reinke, Petra

    2015-10-01

    The impact of ABO desensitization on overall immunity, infectious control, and alloreactivity remains unknown. We compared 35 ABO-incompatible kidney transplant recipients (KTRs) to a control of 62 ABO compatible KTRs. Samples were collected before, at +1, +2, +3, +6, and +12 months post-transplantation. CMV-, BKV-specific, and alloreactive T cells were measured using an interferon-γ ELISPOT assay. The extent of immunosuppression was quantified by enumeration of lymphocyte subpopulations and cytokines. No differences were observed for 5-year allograft survival and function between both groups (P > 0.05). However, ABO-incompatible KTRs were more likely to develop CMV infection, BKV-associated nephropathy, and severe sepsis (P = 0.001). Interestingly, ABO-incompatible KTRs with poor HLA-match showed the highest rates of infections and inferior allograft function (P immunity (P infections. Elimination of B cells serving as antigen-presenting cells, thereby causing impaired T-cell activation, plays a significant role in both impaired infection control and reduced alloreactive T-cell activation. © 2015 Steunstichting ESOT.

  17. Índice del perfil del donante renal (KDPI) como factor pronóstico del trasplante

    OpenAIRE

    Giron Luque, Fernando; Niño Murcia, Alejandro; Niño Torres, Laura; Sanabria, Mauricio

    2016-01-01

    La enfermedad renal crónica ha aumentado a nivel mundial y nacional, mientras que el número de donantes viene en descenso, y los pacientes en lista de espera aumentan. Los donantes cadavéricos son una opción para estos pacientes, y han sido utilizados en últimos años para aumentar los órganos disponibles. La evaluación de la calidad de estos es importante para optimizar su uso. Estudio analítico tipo cohorte retrospectiva, cálculo de KDPI en donantes cadavéricos, seguimiento función renal cr...

  18. Comparison of nutritional parameters after abo incompatible living donor renal transplantation

    Directory of Open Access Journals (Sweden)

    Joon Seok Oh

    2012-06-01

    By the end of the first year, serum hemoglobin, calcium, albumin, HDL, bilirubin, AST, ALT were increased statistically. But serum phosphate, globulin were decreased statistically. In conclusion, successful ABO incompatible living donor kidney transplantation would restore a normal nutritional status even though the patients were performed plasmapheresis during the pre-transplant period.

  19. Score de calcio coronario predice estenosis y eventos en la insuficiencia renal crónica pre trasplante

    OpenAIRE

    ROSÁRIO, Miguel Abraão; LIMA, José Jayme de; PARGA, José R.; ÁVILA, Luiz F.; GOWDAK, Luis H.; LEMOS, Pedro A.; ROCHITTE, Carlos E.

    2010-01-01

    FUNDAMENTO: A doença arterial coronariana (DAC) é a principal causa de óbito em pacientes com insuficiência renal crônica (IRC). Os exames não invasivos tradicionais para detecção de DAC e predição de eventos têm apresentado resultados insuficientes nesse grupo. A avaliação do escore de cálcio coronariano (ECC) por tomografia computadorizada tem comprovado valor prognóstico na população sem doença renal. OBJETIVO: Avaliar a acurácia do ECC para detectar DAC obstrutiva e prever eventos cardiov...

  20. Fatores de risco cardiovascular em pacientes pediátricos após um ano de transplante renal Factores de riesgo cardiovascular en pacientes pediátricos después de un año de trasplante renal Cardiovascular risk factors in pediatric patients after one year of renal transplant

    Directory of Open Access Journals (Sweden)

    Líndia Kalliana da Costa Araújo Alves Carvalho

    2010-01-01

    Full Text Available OBJETIVO: Identificar a frequência de diabetes mellitus e a presença de fatores de risco cardiovascular em pacientes pediátricos após um ano de transplante renal. MÉTODOS: Estudo retrospectivo, de cunho documental e exploratório, realizado de janeiro de 2000 a janeiro de 2006, abrangendo 111 prontuários de pacientes pediátricos (0 a 18 anos incompletos submetidos a transplante renal no Hospital do Rim e Hipertensão e no Hospital São Paulo da Universidade Federal de São Paulo. RESULTADOS: Foram analisados 111 pacientes, 50,5% utilizavam anti-hipertensivos antes do transplante renal. Um ano após este número caiu para 28%. No pré-transplante 13,5% pacientes apresentaram sobrepeso e após um ano não houve alteração importante (12,6%. O número de pacientes obesos aumentou 50% após um ano de transplante renal. Aproximadamente 1% das crianças desenvolveram diabetes mellitus pós-tranplante renal. CONCLUSÃO: A presença de excesso de peso (sobrepeso e obesidade, hipertensão arterial e diabetes mellitus são freqüentes em pacientes pediátricos pós-tranplante renal.OBJETIVO: Identificar la frecuencia de diabetes mellitus y la presencia de factores de riesgo cardiovascular en pacientes pediátricos después de un año de trasplante renal. MÉTODOS: Estudio retrospectivo, de orden documental y exploratorio, realizado de enero de 2000 a enero de 2006, abarcando 111 fichas de pacientes pediátricos (0 a 18 años incompletos sometidos a trasplante renal en el Hospital del Riñón e Hipertensión y en el Hospital Sao Paulo de la Universidad Federal de Sao Paulo. RESULTADOS: Fueron analizados 111 pacientes, 50,5% utilizaban anti-hipertensores antes del trasplante renal. Un año después este número cayó para 28%. En el pre-trasplante, 13,5% pacientes presentaron sobrepeso y después de un año no hubo alteración importante (12,6%. El número de pacientes obesos aumentó 50% después de un año de trasplante renal. Aproximadamente 1

  1. La perspectiva de los nefrólogos acerca de la donación y el trasplante renal en la Argentina

    Directory of Open Access Journals (Sweden)

    Javier Roberti

    2014-10-01

    Full Text Available El objetivo de este trabajo cualitativo fue explorar y describir la perspectiva de los nefrólogos acerca de la situación de la donación y el trasplante en la Argentina. Participaron 22 jefes de equipo de trasplante y/o profesionales a cargo de la toma de decisiones sobre la aceptación de injertos, donantes y candidatos a trasplante, de una muestra intencional. Se realizaron entrevistas en profundidad, semi-estructuradas, que se grabaron, transcribieron, analizaron y codificaron temáticamente. Más de la mitad de los participantes coincidió en la necesidad de promover la donación de órganos; casi la mitad dijo que los centros de diálisis no enviaban todos los pacientes que deberían a realizar estudios para trasplante. La mitad de los participantes confirmó que la información brindada por el equipo de procuración no era confiable. Se identificó la falta de adherencia de los pacientes al tratamiento como un problema serio, principalmente a causa de la situación socio-económica. 5/22 participantes expresaron que la cantidad de trasplantes no aumentaba por bajas tasas de donación, entrenamiento deficiente o falta de información de los nefrólogos. Los participantes percibieron una necesidad de información, entrenamiento y compromiso de los profesionales de la salud en la identificación y derivación de posibles donantes y receptores y señalaron que los problemas socioeconómicos afectan al proceso en diferentes etapas. Estos temas deberían ser tenidos en cuenta para mejorar los resultados del trasplante en un contexto de transparencia y equidad.

  2. Acute fulminant colon cancer metastasis after renal transplantation Metástasis agudas fulminantes de cáncer de colon tras el trasplante renal

    Directory of Open Access Journals (Sweden)

    C. T. Lin

    2010-07-01

    Full Text Available We report a 52-year-old male with no family history of colonic cancer, who was found to have advanced colonic cancer with metastases two months post renal transplantation. With this case, we highlight the possibility of acute fulminant cancer metastases within short period after renal transplantation and the importance of periodic colorectal cancer screening pre-transplant. To our knowledge, this case is not yet reported in the literature, especially with such presentation of acute fulminant colonic cancer metastases post renal transplantation.

  3. ABO incompatibility

    Science.gov (United States)

    Transfusion reaction - hemolytic; Acute hemolytic transfusion reaction; AHTR; Blood incompatibility - ABO ... The following are symptoms of ABO incompatible transfusion reactions: ... doom" Fever Yellow skin and whites of the eyes ( jaundice )

  4. Infeccion urinaria temprana en trasplante renal: Factores de riesgo y efecto en la sobrevida del injerto Early urinary tract infection in kidney transplantation: Risk factors and impact on graft sur-vival

    Directory of Open Access Journals (Sweden)

    Pablo A. Cepeda

    2005-10-01

    Full Text Available La infección urinariatemprana del injerto (IUTI, definida como infección urinaria sintomática en los primeros 3 meses del trasplante, su efecto sobre la sobrevida del injerto y los factores de riesgo han sido poco estudiados. Los objetivos del presente análisis fueron conocer factores de riesgo para IUTI, analizar agentes causantes e impacto en la sobrevida del injerto. En forma retrospectiva se analizaron pacientes que recibieron trasplante renal durante 1997-2000 en el Hospital Privado - Centro Médico de Córdoba. Se dividió en dos grupos de pacientes, según presencia (grupo IUTI o ausencia (grupo control de IUTI. Los factores de riesgo se analizaron con el modelo de riesgos proporcionales de Cox y la sobrevida del injerto con el método de Kaplan-Meier. Recibieron trasplante renal 226 pacientes consecutivos. La IUTI se presentó en 55 (24.3%. Factores de riesgo asociados con IUTI: antecedentes de maniobras urológicas invasivas (RR=4.34, IC 95% 1.42-13.21, diabetes mellitus (RR=3.79, IC 95% 1.42-10.14, infección por citomegalovirus (RR=2.9, IC 95% 1.02-8.24 y antecedente de trasplante previo (RR=2.83, IC 95% 1.08-7.45. El retardo en la función del injerto (RR=0.38, IC 95% 0.15-0.94 se asoció con menor incidencia de IUTI. Agentes más frecuentes: Klebsiella pneumoniae (36%, Pseudomonas aeruginosa (24% y Escherichia coli (9%. La sobrevida del injerto a los 2 años en el grupo IUTI (87.2% no fue diferente del control (81.2%, P = 0.32. En esta serie las maniobras urológicas invasivas fueron el principal factor de riesgo asociado a IUTI. No hubo disminución de la sobrevida del injerto asociada a IUTI. La alta prevalencia de uropatógenos no coli requiere mayor evaluación.The early urinary tract infection (EUTI in kidney transplant recipients is an infection develop during the first 3 months post transplant surgery. The effect of EUTI on graft survival and risk factors have been scarcely studied. Our objetives were the evaluation of

  5. Neuropatía por virus BK post trasplante renal diagnostico y seguimiento por PCR en tiempo real BK virus nephropathy after renal transplantation: Diagnosis and prognosis by real time PCR

    Directory of Open Access Journals (Sweden)

    Marcela Echavarria

    2007-12-01

    Full Text Available La nefropatía producida por el virus BK puede llevar a la pérdida del trasplante renal. El diagnóstico etiológico es importante debido a que la clínica no permite diferenciar entre nefropatía por virus BK y rechazo agudo, en donde los tratamientos de estas dos entidades son diametralmente opuestos. El desarrollo reciente de métodos moleculares muy sensibles y específicos como PCR y PCR en tiempo real para virus BK permiten un diagnóstico de certeza en forma rápida y cuantificar la carga viral presente. El diagnóstico de nefropatía por virus BK se realiza por inmunohistoquímica en una biopsia renal, pero dada la naturaleza multifocal de las lesiones, la sensibilidad no siempre es del 100%. Los nuevos métodos de PCR para detectar virus BK en sangre y orina contribuyen al diagnóstico de nefropatía de una manera más normatizada y menos invasiva. Más aún, la cuantificación del virus BK en sangre por PCR en tiempo real, ha demostrado ser útil en el diagnóstico y monitoreo de esta enfermedad. En este trabajo se presenta el caso de una paciente transplantada renal con nefropatía por virus BK y el desarrollo de un método de PCR en tiempo real para la detección de virus BK en sangre y orina. Esta nueva metodología confirmó el diagnóstico de nefropatía por virus BK lo que permitió un cambio en el esquema de inmunosupresión y la instauración de un tratamiento que pudo ser monitorizado utilizando la carga viral.BK virus nephropathy may lead to kidney transplant failure. BK infection and acute rejection are clinically undistinguishable, therefore diagnosis of these entities is critical to establish the correct treatment. The new molecular methods using PCR and real time PCR have significantly contributed to the rapid and sensitive diagnosis of BK virus. Furthermore, viral load determination in plasma has significantly been associated with BK virus nephropathy. Definite diagnosis of nephropathy requires renal biopsy, although

  6. TRASPLANTE PULMONAR: ESTADO ACTUAL

    Directory of Open Access Journals (Sweden)

    María Teresa Parada C., DRA.

    2015-05-01

    Los desafíos en la actualidad son el déficit de órganos, que lleva aumento de lista de espera por lo que se han desarrollado técnicas de optimización de injertos, la extensión de la edad de los candidatos a trasplante y se mantiene sin grandes modificaciones la disfunción crónica de injerto.

  7. El criterio inmunológico de selección para el trasplante renal: Un aspecto científico-ético Inmunologic choice criterion for renal transplantation: a scientific-ethical issue

    Directory of Open Access Journals (Sweden)

    Roberto Álvarez Hidalgo

    2004-08-01

    Full Text Available La insuficiencia renal crónica se considera una de las enfermedades crónicas no trasmisibles de mayor incidencia (1 / 1000, por lo que constituye un problema de salud en el mundo. En la actualidad es el transplante renal el tratamiento de elección, el cual representa una innovación tecnológica en el contexto de la Revolución Científico técnica, que ha alcanzado niveles altos de eficacia. Uno de los factores que intervienen en el éxito es la selección inmunológica de la pareja donante-receptor en base a los antígenos principales de histocompatibilidad (HLA. Esto asegura la supervivencia del injerto y el paciente a largo plazo. Los dilemas éticos son frecuentes en la donación de órganos tanto en el caso del donante vivo, como en el del cadáver. En la práctica diaria se realizan preguntas tales como: ¿En qué formas distribuir los órganos de donantes cadáver?, ó ¿El xenotrasplante y el trasplante de donante vivo no relacionado son alternativas válidas? Por tanto se pueden hacer ante la escasez de órganos?. Se han diseñado normas para resolver situaciones que exijan la toma de decisiones. Una correcta selección inmunológica sobre bases científicas y éticas asegura la calidad de vida del trasplantado y soluciona su problema de saludChronic renal failure is considered one of the non-transmissible chronic illnesses of higher incidence (1 / 1000, constituting a health problem all over the world. Nowadays, it is renal transplantation the treatment of choice, which represents a technological innovation in the context of the Scientific-Technological Revolution that has reached high levels of effectiveness. One of the factors that intervene in the success is the immunologic selection of the donor-receiver couple based on the main antigens of histocompatibility (HLA. This assures the implant and patient's long term survival. The ethical dilemmas are frequent in the donation of organs either in the case of alive or death donors

  8. Las células T reguladoras y su influencia en la sobrevida del trasplante renal Regulatory T cells and their influence in kidney allograft survival

    Directory of Open Access Journals (Sweden)

    Sonia Y. Velásquez

    2007-10-01

    Full Text Available La respuesta inmune desencadenada frente a un trasplante alogénico conduce usualmente a una respuesta efectora que resulta en el rechazo del aloinjerto; sin embargo, algunos individuos mantienen un trasplante funcionante a largo plazo sin signos de rechazo (tolerancia operacional, aun en ausencia de inmunosupresión. Se ha sugerido que los mismos mecanismos son responsables para la tolerancia hacia antígenos propios y aloantígenos. Uno de estos mecanismos es la regulación inmune y se han identificado varias subpoblaciones de células con propiedades reguladoras. Entre ellas, la población celular mejor caracterizada corresponde a las células T reguladoras (Tregs. Aunque las Tregs en ratones son CD4+CD25+, en humanos el fenotipo de las Treg está restringida a las células T CD4 con alta expresión de CD25 (CD25high y del factor de transcripción Foxp3. El análisis fenotípico y funcional de las células T reguladoras o supresoras circulantes en pacientes trasplantados tal vez sea útil para la detección de pacientes tolerantes operacionales. Además, una futura manipulación in vitro de estas células con fines terapéuticos podría conducir a lograr la inducción de tolerancia in vivo en el trasplante clínico. Aquí, revisamos la evidencia experimental y clínica del papel de las células reguladoras en la biología del trasplante.The immune response elicited by an allogenic transplant usually leads to an effector response resulting in allograft rejection; however, some individuals maintain a long-term functioning transplant without signs of rejection (operational tolerance even in the absence of immunosuppression. It has been suggested that the same mechanisms are responsible for tolerance to self-antigens and alloantigens. One of such mechanisms is immune regulation and several cell subsets with regulatory properties have been identified. Among them, the best characterized cell populations are the regulatory T cells (Treg. Although

  9. Plasmapheresis as preconditioning protocol in an extremely high titer ABO incompatible renal transplant (ABOiRTx) case: A new prospect for chronic kidney disease patients in India.

    Science.gov (United States)

    Pandey, Prashant; Tiwari, Aseem Kumar; Sharma, Jyoti; Dixit, Surbhi; Raina, Vimarsh

    2013-08-01

    The biggest hurdle in renal transplantation is the ABO blood group system. But recently ABO incompatible renal transplants have been performed using plasmapheresis (PP) as a part of the preconditioning protocol. In the present study, the objective of PP along with immunosuppression was to bring down the antibody titer of the patient to ≤ 16 during the transplant and keep it low, around 32, until post-operative 4-14 weeks. The patient (O Negative) had his mother (B Positive) as the ABO non-identical donor. The PP was performed with an apheresis equipment Com.Tec (Fresenius Kabi, Germany) to lower the anti-B antibody titer in the recipient. An Antihuman globulin (AHG) titer was performed for anti-B antibody following the departmental standard operating procedure. A total of 11 plasmapheresis procedures was performed preoperatively and four procedures were performed post-operatively to maintain the titer of the anti-B antibody at or below the desired level. The baseline anti-B antibody titer in the recipient was 512. The baseline titer came down to 8 after the end of the 11th procedure. Post-operatively we performed four plasmapheresis procedures to keep the titer at 32. During the post-operative follow up the titer has been maintained at 32 and the serum creatinine level has been maintained at approximately 1.0mg/dl and other parameters relevant to graft function were within normal limits. Our case could be the first reported case from India in which we used a plasmapheresis procedure as a part of preconditioning protocol instead of using an immunoadsorption column. Furthermore, it could be one of the few ABOiRTx cases, which has been performed at an isoagglutinin titer of 512 using plasma exchange as part of a preconditioning regime. Copyright © 2013 Elsevier Ltd. All rights reserved.

  10. Dinámicas científicas, técnicas e institucionales en el desarrollo de la diálisis y los trasplantes renales en la Argentina

    Directory of Open Access Journals (Sweden)

    Romero, Lucía

    2012-12-01

    Full Text Available This paper analyzes the origin and development of experimental and clinical research about kidney transplant and dialysis in Argentina which were carried out, from 1957, at the Instituto de Investigaciones Médicas (IIM de la Facultad de Medicina, at the Universidad de Buenos Aires (UBA. The aim is to show how these developments were possible due to the convergence of social and cognitive dynamics. The major boost given to research and clinical experience on transplants and dialysis at the IIM was because they were a a central part of the institutional commitment carried out by Alfredo Lanari, the administrative and political authority of the IIM, b a way to continue and take profit of the previous accumulation on local research capacities, human resources and knowledge on transplants and c a consequence of new scientific cooperation links settled between Lanari`s researchers and the international pioneers in this experimental and clinical field, which allowed the acquisition of technical equipment and knowledge applied in the local context. The progressive stabilization of those researches not only gave scientific prestige to the IIM but produced significant changes for Acute Kidney Failure and Chronic Kidney Failure sick people, whose treatment or cure were non-existent for them until then.

    En este trabajo se analiza la emergencia y la evolución de las investigaciones experimentales y clínicas sobre trasplantes renales y diálisis en la Argentina, llevadas a cabo, a partir de 1957, en el Instituto de Investigaciones Médicas (IIM de la Facultad de Medicina, de la Universidad de Buenos Aires (UBA. Se intenta mostrar cómo estas realizaciones fueron posibles gracias a la convergencia de dinámicas sociales y cognitivas. El impulso que recibieron las investigaciones y las prácticas sobre trasplantes y diálisis en el IIM fueron a parte central de las apuestas institucionales llevadas adelante por Alfredo Lanari, director

  11. Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.

    Science.gov (United States)

    Omae, Kenji; Fukuma, Shingo; Ikenoue, Tatsuyoshi; Kondo, Tsunenori; Takagi, Toshio; Ishihara, Hiroki; Tanabe, Kazunari; Fukuhara, Shunichi

    2017-09-01

    To assess the effect of blood type on survival outcomes and adverse events (AEs) in patients treated with tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC). Patients who received TKIs as first-line therapy for mRCC between 2008 and 2015 at our hospital were included in the study (n = 136). Patients were divided into 2 groups based on their blood type as O and non-O. Survival outcomes and AEs were compared according to blood type. Cox regression models were used for univariate and multivariate survival analyses. Of the 136 patients, 34 (25%) and 102 (75%) had O and non-O blood types, respectively. Blood type O was associated with an increased number of disease sites. There were no differences between the 2 groups with respect to other baseline characteristics. The progression-free survival in patients with O and non-O blood types was 12.1 and 11.6 months, respectively; the overall survival was 34.4 and 24.8 months, respectively. On univariate and multivariate analyses, the ABO blood type was not a significant prognostic factor for progression-free survival or overall survival. Furthermore, the incidences of serious AEs were similar in the 2 blood groups. ABO blood type was not associated with survival outcomes or incidences of serious AEs in mRCC patients treated with TKIs. However, blood type O may be associated with an increased number of disease sites. Copyright © 2017. Published by Elsevier Inc.

  12. Educación al paciente y la familia en un programa de trasplante, experiencia en CLC

    Directory of Open Access Journals (Sweden)

    O. Cristina Herzog, E.U.

    2010-03-01

    Full Text Available El trasplante es la terapia de elección que permite dar solución de salud a pacientes con una insuficiencia orgánica terminal e irreversible y que permite mejorar su calidad de vida y sobrevida. El Centro de Trasplantes de Clínica Las Condes es un Centro de Procuramiento de Órganos, Tejidos y Trasplantes hepáticos, renales, cardíacos, pulmonares, riñón páncreas simultáneo y de intestino. La Enfermera Coordinadora es el profesional que organiza el camino desde la detección de un potencial donante, la extracción de los órganos y tejidos, la evaluación del receptor para un trasplante, el implante de los injertos y el seguimiento de los pacientes transplantados. El rol educativo que cumple la enfermera coordinadora en un programa de trasplante multiorgánico es crucial. La educación en salud dirigida tanto al paciente como a su grupo familiar es un componente importante para el éxito y el resultado del trasplante. Este artículo presenta el componente educativo entregado a los pacientes durante el proceso de su trasplante, desde su ingreso al programa hasta el alta y seguimiento ambulatorio post trasplante.

  13. Viviendo con los pacientes el sueño del trasplante: una experiencia enfermera

    Directory of Open Access Journals (Sweden)

    Ana Julia Carrillo Algarra

    2014-06-01

    Full Text Available El trasplante renal puede ser una solución para personas que sufren insuficiencia renal crónica. Durante este proceso es de vital importancia el cuidado de enfermería en las diferentes etapas a las que el paciente y su familia se ven enfrentados. Este es el relato biográfico de una enfermera con amplia experiencia en el cuidado de pacientes que han vivido el trasplante renal, que describe diferentes aspectos que se deben tener en cuenta en la relación del equipo interdisciplinario, con el paciente y la familia; a través del mismo narra las vivencias y los sentimientos que afloran en el diario vivir de su labor y comenta su opinión respecto al futuro de la Enfermería en trasplantes.

  14. Costo-utilidad del trasplante renal frente a la hemodiálisis en el tratamiento de la insuficiencia renal crónica terminal en un hospital peruano Cost utility of renal transplant vs. hemodialysis in the treatment of end stage chronic kidney failure in a peruvian hospital

    Directory of Open Access Journals (Sweden)

    Ricardo E. Loza-Concha

    2011-09-01

    Full Text Available Objetivos. Determinar y comparar las razones de costo-utilidad de los trasplantes renales con donante cadavérico (TRDC practicados en el Hospital Nacional Guillermo Almenara Irigoyen los años 2000-2001, frente a hemodiálisis (HD, cinco años después del inicio del tratamiento. Material y métodos. Se realizó un estudio de costo utilidad, estudiando a todos los pacientes continuadores cinco años post TRDC, a quienes se asignó como controles, dos pacientes con cinco años de HD pareados por edad, sexo y tiempo de enfermedad. Se evaluaron los costos de cada procedimiento, los años de vida ajustados a la calidad (AVAC utilizando el cuestionario SF-36v2TM y se calcularon las razones de costo utilidad (CU y costo utilidad incremental (CUI. Resultados. Se realizaron 58 TRDC los años 2000-2001. Cinco años después, 17 (29 % pacientes fallecieron y 27 (47 % continuaron con su tratamiento post-TRDC. Treinta y uno (53 % TRDC fracasaron; 26 % por rechazo al trasplante, 55 % por complicación y 19 % por tratamiento irregular. Los puntajes SF-36v2TM promedio obtenidos por los TRDC y HD fueron 95±13 y 87±18 puntos respectivamente. En ambos años, los AVAC obtenidos por los TRDC y HD fueron de 251 y 229 puntos respectivamente; las razones de CU para los TRDC y los HD fueron de USD 11 984 y USD 9243, y la razón de CUI fue de USD 40 669. Conclusiones. Los TRDC realizados los años 2000-2001, cinco años después resultaron menos costo útiles que las HD; y los TRDC realizados el 2000 tuvieron una menor razón de costo utilidad incremental que los efectuados el 2001, probablemente por su mayor razón de tratamientos irregulares.Objectives. To assess and compare the cost utility of the cadaveric donor renal transplant (CDRT at the Hospital Nacional Guillermo Almenara Irigoyen between 2000 to 2001, against haemodialysis (HD, 5 years after treatment initiation. Materials and Methods. A cost utility study design was used, which evaluated every patient

  15. ABO-incompatible kidney transplantation

    DEFF Research Database (Denmark)

    Schousboe, Karoline; Titlestad, Kjell; Baudier, Francois

    2010-01-01

    INTRODUCTION: Kidney transplantation is the optimal treatment for many patients with end-stage renal disease (ESRD). Due to shortage of donor kidneys in Denmark, there is a need to expand the possibilities for donation. At the Odense University Hospital (OUH), we have introduced ABO......-incompatible kidney transplantation. We used antigenspecific immunoadsorptions to remove blood group antibodies and anti-CD20 antibody (rituximab) to inhibit the antibody production. The aim of introducing the ABO-incompatible kidney transplantation at the OUH was to increase the rate of living donor kidney...... transplantation without increasing rejection or mortality rates. MATERIAL AND METHODS: Retrospective evaluation. Eleven patients received ABO-incompatible kidney transplantation. The patients were followed for 3-26 months. RESULTS: One patient had an antibody-mediated rejection, one patient suffered T...

  16. ABO-incompatibility in solid organ transplantation.

    Science.gov (United States)

    Rydberg, L

    2001-08-01

    The most important transplantation antigen system in solid organ transplantation is the ABO histo-blood group system. Crossing the ABO barrier in solid organ transplantation is usually not done except for emergency liver transplantations. Early experiences of crossing the ABO barrier in renal transplantation were very disappointing. In the 1970s, clinical trials were started transplanting kidneys of subgroup A2 into blood group O recipients. The tissues of the A2 subgroup expresses reduced amount of A antigens compared to subgroup A1 and the recipients had no special pretreatment and standard immunosuppression. A number of early graft losses were experienced but the trial also resulted in several long time surviving grafts. A few centres have adapted the concept of A2 to non A kidney transplantations with successful results, when the recipient anti-A titres are low or reduced prior to transplantation. In the early 1980s one group successfully transplanted A1 and B kidneys from living related donors across the ABO-barrier using an immunosuppressive protocol consisting of quadruple drugs and splenectomy and this protocol was adapted by a few other groups. In Japan, where cadaver donors are available in very limited number, the largest number of ABO-incompatible transplantations have been performed. Altogether more than 300 ABO-incompatible kidney transplantations have been performed in more than 40 centres since 1989. ABO-incompatible liver transplantations have been performed mainly in emergency cases and the results have generally been inferior to ABO-compatible grafts. In children below the age of three years, liver transplantations across the ABO-barrier have been quite successful especially with living related donors. Very few ABO-incompatible heart/heart-lung/lung-transplantations have been reported with a few successful cases, but the majority have been failures. Recently a series of ABO-incompatible heart transplants performed in small children have been

  17. ABO-incompatible kidney transplantation

    DEFF Research Database (Denmark)

    Schousboe, Karoline; Titlestad, Kjell; Baudier, Francois

    2010-01-01

    INTRODUCTION: Kidney transplantation is the optimal treatment for many patients with end-stage renal disease (ESRD). Due to shortage of donor kidneys in Denmark, there is a need to expand the possibilities for donation. At the Odense University Hospital (OUH), we have introduced ABO-incompatible ......INTRODUCTION: Kidney transplantation is the optimal treatment for many patients with end-stage renal disease (ESRD). Due to shortage of donor kidneys in Denmark, there is a need to expand the possibilities for donation. At the Odense University Hospital (OUH), we have introduced ABO......-incompatible kidney transplantation. We used antigenspecific immunoadsorptions to remove blood group antibodies and anti-CD20 antibody (rituximab) to inhibit the antibody production. The aim of introducing the ABO-incompatible kidney transplantation at the OUH was to increase the rate of living donor kidney...... transplantation without increasing rejection or mortality rates. MATERIAL AND METHODS: Retrospective evaluation. Eleven patients received ABO-incompatible kidney transplantation. The patients were followed for 3-26 months. RESULTS: One patient had an antibody-mediated rejection, one patient suffered T...

  18. Recurrence of ANCA-associated vasculitis in a patient with kidney trasplant

    Directory of Open Access Journals (Sweden)

    Pedro García Cosmes

    2016-03-01

    Full Text Available Renal disease secondary to vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA can lead to chronic renal disease requiring renal replacement therapy. In these patients, kidney transplantation offers excellent long-term rates of allograft and patient survival; consequently, they can be trasplanted when the clinical disease activity has remitted. However, the risk of disease relapses in the renal allograft remains, although at lower rates due to modern immunosuppressive regimes. We describe the case of a male patient with extracapillary glomerulonephritis type III C-ANCA (+ who developed a recurrence in the renal allograft 8 years after transplantation. Intensive immunosupression with plasmapheresis controlled the disease.

  19. Escore de cálcio coronariano prediz estenose e eventos na insuficiência renal crônica pré-transplante Score de calcio coronario predice estenosis y eventos en la insuficiencia renal crónica pre trasplante Coronary calcium score as predictor of stenosis and events in pretransplant renal chronic failure

    Directory of Open Access Journals (Sweden)

    Miguel Abraão Rosário

    2010-02-01

    este grupo. La evaluación del score de calcio coronario (SCC por tomografía computarizada ha estado comprobando valor pronóstico en la población sin enfermedad renal. OBJETIVO: Evaluar la exactitud del SCC para detectar EAC obstructiva y prever eventos cardiovasculares en candidatos a trasplante renal comparada a la angiografía coronaria invasiva (ACI cuantitativa. MÉTODOS: Se evaluaron a 97 pacientes con IRC y edad > 35 años. Se consideró como EAC obstructiva la presencia de estenosis > 50% o > 70% por la ACI. Datos descriptivos, concordancia, pruebas diagnósticas, Kaplan-Meier y análisis multivariado se utilizaron. RESULTADOS: El score de Agatston promedio fue de 580,6 ± 1.102,2; los valores mínimos y máximos fueron 0 y 7.994, y mediana de 176. Solamente 14 pacientes tenían score de calcio de cero. No hubo diferencias entre las etnias y la mayor presencia de calcio regional se asoció a la mayor probabilidad de estenosis coronaria en el mismo segmento. El score de calcio de Agatston presentó buena exactitud para el diagnóstico de estenosis, > 50% y > 70% con área bajo la curva ROC de 0,75 y 0,70, respectivamente. En el umbral de 400, el score de calcio identificó el subgrupo con mayor tasa de eventos cardiovasculares en tiempo promedio de seguimiento de 29,1 ± 11,0 meses. CONCLUSIÓN: El SCC en la evaluación de EAC presentó una buena performance diagnóstica y pronostica para eventos cardiovasculares en pacientes con insuficiencia renal crónica (IRC.BACKGROUND: Coronary artery disease (CAD is the major cause of death among chronic renal failure (CRF patients. Traditional, non-invasive exams to detect CAD and to predict events have shown insufficient results in this group. CT Scan evaluation of Coronary Calcium Score (CCS has proven to be of prognostic value for the population reporting no renal condition. OBJECTIVE: To investigate CCS accuracy in detecting obstructive CAD and in predicting cardiovascular events in candidates to renal transplant

  20. Trasplante cardíaco

    Directory of Open Access Journals (Sweden)

    Dimitri Novitzky

    2007-01-01

    Full Text Available En 1985, en el Tampa General Hospital se inició el Programa de Trasplante Cardíaco. Hasta la fecha se realizaron 815 trasplantes en 795 pacientes, 17 de los cuales fueron sometidos a un retrasplante. La sobrevida actuarial al mes es del 94,5%, al año del 87%, a los 3 años alcanza el 81%, a los 5 años el 74% y a los 10 años el 52%.El Medical Review Board se reúne semanalmente para un seguimiento de la presentación de pacientes y la selección de los candidatos adecuados para el programa. Dentro de las varias Organ Procurement Organizations of the Region, la institución de terapia hormonal para el donante y el receptor está ampliamente aceptada. En el Tampa General Hospital también se le administra levotiroxina al receptor, en la sala de operaciones y en la sala de cuidados intensivos en la situación de un bajo volumen minuto. La mayoría de los trasplantes se efectúan en pacientes con estado 1A o 1B. La inmunosupresión es indicada por especialistas cardiólogos, lo mismo que la realización de la biopsia endomiocárdica con el fin de ajustar la medicación inmunosupresora. En esta revisión se presentan los resultados generales del programa, la selección de pacientes, los procedimientos quirúrgicos, la inmunosupresión y la asistencia que requieren los ventrículos

  1. Trasplante cardíaco

    Directory of Open Access Journals (Sweden)

    Raúl José Burgos Lázaro

    2011-04-01

    En este artículo se revisan las indicaciones y contraindicaciones, criterios de selección y mantenimiento del donante, técnica quirúrgica, complicaciones y resultados. La supervivencia y calidad de vida de los pacientes trasplantados ha mejorado, siendo el número de donantes potenciales la principal limitación del trasplante cardíaco. Este hecho debe condicionar la selección meticulosa de los receptores, para ofrecer este tratamiento a los pacientes que más lo necesitan y con expectativas de obtener los mejores resultados y sin otras posibilidades de tratamiento médico o quirúrgico.

  2. Hemolysis from ABO Incompatibility.

    Science.gov (United States)

    Simmons, Daimon P; Savage, William J

    2015-06-01

    ABO incompatibility of red blood cells leads to brisk complement-mediated lysis, particularly in the setting of red cell transfusion. The ABO blood group is the most clinically significant blood group because of preformed immunoglobulin M (IgM) and IgG antibodies to ABO blood group antigens (isohemagglutinins) in everyone except group AB individuals. In addition to transfusion, ABO incompatibility can cause hemolysis in hematopoietic and solid organ transplantation, hemolytic disease of the newborn, and intravenous immunoglobulin infusion. It is important to prevent ABO incompatibility when possible and to anticipate complications when ABO incompatibility is unavoidable. Copyright © 2015 Elsevier Inc. All rights reserved.

  3. TRANSPLANTE RENAL

    Directory of Open Access Journals (Sweden)

    Soraia Geraldo Rozza Lopes

    2014-01-01

    Full Text Available El objetivo del estudio fue comprender el significado de espera del trasplante renal para las mujeres en hemodiálisis. Se trata de un estudio cualitativo-interpretativo, realizado con 12 mujeres en hemodiálisis en Florianópolis. Los datos fueron recolectados a través de entrevistas en profundidad en el domicilio. Fue utilizado el software Etnografh 6.0 para la pre-codificación y posterior al análisis interpretativo emergieron dos categorías: “las sombras del momento actual”, que mostró que las dificultades iniciales de la enfermedad están presentes, pero las mujeres pueden hacer frente mejor a la enfermedad y el tratamiento. La segunda categoría, “la luz del trasplante renal”, muestra la esperanza impulsada por la entrada en la lista de espera para un trasplante.

  4. Successful ABO-Incompatible Renal Transplantation:  Blood Group A1B Donor Into A2B Recipient With Anti-A1 Isoagglutinins.

    Science.gov (United States)

    Fadeyi, Emmanuel A; Stratta, Robert J; Farney, Alan C; Pomper, Gregory J

    2016-08-01

    Transplantation of the blood group A2B in a recipient was successfully performed in the setting of receiving a deceased donor kidney from an "incompatible" A1B donor. The donor and recipient were both typed for ABO blood group, including ABO genotyping. The donor and recipient were tested for ABO, non-ABO, and human leukocyte antigen (HLA) antibodies. The donor and recipient were typed for HLA antigens, including T- and B-flow cytometry crossmatch tests. The recipient's RBCs were negative with A1 lectin, and immunoglobulin G anti-A1 was demonstrated in the recipient's plasma. The donor-recipient pair was a four-antigen HLA mismatch, but final T- and B-flow cytometry crossmatch tests were compatible. The transplant procedure was uneventful; the patient experienced immediate graft function with no episodes of rejection or readmissions more than 2 years later. It may be safe to transplant across the A1/A2 blood group AB mismatch barrier in the setting of low titer anti-A1 isoagglutinins without the need for pretransplant desensitization even if the antibody produced reacts with anti-human globulin. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

  5. ABO-Incompatible Living Kidney Transplants: Evolution of Outcomes and Immunosuppressive Management.

    Science.gov (United States)

    Okumi, M; Toki, D; Nozaki, T; Shimizu, T; Shirakawa, H; Omoto, K; Inui, M; Ishida, H; Tanabe, K

    2016-03-01

    ABO-incompatible living kidney transplantation (ABO-ILKT) has steadily become more widespread. However, the optimal immunosuppressive regimen for ABO-ILKT remains uncertain. We aimed to determine the longitudinal changes in the outcomes from ABO-ILKT compared with those from ABO-compatible living kidney transplantation (ABO-CLKT) over the last 25 years. Of 1195 patients who underwent living kidney transplantations (LKT) at our institute between 1989 and 2013, 1032-including 247 ABO-ILKT and 785 ABO-CLKT cases-were evaluated for graft survival, patient survival, infectious adverse events, and renal function. The patients were divided into four groups according to the transplantation era and ABO-compatibility. In the past decade, ABO-ILKT and ABO-CLKT recipients yielded almost equivalent outcomes with respect to the 9-year graft survival rates, which were 86.9% and 92.0%, respectively (hazard ratio [HR] 1.38, 95% confidence interval [CI] 0.59-3.22, p = 0.455). The graft survival rate for ABO-ILKT conducted between 2005 and 2013 was better than that for ABO-ILKT conducted between 1998 and 2004 (HR 0.30, 95% CI 0.13-0.72, p = 0.007). ABO-ILKT recipients showed substantial improvements in the graft survival rate over time. Graft survival was almost identical over the past decade, regardless of ABO-incompatibility. Currently, ABO-ILKT is an acceptable treatment for patients with end-stage renal disease. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

  6. Recurrence of ANCA-associated vasculitis in a patient with kidney trasplant.

    Science.gov (United States)

    García Cosmes, Pedro; Fraile Gómez, Pilar; Lewczuk, Kamil; Rodríguez González, Marta; Ruiz Ferreras, Elena; Tabernero Fernández, Guadalupe

    2016-01-01

    Renal disease secondary to vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA) can lead to chronic renal disease requiring renal replacement therapy. In these patients, kidney transplantation offers excellent long-term rates of allograft and patient survival; consequently, they can be trasplanted when the clinical disease activity has remitted. However, the risk of disease relapses in the renal allograft remains, although at lower rates due to modern immunosuppressive regimens. We describe the case of a male patient with extracapillary glomerulonephritis type III C-ANCA (+) who developed a recurrence in the renal allograft 8 years after transplantation. Intensive immunosupression with plasmapheresis controlled the disease. Copyright © 2015 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

  7. ABO genotyping in leukemia patients reveals new ABO variant alleles

    OpenAIRE

    NOVARETTI, M. C. Z.; DOMINGUES, A. E.; MANHANI, R.; PINTO, E. M.; DORLHIAC-LLACER, P. E.; CHAMONE, D. A. F.

    2008-01-01

    The ABO blood group is the most important blood group system in transfusion medicine and organ transplantation. To date, more than 160 ABO alleles have been identified by molecular investigation. Almost all ABO genotyping studies have been performed in blood donors and families and for investigation of ABO subgroups detected serologically. The aim of the present study was to perform ABO genotyping in patients with leukemia. Blood samples were collected from 108 Brazilian patients with chronic...

  8. Uso de medicamentos em transplantados renais: práticas de medicação e representações Utilización de medicamentos en pacientes con trasplante renal: las prácticas de los medicamentos y representaciones Drug utilization in renal transplant patients: medication practices and representations

    Directory of Open Access Journals (Sweden)

    Guilherme Oliveira de Arruda

    2012-12-01

    Full Text Available Pesquisa de abordagem qualitativa, descritiva e exploratória, com o objetivo de conhecer as práticas de medicação e representações sobre o uso de medicamentos por pessoas transplantadas renais. Participaram 18 pessoas no Município de Dourados (MS, por meio de entrevista semiestruturada. Os aportes teóricos foram práticas de medicação de Peter Conrad e representação de Stuart Hall. A definição das categorias de análise teve como referencial teórico Michel Foucault. Os entrevistados apresentaram idade média de 53,5 anos, sendo 13 do sexo masculino e cinco do sexo feminino, com tempo médio de transplante de oito anos. Os medicamentos predominantemente utilizados foram os imunossupressores. Elaboraram-se três categorias de análise: o medicamento como parte do cotidiano; o papel central do medicamento e a correlação com a rejeição; e o medicamento e a autonomia do transplantado renal. Os medicamentos fazem parte do cotidiano e as representações sobre autonomia e qualidade reforçam seu uso diário.Un enfoque de investigación cualitativa, descriptiva y exploratoria, con el objetivo de conocer las prácticas y representaciones de la medicación en el uso de fármacos por las personas trasplantadas de riñón. 18 personas participaron en Dourados (MS, a través de entrevista semi-estructurada. Aportes teóricos de prácticas de medicación fueron Peter Conrad y representación de Stuart Hall. La definición de las categorías de análisis teórico fue Michel Foucault. Los encuestados tenían edad media de 53,5 años, 13 varones y 5 mujeres, tiempo promedio de trasplante de ocho años. Los medicamentos se utilizan principalmente inmunosupresores. Hemos desarrollado tres categorías de análisis: drogas como parte de la vida cotidiana, el papel central de la droga y la correlación con el rechazo, y la medicina y la autonomía del riñón trasplantado. Las drogas son parte de la vida cotidiana y las representaciones de autonom

  9. Our first experiences in applying an original method for removal of ABO-isoagglutinins in ABO-incompatible kidney recipients

    Directory of Open Access Journals (Sweden)

    Ignjatović Ljiljana

    2009-01-01

    Full Text Available Background/Aim. Due to improved methods for removal of ABO isoagglutinins and novel immunosuppressive protocols, short and long term outcome in blood group incompatible is similar to blood group compatible kidney transplantation. The aim of this study was to determine the efficacy of our original method for removal of ABO isoagglutinins from the blood in ABO-incompatible kidney allograft recipients. Method. Between 2006 and 2008 twelve patients were transplanted from ABO incompatible living donors. Titers of ABO isoagglutinins were 4-128 (IgG. Immunosuppressive therapy started 14 days before kidney transplantation with rituximab, followed by a triple therapy (prednisone + tacrolimus + mycophenolate mofetil and the first plasma exchange (PE procedure, in which one plasma volume was substituted with albumin and saline on day 7 before transplantation. For selective extracorporeal immunoadsorption, the removed plasma was mixed with donor blood type filtered red blood cells, centrifuged and the supernatant separated and preserved. In the next PE procedure, the removed plasma was replaced with immunoadsorbed plasma, and so on. Titers of ABO agglutinins, renal allograft function and survival were followed-up. Results. The pre-transplant treatment consisting of 1-5 PE procedures and immunosuppressive therapy resulted in target ABO agglutinins titers below 4. During a 10-24 month follow-up three patients had an early acute rejection, one patient acute rejection and hemolytic anemia, two patients surgical complications and one of them lost his graft. In the post-transplant period, the titers of ABO antibodies remained below 4. All the patients had stable kidney allograft function with mean serum creatinine ±SD of 129 ± 45 μmol/l at the end of the study. Conclusion. Our method for removal of ABO antibodies was effective in a limited series of patients and short-term follow-up.

  10. Trasplante simultáneo de páncreas y riñón: reporte del primer caso realizado en el Perú

    Directory of Open Access Journals (Sweden)

    José De Vinatea

    2010-04-01

    Full Text Available El trasplante simultáneo de páncreas y riñón es la opción terapéutica ideal para pacientes con diabetes mellitus tipo 1 con insuficiencia renal crónica. Permite recuperar la insulino-independencia y evita la necesidad de diálisis, mejorando notablemente la calidad de vida. Así mismo, la restitución de la euglicemia logra que las complicaciones tardías de la diabetes no progresen e incluso regresionen, prolongando la supervivencia global de estos pacientes. Estos beneficios superan a los riesgos de la cirugía y de la inmunosupresión inherentes al trasplante. A nivel mundial, desde 1966, en que se llevó a cabo el primer trasplante de páncreas en Minnesota (Estados Unidos, se han registrado más de 20 000 trasplantes de páncreas, con resultados cada vez mejores gracias al refinamiento en las técnicas quirúrgicas y a los nuevos esquemas de inmunosupresión. En el presente caso clínico, se reporta y describe la realización del primer trasplante simultáneo de páncreas y riñón en el Perú.

  11. Fatores preditivos de diagnósticos de enfermagem em pacientes submetidos ao transplante renal Factores predictores de diagnósticos de enfermería en pacientes sometidos al trasplante de riñón Predisposing factors of nursing diagnoses in patients submitted to kidney transplantation

    Directory of Open Access Journals (Sweden)

    Jaqueline Galdino Albuquerque

    2010-02-01

    Full Text Available O objetivo do estudo foi identificar fatores preditores para diagnósticos de enfermagem de pacientes transplantados renais. Estudo transversal realizado em um hospital universitário com 58 pacientes submetidos ao transplante renal. Os dados foram coletados com um roteiro de entrevista e exame físico. Para análise dos dados foi utilizada a técnica de regressão logística considerando um nível de significância de 5%. Os fatores preditores identificados foram: Estado de Doença para o diagnóstico Fadiga; Procedência e Estado civil para Nutrição desequilibrada: mais do que as necessidades corporais; Tempo de diálise e Mudança relatada ou medida na acuidade sensorial para Percepção sensorial perturbada: auditiva; e Idade e Estado de doença para Percepção sensorial perturbada: visual.El objetivo del estudio fue identificar factores predictores de diagnósticos de enfermería de pacientes trasplantados de riñón. Estudio transversal realizado en un hospital universitario con 58 pacientes sometidos al trasplante de riñón. Los datos fueron recogidos con un guia dee entrevista y examen físico. Para el análisis de los datos fue utilizada la técnica de regresión logística considerando un nivel de significancia del 5%. Los factores predictores identificados fueron: Estado de Enfermedad para el diagnóstico Fatiga; Naturalidad y Estado civil para Desequilibrio nutricional: por exceso; Tiempo de diálisis y Cambio relatado o medido en la acuidad sensorial para Trastorno de la percepción sensorial: auditiva; y Edad y Estado de enfermedad para Trastorno de la percepción sensorial: visual.The purpose of this study was to identify predisposing factors of nursing diagnoses in patients submitted to kidney transplantation. A cross-sectional carried out in an academic hospital with 58 patients submitted to kidney transplantation. The data was collected with an interview script and physical examination. For data analysis was used the

  12. Eventraciones post-trasplante renal: análisis de factores de riesgo y técnica quirúrgica / Post kidney transplantatios incisional hernia: risk factors analysis and surgical repair techniques

    Directory of Open Access Journals (Sweden)

    Santa Maria Victoria

    2015-11-01

    Full Text Available Several factors increase the risk of insicional hernias post-kidney transplantation and different surgical techniques exist for solving this problem. A retrospective study analyzing the risk factors for developing an insicional hernia and eventroplasties made in the kidney transplants performed between 2006-2013 was performed. The incidence of hernias was 12.7%. All elements studied were statistically independent of the appearance of hernias, probably by influence when combined together and not each separately. Consistent with the literature in which patients did not mesh was used or an absorbable mesh used had a recurrence of 100%. It should be more study of the risk factors that influence the development of post-transplant hernias because of the contradictions that arise from the literature. Post-transplant renal ventral hernia repair is safe and effective provided it is carried out for non-resorbable mesh. The risk of post-surgical infections does not appear to be affected by the use of mesh when the necessary precautions are taken, and if it does not change the prognosis.

  13. Factores de riesgo asociados al desarrollo de eventos cardiovasculares en pacientes postrasplante renal

    OpenAIRE

    Ana M. Barón; Ángel A. García-Peña; Paola K. García; Edna Salazar; Carlos Andrés Blanco; María C. Betancur; Nicolás F. Amaya

    2018-01-01

    Objetivo: describir el comportamiento de los factores de riesgo cardiovascular en pacientes con trasplante renal y su relación con los desenlaces cardiovasculares a uno y cinco años luego del trasplante. Métodos: se realizó un estudio analítico de cohorte retrospectivo en los pacientes con trasplante renal del Hospital Universitario San Ignacio con seguimiento institucional por lo menos de un año. Se analizaron las variables demográficas, los factores de riesgo cardiovascular y los desenla...

  14. Nuevas estrategias en trasplante de precursores hematopoyéticos

    Directory of Open Access Journals (Sweden)

    Mauricio Sarmiento

    2016-10-01

    Full Text Available El trasplante hematopoyético es una estrategia terapéutica que permite posibilidad de curación en diversas enfermedades benignas y malignas. El autotrasplante tiene demostrada utilidad en mieloma y linfomas permitiendo recuperar la hematopoyesis luego de quimioterapias de alta intensidad. El alotrasplante permite reemplazar hematopoyesis defectuosa y/o introducir un potente efecto inmunológico llamado “efecto de injerto contra tumor”. En los últimos años, se han desarrollado nuevos fármacos que permiten optimizar la recolección de progenitores autólogos y se han modificado los esquemas de trasplante, permitiendo un uso más amplio. El haplo trasplante alogénico ha favorecido que los enfermos tengan mejores posibilidades de encontrar donantes. En esta revisión, se analizan brevemente estas nuevas modalidades adoptadas en nuestro programa de trasplante hematopoyético.

  15. Factores de riesgo de mortalidad precoz del Trasplante Pulmonar

    OpenAIRE

    Kreis Esmendi, Germán

    2006-01-01

    Consultable des del TDX Títol obtingut de la portada digitalitzada A pesar de la experiencia acumulada, la mortalidad postoperatoria temprana del trasplante pulmonar continua siendo elevada. Los factores asociados a este evento permanecen siendo controvertidos. Objetivo: Revisar la serie de trasplantes pulmonares realizados en el Hospital Vall d' Hebron para establecer la supervivencia acumulada e identificar los factores asociados con riesgo de mortalidad postoperatoria precoz. Pacient...

  16. Trasplante pulmonar: experiencia en clínica las condes

    Directory of Open Access Journals (Sweden)

    C. María Teresa Parada, Dra

    2010-03-01

    Hace 10 años Clínica Las Condes inicia su programa de trasplante pulmonar el que ha sido pionero nacional en número de injertos realizados y resultados obtenidos a largo plazo. Se realiza una revisión de las indicaciones, complicaciones precoces y tardías, capacidad física posterior al trasplante y sobrevida alejada de los pacientes trasplantados de pulmón en nuestro programa.

  17. EVALUACIÓN PSIQUIÁTRICA EN TRASPLANTES

    Directory of Open Access Journals (Sweden)

    Dra. Vania Krauskopf

    2017-11-01

    La identificación de síntomas psiquiátricos y aspectos psicológicos de los candidatos a trasplante son de suma importancia. Especialmente en la etapa de evaluación pre trasplante, debido a que estos factores pueden interferir en el manejo y la evolución postquirúrgica del órgano trasplantado como también en la calidad de vida del paciente y su familia.

  18. Underutilization of A2 ABO incompatible kidney transplantation.

    Science.gov (United States)

    Redfield, Robert R; Parsons, Ronald F; Rodriguez, Eduardo; Mustafa, Moiz; Cassuto, James; Vivek, Kumar; Noorchashm, Hooman; Naji, Ali; Levine, Matthew H; Abt, Peter L

    2012-01-01

    ABO compatibility creates a disadvantage for O and B renal allograft candidates. A2 ABO incompatible transplant may decrease waiting times and generate equivalent graft survival to an ABO compatible transplant. Death-censored graft survival was compared between A recipients and O, B, and AB recipients of an A2 allograft with multivariate Cox regression models utilizing data from the United Network of Organ Sharing (UNOS) between 1997 and 2007. Eighty-five percent of A2 kidneys were transplanted into ABO compatible recipients vs. 15% into ABO incompatible recipients. Rates of A2 incompatible kidney transplants did not increase over the study period (14.8% to 14.6%). Mean wait time for A2→O kidneys was 337 vs. 684 d for O→O and for A2→B kidneys, 542 vs. 734 d for B→B. Adjusted relative risk of graft loss at five-yr was similar between O, B, and AB recipients compared to A recipients of an A2 allograft, corresponding to a five-yr graft survival of 84%, 86.2%, 86.1%, and 86.1%, respectively. A2 incompatible kidney transplantation is underutilized. Graft outcomes are similar among A2 compatible and incompatible recipients. Shorter waiting time and improved access might be achieved if A2 kidneys are considered in all blood groups. © 2011 John Wiley & Sons A/S.

  19. Monitoreo inmunológico: el comienzo de una nueva era en trasplantes

    Directory of Open Access Journals (Sweden)

    Dr. C. Juan Alberto Fierro

    2010-03-01

    Full Text Available La necesidad de ajustar la inmunosupresión en forma individualizada ha estimulado la emergencia de técnicas que permiten predecir eventos clínicos como rechazo agudo o tolerancia. Esta revisión analiza, considerando principalmente el trasplante renal, las limitantes actuales de la inmunosupresión para concluir que una terapia individualizada permitiría mejorar la sobrevida de pacientes y órganos trasplantados en el largo plazo. En segundo lugar describe los métodos diagnósticos que en forma más consistente han demostrado tener valor predictivo con importancia clínica. Entre ellos se cuentan ensayos funcionales, determinación de anticuerpos específicos y linfocitos reactivos contra el donante, así como el análisis de marcadores a nivel de proteínas o genómicos. Los avances logrados auguran el comienzo de una nueva era en trasplantes.

  20. Capítulo 11. Paciente candidato a trasplante cardiaco

    Directory of Open Access Journals (Sweden)

    Juan E. Gómez

    2016-03-01

    Conclusión: La necesidad de trasplante cardiaco se plantea una vez se han agotado las terapias farmacológicas y no farmacológicas disponibles. Los candidatos potenciales debe ser remitidos de forma prioritaria para su evaluación y seguimiento en una clínica de falla cardiaca que cuente con esta alternativa.

  1. Selección de receptores pediátricos en trasplante de riñón

    Directory of Open Access Journals (Sweden)

    M. Viola, Dra.

    2010-03-01

    Full Text Available El trasplante renal es la terapia de elección para el manejo de la Enfermedad Renal Crónica Terminal (ERCT en pediatría. La evaluación previa debe ser cuidadosa, para minimizar los riesgos del trasplante y de las condiciones que afecten la sobrevida del paciente y del injerto. El estudio comprende una adecuada selección del donante, y una evaluación completa del paciente, que debe considerar la etiología de la ERCT, las infecciones e inmunizaciones que ha presentado el paciente a lo largo de su vida, así como el estado serológico para ciertas infecciones relevantes como el CMV y EBV. El estudio inmunológico comprende antecedentes de eventos sensibilizantes, tipificación de grupo sanguíneo y HLA, estudio de anticuerpos y pruebas cruzadas (XM, que permita predecir los riesgos de rechazo y planificar estrategias de inmunosupresión individualizadas, de acuerdo a cada situación particular. Se describen los nuevos métodos de estudio, en fase sólida, de la respuesta aloinmune.

  2. Oxides ABO4

    International Nuclear Information System (INIS)

    Uehlls, A.

    1987-01-01

    Different types of crystal structure of ABO 4 compounds from the structures of the quartz type (BeSO 4 , BPO 4 ) with tetrahedral environment of A and B atoms to oxosalts containing isolated ions BO 4 and atoms A with high coordination number are considered. Many oxides have polymorphic modifications and undergo structural transformations when increasing pressure. MgUO 4 and AlWO 4 compounds with rutile superstructure, where two types of metal atoms are disposed in different chains are described. Uranium (6) in MgUO 4 forms two stronger bonds U-O, that leads to considerable distortion of UO 6 and MgO 6 octahedrons. In AlWO 4 the distortion occurs due to the interaction of metal-metal, that leads to different distances W-W along the chain. NaIO 4 , KIO 4 , KRuO 4 , SrMoO 4 , SrWO 4 , MNbO 4 , MTaO 4 (M = Y or 4f-metals) have the structural types of scheelite and fergusonite

  3. Early humoral-mediated graft injuries in ABO-incompatible kidney transplantation in human beings.

    Science.gov (United States)

    Sekijima, M; Shimizu, A; Ishii, Y; Kudo, S; Horita, S; Nakajima, I; Fuchinoue, S; Teraoka, S

    2010-04-01

    Acute humoral rejection is the most important risk factor for early graft loss in ABO-incompatible (ABO-i) renal transplantation (RTx) and is present from the early period after RTx. However, the characteristics of early humoral-mediated graft injury are pathologically uncertain. To analyze tissue from 10 protocol graft biopsies performed in 10 patients within 30 days post-RTx to clarify the pathologic features of early humoral-mediated graft injuries in ABO-i RTx. Pathologic findings were examined using light and electron microscopy and immunofluorescence studies for C4d. Protocol biopsies were performed within 30 days after RTx in the absence of an episode of dysfunction (creatinine concentration 1.21-1.81 mg/dL). The immunofluorescence study demonstrated C4d deposition in peritubular and glomerular capillaries. Acute glomerulitis with infiltration of mononuclear cells and neutrophils was observed in 3 patients. Furthermore, glomerulitis was accompanied by endothelial cell injuries, widening of subendothelial spaces with a double-contoured glomerular basement membrane, and mesangiolysis. In ABO-i RTx, early humoral-mediated graft injuries were observed in approximately 30% of patients despite normal graft function. They were characterized by C4d deposition and glomerular capillary injury. These findings suggest that renal glomeruli are the first site of graft injury by anti-A or anti-B blood type antibody with complement activation in ABO-i RTx.

  4. Trastorno emocional en el paciente renal trasplantado

    Directory of Open Access Journals (Sweden)

    Fanny Moreno Rubio

    Full Text Available Introducción: el trasplante renal, siendo una terapia que mejora la calidad de vida de los pacientes con insuficiencia Renal Crónica, representa un nuevo reto para el paciente, que lo lleva a presentar trastornos emocionales tales como ansiedad y depresión asociados a factores de riesgo. Objetivo: describir la ansiedad y la depresión de pacientes trasplantados del Hospital de San José a través de la escala Hospital Anxiety and Depression Scale (HADS. Materiales y métodos: se hizo un estudio descriptivo de cohorte transversal, durante los meses de abril-septiembre del 2015. Donde se incluyeron los pacientes pertenecientes al programa de trasplante del Hospital de San José. Aplicando como instrumento la escala HADS, datos sociodemográficos, comorbilidades y tiempo pos trasplante. Resultados: se aplicó el instrumento a 176 pacientes de los cuales 10.7% presentaron ansiedad como problema clínico; con un tiempo pos trasplante ente 5-10años y 1.13% depresión como problema clínico. La comorbilidad prevalente fue Hipertensión Arterial (HTA con 31.2%. Conclusión: no se evidencio datos significativos de ansiedad y depresión en los pacientes del programa de trasplante renal que asistían a control en el Hospital de San José. Sin embargo se considera necesario el apoyo interdisciplinario durante las consultas de seguimiento mensual, viendo al paciente holístico y resaltando la importancia del personal de enfermería en la detección precoz de los trastornos emocionales.

  5. Amiloidosis renal hereditaria por depósito de apolipoproteína AI: un reto diagnóstico

    Directory of Open Access Journals (Sweden)

    Kelly del Rocío Samillán-Sosa

    2015-05-01

    La amiloidosis por depósito de Apo AI progresa a enfermedad renal crónica terminal en el plazo de de 3 a 15 años. Se diferencia clínicamente de la amiloidosis AL por su menor afectación extrarrenal y su mejor pronóstico. El trasplante renal ofrece una supervivencia del injerto aceptable y el trasplante hepato-renal se podría tener en cuenta en pacientes con disfunción significativa de ambos órganos.

  6. TRASPLANTE SIMULTÿNEO DE PANCREAS-RIÿÿN. CONCEPTOS ACTUALES Y EXPERIENCIA EN CLÿNICA LAS CONDES

    Directory of Open Access Journals (Sweden)

    DR. Mario Ferrario B.

    2016-03-01

    Resultados: De los 16 enfermos, 9 de ellos fueron hombres, la edad promedio fue 38,7 años al momento del trasplante, el tiempo promedio de diabetes fue 23,5+/-7.3 años. Todos los injertos pancreáticos fueron anastomosados a los vasos ilíacos comunes derechos en forma término-terminal y el duodeno fue anastomosado en 8 casos a la vejiga y en los últimos 8 al íleon. La sobrevida de los pacientes a 10 años fue del 81%, del injerto de páncreas el 82% y del injerto renal el 65%. La complicación post operatoria más importante fue sepsis, causando la muerte en 2 pacientes. Y entre las complicaciones de tipo inmunológico, 8 pacientes presentaron rechazo agudo, siendo manejados con terapia esteroidal de rescate o timo globulina.

  7. ABO blood groups, rhesus factor and pemphigus

    OpenAIRE

    Valikhani Mahin; Kavand Sima; Toosi Siavash; Kavand Golnaz; Ghiasi Maryam

    2007-01-01

    Background: Pemphigus is an autoimmune blistering disease of the skin and mucous membranes with significant mortality and morbidity. Genetic factors are known to be involved in pemphigus. Several studies have reproducibly shown significant associations of ABO blood groups with various autoimmune human diseases. Aim: To study the relationship between ABO and Rhesus (D) blood groups and pemphigus in Iranian patients. Materials and Methods: Data on age, sex, ABO and Rhesus blood type and cl...

  8. Prevalencia de enfermedad renal en niños aparentemente sanos con antecedente familiar de terapia de reemplazo renal

    OpenAIRE

    Mara Medeiros; Gioconda Daniela Andrade Veneros; Georgina Toussaint Martínez de Castro; Lourdes Ortiz Vásquez; Ana María Hernández Sánchez; Nadia Olvera; Gregorio Tomás Obrador Vera; Luis Velásquez Jones

    2015-01-01

    Introducción: Se ha mencionado que tener un familiar directo con enfermedad renal es un factor de riesgo para el padecimiento. El objetivo del estudio fue conocer la prevalencia de enfermedad renal temprana en niños familiares de pacientes con enfermedad renal crónica terminal (ERCT). Métodos: Se realizó un estudio de tamiz en niños aparentemente sanos, familiares en primer o segundo grado de pacientes con ERCT en programa reemplazo renal (hemodiálisis o trasplante renal). Previa firma de ...

  9. Nuevas estrategias en trasplante de precursores hematopoyéticos

    OpenAIRE

    Mauricio Sarmiento

    2016-01-01

    El trasplante hematopoyético es una estrategia terapéutica que permite posibilidad de curación en diversas enfermedades benignas y malignas. El autotrasplante tiene demostrada utilidad en mieloma y linfomas permitiendo recuperar la hematopoyesis luego de quimioterapias de alta intensidad. El alotrasplante permite reemplazar hematopoyesis defectuosa y/o introducir un potente efecto inmunológico llamado “efecto de injerto contra tumor”. En los últimos años, se han desarrollado nuevos fármacos q...

  10. INDUCCION DE TOLERANCIA INMUNE EN TRASPLANTES DE ORGANOS

    OpenAIRE

    RUIZ ROJAS, PAULINA ANTONIETA

    2013-01-01

    Los trasplantes de órganos son una alternativa terapéutica que permite la sobrevida de pacientes afectados por enfermedades que comprometen gravemente la función de diferentes órganos. Durante las últimas décadas, la introducción de fármacos inmunosupresores ha mejorado la aceptación de los órganos trasplantados, sin embargo, el uso de éstos provoca una serie de efectos adversos como infecciones por patógenos oportunistas, desarrollo de neoplasias e incluso disfunción de órganos d...

  11. ABO Blood Group And Reproductive Performance | Gharoro ...

    African Journals Online (AJOL)

    A cohort of 2839 delivered mothers between January 2000 and October 2003 were studied to investigate the influence of the ABO blood group on their reproductive performance. There were no statistical significant differences between the four ABO blood group phenotypes, in the 16 reproductive variable analysed.

  12. ABO blood groups and musculoskeletal injuries.

    Science.gov (United States)

    Kujala, U M; Järvinen, M; Natri, A; Lehto, M; Nelimarkka, O; Hurme, M; Virta, L; Finne, J

    1992-01-01

    The distribution of the ABO blood groups was studied in 917 patients with specific musculoskeletal diagnoses. The ABO blood group distribution of patients with rupture of the Achilles tendon (P = 0.030) and of patients with chronic Achilles peritendinitis (P = 0.10) differed from the controls. The ABO blood group distribution was not associated with other musculoskeletal injuries studied. The blood group A/O ratio was 1.42 in the control population. In the group with rupture of the Achilles tendon this ratio was 1.0, and in the group with Achilles peritendinitis it was 0.70. The association between injuries of the Achilles tendon and the ABO blood group distribution was in accordance with an earlier report. There may be a genetic linkage between the ABO blood groups and the molecular structure of the tissue of Achilles tendons.

  13. Donación y trasplante de órganos y tejidos

    OpenAIRE

    Caicedo Rusca, Luis Armando; Alex, Castro; Ordóñez, Vasco; Jurado, Fátima; Echeverry, Patricia; Fundación Valle de Lili

    2010-01-01

    Donación y trasplante de órganos y tejidos/¿Crees en la vida después de la vida?/Qué dice la ley colombiana/Tipos de donantes de órganos/el dónate de órganos una urgencia de vida o muerte/ Quién puede ser donante de órganos/ Trayectoria de los trasplantes en la Fundación Valle del Lili/Preguntas y respuestas/ ¿Cuáles son los órganos que más se requieren para trasplante?/¿Qué trasplantes se realizan en Colombia?/¿Cómo hacen para enterarse que una persona es donante de órganos si el paciente es...

  14. ABO-incompatible heart transplants.

    Science.gov (United States)

    Hageman, M; Michaud, N; Chinnappan, I; Klein, T; Mettler, B

    2015-04-01

    A month-old baby girl with blood type O positive received a donor heart organ from a donor with blood type B. This was the first institutional ABO-incompatible heart transplant. Infants listed for transplantation may be considered for an ABO-incompatible heart transplant based on their antibody levels and age. The United Network of Organ Sharing (UNOS) protocol is infants under 24 months with titers less than or equal to 1:4.(1) This recipient's anti-A and anti-B antibodies were monitored with titer assays to determine their levels; antibody levels less than 1:4 are acceptable pre-transplant in order to proceed with donor and transplant arrangements.1 Immediately prior to initiating cardiopulmonary bypass (CPB), a complete whole body exchange transfusion of at least two-times the patient's circulating blood volume was performed with packed red blood cells (pRBC), fresh frozen plasma (FFP) and 25% albumin. Titer assays were sent two minutes after initiation of full CPB and then hourly until the cross-clamp was removed. Institutionally, reperfusion of the donor heart is not restored until the antibody level from the titer assay is known and reported as less than 1:4; failing to achieve an immulogically tolerant recipient will provide conditions for hyperacute rejection. The blood collected during the transfusion exchange was immediately processed through a cell saver so the pRBC's could be re-infused to the patient during CPB, as necessary. The remainder of the transplant was performed in the same fashion as an ABO-compatible heart transplant. The patient has shown no signs of rejection following transplantation. © The Author(s) 2014.

  15. Complicaciones cutáneas de la terapia inmunosupresora: estudio en trasplantados renales

    OpenAIRE

    Diego E. Jaramillo; Beatriz Orozco

    1988-01-01

    Se presenta la experiencia dermatológica obtenida durante el seguimiento prospectivo de 114 pacientes con trasplante renal, atendidos en el Hospital Universitario San Vicente de Paúl, de Medellín; su evolución post-trasplante fluctuaba entre 2 meses y 13 anos y el seguimiento dermatológico fue por dos anos. Se encontró un número elevado de manifestaciones cutáneas (promedio 4,8 por paciente); las más frecuentes fueron: acné, micosis, hirsutismo y xerosis; no se hallaron lesiones malignas. No ...

  16. Discrepancy in abo blood grouping

    International Nuclear Information System (INIS)

    Khan, M.N.; Ahmed, Z.; Khan, T.A.

    2013-01-01

    Discrepancies in blood typing is one of the major reasons in eliciting a transfusion reaction. These discrepancies can be avoided through detailed analysis for the blood typing. Here, we report a subgroup of blood group type-B in the ABO system. Donor's blood was analyzed by employing commercial antisera for blood grouping. The results of forward (known antisera) and reverse (known antigen) reaction were not complimentary. A detailed analysis using the standard protocols by American Association of Blood Banking revealed the blood type as a variant of blood group-B instead of blood group-O. This is suggestive of the fact that blood group typing should be performed with extreme care and any divergence, if identified, should be properly resolved to avoid transfusion reactions. Moreover, a major study to determine the blood group variants in Pakistani population is needed. (author)

  17. A novel ABO O allele caused by a large deletion covering two exons of the ABO gene identified in a Caucasian family showing discrepant ABO blood typing results.

    Science.gov (United States)

    Matzhold, Eva M; Drexler, Camilla; Wagner, Thomas

    2016-11-01

    The presence of ABO subgroup alleles and unusual O alleles often is associated with discrepant serologic findings in ABO blood group typing. In the ABO gene of a Caucasian female and her daughters who had aberrant ABO phenotypes, a novel ABO O allele characterized by a large deletion that included two exons was identified. ABO phenotypes were determined by standard agglutination tests and adsorption-elution studies. Allele-specific sequencing analyses of the ABO gene as well as messenger RNA transcripts were carried out. All three samples showed the same discrepant ABO blood typing results lacking A and B antigens, indicating Blood Group O, whereas anti-A1 and anti-A2 isoagglutinins were not detectable in reverse typing. Analyses of the ABO gene revealed a novel allele characterized by a deletion of 2169 base pairs, including sequences of Intron 1, Exon 2, Intron 2, Exon 3, and Intron 3. Exon 1 was directly joined to Exon 4 in the ABO transcript. Because the novel allele was associated with a well-described O allele, the absence of A-antigens in the inherited ABO subtype phenotype may be due to the identified mutation affecting the transmembrane-spanning domain of the encoded protein and impairing the transferase activity. © 2016 AABB.

  18. TRATAMIENTO DE LA INSUFICIENCIA RENAL CRONICA, CON LASER-PUNTURA

    OpenAIRE

    JIMENEZ SERRANO, ANTONIO

    2010-01-01

    LA INSUFICIENCIA RENAL CRONICA (IRC), ES UNA ENFERMEDAD QUE EN LOS ULTIMOS TIEMPOS SE HA PRESENTADO CON MAYOR FRECUENCIA, ORIGINANDO GASTOS MUY ALTOS PARA LA ECONOMIA DE LAS FAMILIAS, Y PARA LAS INSTITUCIONES DE SALUD. EN ESTADOS UNIDOS EN 1995 SE PRESENTARON 59.000 CASOS NUEVOS DE IRC, PARA UNA INCIDENCIA DE 214 CASOS POR MILLON DE HABITANTES. CON TERAPIA DE REEMPLAZO RENAL (EN DIALISIS O CON TRASPLANTE RENAL) Y CON UNA PREVALENCIA DE 824 PACIENTES EN DIALISIS POR MILLON DE HABITANTES. ESTE...

  19. ABO blood groups of residents and the ABO host choice of malaria vectors in southern Iran.

    Science.gov (United States)

    Anjomruz, Mehdi; Oshaghi, Mohammad A; Sedaghat, Mohammad M; Pourfatollah, Ali A; Raeisi, Ahmad; Vatandoost, Hassan; Mohtarami, Fatemeh; Yeryan, Mohammad; Bakhshi, Hassan; Nikpoor, Fatemeh

    2014-01-01

    Recent epidemiological evidences revealed the higher prevalence of 'O' blood group in the residents of malaria-endemic areas. Also some data indicated preference of mosquitoes to 'O' group. The aim of this study was to determine ABO group ratio in the residents as well as ABO group preference of Anopheles in two malaria endemic areas in south of Iran. Agglutination method was used for ABO typing of residents. Field blood fed Anopheles specimens were tested against vertebrate DNA using mtDNA-cytB PCR-RFLP and then the human fed specimens were tested for ABO groups using multiplex allele-specific PCR. A total of 409 human blood samples were identified, of which 150(36.7%) were 'O' group followed by 113(27.6%), 109(26.7%), and 37(9.0%) of A, B, and AB groups respectively. Analyzing of 95 blood fed mosquitoes revealed that only four Anopheles stephensi had fed human blood with A(1), B(1), and AB(2) groups. Result of this study revealed high prevalence of O group in south of Iran. To our knowledge, it is the first ABO molecular typing of blood meal in mosquitoes; however, due to low number of human blood fed specimens, ABO host choice of the mosquitoes remains unknown. This study revealed that ABO blood preference of malaria vectors and other arthropod vectors deserves future research. Copyright © 2013 Elsevier Inc. All rights reserved.

  20. Frequency of ABO, subgroup ABO and Rh(D) blood groups in major sudanese ethnic groups

    International Nuclear Information System (INIS)

    Hassan, F.M.

    2010-01-01

    Background: There are differences in the distribution of ABO, sub group A BO and Rh(D) blood groups in different populations of the world. Relatively little information is available about blood group distributions in Sudanese population. To see the frequency of ABO, subgroup ABO and Rh(D) blood groups in major Sudanese ethnic groups(Danagla Shaygia and Gaaleen). Blood testing for ABO, subgroup ABO and Rh(D) typing was done over six months, in 300 unrelated individuals, from both genders. Blood samples were collected from students of the college of medical laboratory science - Sudan University of Science and Technology using finger prick method and following routine slide method. Blood group 'O' was the most predominant ( 52.7%) in both Rh positive and negative subjects followed by blood group A, B and AB. Majority (98.0%)o f the subjects were Rh(D) positive and only 2% were Rh negative. The predominant subgroup of ABO was A2 (14.1% ). The frequency of ABO blood groups in both Rh positive and negative subjects among the major Sudanese ethnic group was similar to that reported from neighbouring regions. (author)

  1. Trasplante de la práctica de prueba testimonial civil adversarial al Ecuador

    OpenAIRE

    Yépez Garcés, Diego Francisco

    2015-01-01

    Se utilizan modelos valorativos, contextuales y pragmáticos dentro de lo cuales la tesis se divide en tres capítulos. El trasplante del cual la tesis abarca su investigación, es la práctica de la prueba testimonial oral civil, tomando como referencia el sistema adversarial del cual se verifican varios rasgos característicos; el sistema está en pleno proceso de trasplante al Ecuador, con la aprobación del Código Orgánico General de Procesos del 2015. En el primer capítulo, se abarca la dimensi...

  2. Análisis de supervivencia de pacientes obesos sometidos a trasplante hepático

    OpenAIRE

    Torres-Quevedo Quevedo, Rodrigo

    2015-01-01

    La prevalencia de obesidad ha aumentado en países en vías de desarrollo, de igual modo en receptores de trasplantes hepático (TH) ésta también se ha incrementado de manera significativa. La obesidad tiene un impacto negativo, en cirugía general y trasplante de órgano sólido. Hasta la fecha existen pocos estudios en TH que analizan el impacto de la obesidad en los resultados del mismo. Objetivo: determinar si existen diferencias en la supervivencia (SV) actuarial a 5 años de obesos y no obe...

  3. BIOÉTICA, TRASPLANTE DE ÓRGANOS Y DERECHO PENAL EN COLOMBIA

    Directory of Open Access Journals (Sweden)

    Yolanda M. Guerra García

    2011-01-01

    Full Text Available Este artículo presenta los lineamientos del Derecho Penal que trascienden los conceptos de trasplantes de órganos y las implicaciones Bioéticas de los mismos. Del mismo modo se establecen algunos de los principales criterios relacionados con el debate bioético en torno al problema de la Donación y Trasplante de Órganos, problemas relacionados con temas como la Muerte Encefálica, el consentimiento informado, Justicia y Distribución, los Xenotrasplantes y la Clonación Embrionaria entre otros.

  4. ABO blood group and risk of cancer

    DEFF Research Database (Denmark)

    Vasan, Senthil K; Hwang, Jinseub; Rostgaard, Klaus

    2016-01-01

    INTRODUCTION: The associations between ABO blood group and cancer risk have been studied repeatedly, but results have been variable. Consistent associations have only been reported for pancreatic and gastric cancers. MATERIALS AND METHODS: We estimated associations between different ABO blood...... groups and site-specific cancer risk in a large cohort of healthy blood donors from Sweden and Denmark. RESULTS: A total of 1.6 million donors were followed over 27 million person-years (20 million in Sweden and 7 million in Denmark). We observed 119,584 cancer cases. Blood groups A, AB and B were...... associated either with increased or decreased risk of cancer at 13 anatomical sites (p≤0.05), compared to blood group O. Consistent with assessment using a false discovery rate approach, significant associations with ABO blood group were observed for cancer of the pancreas, breast, and upper gastrointestinal...

  5. Prevención y tratamiento de la enfermedad renal crónica (ERC)

    OpenAIRE

    B. Rodrigo Orozco, Dr.

    2010-01-01

    La enfermedad renal crónica (ERC) es un grave problema de salud pública. Se espera que el número de personas con insuficiencia renal que reciben tratamiento con diálisis y trasplante aumente dramáticamente en los próximos años. Los malos resultados de la ERC no se limitan a la insuficiencia renal terminal, sino que también incluyen a las complicaciones derivadas de una menor función renal, como hipertensión arterial, anemia, desnutrición, trastornos óseos y minerales, neuropatía, así como un ...

  6. Trasplante después del Fontan. Aspectos quirúrgicos

    Directory of Open Access Journals (Sweden)

    Juan-Miguel Gil-Jaurena

    2016-09-01

    Conclusiones: Trasplantar a pacientes con Fontan previo es un reto. Podemos anticipar variantes en cada una de las 5 anastomosis previstas. Es recomendable obtener tejido extra del donante (aorta y arco, vena cava superior e innominada, pericardio. Los resultados pueden superponerse a otras series de trasplante cardiaco.

  7. Trasplante cardíaco pediátrico: pasado, presente y futuro

    Directory of Open Access Journals (Sweden)

    María-Teresa González-López

    2017-01-01

    Conclusión: El trasplante cardíaco pediátrico presenta óptimos resultados en nuestro medio, superponibles a series mundiales. Aunque el perfil de riesgo está incrementándose, los resultados actuales reflejan los avances en el manejo de estos pacientes.

  8. Plasmodium falciparum malaria associated with ABO blood ...

    African Journals Online (AJOL)

    The present study was carried out to investigate the relationship between blood group types and P. falciparum malaria, as well as malaria preventive measures. The venous blood specimens were collected, processed, Giemsa-stained and examined microscopically. ABO groups were determined by agglutination test using ...

  9. ABO blood groups and rheumatic diseases.

    Science.gov (United States)

    Çildağ, Songül; Kara, Yasemin; Şentürk, Taşkın

    2017-12-01

    Various genetic and environmental risk factors have been shown to be associated with the incidence of rheumatic diseases. However, the pathogenesis of rheumatic diseases poorly understood. Several studies have shown associations of ABO blood groups with various diseases. Our study aimed to determine whether there is an association between the types of rheumatic diseases and ABO and Rh blood groups. The study included the patients, followed up at the Immunology-Rheumatology clinic between January 2016 and December 2016 for diagnosis of rheumatic disease, who had an ABO Rh blood data. Age, gender, type of rheumatic disease, ABO Rh blood groups were recorded. When 823 patients were assessed for blood types, 42.5% patients had A type, 33.2% had O type, 15.4% had B type, and 8.9% had AB type. There was significant difference in the distribution of blood types in rheumatic diseases. While SpA, vasculitis, UCTD, Behçet's and RA were more common in the patients with A blood type; FMF, SLE, SSc and SjS were more common in the patients with O blood type. In addition, the blood type where all the diseases are observed the least commonly was AB. There was significant difference in the distribution of Rh factor in rheumatic diseases. 92.2% patients were Rh positive and 7.8% patients were Rh negative. In our study, we thought that the higher incidence of different rheumatic diseases in different blood types was associated with different genetic predisposition.

  10. 220. Asistencia univentricular izquierda Berlin heart como puente al trasplante en pacientes con hipertensión pulmonar grave

    Directory of Open Access Journals (Sweden)

    P. Martínez Cabeza

    2010-01-01

    Conclusiones: En nuestra limitada experiencia, este tipo de estrategia permite: a reducir significativamente la presión pulmonar; b realizar el trasplante cardíaco, y c hacerlo con garantías de éxito.

  11. 253. Experiencia en el puente al trasplante cardíaco con oxigenación de membrana extracorpórea en adultos

    Directory of Open Access Journals (Sweden)

    L. Doñate Bertolín

    2012-04-01

    Conclusiones: La asistencia tipo ECMO permite rescatar pacientes en shock cardiogénico refractario, asistiéndolos con éxito hasta el trasplante. Nuestros resultados postrasplante en pacientes en los que el puente al trasplante se hace sólo con ECMO, son suficientemente buenos como para aceptar esta estrategia, ya que la política nacional de trasplantes nos permite llevarlo a cabo en las primeras semanas de asistencia.

  12. 67. Lecciones aprendidas del trasplante cardiohepático simultáneo

    Directory of Open Access Journals (Sweden)

    F. Gómez

    2010-01-01

    Full Text Available El trasplante simultáneo combinado de corazón e hígado es una opción de tratamiento en pacientes en fase final de la insuficiencia cardíaca y hepática. Desde su descripción inicial por Starzl en 1985, no ha sido un procedimiento muy expandido, siendo pocos y de escasa cuantía los registros que aparecen en la literatura. Presentamos dos hermanos de 51 y 54 años afectos de amiloidosis familiar en su variedad transtiretina amiloidea (ATTR (mutación gen E89K de la transtirretina, ambos con miocardiopatía restrictiva e hígado congestivo con ingresos previos por descompensación hepática e insuficiencia cardíaca. Tras el estudio pretrasplante cardíaco y hepático completo sin contraindicación al mismo, fueron incluidos en lista de trasplante cardíaco-hepático. Dado el grado avanzado de insuficiencia de ambos órganos, se consideró la opción de trasplante en un solo tiempo como única posibilidad. El trasplante fue llevado a cabo en dos fases, con el implante inicial cardíaco y, una vez terminada la circulación extracorpórea, se procedió a la fase hepática. Se plantean los problemas del trasplante en dos tiempos o simultáneo a partir de órganos de un solo donante, la ubicación en las listas de espera, la técnica quirúrgica, el momento de la administración de protamina, el cierre esternal pre o postrasplante hepático y el manejo intra y postoperatorio. Ambos pacientes presentaron un curso postoperatorio correcto, dándose de alta hospitalaria a los 20 y 27 días del trasplante con correcta función cardíaca y hepática. Los controles ambulatorios de ambos pacientes son favorables, mostrándose en clase funcional I y sin descompensaciones hepáticas.

  13. ABO blood group and thrombotic vascular disease.

    Science.gov (United States)

    Franchini, M; Mannucci, P M

    2014-12-01

    ABO blood group antigens are complex carbohydrate molecules expressed on red blood cells and a variety of tissues. The ABO blood type is implicated in the development of a number of human diseases and there is increasing evidence regarding its involvement in the pathogenesis of cardiovascular disorders, mainly through its effect on von Willebrand factor levels. In this review, after a brief analysis of the potential molecular mechanisms by which the blood group influences haemostasis, we focus on the clinical implications of such interaction. Overall, the literature data document the close relationship between venous thromboembolism (VTE) and non-O blood type, which is associated with an approximately two-fold increased risk of venous thrombosis. A supra-additive effect on VTE risk is observed when an inherited thrombophilic condition is associated with non-O blood group. A weaker association exists between non-O blood type and arterial thrombosis, which needs to be further investigated.

  14. Evaluación económica del tratamiento sustitutivo renal en España

    OpenAIRE

    Villa Valdés, Guillermo Ovidio

    2016-01-01

    La insuficiencia renal crónica (IRC) se define como la disminución del filtrado glomerular inferior a 60 ml/min/1,73 m2 o como la presencia de daño renal persistente durante al menos 3 meses. En su etapa terminal (IRCT), el paciente con IRC requiere tratamiento sustitutivo renal (TSR). Las principales modalidades de TSR son la hemodiálisis (HD), la diálisis peritoneal (DP) y el trasplante renal (Tx). En 2010, la incidencia y prevalencia en España de pacientes en TSR fue de 119 y 1.033 casos p...

  15. ABO Blood Groups and Cardiovascular Diseases

    Science.gov (United States)

    Zhang, Hanrui; Mooney, Ciarán J.; Reilly, Muredach P.

    2012-01-01

    ABO blood groups have been associated with various disease phenotypes, particularly cardiovascular diseases. Cardiovascular diseases are the most common causes of death in developed countries and their prevalence rate is rapidly growing in developing countries. There have been substantial historical associations between non-O blood group status and an increase in some cardiovascular disorders. Recent GWASs have identified ABO as a locus for thrombosis, myocardial infarction, and multiple cardiovascular risk biomarkers, refocusing attention on mechanisms and potential for clinical advances. As we highlight in this paper, more recent work is beginning to probe the molecular basis of the disease associations observed in these observational studies. Advances in our understanding of the physiologic importance of various endothelial and platelet-derived circulating glycoproteins are elucidating the mechanisms through which the ABO blood group may determine overall cardiovascular disease risk. The role of blood group antigens in the pathogenesis of various cardiovascular disorders remains a fascinating subject with potential to lead to novel therapeutics and prognostics and to reduce the global burden of cardiovascular diseases. PMID:23133757

  16. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.

    Science.gov (United States)

    Weinstock, Christof; Möhle, Robert; Dorn, Christiane; Weisel, Katja; Höchsmann, Britta; Schrezenmeier, Hubert; Kanz, Lothar

    2015-03-01

    Transfusion of ABO major-incompatible red blood cells (RBCs) can activate the complement system and can cause severe and even lethal acute hemolytic reactions. The activation of the complement system with formation of C3a and C5a (anaphylatoxins) and the release of hemoglobin from the lysed RBCs are thought to mediate clinical signs like fever, hypotension, pain, and acute renal failure. Therapeutic inhibition of the complement cascade in case of ABO-incompatible RBC transfusion would be desirable to ameliorate the signs and symptoms and to improve the outcome of the reaction. A patient with blood group B was erroneously transfused with a unit of group A2 RBCs. Within 1 hour after transfusion she received eculizumab, a monoclonal antibody that binds to the complement component C5 and blocks its cleavage. Clinical and immunohematologic observations are reported here. Hemoglobinemia and hemoglobinuria were present for several hours after transfusion, but she developed no hypotension, no renal failure, and no disseminated intravascular coagulation. As shown by flow cytometry, group A cells survived in the peripheral blood for more than 75 days. No immunoglobulin G was detectable by column agglutination technique on these cells. A low isoagglutinin titer and blood group A2 of the erroneously transfused cells most likely were the reason for the absence of clinical signs during and immediately after the ABO-incompatible transfusion. In the further course, eculizumab successfully protected the incompatible RBCs from hemolysis for several weeks. © 2014 AABB.

  17. Recomendaciones para el uso de everolimus en trasplante renal de novo: falsas creencias, mitos y realidades

    Directory of Open Access Journals (Sweden)

    Julio Pascual

    2017-05-01

    Estas recomendaciones tratan de aportar la evidencia científica que apoya esta práctica, discuten las falsas creencias, mitos y realidades de la combinación y concretan pautas que permiten utilizarla con seguridad y evitar complicaciones.

  18. Bacteriemia recurrente por Bordetella bronchiseptica en un paciente con trasplante de medula ósea

    Directory of Open Access Journals (Sweden)

    Lina Echeverri-Toro

    2015-09-01

    Full Text Available Se reporta un caso de bacteriemia recurrente por Bordetella bronchiseptica en un paciente inmunocomprometido con antecedentes de trasplante alogénico de medula ósea por síndrome mielodisplásico, quien ingresó al hospital por síndrome febril. Bordetella bronchiseptica es un agente patógeno veterinario poco común en humanos que afecta principalmente a pacientes inmunocomprometidos y es causa poco frecuente de bacteriemia.

  19. Intervención psiquiátrica en programa de trasplantes

    Directory of Open Access Journals (Sweden)

    G. Octavio Rojas, Dr.

    2010-03-01

    Full Text Available En los últimos años la Psiquiatría de Enlace e Interconsulta ha experimentado un salto cualitativo, acercándose al espacio común del resto de las especialidades médicas: el hospital general. La participación de psiquiatras en programas clínicos específicos como las unidades de trasplantes de órganos sólidos tiene fundamentaciones técnicas precisas dada la correlación entre síntomas psíquicos y las características clínicas específicas de las enfermedades médicas que requieren de este procedimiento. Cada vez hay una mayor preocupación en los clínicos y cirujanos en relación a los factores psíquicos que obstaculizan la adherencia a los tratamientos e indicaciones médicas tanto antes como después de efectuado el trasplante. La población de pacientes pre y post-trasplantados exhiben elevadas tasas de cuadros psiquiátricos específicos que ameritan un tratamiento coordinado multidisciplinario. El objetivo de este trabajo es mostrar la experiencia inicial que estamos desarrollando en la Unidad de Trasplantes de Clínica Las Condes.

  20. La lipocalina asociada con la gelatinasa de neutrófilos como factor temprano de predicción de la función retardada del injerto renal

    Directory of Open Access Journals (Sweden)

    John Fredy Nieto-Ríos

    2016-06-01

    Conclusión. Los niveles de lipocalina urinaria asociada a la gelatinasa de neutrófilos a las 48 horas del trasplante renal predijeron la función retardada, incluida la necesidad de diálisis, pero no fueron superiores a los de la creatinina sérica para la detección temprana.

  1. Comparative Analysis of the ABO and Rh CDE Phenotype ...

    African Journals Online (AJOL)

    Data presented in this report further evaluate the distribution and inter-ethnic phenotypic variability of the ABO and Rh blood groups among students of a tertiary institution in Port Harcourt. Standard haemagglutination procedures were used. ABO blood group frequencies were obtained as follows: 23.8% for blood group A, ...

  2. The distribution of the ABO blood groups among the diabetes ...

    African Journals Online (AJOL)

    Background: There is strong evidence in the literature that there is an association between ABO blood group and certain diseases. Aim: The aim of this study was to investigate any association between the ABO blood groups and diabetes mellitus (DM) in Qatar. Design: This was a sex.matched case.control study.

  3. Comparative frequency and allelic distribution of ABO and Rh (D ...

    African Journals Online (AJOL)

    Background: Allelic distribution of major blood groups (ABO and rhesus) has not been defined in Bangladeshi population. Determinants of blood group frequency in this region have not been studied properly. Aim: To determine ABO and rhesus blood group frequency and allelic distribution in a multiethnic area of ...

  4. Frequency of ABO and Rhesus blood groups among blood donors ...

    African Journals Online (AJOL)

    Background: The ABO is a blood group system that is responsible for most blood transfusion reactions, transplant rejections and determining some forensic cases. The ABO and Rhesus blood group systems have been shown to show variations in different part of the world and race. Aim: The study is to show the frequency of.

  5. The distribution of the ABO blood groups among the diabetes ...

    African Journals Online (AJOL)

    2014-02-12

    Feb 12, 2014 ... Background: There is strong evidence in the literature that there is an association between ABO blood group and certain diseases. Aim: The aim of this study was to investigate any association between the ABO blood groups and diabetes mellitus (DM) in Qatar. Design: This was a sex-matched case-control ...

  6. Relationship between ABO Blood Groups and Lipid Profile Level in ...

    African Journals Online (AJOL)

    A multitude of risk factors are responsible for development of cardiovascular diseases (CVDs) and association of cardiovascular disease risk factors with the ABO blood antigens is increasingly being reported. Thus, this study was designed to investigate the relationship between ABO blood groups and lipoprotein profiles of ...

  7. [Detection and analysis of ABO Hemolytic disease in newborn].

    Science.gov (United States)

    Lin, Zhao-Xia; Dong, Qing-Song

    2014-10-01

    This study was purposed to investigate the incidence and the model of ABO hemolytic disease in newborn (ABO-HDN) and the results of the three hemolysis test, so as to provide the evidences for clinical diagnosis and therapy. A total of 227 cases of maternal-fetal ABO incompatibility from January 2013 to October 2013 in the First Affiliated Hospital of Xiamen University were enrolled in the study. The ABO blood group of newborn and mother was detemined and three hemolysis tests (direct antiglobulin test, free antibody test, RBC antibody release test) were performed. The results indicated that in 227 cases of ABO incompatible pregnancies,186 cases were ABO-HDN (81.94%). There was no significant difference in the incidence between O-A and O-B incompatible pregnancies (P > 0.05). The positive ratio of direct antiglobulin test, free antibody test and RBC antibody release test were 59.14% (110/186), 84.78% (156/186) and 94.62% (176/186) respectively. It is concluded that the incidence of ABO-HDN is high. The main models of ABO-HDN were O-A and O-B. There was no significant difference in the incidence between O-A and O-B incompatible pregnancies. Three hemolysis tests are high sensitivity and are helpful in early diagnosis and early treatment of HDN.

  8. Comparative frequency and allelic distribution of ABO and Rh (D ...

    African Journals Online (AJOL)

    Gourab Dewan

    2015-02-18

    Feb 18, 2015 ... Abstract Background: Allelic distribution of major blood groups (ABO and rhesus) has not been defined in Bangladeshi population. Determinants of blood group frequency in this region have not been studied properly. Aim: To determine ABO and rhesus blood group frequency and allelic distribution in a.

  9. ABO, rhesus blood groups and transfusion-transmitted infections ...

    African Journals Online (AJOL)

    Background: Few studies focused on the study of blood groups in Gabon. This study aimed to determine the phenotypic frequency of ABO and Rhesus antigens in blood donors of Libreville and to assess the association between ABO blood groups and transfusion-transmitted infections. Materials and Methods: The study of ...

  10. Frequency of ABO and Rhesus blood groups among blood donors ...

    African Journals Online (AJOL)

    Background: The ABO is a blood group system that is responsible for most blood transfusion reactions, transplant rejections and determining some forensic cases. The ABO and Rhesus blood group systems have been shown to show variations in different part of the world and race. Aim: The study is to show the frequency of ...

  11. A Survey of ABO, Rhesus (D) Antigen and Haemoglobin Genes ...

    African Journals Online (AJOL)

    Summary: A survey of ABO and Rhesus (Rh D) antigens and variants of haemoglobin genes (HbGen) in Oyo state was carried out. This longitudinal study involved the determination of ABO and Rh(D) antigens in 3241 and HbGen in 2622 male and female adults (aged 26-65years) respectively using standard methods.

  12. (PTC) taste sensitivity, ABO and Rhesus factor (Rh)

    African Journals Online (AJOL)

    Chibuisi G. Alimba

    diseases [11], thyroid disorders, gastrointestinal ulcers and sus- ceptibility to infectious disease [12,13]. ABO and Rh blood groups are the most studied blood sys- tems among human populations due to their clinical, genetic and anthropological importance [14–16]. While the ABO blood group is expressed by three alleles ...

  13. [Association of abo blood groups with gestational diabetes mellitus].

    Science.gov (United States)

    Huidobro M, Andrea; Torres C, Demetrio; Paredes, Fabio

    2017-04-01

    ABO and Rhesus blood systems are associated with type 2 Diabetes Mellitus (DM2). Gestational Diabetes (GDM) is a model to study DM. To study the association between GDM and ABO and Rhesus groups. A retrospective cohort study was performed in 1,078 women who gave birth to a singleton in Talca Regional Hospital, Chile, during 2008. We analyzed personal, obstetric, medical data and ABO and Rh blood groups. GDM was diagnosed in 6.6% of women. Age and body mass index were significantly associated with GDM. There were no differences in Rh blood groups (p = 0.604), while ABO groups were different between GDM and controls. B antigen was present in 3% of GDM women and in 10.8% of controls (p = 0.037), with an odds ratio of 0.25 after adjusting for other associated risk factors (p = 0.06). ABO group is suggested as a possible protector marker for GDM.

  14. ABO blood group mismatched hematopoietic stem cell transplantation.

    Science.gov (United States)

    Tekgündüz, Sibel Akpınar; Özbek, Namık

    2016-02-01

    Apart from solid organ transplantations, use of ABO-blood group mismatched (ABO-mismatched) donors is acceptable in hematopoietic stem cell transplantation (HSCT) patients. About 20-40% of allogeneic HSCT recipients will receive grafts from ABO-mismatched donors. ABO incompatible HSCT procedures are associated with immediate and late consequences, including but not restricted to acute or delayed hemolytic reactions, delayed red blood cell recovery, pure red cell aplasia and graft-versus-host disease. This review summarizes the current knowledge about consequences of ABO-mismatched HSCT in terms of associated complications and will evaluate its impact on important outcome parameters of HSCT. Copyright © 2016 Elsevier Ltd. All rights reserved.

  15. Evolutionary aspects of ABO blood group in humans.

    Science.gov (United States)

    Franchini, Massimo; Bonfanti, Carlo

    2015-04-15

    The antigens of the ABO blood group system (A, B and H determinants) are complex carbohydrate molecules expressed on red blood cells and on a variety of other cell lines and tissues. Growing evidence is accumulating that ABO antigens, beyond their key role in transfusion medicine, may interplay with the pathogenesis of many human disorders, including infectious, cardiovascular and neoplastic diseases. In this narrative review, after succinct description of the current knowledge on the association between ABO blood groups and the most severe diseases, we aim to elucidate the particularly intriguing issue of the possible role of ABO system in successful aging. In particular, focus will be placed on studies evaluating the ABO phenotype in centenarians, the best human model of longevity. Copyright © 2015 Elsevier B.V. All rights reserved.

  16. Funcionamiento familiar en situación de trasplante de órganos pediátrico

    Directory of Open Access Journals (Sweden)

    Elisa Kernde Castro

    2005-01-01

    Full Text Available El presente trabajo revisa recientes hallazgos y examina algunas cuestiones relacionadas a las implicaciones del trasplante de órganos en la infancia para las relaciones familiares. El trasplante de órganos pediátrico es un procedimiento que puede desestabilizar el funcionamiento familiar y puede influenciar la adaptación y manejo del niño con respecto a la enfermedad y tratamiento. Los estudios revisados muestran que se pueden producir cambios importantes en las relaciones familiares cuando se plantea la posibilidad de un trasplante de órganos, especialmente un aumento en el estrés de los padres y la aparición de conductas sobreprotectoras con el niño. Actualmente existen pocos estudios sobre el tema, pero las evidencias revelan que el funcionamiento familiar y la salud mental de los padres son aspectos importantes que pueden influenciar el bienestar psicológico del niño.

  17. Trasplante hepático pediátrico estudio descriptivo de la experiencia recogida por el grupo de trasplante pediátrico de clínica las condes y hospital luis calvo mackenna

    Directory of Open Access Journals (Sweden)

    M. Mario Uribe, Dr.

    2010-03-01

    Conclusión: Los resultados del THP en términos de sobrevida y complicaciones es similar a la experiencia de centros extranjeros, la cual es superior a las expectativas y calidad de vida de los pacientes sin trasplante. Las áreas de mayor desarrollo de nuestro centro y que presentan los mayores desafíos son el trasplante hepático en niños menores de 10 kilos, en falla hepática aguda, y el uso de donante vivo.

  18. Factores de riesgo para la supervivencia en pacientes renales crónicos en hemodiálisis y transplante renal

    OpenAIRE

    Valdivia Arencibia, Julio

    2009-01-01

    El incremento del número de pacientes con insuficiencia renal crónica terminal en tratamiento de hemodiálisis y trasplante renal constituye una problemática mundial. El objetivo fue determinar los factores de riesgo y sobrevida en un grupo de estos pacientes. Se realizó un estudio descriptivo, longitudinal y prospectivo, en un período de diez años. Los factores de riesgo de los pacientes en hemodiálisis más frecuentes al inicio fueron la hipertensión arterial y la anemia crónica, 96% en ambos...

  19. ABO blood groups and psychiatric disorders: a Croatian study.

    Science.gov (United States)

    Pisk, Sandra Vuk; Vuk, Tomislav; Ivezić, Ena; Jukić, Irena; Bingulac-Popović, Jasna; Filipčić, Igor

    2018-02-15

    The prevalence of ABO alleles is different in different populations, and many studies have shown a correlation between the occurrences of some diseases and different genotypes of ABO blood groups. The aim of this study was to determine whether there is a significant association between psychiatric syndromes and ABO blood groups. This case-control study involved 156 psychiatric patients and 303 healthy, unrelated, voluntary blood donors. Genomic DNA was isolated from blood on a QIAcube device using a QIAamp DNA Blood mini QIAcube kit. ABO genotyping on five basic ABO alleles was performed using allele-specific polymerase chain reaction analysis. Compared with healthy subjects, a significantly higher proportion of psychiatric patients had AB blood group (χ 2 =9.359, df=3, p=0.025) and, accordingly, a significantly higher incidence of A1B genotype (χ 2 =8.226, df=3, p=0.042). The odds ratio showed that psychiatric disorders occur almost three times more frequently in carriers of AB group compared to other blood groups. However, no statistically significant difference was found in the distribution of ABO blood groups among patients with different psychiatric diagnoses. Likewise, no correlations were found between ABO blood groups and other characteristics of the psychiatric patients (sex, psychiatric heredity, somatic comorbidity, suicidality). The results of this study support the hypothesis of an association between psychiatric disorders and ABO blood groups. The probability is that psychiatric disorders will occur almost three times more frequently in carriers of AB group compared to other ABO blood groups in the Croatian population.

  20. Renal arteriography

    Science.gov (United States)

    Renal angiogram; Angiography - kidney; Renal angiography; Renal artery stenosis - arteriography ... artery by a blood clot Renal artery stenosis Renal cell cancer Angiomyolipomas (noncancerous tumors of the kidney) Some of these problems can be treated with ...

  1. Seguridad de la vacuna de la gripe en el receptor de trasplante de órgano sólido

    OpenAIRE

    Bulnes Ramos, Ángel

    2016-01-01

    La infección por influenza en los pacientes receptores de trasplante de órgano sólido (TOS) se ha asociado con altas tasas de morbilidad y mortalidad, especialmente en los primeros tres meses tras el trasplante. La vacunación de la gripe se ha propuesto como una medida eficaz para la prevención de la infección en estos pacientes. La mayoría de los estudios realizados para evaluar la eficacia de la vacunación en este grupo de pacientes han reflejado una respuesta humoral óptima en el receptor ...

  2. Adult Living Donor Liver Transplantation Across ABO-Incompatibility.

    Science.gov (United States)

    Lee, Chen-Fang; Cheng, Chih-Hsien; Wang, Yu-Chao; Soong, Ruey-Shyang; Wu, Tsung-Han; Chou, Hong-Shiue; Wu, Ting-Jung; Chan, Kun-Ming; Lee, Ching-Song; Lee, Wei-Chen

    2015-10-01

    The objective of this study was to evaluate the results of adult ABO-incompatible living donor liver transplantation (LDLT).ABO-incompatible LDLT is an aggressive treatment that crosses the blood-typing barrier for saving lives from liver diseases. Although graft and patient survival have been improved recently by various treatments, the results of adult ABO-incompatible LDLT require further evaluation.Two regimens were designed based on isoagglutinin IgG and IgM titers and the time course of immunological reactions at this institute. When isoagglutinin IgG and IgM titers were ≤64, liver transplantation was directly performed and rituximab (375 mg/m) was administrated on postoperative day 1 (regimen I). When isoagglutinin titers were >64, rituximab (375 mg/m) was administered preoperatively with or without plasmapheresis and boosted on postoperative day 1 (regimen II). Immunosuppression was achieved by administration of mycophenolate mofetil, tacrolimus, and steroids.Forty-six adult ABO-incompatible and 340 ABO-compatible LDLTs were performed from 2006 to 2013. The Model for End-Stage Liver Disease scores for ABO-incompatible recipients ranged from 7 to 40, with a median of 14. The graft-to-recipient weight ratio ranged from 0.61% to 1.61% with a median of 0.91%. The 1-, 3-, and 5-year survival rates were 81.7%, 75.7%, and 71.0%, respectively, for ABO-incompatible LDLT recipients, compared to 81.0%, 75.2%, and 71.5% for ABO-C recipients (P = 0.912). The biliary complication rate was higher in ABO-incompatible LDLT recipients than in the ABO-compatible recipients (50.0% vs 29.7%, P = 0.009).In the rituximab era, the blood type barrier can be crossed to achieve adult ABO-incompatible LDLT with survival rates comparable to those of ABO-compatible LDLT, but with more biliary complications.

  3. Algunas reflexiones éticas sobre los trasplantes de órganos sólidos

    Directory of Open Access Journals (Sweden)

    P. Patricio Burdiles, Dr.

    2010-03-01

    Full Text Available Durante el año 2009 se evidenció una disminución en el número de donaciones de órganos en Chile, aún cuando las listas de espera de pacientes que requieren un trasplante de órganos sólidos han seguido aumentando. Estas materias contribuyen a generar gran preocupación en los pacientes, familiares y en los equipos de salud involucrados. La consolidación de los trasplantes como recursos terapéuticos probados y validados por varias décadas de experimentación y experiencias clínicas, trae como consecuencia que se anhele y promueva, desde distintos estamentos médicos, científicos y sociales, aumentar la tasa de donaciones. Sin embargo por ser de suyo un tema relativamente nuevo en nuestra sociedad, que involucra aspectos morales, espirituales y afectivos, es esperable que resulten en cuestionamientos y tensiones éticas. Esto mismo hace necesario que se genere, facilite y profundice en los actores sociales, un debate sobre esta materia, que toca en lo más profundo, nuestras concepciones respecto a la vida, la dignidad e integridad corporal y en torno a la muerte y a sus definiciones. La familiarización con estos temas y la comprensión de los principios y valores que fundamentan los trasplantes, contribuirá a reducir la paradójica realidad del discurso mayoritario a favor de la donación de órganos y el escaso número real de donaciones efectuadas en los últimos años.

  4. Mecanismos sociales de coordinación en el Sistema Español de Trasplantes

    Directory of Open Access Journals (Sweden)

    Carmen De Pablos Heredero

    2013-01-01

    Full Text Available El proceso de donación de órganos es complejo y demanda de un conjunto de recursos muy especializados e interconectados que operan con altas restricciones de tiempos. El presente trabajo analiza desde las perspectivas organizativas y sociales el Sistema Nacional de Trasplantes. Por medio de una metodología cualitativa basada en el desarrollo de un análisis Delphi, se presenta y describe el complejo sistema de donación de órganos, a continuación se analizan los factores de éxito del sistema de gestión. Se muestra como los mecanismos de coordinación intrahospitalarios, que promueven los hospitales, así como los extra hospitalarios que facilita la Organización Nacional de Trasplantes, posibilitan la colaboración y el consenso que se requieren para conseguir los resultados exitosos que hacen del modelo español un referente mundial. Los resultados apuntan que se dan un conjunto de elementos de gestión que constituyen factores críticos de éxito en el sistema, como las competencias de coordinación que desarrollan por un lado la Organización de Trasplantes y por otro los coordinadores hospitalarios en materia de donación de órganos, factores como la formación a los especialistas, la sensibilización hacia la importancia de la donación, la gestión y el control de la información y la dualidad en el perfil de los coordinadores constituyen los pilares básicos de este sistema excelente.

  5. Antibody-mediated rejection after ABO-incompatible pediatric living donor liver transplantation for propionic acidemia: A case report.

    Science.gov (United States)

    Honda, Masaki; Sakamoto, Seisuke; Sakamoto, Rieko; Matsumoto, Shirou; Irie, Tomoaki; Uchida, Koushi; Shimata, Keita; Kawabata, Seiichi; Isono, Kaori; Hayashida, Shintaro; Yamamoto, Hidekazu; Endo, Fumio; Inomata, Yukihiro

    2016-09-01

    We herein present the case of a four-yr-old boy with PA who developed AMR after ABO-incompatible LDLT despite undergoing B cell desensitization using rituximab. Although the CD19+ lymphocyte count decreased to 0.1% nine days after the administration of rituximab, he developed a high fever which was accompanied by arthralgia due to a streptococcal infection 13 days after rituximab prophylaxis. After the clearance of the infection, he underwent ABO-incompatible LDLT 36 days after the administration of rituximab. The CD19+ lymphocyte count just prior to LDLT was 1.2%. He developed AMR five days after LDLT, and the antidonor-type IgM and IgG antibody titers increased to 1:1024 and 1:1024, respectively. He was treated by plasma exchange, IVIG, steroid pulse therapy, and rituximab re-administration; however, his liver dysfunction continued. Despite intensive treatment, he died due to complicated abdominal hernia, acute renal failure, and ARDS. This case suggests that a streptococcal infection may induce the activation of innate immune responses; thus, additional desensitization therapy should be considered prior to ABO-incompatible LDLT if B cell reactivation is suspected. © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

  6. Outcomes after ABO-incompatible heart transplantation in adults: A registry study.

    Science.gov (United States)

    Bergenfeldt, Henrik; Andersson, Bodil; Bućin, Dragan; Stehlik, Josef; Edwards, Leah; Rådegran, Göran; Nilsson, Johan

    2015-07-01

    In the past, ABO incompatibility was considered an absolute contraindication to heart transplantation (HT) in adults. Advances in ABO-incompatible HT in pediatric patients and ABO-incompatible abdominal transplantation in adult patients have led to clinical exploration of intentional ABO-incompatible HT in adults. However, it is not well known how outcomes in ABO-incompatible adult heart transplant recipients compare with outcomes in ABO-compatible recipients. We analyzed International Society for Heart and Lung Transplantation transplant registry data from heart donors and recipients ≥18 years old at the time of transplant for HT performed between 1988 and 2011. We compared baseline characteristics and post-transplant outcomes in ABO-incompatible and ABO-compatible HT. Death or retransplantation was the composite primary end-point. Among 76,663 adult patients undergoing HT between 1988 and June 30, 2011, 94 ABO-incompatible heart transplants were performed. The incidence of death or retransplantation in the ABO-incompatible group was higher than in the ABO-compatible group: 21% vs 9% at 30 days (hazard ratio = 2.38, p transplant. However, ABO-incompatible grafts surviving past the first year after transplant had a similar incidence of failure compared with the ABO-compatible group. After 2005, the rate ABO-incompatible HT in adults increased, likely as a result of planned, intentional (rather than accidental) ABO-incompatible HT. In this group of patients, short-term and long-term incidence of death or retransplantation was similar to ABO-compatible recipients (p = 0.822): 7% at 30 days and 19% at 1 year after transplantation. We found no difference in incidence of death or retransplantation between ABO-compatible and ABO-incompatible HT in patients who underwent transplantation after 2005. Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

  7. ABO incompatibility hemolytic disease following exchange transfusion 96 newborn

    OpenAIRE

    Khatami S.F; Behjati SH.

    2007-01-01

    Background: ABO incompatibility hemolytic disease of the newborn is a common cause of clinical jaundice and causes two-thirds of the hemolytic disease in newborns. This study was undertaken to determine the frequency of ABO incompatibility hemolytic disease and its complications in newborns undergoing exchange transfusion.Methods: This prospective and descriptive study was performed in jaundiced newborn infants during a three-year period. Inclusion criteria were: maternal blood type O, newbor...

  8. Qualitative analysis fingertip patterns in ABO blood group

    OpenAIRE

    S. V. KShirsagar

    2013-01-01

    The inheritance of the dermatoglyphic patterns is polygenic. The genetic basis of the blood group is well established. The correlation between the dermatoglyphic patterns and the ABO blood group is studied by some workers in different populations. In the present study, the correlation between dermatoglyphics and ABO blood group is studied in the Marathwada Region of Maharashtra. The qualitative data included fingertip patterns and three indices. It was observed that, the Arch pattern is more ...

  9. Evolución de la inmunología e influencia en los trasplantes de órganos

    OpenAIRE

    Carretero Vegas, Luz María

    2012-01-01

    Se profundiza en el conocimiento sobre los mecanismos del sistema inmunológico y la evolución histórica de los mismos para conocer la influencia de la inmunología en los trasplantes y las medidas preventivas más adecuadas para evitar las complicaciones

  10. Genética de las complicaciones del trasplante de Células Madre Hematopoyéticas

    OpenAIRE

    José Domingo Torres Hernández

    2006-01-01

    El trasplante de células madre hematipoyéticas (TCMH) se efectúa cada vez con mayor frecuencia puesto que en muchas ocasiones es la única alternativa de tratamiento con posibilidad de curación en algunos desórdenes hematológicos.

  11. Selección de donantes y receptores en trasplante pulmonar: procedimientos generales

    Directory of Open Access Journals (Sweden)

    C. María Teresa Parada, Dra.

    2010-03-01

    Full Text Available El trasplante pulmonar es una alternativa terapéutica que se ha validado en lo últimos 30 años para aquellos pacientes portadores de una enfermedad pulmonar terminal. Las características propias del trasplante pulmonar dadas por su conexión al ambiente a través de la vía aérea y la isquemia presente en las suturas durante el primer mes han constituído por mucho tiempo la principal causa de morbilidad y mortalidad de los pacientes trasplantados pulmonares. Los nuevos medicamentos inmunosupresores, la mejoría de las soluciones de preservación y de las técnicas quirúrgicas han disminuido las complicaciones y mortalidad precoz, siendo el gran desafío aún, el rechazo crónico conocido como el Sindrome de Bronquiolitis Obliterante (SBO. La selección del receptor de acuerdo a la patología de base se ha modificado, promoviendo la derivación precoz en patologías como la fibrosis pulmonar y la fibrosis quística disminuyendo así la mortalidad en la lista de espera.

  12. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States.

    Science.gov (United States)

    Ge, Jin; Roberts, John P; Lai, Jennifer C

    2017-08-01

    United Network for Organ Sharing (UNOS) policies allow for ABO-nonidentical liver transplantation (LT) in candidates with Model for End-Stage Liver Disease (MELD) scores greater than 30. Previous studies showed ABO-nonidentical LT resulted in an 18% and 55% net gain in livers for B and AB candidates. These results suggested that the current liver ABO allocation policies may need refinement. There are, however, strong associations between ABO blood groups and race/ethnicity. We hypothesized that race/ethnicity is associated with ABO-nonidentical LT and that this is primarily influenced by recipient ABO status. We examined non-status 1 adult candidates registered between July 1, 2013, and December 31, 2015. There were 27 835 candidates (70% non-Hispanic White, 15% Hispanic, 9% Black, 4% Asian, 1% Other/Multiracial). A total of 11 369 underwent deceased donor LT: 93% ABO identical, 6% ABO compatible, and 1% ABO incompatible. Black and Asian race/ethnicity were associated with increased likelihoods of ABO-nonidentical LT. Adjustment for disease etiology, listing MELD, transplant center volume, and UNOS region did not alter this association. Stepwise inclusion of recipient ABO status did eliminate this significant association of race/ethnicity with ABO-nonidentical LT. Blacks and Asians may be advantaged by ABO-nonidentical LT, and we suspect that changes to the existing policies may disproportionately impact these groups. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

  13. Sangrado de angiomiolipoma renal en paciente con síndrome de genes contiguos (TSC2/PKD1 tras 17 años de tratamiento renal sustitutivo

    Directory of Open Access Journals (Sweden)

    Mónica Furlano

    2017-01-01

    Full Text Available Presentamos el caso de un varón de 32 años, con síndrome de genes contiguos TSC2/PKD1, que le ocasiona esclerosis tuberosa (ET y poliquistosis renal autosómica dominante simultáneamente. Evolucionó a enfermedad renal terminal y se realizó trasplante renal a los 12 años. Los riñones presentaban angiomiolipomas (AML, que son tumores benignos frecuentes en pacientes con ET. A los 17 años postrasplante, presentó un cuadro de dolor abdominal, anemización y hematoma retroperitoneal. Dicho hematoma se produjo por el sangrado de los AML. Como tratamiento se realizó embolización selectiva. Nuestro paciente podría haberse beneficiado en el momento del trasplante renal del tratamiento con inhibidores de mTOR. Este fármaco actúa como inmunosupresor y reductor tumoral en la ET, al disminuir el riesgo de rotura y hemorragia. En este paciente no se administró porque cuando se trasplantó no se conocía la relación de los inhibidores de mTOR con la ET. Este caso confirma que, a pesar de tratarse de pacientes trasplantados o en diálisis, el riesgo de sangrado por los AML persiste, por lo cual se propone realizar controles periódicos de los riñones propios y valorar la nefrectomía.

  14. "Aprende a cuidar a tus riñones y ellos cuidaran de ti". Programa de educación para la salud dirigido a pacientes con Insuficiencia Renal Crónica (IRC)

    OpenAIRE

    Niso Andrade, Rebeca

    2016-01-01

    La Enfermedad renal crónica (ERC) es una enfermedad crónica que avanza progresivamente. Según la tasa de filtrado glomerular (TFG), se pueden diferenciar 5 estadios dentro de la enfermedad. En el estadio 5, ya es demasiado tarde para trabajar desde la prevención, ya que la TFG, y con ella la función renal, ha disminuido tanto que la supervivencia de los pacientes entra en juego y es necesario iniciar una terapia renal sustitutiva, diálisis o trasplante renal. Los estadios 3 y 4...

  15. Evaluación de la función renal en pacientes con enfermedad renal crónica (ERC) sin tratamiento sustitutorio, tras un programa de intervención nutricional (PIN): estudio aleatorizado

    OpenAIRE

    Beltrán López, Antonio

    2016-01-01

    La Enfermedad Renal Crónica (ERC) se define como la disminución de la función renal, donde se reduce el filtrado glomerular (FG) estimado < 60 ml/min/1,73m2 o como la presencia de daño renal de forma persistente durante al menos tres meses. La enfermedad renal crónica (ERC) es una patología progresiva que afecta cada vez más a la población, el daño renal aumenta con el paso del tiempo, siendo su resultado el tratamiento renal sustitutivo, trasplante o incluso la muerte, el gran problema es qu...

  16. Trasplante cardiaco en pacientes adultos con cardiopatía congénita

    Directory of Open Access Journals (Sweden)

    Manel Tauron

    2017-11-01

    Full Text Available Resumen: Introducción y objetivos: Los pacientes adultos con cardiopatías congénitas representan un porcentaje pequeño del total de pacientes trasplantados de corazón. Tradicionalmente se ha asociado a este subgrupo de pacientes a una mayor mortalidad precoz. En nuestro centro hemos experimentado un incremento en el número de pacientes adultos con cardiopatía congénita remitidos para valoración de trasplante. Presentamos nuestra experiencia. Métodos: Entre mayo de 1984 y diciembre del 2014 se realizaron 508 trasplantes cardiacos. De ellos 16 (3% fueron en adultos con cardiopatía congénita. Se han analizado las características de este grupo, comparando su evolución con el resto de trasplantes de causa no congénita. Resultados: En el grupo de pacientes trasplantados con cardiopatía congénita la causa más frecuente fue la transposición completa de grandes vasos. Los pacientes congénitos trasplantados tuvieron una edad media inferior, menos factores de riesgo cardiovascular y mayor número de intervenciones previas que el grupo de trasplantados no congénitos, todas ellas diferencias estadísticamente significativas (p < 0,001 en todos los casos. La supervivencia de los trasplantados por cardiopatías congénitas fue del 87,5% (IC del 95%, 58,60%-96,72% al año, 78,6% (IC del 95%, 46,62%-92,79% a los 5 años y 57,4% (IC del 95%, 24,07-80,57% a los 10 años, sin diferencia (p = 0,23 respecto al grupo de no congénitos. Conclusiones: A pesar de que ha aumentado el número de pacientes con cardiopatías congénitas complejas remitidos a programas de trasplante cardiaco, continúan representando un porcentaje pequeño del total de trasplantes. Una minuciosa selección de pacientes candidatos, una buena planificación quirúrgica y un estricto control postoperatorio permiten disminuir la mortalidad precoz en los trasplantes de pacientes con cardiopatías congénitas complejas, haciéndola semejante a la de los pacientes

  17. Seguridad y efectividad de la eliminación linfocitaria en trasplante de manos

    Directory of Open Access Journals (Sweden)

    Luis Landín-Jarillo

    Full Text Available Introducción y Objetivo. Los trasplantes de tejidos compuestos están indicados para casos en los que no hay alternativa reparadora y la reconstrucción alogénica es la única opción terapéutica disponible. Los receptores de tejidos compuestos requieren inmunosupresión crónica que entraña ciertos riesgos. Pese al uso de triple terapia inmunosupresora estándar se pueden producir episodios de rechazo agudo (RA, cuyo tratamiento habitual incluye ajuste del tratamiento, bolos de corticoides y el uso de inmunosupresores de forma tópica, aunque en ocasiones es necesario eliminar la población linfocitaria. En el presente trabajo evaluamos la seguridad y efectividad de la eliminación linfocitaria utilizando globulina anti-timocítica (GAT en el rescate de RA. Material y Método. Llevamos a cabo una revisión sistemática sobre resultados y complicaciones tras la administración de GAT en trasplante de tejidos compuestos, incluyendo un total de 108 publicaciones que resumen la evolución de 57 pacientes. La revisión se acompaña de la presentación del curso inmunológico de 1 paciente trasplantado de brazos en nuestro centro. Resultados. En 5 casos la GAT se administró con éxito para el tratamiento de rechazo resistente a corticoides, si bien no se consiguió prevenir la aparición de episodios de rechazo posteriormente. Nuestro paciente presentó un episodio de RA celular de grado III en la escala Banff que fue tratado con 2 cursos de metil-prednisolona y ajuste al alza del tratamiento inmunosupresor sin respuesta clínica. Finalmente el paciente recibió 2 dosis de GAT en el día 50 y 57 posttrasplante y tras 450 días de seguimiento permanece libre de rechazo. Por el momento no ha presentado complicaciones relacionadas con el uso de GAT. Conclusiones. El rescate del RA resistente a corticoides en trasplantes de tejidos compuestos puede realizarse mediante administración de GAT. Todos los casos descritos en la literatura respondieron

  18. Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis

    NARCIS (Netherlands)

    A. de Weerd (Annelies); A.G. Vonk (Alieke); H. van der Hoek (Hans); M. van Groningen (Marian); W. Weimar (Willem); M.G.H. Betjes (Michiel); M. Agteren (Madelon)

    2014-01-01

    textabstractBackground: The major challenge in ABO-incompatible transplantation is to minimize antibody-mediated rejection. Effective reduction of the anti-ABO blood group antibodies at the time of transplantation has made ABO-incompatible kidney transplantation a growing practice in our hospital

  19. SINGLE-CENTER EXPERIENCE OF ABO-INCOMPATIBLE LIVER TRANSPLANTATION

    Directory of Open Access Journals (Sweden)

    S. V. Gautier

    2011-01-01

    Full Text Available Since 2008 up to 2010 eight ABO-incompatible liver transplantations have been performed in our center: one of them was urgent liver transplantation to adult patient from deceased donor, other seven were transplantations of left lateral segment to children from living relative donors. Own experience, as well as world one, proves, that barrier of ABO-incompatibility can be overcome more successfully in liver transplantation, particularly in pediatric population, that in other solid organs transplantation. Good results can be achieved even with less ag- gressive immunosuppressive therapy. Recipient conditioning before operation can significantly improve results of ABO-incompatible liver transplantation, but as own experience has shown, often there’s no need to hold some special preparation of children, because their anti-ABO antibodies are very low or absent before transplantation and do not increase after it. Thereby ABO-incompatible liver transplantation is reasonable in urgent cases and in pediatric population because of the limited pull of living relative donors for children. 

  20. ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.

    Science.gov (United States)

    Worel, Nina

    2016-01-01

    Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative option for a variety of malignant and non-malignant hematological and congenital diseases. Due to the fact that the human leukocyte antigen system is inherited independently of the blood group system, approximately 40-50% of all HSCTs are performed across the ABO blood group barrier. The expected immune-hematological consequences after transplantation of an ABO-mismatched stem cell graft are immediate and delayed hemolytic complications due to presence of isohemagglutinins or passenger lymphocyte syndrome. The risks of these complications can partially be prevented by graft manipulation and appropriate transfusion support. Dependent on the kind of ABO mismatch, different effects on engraftment have been observed, e.g. delayed red blood cell recovery and pure red cell aplasia. Data on incidence of acute graft-versus-host disease (GVHD), non-relapse mortality, relapse, and overall survival are inconsistent as most studies include limited patient numbers, various graft sources, and different conditioning and GVHD prophylaxis regimens. This makes it difficult to detect a consistent effect of ABO-mismatched transplantation in the literature. However, knowledge of expectable complications and close monitoring of patients helps to detect problems early and to treat patients efficiently, thus reducing the number of fatal or life-threatening events caused by ABO-mismatched HSCT.

  1. Proposed criterion for distinguishing ABO mosaics from ABO chimeras using flow cytometric analysis.

    Science.gov (United States)

    Oda, Akira; Matsuyama, Nobuki; Hirashima, Mizuko; Ishii, Hiroyuki; Kimura, Keiko; Matsukura, Harumichi; Hirayama, Fumiya; Kawa, Keisei; Fukumori, Yasuo

    2015-01-01

    Differentiation of ABO mosaics from chimeras is performed using flow cytometry (FCM) analysis. Although mosaics and chimeras have been distinguished by presence or absence of clear resolution using FCM analysis, the lack of quantitative metrics and definitive criteria for this differentiation has made some cases difficult to differentiate. In this study, therefore, we attempted to establish a definitive and quantitative criterion for this differentiation. When FCM histogram gates for group "A" or "B" antigen-negative and -positive red blood cells (RBCs) were set such that group O RBCs were classified as 99 percent negative and group A or B RBCs as 99 percent positive, the percentages of RBCs in the middle region of six chimeras and 23 mosaics (12 A mosaics and 11 B mosaics) were 0.1-0.6 percent and 7.0-19.0 percent, respectively. This results suggested that ABO mosaics and chimeras can be unambiguously differentiated when the cutoff point of the intermediate region is set to 1 percent.

  2. Trasplante cardíaco en pacientes con enfermedad de Chagas. Experiencia de un único centro

    Directory of Open Access Journals (Sweden)

    Alfredo Inácio Fiorelli

    2011-07-01

    Conclusiones: El trasplante cardíaco es el único tratamiento actual eficaz de tratamiento de la enfermedad de Chagas en fase terminal. La reactivación de la enfermedad es un problema real que es fácilmente revertido con la introducción de la terapéutica farmacológica específica, restaurando los padrones histológicos del miocardio sin dejar secuelas. La inmunosupresión, en especial los corticoides, predisponen al desarrollo de neoplasias y a la reactivación de la enfermedad, exigiendo una atención especial su interrupción o reducción precoz.

  3. ABO and Rh blood groups and risk of colorectal adenocarcinoma.

    Science.gov (United States)

    Urun, Yuksel; Ozdemir, Nuriye Yildirim; Utkan, Gungor; Akbulut, Hakan; Savas, Berna; Oksuzoglu, Berna; Oztuna, Derya Gokmen; Dogan, Izzet; Yalcin, Bulent; Senler, Filiz Cay; Onur, Handan; Demirkazik, Ahmet; Zengin, Nurullah; Icli, Fikri

    2012-01-01

    Previous studies have observed an association between ABO blood group and risk for certain gastrointestinal malignancies, including pancreatic and gastric cancer. However, it is unclear whether there is such an association with colorectal cancer (CRC). In this study, possible relationships between ABO blood groups and Rh factor and KRAS status in patients with CRC were investigated. In 1,620 patients with CRC, blood group and Rh factor were examined and compared with the control group of 3,022,883 healthy volunteer blood donors of the Turkish Red Crescent between 2004 and 2011. The relationship of blood groups with wild type K-ras status was also evaluated. Overall distributions of ABO blood groups as well as Rh factor were comparable between patients (45% A, 7.2% AB, 16.4% B, 31.4% O, and 87.2% Rh+) and controls (42.2% A, 7.6% AB, 16.3% B, 33.9% O, and 87.7% Rh+) (p=0.099). However, there were statistically significant difference between patients and controls with respect to O vs. non O blood group (p=0.033) and marginally significant difference for A vs. non-A blood group (p=0.052). Among patients, the median age was 62 (range 17-97), 58.1% were male. There were no statistically significant differences respect to sex and K-ras status. In present study, the ABO/Rh blood groups were statistically significantly associated with the risk of CRC. There were no relationship between K-ras status and ABO blood group and Rh factor. However further studies with larger numbers of patients are needed to establish the role of blood groups and to define the mechanisms by which ABO blood type affect CRC.

  4. Morbidity of ABO haemolytic disease in the newborn.

    Science.gov (United States)

    Bhat, Y R; Kumar, C G Pavan

    2012-05-01

    Better understanding of the clinical characteristics of ABO haemolytic disease in neonates helps optimise care. To assess the morbidity associated with maternal-neonatal ABO incompatibility. Neonates with blood groups A or B born to mothers with blood group O with simultaneous rhesus blood factor compatibility were studied prospectively. Maternal and neonatal details, direct Coomb's test (DCT) on the cord blood, onset and progression of jaundice, and requirement and duration of phototherapy were studied. Neonates requiring phototherapy were considered to have significant hyperbilirubinaemia, and peripheral smear, reticulocyte count and haematocrit values were obtained. ABO haemolytic disease of the newborn (ABO HDN) is defined as a newborn with a positive DCT and/or laboratory evidence of haemolysis such as reticulocytosis and spherocytes on blood smear. Of 878 deliveries, 151 (17.3%) neonates were ABO incompatible with their mothers. The proportions who were O-A and O-B incompatible were 50.4% and 49.6%, respectively. Forty-six (30.4%) had significant hyperbilirubinaemia (119.7-256.5 mmol/L) and required phototherapy, 26 (34.2%) of them in the O-A group and 20 (26.6%) in the O-B group. None required exchange transfusion. Jaundice was detected within the first 24 hours in 47.8%. Of 46 newborns who required phototherapy, 25 (54.3%) had laboratory evidence of haemolysis. DCT was positive in 1.9% of ABO-incompatible newborns. There was no significant difference in the incidence and severity of haemolysis between the O-A and O-B-incompatible neonates. Neonates with haemolysis required phototherapy significantly earlier and for longer than neonates without haemolysis (PABO incompatibility was observed in 17.3% of pregnancies with almost equal O-A and O-B frequency. About a third of infants had significant hyperbilirubinaemia. There was no difference in severity between those with O-A and O-B HDN.

  5. Ready-made allogeneic ABO-specific serum eye drops

    DEFF Research Database (Denmark)

    Harritshøj, Lene Holm; Nielsen, Connie; Ullum, Henrik

    2014-01-01

    PURPOSE: To overcome problems and delays of the preparation of autologous serum eye drops, a production line of ABO-specific allogeneic serum eye drops from male blood donors was set up in a blood bank. Feasibility, clinical routine, safety and efficacy were evaluated in a cohort of patients...... serum treatment. CONCLUSION: Ready-made ABO-identical allogeneic serum eye drops were straightforwardly produced, quality-assured and registered as a safe standard blood product for the treatment of certain cases of severe dry eye disease. Therapeutic efficacy was comparable to previous reports...

  6. Manual Técnico del Sistema de Siembra de Trasplante Mecanizado del Cultivo de Arroz (Oryza Sativa).

    OpenAIRE

    Álvarez-Rodríguez, Jorge Andrés

    2011-01-01

    Proyecto de Graduación (Maestría en Gestión de Recursos Naturales y Tecnologías de Producción) Instituto Tecnológico De Costa Rica, Área Académica Agroforestal, 2011. La tecnología del trasplante mecanizado, ha sido validada por el continente asiático, en países como Japón, China y Corea del Sur, que para el 2002 sembró 10,53 millones de hectáreas, de las cuales 8,13 millones de ha, que representan el 77 %; fueron sembradas mediante el sistema de trasplante mecanizado. Por otro lado para e...

  7. Donación de órganos para trasplante: una oportunidad para la equidad en chile

    Directory of Open Access Journals (Sweden)

    C. Marcelo Muñoz, Dr.

    2010-03-01

    Full Text Available La donación efectiva de órganos en Chile se encuentra en un preocupante estancamiento. La tasa de donantes efectivos no sólo no se ha incrementado en el periodo 1998–2008, sino que por el contrario en los últimos años ha disminuido. Cualquier análisis en estas circunstancias debe interpelar a los principios o a priori que fundamentan el actual sistema de donación y trasplante. Un modelo de donación de órganos para trasplante y todas aquellas etapas que permiten el éxito de esta técnica deben fundamentarse en el respeto a un principio ético central que es la equidad y en el resguardo con celo, la eficiencia, transparencia y credibilidad del mismo.

  8. Tumores malignos de novo en el trasplante hepático experiencia de un centro en la Argentina

    Directory of Open Access Journals (Sweden)

    Florencia Antinucci

    2015-02-01

    Full Text Available El objetivo del presente trabajo ha sido evaluar la incidencia y las características clínicas de los tumores aparecidos de novo en los pacientes sometidos a trasplante hepático, como así también su supervivencia. Para ello, analizamos en forma retrospectiva los 168 trasplantes hepáticos realizados en 159 pacientes adultos en el período mayo 2006 hasta mayo 2014, encontrando una incidencia de neoplasia de novo de 7.5% (n = 12. La edad media en el momento del diagnóstico fue de 63 ± 7 años. Las neoplasias más frecuentes fueron las de piel no melanoma y adenocarcinomas. El 50% de las neoplasias se desarrollaron en el segundo y tercer año postrasplante. El tipo de inmunosupresión no influyó en el tipo de tumor; sin embargo, debemos destacar que la mayor parte de los pacientes recibieron tacrolimus, micofenolato y/o corticoides. El tiempo medio de seguimiento tras el diagnóstico del tumor fue 25 ± 29 meses (0-76, y la tasa de mortalidad fue de un 41% (5/12 pacientes IC95%,15-72.La supervivencia global luego del trasplante a 1 y 5 años, calculada por análisis de Kaplan-Meier, fue de 83 y 55%, respectivamente. Los tumores de novo son frecuentes luego del trasplante hepático y presentan un patrón evolutivo diferente al de la población general. Teniendo en cuenta esta evolución más agresiva, es fundamental el seguimiento periódico en estos pacientes para realizar un diagnóstico lo más precoz posible.

  9. La asistencia ventricular mecánica como puente al trasplante cardíaco: fundamentos y objetivos

    Directory of Open Access Journals (Sweden)

    Carlos García Montero

    2009-04-01

    Full Text Available La introducción clínica de los dispositivos de tercera generación para asistencia cardiocirculatoria ha significado un notable avance en la terapia de los candidatos a trasplante cardíaco en fase de descompensación hemodinámica, mediante la modalidad conocida como puente al trasplante (PAT. La situación actual de dicha estrategia en nuestro país refleja una dispersión de criterios en cuanto a la selección de pacientes, indicación del dispositivo, manejo táctico de las opciones terapéuticas y, especialmente, detección del momento adecuado del trasplante. El presente trabajo: a analiza las características del régimen a flujo continuo y sus consecuencias sobre distintos órganos diana en el contexto de la estrategia PAT; b describe de forma resumida las líneas de actuación cubiertas por los dispositivos mecánicos de uso más frecuente, y, finalmente, c proporciona unas recomendaciones de manejo clínico antes, durante y para el momento de la desconexión del dispositivo. resulta imprescindible una adecuación de los distintos centros implicados en este tipo de terapia si se pretende avanzar en su aplicación y resultados.

  10. Gene frequencies of ABO and rhesus blood groups and ...

    African Journals Online (AJOL)

    The distribution and gene frequencies of ABO and rhesus (Rh) blood groups and haemoglobin variants for samples of the Nigerian population at Ogbomoso was determined. Data consisting of records of blood groups and haemoglobin types of different ages ranging from infants to adults for a period of 4 to 6 years (1995 ...

  11. Distribution of abo, rhesus blood groups and haemoglobin ...

    African Journals Online (AJOL)

    Summary: The distribution of ABO, Rhesus blood groups and haemoglobin electrophoresis among 200 undergraduate students of Niger Delta University, Bayelsa State, Nigeria randomly selected were studied. Blood samples were collected by venepuncture from the antecubital vein. The blood sample were transferred into ...

  12. Abo And Rhesus Blood Groups Distribution In Mothers And ...

    African Journals Online (AJOL)

    Objective: To provide information in the distribution of ABO and Rhesus Blood Group in our population. Study Population/Methods: One hundred and twenty one antenatal mothers who were sequentially booked in antenatal care clinic of University of Jos Health Clinic, Jos, Plateau State after their informed consent.

  13. Association of ABO blood groups with diabetes mellitus | Kamil ...

    African Journals Online (AJOL)

    Objective: So far no studies have been performed in Malaysia to look at association of diabetes mellitus (DM) with blood groups. We studied the association of ABO blood groups with DM type 2. Patients and methodology: It was a case control study conducted at Kepala Batas Hospital Batas, Penang, Malaysia in the year ...

  14. ABO blood group distribution and ischaemic heart disease

    International Nuclear Information System (INIS)

    Lutfullah, A.; Bhatti, T.A.; Hanif, A.; Shaikh, S.H.

    2011-01-01

    To study the association of ABO blood groups with ischaemic heart disease (IHD) in our setting. Analytic comparative study. Department of Cardiology, Mayo hospital, Lahore over a period of two years from January 2008 to December 2009. The study group included 907 patients of IHD. The distribution of ABO blood groups in IHD patients was compared with the control group of 907 non-IHD individuals. Data was analyzed using SPSS 16. Chi-square test for significance was used. P-value less than 0.05 was taken as significant. In this study, the following pattern of ABO blood groups was observed in IHD patients and non-IHD patients respectively : Blood group A 251 (27.67%) and 248 (27.34%); Blood group B 329 (36.27%) and 358 (39.47%); Blood group O 235 (25.90%) and 240 (24.46%); Blood group AB 92 (10.14%) and 61 (6.72%), P-value = 0.06. There is no association of ABO blood groups and ischaemic heart disease. (author)

  15. Frequency distribution 0f ABO, RH blood groups and blood ...

    African Journals Online (AJOL)

    One hundred and fifty students (150) were randomly selected from the Department of Cell Biology and Genetics of University of Lagos, Akoka, Nigeria for ABO, RH blood groups and 6 haemoglobin genotypes studies. Blood group O was the highest with the percentage frequency of 55.3%, followed by blood group A (25.3%) ...

  16. Differential Rheology Among ABO Blood Group System In Nigerians

    African Journals Online (AJOL)

    Sci. 3 (1): 30-35, July 2015. Journal of African Association of Physiological Sciences. Official Publication of the African Association of Physiological Sciences http://www.jaaps.aapsnet.org. Research Article. Differential Rheology Among ABO Blood Group System In. Nigerians. O.I. Ajayi* O.O. Ekakitie**, O.C. Okpalaugo*.

  17. Association of ABO blood groups with diabetes mellitus

    African Journals Online (AJOL)

    2010-02-08

    Feb 8, 2010 ... Objective: So far no studies have been performed in Malaysia to look at association of diabetes mellitus (DM) with blood groups. We studied the association of ABO blood groups with DM type 2. Patients and methodology: It was a case control study conducted at Kepala Batas Hospital Batas, Penang,.

  18. High dose intravenous immunoglobulin in Rh and ABO hemolytic ...

    African Journals Online (AJOL)

    Ehab

    High dose intravenous immunoglobulin in Rh and ABO hemolytic disease of Egyptian neonates. INTRODUCTION. Hemolytic disease of the newborn (HDN) due to red cell alloimmunisation is an important cause of hyperbilirubinemia with significant morbidity in the neonatal period.1,2. Hemolytic disease of the newborn has ...

  19. ABO Blood Group Distribution among Voluntary Blood Donors in ...

    African Journals Online (AJOL)

    Background: ABO blood group antigens are the most important in blood transfusion service. Everyone over six months has naturally acquired antibody against the corresponding antigen absent on their red blood cell membrane. Safe blood transfusion includes the transfusion of group specific compatible units to recipients.

  20. Frequency distribution 0f ABO, RH blood groups and blood ...

    African Journals Online (AJOL)

    user

    2006-11-16

    Nov 16, 2006 ... Furthermore, the presence of Rhesus system was recognized in 1939 and it was confirmed within few years. (Landesteiner and Weiner, 1940). In the ABO blood group, individuals are divided into four major blood groups, A, B, AB and O, according to the presence of the antigens and agglutinins. Type A.

  1. ABO and Rhesus blood groups in Alzheimer's disease.

    Science.gov (United States)

    Renvoize, E B

    1985-01-01

    ABO and rhesus (Rh) blood groups were examined in 124 patients with presenile dementia of the Alzheimer type (PDAT) and senile dementia of the Alzheimer type (SDAT), and their distribution was compared with controls. No significant associations between these blood groups and Alzheimer's disease (AD) were found after statistical correction for multiple comparisons.

  2. Genetic characterization of the ABO blood group in Neandertals

    Directory of Open Access Journals (Sweden)

    Bertranpetit Jaume

    2008-12-01

    Full Text Available Abstract Background The high polymorphism rate in the human ABO blood group gene seems to be related to susceptibility to different pathogens. It has been estimated that all genetic variation underlying the human ABO alleles appeared along the human lineage, after the divergence from the chimpanzee lineage. A paleogenetic analysis of the ABO blood group gene in Neandertals allows us to directly test for the presence of the ABO alleles in these extinct humans. Results We have analysed two male Neandertals that were retrieved under controlled conditions at the El Sidron site in Asturias (Spain and that appeared to be almost free of modern human DNA contamination. We find a human specific diagnostic deletion for blood group O (O01 haplotype in both Neandertal individuals. Conclusion These results suggest that the genetic change responsible for the O blood group in humans predates the human and Neandertal divergence. A potential selective event associated with the emergence of the O allele may have therefore occurred after humans separated from their common ancestor with chimpanzees and before the human-Neandertal population divergence.

  3. Primate ABO Gene is under Weak Positive Selection

    Directory of Open Access Journals (Sweden)

    Eliane Santos EVANOVICH

    2012-05-01

    Full Text Available ABO locus presents three main alleles: A, B and O. A and B encode glycosyltransferases that catalyze the addiction of an N-GalNac and D-galactose to a precursor substance (H substance, producing A and B antigens, while the O allele does not produce a functional protein. The presence of A and B antigens have been associated to resistance against infectious agents which could use them as attachment factors increasing the virulence of some parasitic agents. As these antigens are not restrict to humans, analyses them in others species, for instance non-human primates, may be crucial to understand the relationship between pathogens and ABO phenotypes. Despite of the relevance of this issue, in the last decade few studies have addressed, mainly in New World Monkeys (NWM, natural reservoir of tropical diseases in Amazon Region. In order to understand the evolution of the ABO system in the primates, it has been obtained the partial sequence of the most important exon of ABO gene (exon 7, in platyrrhini families: Atelidae, Pithecidae and Cebidae. Then, it has been compared the sequences obtained those present in the literature, and measured the selective pressure. The present results shown that residues 266 and 268 are also crucial to distinguish A and B phenotypes in the platyrrhines, such as in catarrhines, and the 266 codon is under positive selection, although the most site codons are under action of purifying selection.

  4. ABO blood group antigens in oral mucosa. What is new?

    DEFF Research Database (Denmark)

    Dabelsteen, Erik

    2002-01-01

    healing show similarly decreased expression of A/B antigens on migrating epithelial cells. Some studies suggest that the relationship between expression of blood group antigens and cell motility can be explained by different degrees of glycosylation of integrins. Changes in ABO expression in tumours have...

  5. Differential Rheology Among ABO Blood Group System In Nigerians ...

    African Journals Online (AJOL)

    Background: ABO blood groups have been reported to have rheological significance and association with different disease conditions. The non-O blood groups (A, B, and AB) have shown more susceptibility to arterial and venous thrombotic diseases with no rheological delineation. The determinants of these blood groups ...

  6. ABO blood groups and chicken pox in an Indian population.

    Science.gov (United States)

    Chakravartti, M R; Chakravartti, R

    1977-01-01

    ABO blood groups have been examined in a sample of 400 chicken-pox patients and their 383 unaffected siblings from Hyderabad, Andhra Pradesh, India. Subjects of blood group A (and possibly AB) would appear to have a somewhat higher risk than persons with group B and O to develop chicken pox.

  7. Estimation of allelic frequencies for ABO and Rh blood groups

    African Journals Online (AJOL)

    Mostafa Saadat

    2015-02-18

    Feb 18, 2015 ... Estimation of allelic frequencies for ABO and Rh blood groups. Dear Editor. Estimation of the allelic frequencies for genetic markers is very important in genetic studies. Also investigation of the concordance between observed and expected value based on the Hardy–Weinberg equilibrium (HWE) is strongly ...

  8. Structural stability and formability of ABO3-type perovskite compounds

    International Nuclear Information System (INIS)

    Zhang Huan; Li Na; Li Keyan; Xue Dongfeng

    2007-01-01

    On the basis of the bond-valence model (BVM) and structure-map technology, the structural stability and formability of ABO 3 -type perovskite compounds were investigated in 376 ABO 3 -type compounds. A new criterion of structural stability for ABO 3 -type perovskite compounds has been established by the bond-valence calculated tolerance factors, which are in the range 0.822-1.139. All global instability indices for ABO 3 -type perovskite compounds are found to be less than 1.2 v.u. (valence units) and increase with a decrease in oxidation state of the B cations (i.e. structural stability in the formation of an ideal cubic perovskite follows the order A + B 5+ O 3 -type > A 2+ B 4+ O 3 -type > A 3+ B 3+ O 3 -type). Three new two-dimensional structure maps were constructed based on the ideal A-O and B-O bond distances derived from the BVM. These maps indicate the likelihood of particular perovskite compounds being formed. The present work enables novel perovskite and perovskite-related compounds to be explored by screening all the possible elemental combinations in future crystal engineering. (orig.)

  9. ABO locus O1 allele and risk of myocardial infarction.

    Science.gov (United States)

    von Beckerath, Nicolas; Koch, Werner; Mehilli, Julinda; Gorchakova, Olga; Braun, Siegmund; Schömig, Albert; Kastrati, Adnan

    2004-01-01

    An association between ABO blood group and myocardial infarction (MI) has been described. One probable mechanism underlying this association is the influence of ABO blood group on plasma von Willebrand factor (vWF) levels. We conducted this genetic study to test whether the ABO O1 allele is associated with low vWF plasma levels and with a reduced risk of MI. Cases consisted of 793 consecutive, angiographically examined patients with either acute or prior MI. As controls served 340 angiographically examined patients with neither coronary artery disease nor signs of MI. ABO1 locus alleles (A1, A2, B, O1, O2) were identified with polymerase chain reaction and fluorogenic probes. The distribution of O1 alleles in the MI group versus the control group was: no O1 allele (15.4%/10.0%), one O1 allele (49.7%/50.0%) and two O1 alleles (34.9%/40.0%) (P = 0.035). O1 allele carriage was associated with a 39% reduction in the risk of MI unadjusted odds ratio, 0.61; 95% confidence interval, 0.41-0.91). The significant association was maintained after adjustment for other cardiovascular risk factors. vWF antigen levels correlated with the number of O1 alleles (P = 0.00003) in a separate control group (n = 164). Carriage of the O1 allele is associated with a decreased risk of myocardial infarction, with homozygosity providing the greatest protection. Copyright 2004 Lippincott Williams and Wilkins

  10. Relationship between ABO Blood Group and ABH Secretor Status in ...

    African Journals Online (AJOL)

    BACKGROUND: The determination of ABO Blood groups and ABH secretor status in blood and body fluid antigens respectively may have certain structural and disease related genetic linkages, hence the need to establish relationship between blood group and secretor status in the population. METHOD: A total of 256 ...

  11. Prevalence Of Rh And ABO Blood Groups In HIV Seropositive ...

    African Journals Online (AJOL)

    The obvious absence of Rh- in AB group suggests that AB may have a higher percentage of protection against immunization. Hence in group B, less incidence of Rh incompatibility and haemolytic disease of the young in the mothers in blood group AB will occur. Key words: Rhesus genes, ABO blood groups, prevalence, ...

  12. Association of ABO blood group and Plasmodium falciparum ...

    African Journals Online (AJOL)

    This study investigated the distribution of these blood group systems and assessed the association of malaria infection with the ABO blood groups among children in Federal Capital Territory, Abuja. Blood specimens from deep finger pricks of 730 children aged between 0-2 years were examined for malaria parasites using ...

  13. Trasplante de células madre de médula ósea asociado a derivación coronaria para el tratamiento de la insuficiencia cardíaca de tipo isquémico

    Directory of Open Access Journals (Sweden)

    Alfonso Rivas-Plata

    2008-07-01

    Conclusiones: El trasplante de células madre asociado a DC en pacientes con infarto de miocardio previo mejora significativamente la función ventricular izquierda en relación con el grupo control, y podría retrasar o evitar la indicación del trasplante cardíaco.

  14. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.

    Science.gov (United States)

    Nasseri, Fatemeh; Mamouri, Gholam A; Babaei, Homa

    2006-12-01

    To evaluate whether the use of intravenous immunoglobulin in newborn infants with isoimmune hemolytic jaundice due to Rh and ABO incompatibility is an effective treatment in reducing the need for exchange transfusion. This study included all direct Coombs' test positive Rh and ABO isoimmunized babies, who admitted in the Neonatal Intensive Care Unit of Ghaem Hospital of Mashhad University of Medical Sciences, Iran, from October 2003 to October 2004. Significant hyperbilirubinemia was defined as rising by >or=0.5 mg/dl per hour. Babies were randomly assigned to received phototherapy with intravenous immunoglobulin (IVIg) 0.5 g/kg over 4 hours, every 12 hours for 3 doses (study group) or phototherapy alone (control group). Exchange transfusion was performed in any group if serum bilirubin exceeded >or=20mg/dl or rose by >or=1mg/dl/h. A total of 34 babies were eligible for this study (17 babies in each group). The number of exchange transfusion, duration of phototherapy and hospitalization days, were significant shorter in the study group versus control group. When we analyzed the outcome results in ABO and Rh hemolytic disease separately, the efficacy of IVIg was significantly better in Rh versus ABO isoimmunization. Late anemia was more common in the IVIg group 11.8% versus 0%, p=0.48. Adverse effects were not observed during IVIg administration. Administration of IVIg to newborns with significant hyperbilirubinemia due to Rh hemolytic disease reduced the need for exchange transfusion but in ABO hemolytic disease there was no significant difference between IVIg and double surface blue light phototherapy.

  15. ABO incompatibility hemolytic disease following exchange transfusion 96 newborn

    Directory of Open Access Journals (Sweden)

    Khatami S.F

    2007-09-01

    Full Text Available Background: ABO incompatibility hemolytic disease of the newborn is a common cause of clinical jaundice and causes two-thirds of the hemolytic disease in newborns. This study was undertaken to determine the frequency of ABO incompatibility hemolytic disease and its complications in newborns undergoing exchange transfusion.Methods: This prospective and descriptive study was performed in jaundiced newborn infants during a three-year period. Inclusion criteria were: maternal blood type O, newborn blood type A or B, rising indirect hyperbilirubinemia in the first two days of life, positive immunohematologic test for newborns and exchange transfusion. Exclusion criteria were: incomplete information, other accompanying diseases that induce hyperbilirubinemia. All newborn infants received phototherapy before and after exchange transfusion. We did not use intravenous immunoglobulin, hemoxygenase inhibitor drugs and blood products before exchange transfusion.Results: Double-volume exchange transfusion via umbilical cord catheter was performed in 96 patients, 19 (20% of whom suffered from ABO incompatibility. Of these 19 newborns, two-thirds (13 were preterm infants. The minimum level of serum bilirubin was 10 mg/dl and the maximum serum bilirubin level was 35 mg/dl. In six patients (32% serum bilirubin levels were >25mg/dl. The most common blood group was type A for newborns. Immunohematologic tests were positive in 84% of the mothers. ABO incompatibility hemolytic disease was the fourth and second most common reasons for blood exchange transfusion in preterm and term infants, respectively. Laboratory complications were more common than clinical complications. The etiology of 48% of the alloimmunization and 42% of the hemolytic disease in these newborns was ABO incompatibility.Conclusions: Mothers with blood group O and newborns with blood group A or B with positive immunohematologic tests in first hours of life are at high risk for hemolytic disease

  16. Hyperuricemia and Acute Renal Failure in Renal Transplant Recipients Treated With High-Dose Mizoribine.

    Science.gov (United States)

    Akioka, K; Ishikawa, T; Osaka, M; Kadotani, Y; Okugawa, K; Nakano, K; Osaka, Y; Tsuchiya, K; Sako, H

    Hyperuricemia is a common adverse event frequently found in renal transplant recipients with mizoribine (MZ). Hyperuricemia itself will be a cause of renal dysfunction, and renal dysfunction also will be a cause of hyperuricemia simultaneously. This study investigates frequency of hyperuricemia and renal failure in renal transplant recipients treated with high-dose MZ. From December 2007 to October 2015, there was a total of 32 living related renal transplant recipients treated with high-dose MZ. Of the 32 patients, 28 were treated with urate-lowering medications. One patient received allopurinol (AP) and 13 patients received benzbromarone (BB). For 6 of them, their urate-lowering medications were converted to febuxostat (FX) form AP or BB. In the remaining 14 patients, FX was administered from the beginning. In 2 cases of ABO-incompatible living related renal transplant recipients who were maintained with high-dose MZ and BB, severe hyperuricemia and acute renal failure occurred. One patient was a 48-year-old man, and his creatinine (Cr) level increased to 8.14 mg/dL and his serum uric acid (UA) was 24.6 mg/dL. Another patient was a 57-year-old man, and his Cr level increased to 3.59 mg/dL and his UA was 13.2 mg/dL. In both cases Cr and UA were improved, and no finding of acute rejection and drug toxicity was observed in graft biopsy specimens. BB was switched to FX and discontinuance or reduction of MZ was done. Combination of MZ and BB has the risk of acute renal dysfunction after renal transplantation. Latent renal dysfunction should be watched for in renal transplant recipients receiving high-dose MZ. Copyright © 2016 Elsevier Inc. All rights reserved.

  17. Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.

    Science.gov (United States)

    Kawaguchi, Keiko; Kawanishi, Kunio; Sato, Masayo; Itabashi, Mitsuyo; Fujii, Akiko; Kanetsuna, Yukiko; Huchinoue, Shouhei; Ohashi, Ryuji; Koike, Junki; Honda, Kazuho; Nagashima, Yoji; Nitta, Kosaku

    2015-07-01

    Atypical hemolytic uremic syndrome (aHUS) in allograft kidney transplantation is caused by various factors including rejection, infection, and immunosuppressive drugs. We present a case of a 32 year old woman with aHUS four years after an ABO-incompatible kidney transplantation from a living relative. The primary cause of end-stage renal disease was unknown; however, IgA nephropathy (IgAN) was suspected from her clinical course. She underwent pre-emptive kidney transplantation from her 60 year old mother. The allograft preserved good renal function [serum creatinine (sCr) level 110-130 μmol/L] until a sudden attack of abdominal pain four years after transplant, with acute renal failure (sCr level, 385.3 μmol/L), decreasing platelet count, and hemolytic anemia with schizocytes. On allograft biopsy, there was thrombotic microangiopathy in the glomeruli, with a cellular crescent formation and mesangial IgA and C3 deposition. Microvascular inflammation, such as glomerulitis, peritubular capillaritis, and arteriole endarteritis were also detected. A disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13 (ADAMTS13) did not decrease and Shiga toxin was not detected. Donor-specific antibodies or autoantibodies, including anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane (anti-GBM) antibody, were negative. The patient was diagnosed with aHUS and received three sessions of plasmapheresis and methylprednisolone pulse therapy, followed by oral methylprednisolone (0.25-0.5 mg/kg) instead of tacrolimus. She temporarily required hemodialysis (sCr level, 658.3 μmol/L). Thereafter, her sCr level improved to 284.5 μmol/L without dialysis therapy. This case is clinically considered as aHUS after kidney transplantation, associated with various factors, including rejection, glomerulonephritis, and toxicity from drugs such as tacrolimus. © 2015 Asian Pacific Society of Nephrology.

  18. CALIDAD DE VIDA RELACIONADA CON LA SALUD INFANTIL Y EL TRASPLANTE DE ÓRGANOS: UNA REVISIÓN DE LITERATURA

    Directory of Open Access Journals (Sweden)

    Elisa Kern de Castro

    2005-06-01

    Full Text Available En el presente artículo los autores revisan algunas cuestiones teóricas y estudios empíricos sobre la calidad de vida relacionada con la salud infantil, en especial en niños con enfermedades crónicas que necesitan trasplantes de órganos. Pocas investigaciones han sido realizadas sobre el tema hasta el momento. Sus resultados han mostrado que el trasplante mejora el bienestar físico pero no hay conclusiones definitivas sobre su relación con el bienestar psicológico. Se discute la necesidad de evaluar los efectos del trasplante de órganos pediátrico en cada fase evolutiva, en distintos órganos y en diversas culturas.

  19. Calidad de vida relacionada con la salud infantil y el trasplante de órganos: una revisión de literatura

    Directory of Open Access Journals (Sweden)

    Bernardo Moreno-Jiménez

    2005-01-01

    Full Text Available En el presente artículo los autores revisan algunas cuestiones teóricas y estudios empíricos sobre la calidad de vida relacionada con la salud infantil, en especial en niños con enfermedades crónicas que necesitan trasplantes de órganos. Pocas investigaciones han sido realizadas sobre el tema hasta el momento. Sus resultados han mostrado que el trasplante mejora el bienestar físico pero no hay conclusiones definitivas sobre su relación con el bienestar psicológico. Se discute la necesidad de evaluar los efectos del trasplante de órganos pediátrico en cada fase evolutiva, en distintos órganos y en diversas culturas.

  20. Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?

    OpenAIRE

    Beken, Serdar; Hirfanoglu, Ibrahim; Turkyilmaz, Canan; Altuntas, Nilgun; Unal, Sezin; Turan, Ozden; Onal, Esra; Ergenekon, Ebru; Koc, Esin; Atalay, Yildiz

    2012-01-01

    Intravenous Immunoglobulin G (IVIG) therapy has been used as a component of the treatment of hemolytic disease of the newborn. There is still no consensus on its use in ABO hemolytic disease of the newborn routinely. The aim of this study is to determine whether administration of IVIG to newborns with ABO incompatibility is necessary. One hundred and seventeen patients with ABO hemolytic disease and positive Coombs test were enrolled into the study. The subjects were healthy except jaundice. ...

  1. Is there an association between ABO blood grouping and periodontal disease? A literature review

    OpenAIRE

    Al-Askar, Mansour

    2017-01-01

    Introduction Although several studies have investigated the relationship between ABO blood group and medical diseases, few reports have explored the association with oral diseases, including periodontal disease (PD). Aim The aim of this literature review was to assess the association between the ABO blood grouping and PD. Methods We searched PubMed and Google Scholar databases using the following terms in different combinations: “ABO blood group,” “periodontitis,” “aggressive periodontitis (A...

  2. ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.

    Science.gov (United States)

    Kim, Jong Man; Kwon, Choon Hyuck David; Joh, Jae-Won; Han, Sangbin; Yoo, Jeejin; Kim, Kyunga; Sinn, Dong Hyun; Choi, Gyu-Seong; Gerber, David A; Egawa, Hiroto; Lee, Suk-Koo

    2018-02-28

    ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) has a high success rate. This study compares HCC recurrence in ABO-I LDLT with that in ABO-compatible (ABO-C) LDLT and explores the effects of rituximab prophylaxis and total plasma exchange (TPE) on HCC recurrence after LDLT. Two-hundred forty patients with a diagnosis of HCC underwent LDLT between 2010 and 2015. Fifty-nine patients underwent ABO-I LDLT. Baseline, perioperative, and tumor characteristics did not vary between the two groups. The 1-, 2-, and 3-year disease-free survival rates in the ABO-I LDLT and ABO-C LDLT groups were 90.3%, 79.7%, and 73.3% and 86.7%, 79.0%, and 75.3%, respectively (p=0.96). The overall patient survival rates for the same period in the ABO-I LDLT and ABO-C LDLT groups were 90.6%, 85.0%, and 81.9% and 88.0%, 83.5%, and 82.5%, respectively (p=0.77). HCC recurrence after LDLT was associated with preoperative alpha-fetoprotein >35 ng/mL, increased tumor size, encapsulation, and microvascular invasion. ABO-incompatibility was not related to HCC recurrence after LDLT. HCC recurrence and patient survival in the ABO-I LDLT group are comparable to those in the ABO-C LDLT group. Rituximab prophylaxis and TPE do not increase HCC recurrence after LT.

  3. Molecular genotyping of ABO blood groups in some population groups from India.

    Science.gov (United States)

    Ray, Sabita; Gorakshakar, Ajit C; Vasantha, K; Nadkarni, Anita; Italia, Yazdi; Ghosh, Kanjaksha

    2014-01-01

    Indian population is characterized by the presence of various castes and tribal groups. Various genetic polymorphisms have been used to differentiate among these groups. Amongst these, the ABO blood group system has been extensively studied. There is no information on molecular genotyping of ABO blood groups from India. Therefore, the main objective of this study was to characterize the common A, B and O alleles by molecular analysis in some Indian population groups. One hundred samples from the mixed population from Mumbai, 101 samples from the Dhodia tribe and 100 samples from the Parsi community were included in this study. Initially, the samples were phenotyped by standard serologic techniques. PCR followed by single strand conformational polymorphsim (SSCP) was used for molecular ABO genotyping. Samples showing atypical SSCP patterns were further analysed by DNA sequencing to characterize rare alleles. Seven common ABO alleles with 19 different genotypes were found in the mixed population. The Dhodias showed 12 different ABO genotypes and the Parsis revealed 15 different ABO genotypes with six common ABO alleles identified in each of them. Two rare alleles were also identified. This study reports the distribution of molecular genotypes of ABO alleles among some population groups from India. Considering the extremely heterogeneous nature of the Indian population, in terms of various genotype markers like blood groups, red cell enzymes, etc., many more ABO alleles are likely to be encountered.

  4. Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos

    Science.gov (United States)

    Akanmu, Alani Sulaimon; Oyedeji, Olufemi Abiola; Adeyemo, Titilope Adenike; Ogbenna, Ann Abiola

    2015-01-01

    Background. ABO hemolytic disease of the newborn is the most common hemolytic consequence of maternofetal blood group incompatibility restricted mostly to non-group-O babies of group O mothers with immune anti-A or anti-B antibodies. Aim. We estimated the risk of ABO HDN with view to determining need for routine screening for ABO incompatibility between mother and fetus. Materials and Methods. Prevalence of ABO blood group phenotypes in blood donors at the donor clinic of the Lagos University Teaching Hospital and arithmetic methods were used to determine population prevalence of ABO genes. We then estimated proportion of pregnancies of group O mothers carrying a non-group-O baby and the risk that maternofetal ABO incompatibility will cause clinical ABO HDN. Results. Blood from 9138 donors was ABO typed. 54.3%, 23%, 19.4%, and 3.3% were blood groups O, A, B, and AB, respectively. Calculated gene frequencies were 0.1416, 0.1209, and 0.7375 for A, B, and O genes, respectively. It was estimated that 14.3% of deliveries will result in a blood group O woman giving birth to a child who is non-group-O. Approximately 4.3% of deliveries are likely to suffer ABO HDN with 2.7% prone to suffer from moderately severe to severe hemolysis. PMID:26491605

  5. Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos.

    Science.gov (United States)

    Akanmu, Alani Sulaimon; Oyedeji, Olufemi Abiola; Adeyemo, Titilope Adenike; Ogbenna, Ann Abiola

    2015-01-01

    Background. ABO hemolytic disease of the newborn is the most common hemolytic consequence of maternofetal blood group incompatibility restricted mostly to non-group-O babies of group O mothers with immune anti-A or anti-B antibodies. Aim. We estimated the risk of ABO HDN with view to determining need for routine screening for ABO incompatibility between mother and fetus. Materials and Methods. Prevalence of ABO blood group phenotypes in blood donors at the donor clinic of the Lagos University Teaching Hospital and arithmetic methods were used to determine population prevalence of ABO genes. We then estimated proportion of pregnancies of group O mothers carrying a non-group-O baby and the risk that maternofetal ABO incompatibility will cause clinical ABO HDN. Results. Blood from 9138 donors was ABO typed. 54.3%, 23%, 19.4%, and 3.3% were blood groups O, A, B, and AB, respectively. Calculated gene frequencies were 0.1416, 0.1209, and 0.7375 for A, B, and O genes, respectively. It was estimated that 14.3% of deliveries will result in a blood group O woman giving birth to a child who is non-group-O. Approximately 4.3% of deliveries are likely to suffer ABO HDN with 2.7% prone to suffer from moderately severe to severe hemolysis.

  6. Pseudo-obstrucción colónica aguda (síndrome de Ogilvie post-trasplante renal

    Directory of Open Access Journals (Sweden)

    Erik Antonio Mier Escurra

    2016-07-01

    Conclusiones: Se reporta este caso debido a que es un síndrome muy raro en la edad pediátrica, existe poca sospecha clínica y hacen falta guías de manejo para el diagnóstico y tratamiento en pacientes infantiles.

  7. Trasplantation of larynx and trachea: both a present and future option Trasplantes de la laringe y tráquea, una opción para el presente y el futuro

    Directory of Open Access Journals (Sweden)

    Francisco Martínez

    2004-01-01

    Full Text Available

    Lost functions of the larynx and the trachea may be restored by different means, but none of them is physiologic and patients are left with functional difficulties and self-esteem disorders that alter the quality of their lives.  Transplantation of these organs is an useful alternative but certain basic requirements concerning revascularization, reinnervation and immunosupression should be fulfilled.  The former has been achieved through the knowledge of vascular territories and the advances in surgical techniques.  Difficulties for reinnervation have no yet been thoroughly overcome but tone can be achieved in the vocal folds and functionality may be obtained by manipulation of their position.  Immunosupression is produced with cyclosporine which requirements were determined in experimental models.  The main reason for carrying out these and other transplantations is to improve the quality of life of persons who have suffered the loss of an organ.  A review is presented on important aspects that have to be taken into account when performing these transplantations.

    Las funciones perdidas de la laringe o la tráquea se pueden reemplazar de diferentes maneras; sin embargo, ninguna alternativa es fisiológica y los trasplantes quedan con dificultades funcionales y de autoestima que alteran la calidad de sus vidas,  El Trasplante de estos órganos es una alternativa útil, pero deben cumplirse ciertos requisitos básicos en cuanto a la revascularización, la reinervación y la imunosupresión.  El primero se logró con el conocimiento de los territorios vasculares y los avances en las técnicas quirúrgicas.  Las dificultades para la reinervación todavía no se han superado totalmente, pero se puede lograr tono en los pliegues vocales y obtener funcionalidad manipulando su posición.  la inmunosupresión se logra con ciclosporina cuyos requerimientos se definieron en modelos experimentales.  La principal razón para hacer estos y

  8. Supervivencia en pacientes con trasplante hepático realizado en la Fundación Cardioinfantil entre 2005 y 2013

    OpenAIRE

    Olarte Parra, Camila; Otero Arrázola, Lina María

    2015-01-01

    Introducción: El trasplante hepático es la terapia de elección para los pacientes con enfermedad hepática terminal, logrando mejorar su expectativa y calidad de vida, de acuerdo a estudios realizados en otros países. En la Fundación Cardioinfantil – Instituto de Cardiología (FCI-IC) se han realizado 332 trasplantes hepáticos hasta el 2014, pero no se conoce la supervivencia y los factores pronósticos propios de los pacientes intervenidos. Objetivo Principal: Estimar la supervivencia a 1,...

  9. Evaluación de una herramienta educativa en conocimiento de donación y trasplante de órganos y tejidos en Colombia

    OpenAIRE

    Gómez Bossa, Mauricio Andrés; Mijares Benavides, Cesar Augusto

    2014-01-01

    El trasplante de órganos es considerado uno de los avances más significativos de la medicina moderna y es un procedimiento cada vez más exitoso en términos de supervivencia de los pacientes, siendo actualmente la mejor opción de tratamiento para los pacientes con innumerables patologías. El proceso de donación es insuficiente para cubrir las necesidades de trasplante de la población, por lo tanto, se hace necesario el desarrollo de nuevas estrategias para fortalecer la experiencia y efectiv...

  10. Hepatitis C tras el trasplante hepático: Historia natural y factores de riesgo de evolución desfavorable.

    OpenAIRE

    Berenguer Haym, Marina

    2001-01-01

    La infección por el virus de la hepatitis C (VHC) tiene gran importancia a nivel del trasplante hepático (HC) por varias razones. Por lo tanto, resulta de una gran importancia establecer el pronóstico post-trasplante en dichos casos.El objetivo del presente proyecto de tesis fue, por un lado, definir la historia natural de la hepatitis C postrasplante en nuestro medio; y por otro, establecer los factores de riesgo de evolución desfavorable. Dicha información es fundamental para validar la ido...

  11. ABO Blood Group and Risk of Thromboembolic and Arterial Disease

    DEFF Research Database (Denmark)

    Vasan, Senthil K; Rostgaard, Klaus; Majeed, Ammar

    2016-01-01

    BACKGROUND: ABO blood groups have been shown to be associated with increased risks of venous thromboembolic and arterial disease. However, the reported magnitude of this association is inconsistent and is based on evidence from small-scale studies. METHODS AND RESULTS: We used the SCANDAT2...... (Scandinavian Donations and Transfusions) database of blood donors linked with other nationwide health data registers to investigate the association between ABO blood groups and the incidence of first and recurrent venous thromboembolic and arterial events. Blood donors in Denmark and Sweden between 1987......-up. Compared with blood group O, non-O blood groups were associated with higher incidence of both venous and arterial thromboembolic events. The highest rate ratios were observed for pregnancy-related venous thromboembolism (incidence rate ratio, 2.22; 95% confidence interval, 1.77-2.79), deep vein thrombosis...

  12. Qualitative analysis fingertip patterns in ABO blood group

    Directory of Open Access Journals (Sweden)

    S. V. KShirsagar

    2013-01-01

    Full Text Available The inheritance of the dermatoglyphic patterns is polygenic. The genetic basis of the blood group is well established. The correlation between the dermatoglyphic patterns and the ABO blood group is studied by some workers in different populations. In the present study, the correlation between dermatoglyphics and ABO blood group is studied in the Marathwada Region of Maharashtra. The qualitative data included fingertip patterns and three indices. It was observed that, the Arch pattern is more common in blood group O both in male and female. Ulnar loop is most common in the blood group AB. Simple whorl and double loop whorl patterns are less frequent in blood group AB. Accidentals were not recorded in blood group A while blood group O show highest percentage of accidentals. Dankmeijer’s index was highest in blood group AB and lowest in blood group B.

  13. Qualitative analysis fingertip patterns in ABO blood group

    Directory of Open Access Journals (Sweden)

    S. V. KShirsagar

    2013-05-01

    Full Text Available The inheritance of the dermatoglyphic patterns is polygenic. The genetic basis of the blood group is well established. The correlation between the dermatoglyphic patterns and the ABO blood group is studied by some workers in different populations. In the present study, the correlation between dermatoglyphics and ABO blood group is studied in the Marathwada Region of Maharashtra. The qualitative data included fingertip patterns and three indices. It was observed that, the Arch pattern is more common in blood group O both in male and female. Ulnar loop is most common in the blood group AB. Simple whorl and double loop whorl patterns are less frequent in blood group AB. Accidentals were not recorded in blood group A while blood group O show highest percentage of accidentals. Dankmeijer’s index was highest in blood group AB and lowest in blood group B.

  14. ALLOTRANSPLANTATION OF ABO-INCOMPATIBLE KIDNEYS IN CHILDREN

    Directory of Open Access Journals (Sweden)

    V. A. Goryaynov

    2012-01-01

    Full Text Available At present the problem of donor organs for transplantation shortage remains unsolved. Cautious and mixed attitude towards the transplantation of incompatible kidneys remains, while it could considerably reduce the donor organ waiting time for a recipient. Experience of 19 allotransplantations of ABO-incompatible kidneys in children is analyzed in the article. A group of 14 patients who received ABOcompatible kidneys was chosen for the comparative analysis. Such parameters as the assessment of function of allotransplanted kidneys, morphology character comparison of biopsy materials of allo-kidneys in both groups, actuarial survival rate of the recipients with functioning allografts are used to assess the results. Comparison of the aforementioned parameters showed practically the same results, and that enables us to assert that transplantations of kidneys of ABO-incompatible donors have the right to exist.

  15. Influencia de cuatro distancias de trasplante sobre el rendimiento agrícola del cultivar de arroz Amistad-82.

    Directory of Open Access Journals (Sweden)

    Alexander Calero Hurtado

    2012-04-01

    Full Text Available El trabajo consistió en comparar cuatro distancias de trasplante sobre el rendimiento agrícola del cultivar de arroz Amistad-82, durante la siembra de primavera de 2012, el trasplante se realizó de forma manual, sobre un suelo pardo sialítico carbonatado en la finca “La Rosita” perteneciente a la CCS “Heriberto Orellane”, en la provincia de Sancti Spíritus, se utilizó un diseño de bloques al azar, se tomaron posturas jóvenes de 18 días de germinadas, cuatro distancias de plantación 10x15, 15x15, 20x15 y 20x20 cm y una postura por sitio. Se evaluaron los indicadores productivos como el número de tallos, panículas por metro cuadrado, longitud de la panícula, granos por panículas, granos llenos y vanos por panículas, peso de 1000 granos, el rendimiento, así como las ganancias y los costos de producción. Los mejores resultados sobre el rendimiento agrícola del cultivar de arroz Amistad-82 lo alcanzaron las distancias de trasplante 10x15 y 20x15 cm, porque lograron rendimientos superiores a las distancias 15x15 y 20x20 cm, mayor cantidad de granos por panículas y mayores porcentajes de granos llenos por panículas y superaron también el peso en 1000 granos y las ganancias.

  16. A Survey of ABO, Rhesus (D) Antigen and Haemoglobin Genes ...

    African Journals Online (AJOL)

    olayemitoyin

    while 5.5% were Rh(D) negative respectively based on the detection (Positive) or absence (Negative) of Rh(D) antigen. 22.8% of the subjects had ABO blood group A, 26.4% were group B, 4.1% were group AB while 46.7% were group O. Further analysis revealed that 695 (21.4%) of the group A were Apositive while 44 ...

  17. Polymorphisms at the ABO locus in subgroup A individuals.

    Science.gov (United States)

    Olsson, M L; Chester, M A

    1996-04-01

    The common ABO allele sequences are known, but little or no genetic information is available on the rare but important A subgroups. Blood group ABO polymorphism was analyzed in genomic DNA from 45 rare subgroup A individuals by sequence-specific primer polymerase chain reaction and amplified fragment length polymorphism investigating exons VI and VII in the ABO genes. These methods are used to detect specific mutations only, and not all changes that might be present can be detected. ABO genotypes discriminating six alleles (A1, A2, B, O1, O1var, and O2) were determined. The C-->T substitution at nucleotide position 467 (C467T) is not restricted to A2 and cis-AB individuals, but was found also in some A subgroups. Detection of the functionally more relevant C1060-single-point deletion in A2 was accomplished by a novel sequence-specific primer polymerase chain reaction approach. A 100-percent correlation between the C467T and the C1060-mutations was found. Fifteen of 17 samples showing the T646A mutation (described earlier in one case of Ax) showed a positive correlation with the C771T mutation in a frequently occurring O1var allele. The two exceptions were defined serologically as Ax. Indications have been found of an evolutionary relationship between A1 alleles and Ael and A3 subgroups as well as between A2 alleles and Aend and Aweak subgroups. Genetic heterogeneity within the Ax and Aint subgroups was also seen.

  18. Blood type, ABO genetic variants, and ovarian cancer survival

    Science.gov (United States)

    Cozzi, Gabriella D.; Levinson, Rebecca T.; Toole, Hilary; Snyder, Malcolm-Robert; Deng, Angie; Crispens, Marta A.; Khabele, Dineo; Beeghly-Fadiel, Alicia

    2017-01-01

    Objective Blood type A and the A1 allele have been associated with increased ovarian cancer risk. With only two small studies published to date, evidence for an association between ABO blood type and ovarian cancer survival is limited. Methods We conducted a retrospective cohort study of Tumor Registry confirmed ovarian cancer cases from the Vanderbilt University Medical Center with blood type from linked laboratory reports and ABO variants from linked Illumina Exome BeadChip data. Associations with overall survival (OS) were quantified by hazard ratios (HR) and confidence intervals (CI) from proportional hazards regression models; covariates included age, race, stage, grade, histologic subtype, and year of diagnosis. Results ABO phenotype (N = 694) and/or genotype (N = 154) data were available for 713 predominantly Caucasian (89.3%) cases. In multivariable models, blood type A had significantly better OS compared to either O (HR: 0.75, 95% CI: 0.60–0.93) or all non-A (HR: 0.77, 95% CI: 0.63–0.94) cases. Similarly, missense rs1053878 minor allele carriers (A2) had better OS (HR: 0.50, 95% CI: 0.25–0.99). Among Caucasians, this phenotype association was strengthened, but the genotype association was attenuated; instead, four variants sharing moderate linkage disequilibrium with the O variant were associated with better OS (HR: 0.62, 95% CI: 0.39–0.99) in unadjusted models. Conclusions Blood type A was significantly associated with longer ovarian cancer survival in the largest such study to date. This finding was supported by genetic analysis, which implicated the A2 allele, although O related variants also had suggestive associations. Further research on ABO and ovarian cancer survival is warranted. PMID:28448592

  19. Infección por virus BK en paciente pediátrico trasplantado renal BK virus infection in a pediatric renal transplant recipient

    Directory of Open Access Journals (Sweden)

    R. Bonaventura

    2005-09-01

    Full Text Available El poliomavirus humano BK causa infección primaria asintomática en la niñez, estableciendo latencia principalmente en el tracto urinario. En individuos con alteración en la inmunidad celular se puede producir su reactivación desencadenando patología a nivel renal. Por estas razones es particularmente importante en la población pediátrica trasplantada renal, en la que puede producir la infección primaria cuando el paciente está inmunosuprimido. En nuestro trabajo se realizó el seguimiento de un paciente de 5 años trasplantado renal en octubre de 2003 que 45 días post-trasplante sufrió un deterioro del órgano injertado. Desde la fecha del trasplante hasta junio de 2004 se produjeron 3 episodios de alteración en la función renal, durante los cuales se analizaron muestras de sangre, orina, biopsia renal y líquido de linfocele. Para el diagnóstico difererencial entre rechazo agudo versus causa infecciosa se emplearon técnicas de detección para los virus BK, CMV y ADV, además del estudio citológico del tejido renal. Los resultados obtenidos junto con la clínica del paciente indican un probable caso de infección por BK. La importancia de realizar el diagnóstico diferencial entre rechazo agudo y la infección por BK radica en que la conducta en cuanto a la terapia inmunosupresora es opuesta en cada caso.BK Human Polyomavirus causes an asymptomatic primary infection in children, then establishing latency mainly in the urinary tract. Viral reactivation can lead to renal pathology in individuals with impaired cellular immune response. This is particularly important in pediatric transplant recipients, who can suffer a primary infection when immunosupressed. We followed up the case of a 5 years old patient who received a renal transplant in October 2003, and presented damaged graft 45 days after the intervention. The patient suffered 3 episodes of renal function failure between October 2003 and June 2004. Blood, urine, renal biopsy

  20. Trasplante de células madre hematopoyéticas a embriones preinmunes vía celocentesis

    OpenAIRE

    León Luis, Juan Antonio

    2004-01-01

    La terapia celular mediante la introducción de células madre hematopoyéticas en un paciente afecto de una enfermedad susceptible de tratamiento, es una forma de terapia génica. El alo-trasplante de células madre hematopoyéticas ocurre de forma natural en embarazos gemelares dicigóticos, que establecen comunicaciones placentarias en útero. Esto se debe a que diversas características del embrión en desarrollo, brindan la oportunidad de tolerar sangre de un donante durante este periodo. Si se pe...

  1. Distribution of ABO Blood Groups and Coronary Artery Calcium.

    Science.gov (United States)

    Wang, Yao; Zhou, Bing-Yang; Zhu, Cheng-Gang; Guo, Yuan-Lin; Wu, Na-Qiong; Qing, Ping; Gao, Ying; Liu, Geng; Dong, Qian; Li, Jian-Jun

    2017-06-01

    ABO blood groups have been confirmed to be associated with cardiovascular diseases such as coronary artery disease. However, whether ABO blood group is correlated with coronary artery calcium (CAC) is still unknown. 301 patients with coronary artery calcium score (CACS) assessed by computed tomography were consecutively enrolled and divided into two groups: with calcium group (CACS>0, n=104) and without calcium group (CACS=0, n=197). Distribution of ABO blood groups was evaluated between the two groups. The percentage of A blood type was significantly higher (p=0.008) and O blood type was significantly lower (p=0.037) in the calcium group. Univariate regression analysis showed that age, total cholesterol, low density lipoprotein cholesterol, high-sensitivity C-reactive protein, A blood type were positively correlated with CAC, and O blood type was inversely associated with CAC. Multivariate regression analysis showed that A blood type was independently associated with CAC (odds ratio: 2.217, 95% confidence interval: 1.260-3.900, p=0.006) even after further adjustment for variables that were clearly different between the two groups. Our data has suggested for the first time that A blood type was an independent risk marker for CAC. Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

  2. Costos de intervenciones para pacientes con insuficiencia renal crónica

    Directory of Open Access Journals (Sweden)

    Arredondo Armando

    1998-01-01

    Full Text Available INTRODUCCIÓN: Se presentan resultados sobre un estudio que pretendió identificar los costos de intervenciones en salud en el manejo de pacientes con insuficiencia renal crónica. MATERIAL Y MÉTODO: El método de costeo se basó en técnicas de consenso y de instrumentación de manejo de caso a través de la identificación de insumos y funciones de producción para la demanda de cada servicio solicitado. Las intervenciones costeadas incluyeron: diálisis peritoneal, hemodiálisis y trasplante renal. RESULTADOS: El costo por evento en US dóllares fué de $3.71, $57.95 y $ 8,778.32 respectivamente. En cuanto al costo de manejo anual de caso los resultados fueron: diálisis peritoneal $5,643.07, hemodiálisis $9,631.60 y trasplante $3,021.67. CONCLUSIONES: La información generada a partir de los costos de eventos difiere considerablemente de la información generada a partir del costo de manejo anual de caso. Estas diferencias resultan significativas para el diseño y evaluación de patrones de asignación de recursos

  3. Gene frequencies of ABO and Rh blood groups in Nigeria: A review ...

    African Journals Online (AJOL)

    Background: ABO and Rhesus factor (Rh) blood type are germane in human life in genetics and clinical studies. Aim of the study: The review was undertaken with the objective to provide data on the ABO and Rh(D) blood group distribution and gene frequency across Nigeria which is vital for blood transfusion and ...

  4. Distribution of ABO and Rh-Hr blood group antigens, alleles and ...

    African Journals Online (AJOL)

    ABO and Rh-Hr blood group antigens represent a genetically stably determined trait with many-sided biological and clinical significance. The indigenous Ajarian population (105 subjects) was investigated for ABO Rh-Hr red cell blood group antigens. Using immunoserologic methods, seven blood group antigens (A, B, C, c, ...

  5. Distribution of Abo and Rhesus D blood groups among the Bini ...

    African Journals Online (AJOL)

    Background: ABO and Rhesus (Rh) blood group antigens are hereditary characters and are useful in population genetic studies, in resolving medico-legal issues and more important in planning blood utilization by health care service providers and policy markers. In Nigeria, the prevalence of ABO and Rhesus D blood ...

  6. Distribution of ABO Blood Groups in a Tertiary Care Centre in North ...

    African Journals Online (AJOL)

    Background: ABO blood group antigens are hereditary, and are the most important compatibility test in any blood transfusion service. These antigens are also important in genetic studies, and in resolving medico-legal issues. It is important to determine the ABO blood group in blood banking and transfusion medicine.

  7. The pattern of distribution of ABO blood groups in North Western ...

    African Journals Online (AJOL)

    Background: Everybody over the age of about six months has clinically significant anti-A or Anti-B in their serum, if they lack the corresponding antigens on their red cells. ABO blood group antigens are the most important in blood transfusion services. This study was to determine the current incidence of ABO blood group ...

  8. The Classroom-Friendly ABO Blood Types Kit: Blood Agglutination Simulation

    Science.gov (United States)

    Arnold, Savittree Rochanasmita; Kruatong, Tussatrin; Dahsah, Chanyah; Suwanjinda, Duongdearn

    2012-01-01

    The classroom-friendly ABO blood type kit was developed by combining advantages of modelling and a simulation laboratory to teach the topics of ABO blood types and blood transfusion. Teachers can easily simulate the agglutination reaction on a blood type testing plate in the classroom, and show the students how this reaction occurs by using the…

  9. Effects of ABO/Rh blood groups, G-6-P-D enzyme activity and ...

    African Journals Online (AJOL)

    Effects of ABO/Rh blood groups, G-6-P-D enzyme activity and haemoglobin. Theresa K Nkuo-Akenji, Paul Wepngong, Jane-Frances Akoachere. Abstract. The main objective was to investigate the effects of ABO/Rh blood groups, haemoglobin genotype and G-6-P-D enzyme activity on malaria. The study was carried out in ...

  10. Gene frequencies of ABO and Rh(D) blood group alleles in Lagos ...

    African Journals Online (AJOL)

    Subjects and methods: This study investigated the gene frequencies for the ABO and Rh(D) alleles in a population consisting of different ages in Lagos, Nigeria, over a period spanning 12 years (1998–2009). The 23,832 and 23,764 individuals were typed for ABO and Rh blood groups, respectively. We analyzed the ...

  11. Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?

    Science.gov (United States)

    Zhou, Shan; Welsby, Ian

    2014-09-26

    ABO blood type is one of the most readily available laboratory tests, and serves as a vital determinant in blood transfusion and organ transplantation. The ABO antigens are expressed not only on red blood cell membranes, determining the compatibility of transfusion, but also on the surface of other human cells, including epithelium, platelet and vascular endothelium, therefore extending the research into other involvements of cardiovascular disease and postoperative outcomes. ABO blood group has been recognized as a risk factor of venous thrombosis embolism since the 1960's, effects now understood to be related to ABO dependent variations are procoagulant factor VIII (FVIII) and von Willebrand factor (vWF) levels. Levels of vWF, mostly genetically determined, are strongly associated with venous thromboembolism (VTE). It mediates platelet adhesion aggregation and stabilizes FVIII in plasma. Moreover, many studies have tried to identify the relationship between ABO blood types and ischemic heart disease. Unlike the clear and convincing associations between VTE and ABO blood type, the link between ABO blood type and ischemic heart disease is less consistent and may be confusing. Other than genetic factors, ischemic heart disease is strongly related to diet, race, lipid metabolism and economic status. In this review, we'll summarize the data relating race and genetics, including ABO blood type, to VTE, ischemic heart disease and postoperative bleeding after cardiac surgery.

  12. [Effect of ABO-Incompatibility on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation].

    Science.gov (United States)

    Yang, Bing-Bing; Gan, Yi-Feng; Chen, Peng; Chen, Yi; Yu, Kang

    2017-04-01

    To investigate the effect of ABO-incompatibility on the efficacy and complications of allogeneic hematopoietic stem cell transplantation(HSCT). The clinical data of 54 recipients who received ABO-incompatible allo-HSCT were retrospectively analyzed and were compared with 54 ABO-identical recipients as controls. Hematopoietic reconstruction and the blood type conversion time were dynamically observed and compared between 2 groups. The time of erythrocyte reconstitution was prolonged to 24 d in ABO-incompatible group, compared with that of 19 d in ABO-compatible group (P0.05). Major mismatch group and bidirectional mismatch group required more erythrocyte transfusions than that of ABO-compatible group. The surface antigen of erythrocyte change in major mismatch group was earlier than that of minor mismatch group (Pdisease (aGVHD) and survival were not significantly different between 2 groups. ABO-incompatibility can not influence the effect of allo-HSCT, but ABO-incompatibility delayed erythrocyte recovery, and required more RBC and platelet transfusions.

  13. Gene frequencies of ABO and Rh blood groups in Nigeria: A review

    African Journals Online (AJOL)

    Abass Toba Anifowoshe

    2016-12-05

    Dec 5, 2016 ... Background: ABO and Rhesus factor (Rh) blood type are germane in human life in genetics and clinical studies. Aim of the study: The review was undertaken with the objective to provide data on the ABO and Rh(D) blood group distribution and gene frequency across Nigeria which is vital for blood ...

  14. 212. Incidencia de complicaciones graves en trasplantes cardíacos urgentes y no urgentes. 10 años de experiencia

    Directory of Open Access Journals (Sweden)

    L. Donate Bertolín

    2010-01-01

    Conclusiones: En nuestra serie, el trasplante urgente no presentó una mayor mortalidad perioperatoria. Sin embargo, observamos mayor número de complicaciones graves, asociadas a mortalidad a más largo plazo, como FAI, infección bacteriana y ventilación mecánica prolongada.

  15. Resultados funcionales de la procuración corneal con fines de trasplante realizado por un licenciado en Optometría

    Directory of Open Access Journals (Sweden)

    Oswaldo Manuel Aguirre-Luna

    2017-01-01

    Conclusiones: Todos los pacientes mejoraron visualmente con rechazo similar a lo reportado en otros estudios. Un licenciado en Optometría capacitado podría ser el profesional de salud idóneo para realizar procuraciones corneales con fines de trasplante.

  16. Dieciséis años de experiencia de trasplante hepático en clínica las condes

    Directory of Open Access Journals (Sweden)

    G. Erwin Buckel, Dr.

    2010-03-01

    Conclusión: Los resultados obtenidos por el equipo de trasplante de Clínica Las Condes son en todo comparables a las series publicadas por centros internacionales y confirman la utilidad de esta terapia a nivel nacional. Aún existen nuevos desafíos que vencer en términos de inmunosupresión, infecciones y adherencia al tratamiento.

  17. Implementación y resultados de un nuevo programa de ECMO para trasplante de pulmón y distrés respiratorio agudo

    Directory of Open Access Journals (Sweden)

    Eduardo San Roman

    2015-06-01

    Full Text Available RESUMEN Objetivo: El desarrollo de la membrana de oxigenación extracorpórea en América Latina representa un desafío para la especialidad. El objetivo de este artículo fue describir los resultados de un nuevo programa de membrana de oxigenación extracorpórea en una unidad de cuidados intensivos. Métodos: Estudio de cohorte retrospectivo. Incluye 22 pacientes que requirieron membrana de oxigenación extracorpórea desde Enero de 2011 hasta Junio de 2014. Se evaluaron características basales, indicaciones, duración de la corrida, días de ventilación mecánica, días de unidad de cuidados intensivos, complicaciones y mortalidad hospitalaria. Resultados: Quince pacientes requirieron membrana de oxigenación extracorpórea post-trasplante pulmonar y 7 pacientes por distrés respiratorio agudo. Todos los pacientes trasplantados fueron destetados de membrana de oxigenación extracorpórea, con una duración mediana de 3 días (Rango intercuantil - IQR: 2 - 5, de ventilación mecánica 15,5 días (IQR: 3 - 35, de estadía unidad de cuidados intensivos 31,5 días (IQR: 19 - 53 y de estadía hospitalaria 60 días (IQR: 36 - 89, con una mortalidad de 20%. Los pacientes con distrés respiratorio agudo tuvieron una mediana de duración de membrana de oxigenación extracorpórea de 9 días (IQR: 3 - 14, mediana de ventilación mecánica 25 días (IQR: 13 - 37, de estadía en terapia 31 días (IQR: 11 - 38, y hospitalaria 32 días (IQR: 11 - 41, y 57% de mortalidad. Las principales complicaciones fueron infecciones (80%, insuficiencia renal aguda (43%, sangrados en sitio quirúrgico y de inserción de cánulas (22%, plaquetopenia (60% y coagulopatía (30%. Conclusión: A pesar de encontrarnos transitando una curva de aprendizaje, consideramos la experiencia satisfactoria, con resultados y complicaciones comparables a las reportadas en la literatura.

  18. Possible role of ABO system in age-related diseases and longevity: a narrative review.

    Science.gov (United States)

    Rizzo, Claudia; Caruso, Calogero; Vasto, Sonya

    2014-01-01

    ABO blood group antigens are expressed either on the surface of red blood cells either on a variety of other cells. Based on the available knowledge of the genes involved in their biosynthesis and their tissue distribution, their polymorphism has been suggested to provide intraspecies diversity allowing to cope with diverse and rapidly evolving pathogens. Accordingly, the different prevalence of ABO group genotypes among the populations has been demonstrated to be driven by malaria selection. In the similar manner, a particular ABO blood group may contribute to favour life-extension via biological mechanisms important for surviving or eluding serious disease. In this review, we will suggest the possible association of ABO group with age-related diseases and longevity taking into account the biological role of the ABO glycosyltransferases on some inflammatory mediators as adhesion molecules.

  19. Renal angiomyolipoma

    DEFF Research Database (Denmark)

    Holm-Nielsen, P; Sørensen, Flemming Brandt

    1988-01-01

    Renal angiomyolipoma is a rare lesion composed of smooth muscle cells, adipose tissue and abnormal vessels. It is currently classified as a benign, non-epithelial renal tumor. It has a high incidence in patients suffering from tuberous sclerosis but is more frequently found as an isolated renal...... lesion. Three cases of renal angiomyolipoma, 2 of which underwent perfusion-fixation, were studied by electron microscopy to clarify the cellular composition of this lesion. In the smooth muscle cells abundant accumulation of glycogen was found, whereas the lipocytes disclosed normal ultrastructural......-specific vesicular structures. These findings suggest a secondary vascular damage, i.e. the thickened vessels may not be a primary, integral part of renal angiomyolipoma. Evidence of a common precursor cell of renal angiomyolipoma was not disclosed. It is concluded that renal angiomyolipoma is a hamartoma composed...

  20. Certeza diagnóstica en la mortalidad de una población de pacientes con trasplante cardíaco

    Directory of Open Access Journals (Sweden)

    Marcos Amuchástegui

    2008-01-01

    Full Text Available RESUMENIntroducciónA pesar de que la morbimortalidad en el trasplante cardíaco ha sido motivo de extensoanálisis, la mayoría de los estudios y registros de mortalidad en pacientes trasplantados sebasan sobre datos clínicos. En la bibliografía existen comunicaciones aisladas de autopsiasen pacientes con trasplante cardíaco.ObjetivoDeterminar la importancia de la realización de estudios anatomopatológicos para el diagnósticode causa de muerte en un programa de trasplante cardíaco.Material y métodosSe incluyeron todos los pacientes con trasplante cardíaco fallecidos entre enero 1990 y enero2005. El diagnóstico definitivo de la causa de muerte fue corroborado por autopsia obiopsia de órgano sólido. Las causas de muerte evaluadas fueron falla precoz del injerto,rechazo celular, infección, enfermedad vascular del injerto, neoplasia y otros.ResultadosDurante el período en estudio 73 pacientes fueron sometidos a trasplante cardíaco; de ellos,fallecieron 31. Se obtuvieron 12 autopsias y 7 biopsias de órgano sólido que certificaron lacausa de muerte (61%. La causa de muerte más frecuente fue el rechazo celular mayor degrado III. En el 12,9%, la anatomía patológica difirió de la sospecha clínica de la causa demuerte.ConclusiónLa información clinicopatológica derivada de estudios post mortem es un indicador de nuestrarealidad asistencial y se constituye en un pilar fundamental para el conocimiento y elmanejo futuro de los pacientes trasplantados, por lo que consideramos que la realización deautopsias en estos pacientes es de vital importancia.REV ARGENT CARDIOL 2008;76:292-294.

  1. Critical appraisal on the use of everolimus in renal transplantation as an immunosuppressant to prevent organ transplant rejection

    Directory of Open Access Journals (Sweden)

    Fernando Giron

    2010-01-01

    Full Text Available Fernando Giron, Yenny BaezKidney Transplant Service, Colombiana de Trasplantes, Bogota, ColombiaAbstract: Everolimus is a proliferation inhibitor designed to target chronic allograft nephropathy including prevention of acute rejection. Acute renal allograft rejection incidence varies with the therapy used for immunosuppression. Registry data show that 15% to 35% of kidney recipients will undergo treatment for at least one episode of acute rejection within the first post-transplant year. Everolimus has been used as therapy with full- or reduced-dose cyclosporine A without evidence of increasing the acute rejection incidence. This review will summarize the available clinical trial data on the use of everolimus and its role in preventing acute rejection incidence in renal transplantation.Keywords: calcineurin inhibitors, cyclosporine, everolimus, biopsy-proven acute rejection, renal transplantation, acute rejection

  2. Association of ABO and Rh blood groups with breast cancer.

    Science.gov (United States)

    Meo, Sultan Ayoub; Suraya, Faryal; Jamil, Badar; Rouq, Fwziah Al; Meo, Anusha Sultan; Sattar, Kamran; Ansari, Mohammad Javed; Alasiri, Saleh A

    2017-11-01

    The aim of this study was to determine the association of "ABO" and "Rhesus" blood groups with incidence of breast cancer. In this study, we identified 70 research documents from data based search engines including "PubMed", "ISI-Web of Knowledge", "Embase" and "Google Scholar". The research papers were selected by using the primary key-terms including "ABO blood type", "Rhesus" blood type and "breast cancer". The research documents in which "ABO" and "Rhesus" blood types and breast cancer was debated were included. After screening, we reviewed 32 papers and finally we selected 25 research papers which met the inclusion criteria and remaining documents were excluded. Blood group "A" has high incidence of breast cancer (45.88%), blood group "O" has (31.69%); "B" (16.16%) and blood group "AB" has (6.27%) incidence of breast cancer. Blood group "A" has highest and blood group "AB" has least association with breast cancer. Furthermore, "Rhesus +ve" blood group has high incidence of breast cancer (88.31%) and "Rhesus -ve" blood group has least association with breast cancer (11.68%). Blood group "A" and "Rhesus +ve" have high risk of breast cancer, while blood type "AB" and "Rhesus -ve" are at low peril of breast cancer. Physicians should carefully monitor the females with blood group "A" and "Rh +ve" as these females are more prone to develop breast cancer. To reduce breast cancer incidence and its burden, preventive and screening programs for breast cancer especially in young women are highly recommended.

  3. ABO blood group antigens in oral mucosa. What is new?

    DEFF Research Database (Denmark)

    Dabelsteen, Erik

    2002-01-01

    Histo-blood group ABH (O) antigens are major alloantigens in humans. These antigens are widely distributed in human tissues and undergo changes in expression during cellular differentiation and malignant development. The ABH antigens have been characterized as terminal disaccharide determinants...... healing show similarly decreased expression of A/B antigens on migrating epithelial cells. Some studies suggest that the relationship between expression of blood group antigens and cell motility can be explained by different degrees of glycosylation of integrins. Changes in ABO expression in tumours have...

  4. RENAL CRYOABLATION

    Directory of Open Access Journals (Sweden)

    A. V. Govorov

    2012-01-01

    Full Text Available Renal cryoablation is an alternative minimally-invasive method of treatment for localized renal cell carcinoma. The main advantages of this methodology include visualization of the tumor and the forming of "ice ball" in real time, fewer complications compared with other methods of treatment of renal cell carcinoma, as well as the possibility of conducting cryotherapy in patients with concomitant pathology. Compared with other ablative technologies cryoablation has a low rate of repeat sessions and good intermediate oncological results. The studies of long-term oncological and functional results of renal cryoablation are presently under way.

  5. ABO blood groups, Rhesus factor, and Behçet's disease.

    Science.gov (United States)

    Ozyurt, Kemal; Oztürk, Perihan; Gül, Mustafa; Benderli, Yasemin Cihan; Cölgeçen, Emine; Inci, Rahime

    2013-09-01

    Recently, numerous studies have been carried out to explain the genetics and immunopathogenesis of Behçet's disease (BD). There is still insufficient understanding of its etiopathogenesis, but substantial genetic and immune system abnormalities have been suggested. Several studies have shown remarkable associations of ABO blood groups with various diseases. This study investigated the relationship between ABO and Rhesus (D) blood groups and Behçet's disease in Turkish patients. Clinical data on gender, ABO, and Rhesus blood type of patients with BD were collected at the Kayseri Education and Research Hospital from 2005 to 2012. A total of 115 patients with BD were assessed for their association with ABO or Rhesus (D) blood groups and compared with the distribution of the blood groups of 25,701 healthy donors admitted to the Kayseri Education and Research Hospital Blood Center in 2010 and 2011. The distribution of ABO and Rhesus blood groups in patients with BD was similar to the healthy donors. No relationship was found between ABO or Rhesus blood groups and BD at our hospital. Further studies with a larger series and in different centers may be valuable for identifying the association between ABO or Rhesus (D) blood groups and BD.

  6. PERSONALITY FACTORS, SELF-EFFICACY AND DEPRESSION IN CHRONIC RENAL PATIENTS AWAITING KIDNEY TRANSPLANT IN BRAZIL

    Directory of Open Access Journals (Sweden)

    Caroline Venzon Thomas

    2014-01-01

    Full Text Available El objetivo del estudio fue evaluar factores de personalidad, autoeficacia y depresión en pacientes con enfermedad renal crónica en espera para trasplante de riñón. Los pacientes (n=85 eran adultos que realizaban tratamiento de hemodiálisis y estaban en lista de espera para trasplante de riñón, con edad media de 49,11 años. El análisis de correlación de Pearson mostró una asociaci ón entre los factores Insurgencia ( r = - 0,353, p <0,01 Conciencia ( r =0,415, p <0,01 y Autoeficacia. Neuroticismo tuvo correlación negativa con autoeficacia ( r = - 0,389, p <0,01 y los niveles de depresión total ( r =0,688, p <0.01, psicológica ( r =0,627, p <0.01 y somática ( r =0,673, p <0,01; y los factores Conciencia y Amabilidad también se correlacionaron de forma positiva y significativa con edad ( r =0,381, p <0,01; r =0,309, p <0,05 respectivamente y edad en el diagnostico ( r =0,450, p <0,05; r =0,271, p <0,01. Neurot icismo fue un predictor significativo ( R2 = 0,47, β =5.35, p<0,01 de los síntomas depresivos, mientras los factores Conciencia, Neuroticismo y Insurgencia juntos fueron predictores de autoficacia en los pacientes ( R2 = 0,33, β =0,23, p <0,05. Los factores de personalidad deben ser considerados en pacientes en lista de trasplante de riñón pues tienen implicación en la conducta y niveles de depresión en los pacientes.

  7. Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.

    Science.gov (United States)

    Klatte, Tobias; Xylinas, Evanguelos; Rieken, Malte; Kluth, Luis A; Rouprêt, Morgan; Pycha, Armin; Fajkovic, Harun; Seitz, Christian; Karakiewicz, Pierre I; Lotan, Yair; Babjuk, Marko; de Martino, Michela; Scherr, Douglas S; Shariat, Shahrokh F

    2014-05-01

    ABO blood type is an established prognostic factor for several malignancies but its role in bladder urothelial carcinoma is largely unknown. We determined whether ABO blood type is associated with the outcome of transurethral resection of nonmuscle invasive bladder urothelial carcinoma. We retrospectively studied ABO blood types in 931 patients with primary nonmuscle invasive bladder urothelial carcinoma treated with transurethral bladder resection with or without intravesical instillation therapy. Disease recurrence and progression were analyzed with univariable and multivariable competing risks regression models. Median followup was 67 months. Discrimination was evaluated by the concordance index. The ABO blood type was O, A, B and AB in 414 (44.5%), 360 (38.7%), 103 (11.1%) and 54 patients (5.8%), respectively. ABO blood type was significantly associated with outcome on univariable and multivariable analysis. Overall, patients with blood type O had worse recurrence and progression rates than those with A (p = 0.015 and 0.031) or B (p = 0.004 and 0.075, respectively). The concordance index of multivariable base models increased after including ABO blood type. In patients with nonmuscle invasive bladder urothelial carcinoma the ABO blood type may predict the outcome. Those with blood type O showed the highest recurrence and progression rates. Including ABO blood type in multivariable models increases the accuracy of standard prognostic factors. Since the ABO blood type is available for most patients, it may represent an ideal adjunctive marker to predict recurrence and progression. The biological explanation and prognostic value of this finding must be further elucidated. Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

  8. Relationship between Malaria and ABO Blood Types in East China

    Directory of Open Access Journals (Sweden)

    Xuan Zhang

    2017-01-01

    Full Text Available Objectives. This study aims at investigating the relationship between malaria and blood group types in east China. Methods. Between 1 January 2011 and 31 March 2017, 99 malaria patients were enrolled for the study. Laboratory tests were conducted on their infection status and blood types. Clinical data of the participants were retrieved for analysis. Results. There was no mortality during the period of study. Overall, 90 (90.91% of the patients were positive for Plasmodium falciparum, 8 (8.08% were infected with Plasmodium vivax, and only 1 (1.01% was infected with Plasmodium malariae. The most common blood group among the participants was group O (38.38% followed by blood groups A, B, and AB, with 32.32%, 22.22%, and 7.07% cases, respectively. There was no significant relationship between the prevalence of malaria and ABO blood types (P>0.05. In the blood group O, the prevalence of haemolytic-uremic syndrome and cerebral malaria was 13.16% and 5.25%, respectively, which was lower than that of the other three blood types (P>0.05. Conclusion. There was no mortality among the malaria patients in this study. The blood group O was the most common blood type. Due to small sample size of data, there was no significant association between ABO blood types and malaria infection.

  9. A new method for ABO genotyping to avoid discrepancy between genetic and serological determinations.

    Science.gov (United States)

    Shintani-Ishida, Kaori; Zhu, Bao-Li; Maeda, Hitoshi; Uemura, Koichi; Yoshida, Ken-Ichi

    2008-01-01

    In Japan and elsewhere, ABO genotyping is frequently used in forensic practice for identification of a decomposed body. However, the phenotype deduced from the genotyping data is occasionally inconsistent with the real phenotype. In this paper, we report a simple ABO genotyping method in which five single nucleotide polymorphism at nps 220, 261, 796, 802, and 803 are analyzed simultaneously to avoid discrepancies between genetic and serological determinations in ABO*A204, *O303, *O207, *cis-AB01 and *cis-AB02 alleles. This method can be used for the genotyping of badly decomposed remains or old bloodstains.

  10. Aspectos ético legales del trasplante de corazón Ethical and legal aspects of heart transplant

    Directory of Open Access Journals (Sweden)

    Fernán del C Mendoza

    2007-12-01

    Full Text Available El trasplante cardiaco constituye el tratamiento de elección para los pacientes en falla cardiaca refractaria. Desde el punto de vista médico, existen claras indicaciones para realizar el trasplante, pero a nivel local y mundial hay problemas por el escaso número de donantes. Para que se realice un trasplante de corazón, el donante debe reunir criterios de muerte encefálica, la cual se diagnostica por ausencia irreversible de las funciones del tallo encefálico, determinadas por un examen clínico. A pesar de las controversias que existen acerca de cuándo muere una persona, cada vez hay más claridad en este hecho. Existen otros problemas bioéticos que se relacionan con el trasplante como la donación (algunas personas en vida manifiestan su voluntad y autonomía de servir como donantes y otras no, la distribución de órganos y el comercio de órganos y tejidos. Desde el punto de vista legal y ético, se prohíbe la gratificación o pago al donante vivo, a la familia del donante fallecido, al banco de tejidos o de médula ósea, a las clínicas y hospitales, y a las aseguradoras por la donación o suministro de órganos o tejidos humanos. La promoción de la donación y la obtención de componentes anatómicos deberán efectuarse denotando su carácter voluntario, altruista y desinteresado. Debe primar el principio de justicia y excluirse cualquier consideración no equitativa de índole geográfica, racial, sexual, religiosa, etc. Los órganos deben distribuirse con base en criterios médicos; así mismo debe buscarse la más idónea utilización del órgano donado, teniendo como fundamento el manejo equitativo y como principio el respeto por la vida y la dignidad humana.Cardiac transplant is the treatment of choice for patients with refractory cardiac failure. There are clear indications from the medical point of view to perform the transplant, but locally and world - wide there are problems due to the scarce number of donors. In order

  11. [Renal angioscopy].

    Science.gov (United States)

    Franco Miranda, E; Rodríguez Tolra, J; Díaz Rodrigues, J; Serrallach Mila, N

    1994-01-01

    Presentation as a novelty of the application of endoscopic methods in the display of the renal artery (angioscopy). Review of findings seen in the renal artery of a donor corpse with polytraumatism using direct view with a MiniScope-type rigid urethroscopy and the possible future application of this technique.

  12. ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation.

    Science.gov (United States)

    Grube, Matthias; Wolff, Daniel; Ahrens, Norbert; Herzberg, Philipp Y; Herr, Wolfgang; Holler, Ernst

    2016-11-01

    ABO blood group antigen incompatibility (ABO mismatch) is not an obstacle to allogeneic stem cell transplantation (allo-SCT). However, the impact on clinical outcome after allo-SCT remains controversial. We analyzed 512 patients after allogeneic peripheral blood SCT (allo-PBSCT) for an association of ABO mismatch with transfusion requirements, myeloid and platelet engraftment, the incidence of GvHD, relapse, transplant-related mortality (TRM), and overall survival (OS). A total of 260 patients underwent ABO-mismatched transplantation and the control group consisted of 252 patients with ABO-matched allo-PBSCT. We found a significant association between major-0 ABO mismatch (group 0 recipient/group A, B, or AB donor) and increased red blood cell (RBC) and platelet transfusion requirements (both Pmismatch was significantly associated with an increased TRM after allo-PBSCT (P=.001 and P=.02). In multivariate analysis performed using Cox regression, minor ABO mismatch appeared as independent risk factor for TRM after allo-PBSCT. No association was found for ABO mismatch with the incidence of GvHD, relapse, and OS. Our results suggest that ABO blood group mismatch has a significant impact on the outcome and that minor-A and minor-AB ABO mismatch represents a risk factor for increased TRM after allo-PBSCT. © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

  13. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.

    Science.gov (United States)

    Damodar, Sharat; Shanley, Ryan; MacMillan, Margaret; Ustun, Celalettin; Weisdorf, Daniel

    2017-05-01

    The impact of ABO mismatch has been studied on various hematopoietic cell transplant (HCT) outcomes, including neutrophil and platelet engraftment, pure red cell aplasia, acute and chronic graft-versus-host disease (GVHD), nonrelapse mortality (NRM), and overall survival (OS). Yet conflicting results have been reported. However, the impact of ABO mismatch on transplant outcomes with various graft types has not been carefully investigated. We analyzed the impact of various graft sources and type of ABO mismatch on transplant outcomes for 1502 patients who underwent HCT at the University of Minnesota between 2000 and 2014: 312 receiving marrow (BM), 475 filgrastim-mobilized blood (peripheral blood stem cell [PBSC]), and 715 umbilical cord blood (UCB) grafts. Neutrophil engraftment by day 28 was marginally less frequent in the bidirectional ABO mismatched transplants receiving UCB, whereas ABO matching had no influence on engraftment in the BM or PBSC cohorts. ABO mismatch led to no significant differences in platelet engraftment irrespective of stem cell source. We observed a modest but not significantly lower incidence of grades II/IV acute GVHD in the bidirectional ABO mismatched transplants in the UCB and the PBSC cohorts but not in the BM group. We found a higher incidence of chronic GVHD in the PBSC group, but it was not significantly lower in the minor ABO mismatched transplants. The incidence of chronic GVHD was similar in the major ABO mismatched transplants receiving BM. We found no significant difference in the OS and NRM between ABO matched and ABO mismatched transplants within each of the 3 graft source groups. Multivariable analysis adjusting for other relevant factors confirmed that ABO match status did not significantly influence the outcomes of either engraftment, acute or chronic GVHD or NRM. We conclude that ABO mismatch does not influence the outcomes of allogeneic HCT, regardless of stem cell source. Copyright © 2017 The American Society for

  14. Registro Español de Trasplante Cardíaco. XIX Informe Oficial de la Sección de Insuficiencia Cardíaca, Trasplante Cardíaco y Otras Alternativas Terapéuticas de la Sociedad Española de Cardiología(1984-2007

    Directory of Open Access Journals (Sweden)

    Luis Almenar Bonet

    2008-07-01

    Conclusiones: La supervivencia obtenida en España con el TC, sobre todo en los últimos años, sitúa al trasplante cardíaco como el mejor tratamiento ante cardiopatías terminales en situación funcional avanzada y sin otras opciones médicas o quirúrgicas establecidas.

  15. Registro Español de Trasplante Cardíaco. XX Informe oficial de la sección de insuficiencia Cardíaca y Trasplante Cardíaco de la sociedad Española de Cardiología (1984-2008

    Directory of Open Access Journals (Sweden)

    Luis Almenar Bonet

    2009-07-01

    Conclusiones: La supervivencia obtenida en España con el TC, sobre todo en los últimos años, sitúa al trasplante cardíaco como el tratamiento de elección para cardiopatías irreversibles en situación funcional avanzada y sin otras opciones médicas o quirúrgicas establecidas.

  16. FACTORES SOCIO-DEMOGRÀFICOS Y DIAGNÓSTICOS DE ENFERMERÍA EN PACIENTES TRASPLANTADOS RENALES

    Directory of Open Access Journals (Sweden)

    ANA LUISA BRANDÃO DE CARVALHO LIRA

    2009-01-01

    Full Text Available Analizar la asociación estadística entre diagnósticos de enfermería identificados en pacientes con trasplante renal y sus factores socio-económicos. Estudio transversal realizado en un hospital universitario en Fortaleza-CE, entre diciembre de 2004 a abril de 2005. Se identificaron 38 diagnósticos de enfermería. Diez diagnósticos presentaron frecuencias superiores al porcentaje 75: Riesgo de infección; percepción sensorial perturbada: visual; Modelo de sueño perturbado; Nutrición desequilibrada: por exceso; Fatiga; Disfunción sexual; Percepción sensorial perturbada: audici- ón; Dolor agudo; Modelos sexuales ineficaces; Riesgo de desequilibrio nutricional: más de lo necesario. El estudio sobre los diagnósticos de enfermería ayudó a ampliar el conocimiento de la realidad de los pacientes, lo que es necesario para el establecimiento de cuidados de enfermería en el trasplante renal, y también para tratar de los resultados que vayan a desarrollarse buscando mejorar la calidad de vida.

  17. Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups.

    Science.gov (United States)

    Franchini, Massimo; Lippi, Giuseppe

    2016-03-01

    The ABO blood group system is composed of complex carbohydrate molecules (i.e., the A, B, and H determinants) that are widely expressed on the surface of red blood cells and in a variety of other cell and tissues. Along with their pivotal role in transfusion and transplantation medicine, the ABO antigens participate in many other physiological processes and, in particular, are important determinants of von Willebrand factor and factor VIII circulating plasma levels. The precise influence of the ABO system on hemostasis has led the way to the investigation of a putative implication in the risk of developing cardiovascular disorders. Along with the underlying molecular mechanisms, the current knowledge on the role of ABO blood group antigens in both the thrombotic and hemorrhagic risk will be summarized in this narrative review. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

  18. ABO blood groups, Rhesus factor, and anaphylactic reactions due to Hymenoptera stings.

    Science.gov (United States)

    Pałgan, Krzysztof; Bartuzi, Zbigniew; Chrzaniecka, Elżbieta

    2017-09-21

    Numerous publications indicate that the prevalence of some infectious, neoplastic and immunological diseases are associated with ABO blood groups. The aim of this study was to verify whether ABO and Rh blood groups are associated with severe anaphylactic reactions after Hymenoptera stings. A study was undertaken of 71,441 Caucasian subjects living in the same geographic area. The study group included 353 patients with diagnosed systemic anaphylaxis to Hymenoptera venom. Control group included 71,088 healthy blood donors. Frequencies of ABO and Rhesus groups in the study and control groups were compared using univariate and multivariate analyses. No statistically significant interactions were observed between the ABO blood group and anaphylactic reactions to Hymenoptera.

  19. ABO/RH DISTRIBUTION PATTERN AND PREVALENCE OF IRREGULAR ANTIBODIES IN HEALTHY BLOOD DONORS OF UTTARAKHAND

    OpenAIRE

    Brijesh Thakur; Sanjay Kaushik; Sanjeev Kishore; Rajnish Kuma; Anil Rajput

    2016-01-01

    BACKGROUND Blood group plays a vital role in transfusion safety, understanding genetics, inheritance pattern and disease susceptibility. This study is aimed to determine distribution pattern of ABO and Rh blood group, incidence and identification of irregular antibodies among blood donors of Uttarakhand. METHOD ABO/Rh blood grouping was performed by test tube agglutination method (both cell and serum grouping) using antisera A, B and Rh from Tulip and Orthodiagnostics. Do...

  20. Plasma exchange in small intestinal transplantation between ABO-incompatible individuals: A case report

    OpenAIRE

    ZHANG, QIUHUI; HU, XINGBIN; XIA, AIJUN; YI, JING; AN, QUNXING; ZHANG, XIANQING

    2013-01-01

    The aim of this study was to investigate the application of plasma exchange in small intestinal transplantation between ABO blood type-incompatible patients. A small intestinal transplantation case between ABO-incompatible individuals is hereby presented and analyzed. The main treatment included plasma exchange, splenectomy and immunosuppression. The patient undergoing small intestinal transplantation exhibited stable vital signs. A mild acute rejection reaction developed ~2 weeks after the s...

  1. ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial infarction.

    Science.gov (United States)

    Sari, Ibrahim; Ozer, Orhan; Davutoglu, Vedat; Gorgulu, Sevket; Eren, Mehmet; Aksoy, Mehmet

    2008-04-01

    We aimed to investigate whether there is an association between ABO blood groups, cardiovascular risk factors and myocardial infarction (MI) in a Turkish cohort. Four hundred and seventy-six patients with acute ST elevation MI (mean age 56.7+/-11.7; 80% men) and 203 age and sex matched healthy subjects were enrolled in the study. ABO blood group distribution of patients was compared with control group. Furthermore, in each ABO blood group, frequency of major cardiac risk factors was determined to find any correlation between blood groups and cardiovascular risk factors. The distribution of ABO blood groups in patients versus control group was A in 43.1 versus 44.3%, B in 15.1 versus 15.3%, AB in 10.7 versus 12.3% and O in 31.1 versus 28.1% (P>0.05 for all). ABO blood group distribution of both patients and control group was concordant with the official data from general Turkish population. The frequency of cardiovascular risk factors was similar in patients with different blood groups; however, the patients with blood group A were younger (P=0.004) and coronary artery disease detection age was lower (P=0.001) than those with the other blood groups. The distribution of ABO blood groups in patients with MI was quite similar to that in control group and that of general Turkish population, which supports the idea that ABO blood group might not be significantly associated with the development of MI. Association of ABO blood group distribution with cardiovascular risk factors, coronary artery disease and MI needs to be clarified with multicenter, prospective and large-scale studies.

  2. Possible role of ABO system in age-related diseases and longevity: a narrative review

    OpenAIRE

    Rizzo, Claudia; Caruso, Calogero; Vasto, Sonya

    2014-01-01

    ABO blood group antigens are expressed either on the surface of red blood cells either on a variety of other cells. Based on the available knowledge of the genes involved in their biosynthesis and their tissue distribution, their polymorphism has been suggested to provide intraspecies diversity allowing to cope with diverse and rapidly evolving pathogens. Accordingly, the different prevalence of ABO group genotypes among the populations has been demonstrated to be driven by malaria selection....

  3. Complicaciones cutáneas de la terapia inmunosupresora: estudio en trasplantados renales

    Directory of Open Access Journals (Sweden)

    Diego E. Jaramillo

    1988-01-01

    Full Text Available Se presenta la experiencia dermatológica obtenida durante el seguimiento prospectivo de 114 pacientes con trasplante renal, atendidos en el Hospital Universitario San Vicente de Paúl, de Medellín; su evolución post-trasplante fluctuaba entre 2 meses y 13 anos y el seguimiento dermatológico fue por dos anos. Se encontró un número elevado de manifestaciones cutáneas (promedio 4,8 por paciente; las más frecuentes fueron: acné, micosis, hirsutismo y xerosis; no se hallaron lesiones malignas. No hubo asociación de las manifestaciones cutáneas con la edad del paciente, el tipo de donante o el esquema Inmunosupresor. Dada la alta frecuencia de patología cutánea se sugiere que estos pacientes sean educados adecuadamente sobre este aspecto y examinados periódicamente con el fin de detectar y manejar a tiempo sus problemas dermatológicos benignos O potencialmente malignos.

  4. A General Model of Negative Frequency Dependent Selection Explains Global Patterns of Human ABO Polymorphism

    Science.gov (United States)

    Villanea, Fernando A.; Safi, Kristin N.; Busch, Jeremiah W.

    2015-01-01

    The ABO locus in humans is characterized by elevated heterozygosity and very similar allele frequencies among populations scattered across the globe. Using knowledge of ABO protein function, we generated a simple model of asymmetric negative frequency dependent selection and genetic drift to explain the maintenance of ABO polymorphism and its loss in human populations. In our models, regardless of the strength of selection, models with large effective population sizes result in ABO allele frequencies that closely match those observed in most continental populations. Populations must be moderately small to fall out of equilibrium and lose either the A or B allele (Ne ≤ 50) and much smaller (Ne ≤ 25) for the complete loss of diversity, which nearly always involved the fixation of the O allele. A pattern of low heterozygosity at the ABO locus where loss of polymorphism occurs in our model is consistent with small populations, such as Native American populations. This study provides a general evolutionary model to explain the observed global patterns of polymorphism at the ABO locus and the pattern of allele loss in small populations. Moreover, these results inform the range of population sizes associated with the recent human colonization of the Americas. PMID:25946124

  5. A General Model of Negative Frequency Dependent Selection Explains Global Patterns of Human ABO Polymorphism.

    Directory of Open Access Journals (Sweden)

    Fernando A Villanea

    Full Text Available The ABO locus in humans is characterized by elevated heterozygosity and very similar allele frequencies among populations scattered across the globe. Using knowledge of ABO protein function, we generated a simple model of asymmetric negative frequency dependent selection and genetic drift to explain the maintenance of ABO polymorphism and its loss in human populations. In our models, regardless of the strength of selection, models with large effective population sizes result in ABO allele frequencies that closely match those observed in most continental populations. Populations must be moderately small to fall out of equilibrium and lose either the A or B allele (N(e ≤ 50 and much smaller (N(e ≤ 25 for the complete loss of diversity, which nearly always involved the fixation of the O allele. A pattern of low heterozygosity at the ABO locus where loss of polymorphism occurs in our model is consistent with small populations, such as Native American populations. This study provides a general evolutionary model to explain the observed global patterns of polymorphism at the ABO locus and the pattern of allele loss in small populations. Moreover, these results inform the range of population sizes associated with the recent human colonization of the Americas.

  6. Simplification of genotyping techniques of the ABO blood type experiment and exploration of population genetics.

    Science.gov (United States)

    Hu, Jian; Zhou, Yi-ren; Ding, Jia-lin; Wang, Zhi-yuan; Liu, Ling; Wang, Ye-kai; Lou, Hui-ling; Qiao, Shou-yi; Wu, Yan-hua

    2017-05-20

    The ABO blood type is one of the most common and widely used genetic traits in humans. Three glycosyltransferase-encoding gene alleles, I A , I B and i, produce three red blood cell surface antigens, by which the ABO blood type is classified. By using the ABO blood type experiment as an ideal case for genetics teaching, we can easily introduce to the students several genetic concepts, including multiple alleles, gene interaction, single nucleotide polymorphism (SNP) and gene evolution. Herein we have innovated and integrated our ABO blood type genetics experiments. First, in the section of Molecular Genetics, a new method of ABO blood genotyping was established: specific primers based on SNP sites were designed to distinguish three alleles through quantitative real-time PCR. Next, the experimental teaching method of Gene Evolution was innovated in the Population Genetics section: a gene-evolution software was developed to simulate the evolutionary tendency of the ABO genotype encoding alleles under diverse conditions. Our reform aims to extend the contents of genetics experiments, to provide additional teaching approaches, and to improve the learning efficiency of our students eventually.

  7. Is there an association between ABO blood grouping and periodontal disease? A literature review.

    Science.gov (United States)

    Al-Askar, Mansour

    2017-09-01

    Although several studies have investigated the relationship between ABO blood group and medical diseases, few reports have explored the association with oral diseases, including periodontal disease (PD). The aim of this literature review was to assess the association between the ABO blood grouping and PD. We searched PubMed and Google Scholar databases using the following terms in different combinations: "ABO blood group," "periodontitis," "aggressive periodontitis (AP)," "risk factor," and "Rhesus factor." Databases were searched for articles published from 1977 to August 2016. Titles and abstracts of articles were screened for English-language papers describing clinical studies, case reports, or retrospective studies of oral health status in patients with different ABO blood groups. Letters to the editor, historic reviews, and articles including unpublished data were excluded. Reference lists of included studies were reviewed for additional original and review studies. We identified eight articles describing studies of the relationship between ABO blood groups and PD. The findings suggested a possible genetic basis in the association of the blood group AB with AP. Four studies showed that chronic periodontitis was more common among patients with blood group O. ABO blood subgroup and Rhesus factor could constitute risk predictors in the development of PD.

  8. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.

    Science.gov (United States)

    Shimmura, H; Tanabe, K; Tokumoto, T; Ishida, H; Ishikawa, N; Miyamoto, N; Shimizu, T; Shirakawa, H; Setoguchi, K; Toma, H

    2004-09-01

    Due to the continuing shortage of cadaveric donors in Japan, ABO-incompatible living kidney transplantation (LKT) is being performed. It is well known that highly sensitized patients with positive panel reactive antibodies (PRA) often present with acute rejection. Therefore, we examined the impact of a positive PRA on the results of ABO-incompatible LKT. One hundred seventy-seven recipients underwent ABO-incompatible LKT between January 1989 and March 2003. Of these patients, 37 who had been examined for PRA before transplantation were included in this study. There were 25 men and 12 women of mean age 37.3 years. Plasmapheresis was performed to remove anti-ABO antibodies before transplantation. During the induction phase, methylprednisolone, azathioprine, or mycophenolate mofetil and cyclosporine or tacrolimus were used for immunosuppression. Splenectomy was performed at the time of kidney transplantation in all patients. PRA was measured using FlowPRA by flow cytometer. Eight of the 37 patients had a positive PRA before transplantation (class I, 5; class II, 1; class I and class II, 2). The incidence of acute rejection was 37.9% in the patients with a negative PRA and 37.5% in patients with a positive PRA. One patient with a negative PRA and one patient with a positive PRA lost grafts due to acute rejection. Positive PRA may not increase the incidence of acute rejection in ABO-incompatible LKT because plasmapheresis and splenectomy are performed to eliminate anti-ABO antibody.

  9. [Association between ABO blood group and acute myocardial infarction].

    Science.gov (United States)

    Hu, Xiaoying; Qiao, Shubin; Qiu, Hong; Ye, Shaodong; Feng, Lei; Song, Lei

    2015-09-01

    To explore the association between the ABO blood group and the risk of myocardial infarction in Chinese people. We retrospectively recruited 1 988 consecutive patients with acute myocardial infarction (AMI) and 1 856 non-coronary artery disease (non-CAD) subjects who hospitalized in our hospital between January 2013 and December 2013. The clinical features and ABO blood group were analyzed. Blood group distribution was A (27.1%, 539/1 988), B (34.4%, 684/1 988), AB (10.8%, 215/1 988), O (27.7%, 551/1 988) in patients with AMI and A (26.7%, 496/1 856), B(32.2%, 598/1 856), AB(10.8%, 200/1 856), O (30.4%, 564/1 856) in non-CAD group. The single factor analysis showed that blood group O tended to be more common in the non-CAD group than in AMI group (P = 0.06). After adjustment for common cardiovascular risk factors such as age, gender, hypertension, diabetes, smoking and serum cholesterol level, the A, B, and AB blood groups were associated with increased risk of AMI compared with O blood group, and the difference was significant with A blood group (OR = 1.229, 95% CI 1.019-1.482, P = 0.031) and B blood groups (OR = 1.214, 95% CI 1.017-1.449, P = 0.032). In addition, non-O blood group remained significantly associated with the increased risk of AMI than O blood group after logistic regression analysis (OR = 1.223, 95% CI 1.048-1.426, P = 0.01). Our results suggest that non-O blood group is associated with the increased risk of AMI.

  10. Prevención y tratamiento de la enfermedad renal crónica (ERC

    Directory of Open Access Journals (Sweden)

    B. Rodrigo Orozco, Dr.

    2010-09-01

    Full Text Available La enfermedad renal crónica (ERC es un grave problema de salud pública. Se espera que el número de personas con insuficiencia renal que reciben tratamiento con diálisis y trasplante aumente dramáticamente en los próximos años. Los malos resultados de la ERC no se limitan a la insuficiencia renal terminal, sino que también incluyen a las complicaciones derivadas de una menor función renal, como hipertensión arterial, anemia, desnutrición, trastornos óseos y minerales, neuropatía, así como un mayor riesgo de enfermedad cardiovascular. El diagnóstico precoz basado en la presencia de proteinuria o una velocidad de filtración glomerular estimada reducida, puede permitir la intervención temprana para reducir: el riesgo de insuficiencia renal progresiva, los eventos cardiovasculares y la mortalidad que se asocian con la ERC. Las estrategias eficaces para frenar la progresión de la ERC y reducir el riesgo cardiovascular están disponibles en la actualidad. Los modelos clínicos de atención que faciliten la entrega de los aspectos diversos y complejos del tratamiento en forma simultánea, podrían mejorar la gestión y probablemente los resultados clínicos.

  11. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.

    Science.gov (United States)

    Canaani, Jonathan; Savani, Bipin N; Labopin, Myriam; Michallet, Mauricette; Craddock, Charles; Socié, Gerard; Volin, Lisa; Maertens, Johan A; Crawley, Charles; Blaise, Didier; Ljungman, Per T; Cornelissen, Jan; Russell, Nigel; Baron, Frédéric; Gorin, Norbert; Esteve, Jordi; Ciceri, Fabio; Schmid, Christoph; Giebel, Sebastian; Mohty, Mohamad; Nagler, Arnon

    2017-08-01

    ABO incompatibility is commonly observed in stem cell transplantation and its impact in this setting has been extensively investigated. HLA-mismatched unrelated donors (MMURD) are often used as an alternative stem cell source but are associated with increased transplant related complications. Whether ABO incompatibility affects outcome in MMURD transplantation for acute myeloid leukemia (AML) patients is unknown. We evaluated 1,013 AML patients who underwent MMURD transplantation between 2005 and 2014. Engraftment rates were comparable between ABO matched and mismatched patients, as were relapse incidence [34%; 95% confidence interval (CI), 28-39; for ABO matched vs. 36%; 95% CI, 32-40; for ABO mismatched; P = .32], and nonrelapse mortality (28%; 95% CI, 23-33; for ABO matched vs. 25%; 95% CI, 21-29; for ABO mismatched; P = .2). Three year survival was 40% for ABO matched and 43% for ABO mismatched patients (P = .35), Leukemia free survival rates were also comparable between groups (37%; 95% CI, 32-43; for ABO matched vs. 38%; 95% CI, 33-42; for ABO mismatched; P = .87). Incidence of grade II-IV acute graft versus host disease was marginally lower in patients with major ABO mismatching (Hazard ratio of 0.7, 95% CI, 0.5-1; P = .049]. ABO incompatibility probably has no significant clinical implications in MMURD transplantation. © 2017 Wiley Periodicals, Inc.

  12. ABO hemolytic disease of the fetus and newborn: an iatrogenic complication of heterologous assisted reproductive technology-induced pregnancy.

    Science.gov (United States)

    Zuppa, Antonio Alberto; Cardiello, Valentina; Lai, Marco; Cataldi, Luigi; D'Andrea, Vito; Romagnoli, Costantino

    2010-10-01

    ABO hemolytic disease of the fetus and newborn (ABO HDFN) may manifest itself in cases of mothers belonging to blood group O and newborns of groups A or B and more frequently in group A and less so in group B. The case subjects are twin-birth newborns with ABO HDFN, of group AB born to a mother of group O. These cases of ABO HDFN prove inconsistent with Mendel's law of segregation. This case study finds its explanation in new methods of assisted reproduction, particularly heterologous in vitro fertilization with ovodonation. © 2010 American Association of Blood Banks.

  13. Non-anatomical intestinal transplantation Trasplante intestinal en posición no anatómica

    Directory of Open Access Journals (Sweden)

    R. Charco

    2009-02-01

    Full Text Available Introduction: intestinal transplantation is the only long-range treatment option for patients with intestinal failure. We report an exceptional case of isolated intestinal transplantation with the implant in a non-anatomical position. Clinical case: the patient was a thirty-eight-year-old man (60 kg weight, 180 cm height, 18.3 body mass index with intestinal failure and home parenteral nutrition due to a short-bowel syndrome for which intestinal transplantation was indicated. The patient had a vascular malformation with the cava vein located left to the aorta, and the intestine was implanted with a 180º rotation around the mesenteric axis, so that the implant's superior mesenteric artery and vein matched the recipient's cava and aorta. Postoperative follow-up was excellent and the patient was discharged after six weeks with a 10-kg gain in body weight. Discussion: this non-anatomical intestinal implantation of the small bowel, previously unreported, offers technical advantages over other options. Adequate intestinal function represents a unique model to prove the viability of intestinal implants in a non-anatomical position.Introducción: el trasplante intestinal es el único tratamiento eficaz a largo plazo de los pacientes con fallo intestinal. Se presenta un caso clínico excepcional de trasplante intestinal aislado en posición no anatómica. Caso clínico: se trata de un varón de 38 años de edad con fallo intestinal y nutrición parenteral domiciliaria por un síndrome de intestino corto al que se le indicó un trasplante intestinal. Fue incluido en lista de espera con un peso de 60 kg, 180 cm de altura y 18,3 de índice de masa corporal. El receptor presentaba una trasposición de los grandes vasos con la vena cava situada a la izquierda de la arteria aorta por lo que el intestino se implantó con una rotación del injerto de 180º sobre su eje mesentérico, con el objetivo de que la vena y la arteria mesentérica superior del injerto

  14. Proporcionalidad impura : El trasplante de los principios de razonabilidad y proporcionalidad de la Moda Brasileña

    Directory of Open Access Journals (Sweden)

    Luiz Henrique Urquhart Cademartori

    2016-06-01

    Full Text Available Razonabilidad y proporcionalidad son conceptos jurídicos desarrollados histórica- mente en los Estados Unidos y Alemania, respectivamente. En Brasil, los dos institutos fueron importados e incorporados al sistema jurídico con la denominación mayoritaria de principio de proporcionalidad. No necesariamente sinónimos, la condensación de razo- nabilidad y proporcionalidad en tan sólo un postulado jurídico sin duda trae problemas al intérprete y el agente de la ley. Para empeorar las cosas, y utilizando la idea de “trasplante jurídico” desarrollada por el jurista colombiano Diego López Medina en su Teoría Impura del Derecho, el trasplante descontextualizado de los institutos desarrollados en los “centros de producción” estadounidenses y alemanes terminaron por dar a luz, en suelo brasileño, una especie de proporcionalidad impura, ignorando casi por completo el contexto históri- co y legal detrás de las instituciones que se inspiraron. Simplemente usando la “fórmula mágica” (idoneidad, necesidad y proporcionalidad en sentido estricto, desarrollada por el derecho alemán con la noción de “sentido común” y “justa medida” consagrada en el derecho anglosajón, se creó en Brasil el principio constitucional implícito de propor- cionalidad. Como efecto de su rápida popularización entre los abogados, el principio resultó ser una especie de panacea – remedio contra todos los problemas legales – para ser utilizado por la justicia brasileña en especial contra las normas legales producidas por la legislatura, que se consideran inconvenientes: en efecto, con la proporcionalidad, el control de constitucionalidad fue relegado a la discreción de la Corte Suprema brasileña y demás jueces de los niveles más bajos.

  15. Determination of ABO blood grouping and Rhesus factor from tooth material.

    Science.gov (United States)

    Kumar, Pooja Vijay; Vanishree, M; Anila, K; Hunasgi, Santosh; Suryadevra, Sri Sujan; Kardalkar, Swetha

    2016-01-01

    The aim of the study was to determine blood groups and Rhesus factor from dentin and pulp using absorption-elution (AE) technique in different time periods at 0, 3, 6, 9 and 12 months, respectively. A total of 150 cases, 30 patients each at 0, 3, 6, 9 and 12 months were included in the study. The samples consisted of males and females with age ranging 13-60 years. Patient's blood group was checked and was considered as "control." The dentin and pulp of extracted teeth were tested for the presence of ABO/Rh antigen, at respective time periods by AE technique. Data were analyzed in proportion. For comparison, Chi-square test or Fisher's exact test was used for the small sample. Blood group antigens of ABO and Rh factor were detected in dentin and pulp up to 12 months. For both ABO and Rh factor, dentin and pulp showed 100% sensitivity for the samples tested at 0 month and showed a gradual decrease in the sensitivity as time period increased. The sensitivity of pulp was better than dentin for both the blood grouping systems and ABO blood group antigens were better detected than Rh antigens. In dentin and pulp, the antigens of ABO and Rh factor were detected up to 12 months but showed a progressive decrease in the antigenicity as the time period increased. When compared the results obtained of dentin and pulp in ABO and Rh factor grouping showed similar results with no statistical significance. The sensitivity of ABO blood grouping was better than Rh factor blood grouping and showed a statistically significant result.

  16. Pleiotropy of ABO gene: correlation of rs644234 with E-selectin and lipid levels.

    Science.gov (United States)

    Arguinano, Alex-Ander Aldasoro; Ndiaye, Ndeye Coumba; Masson, Christine; Visvikis-Siest, Sophie

    2018-01-26

    The ABO gene has been widely studied and associated with many different diseases such as myocardial infarction and diabetes. Pleiotropic effects of the ABO locus have been demonstrated. Indeed it affects different phenotypes such as E- and P-selectins, triglycerides and total cholesterol. The goal of this work was to study the SNP rs644234 located in the ABO gene with different phenotypes related with diseases where the ABO gene has been involved. We analyzed the SNP rs644234 located in the ABO gene, by performing association studies with different lipid phenotypes as well as with the soluble E-selectin levels in 348 adults from the STANISLAS Family Study. The major rs644234*T allele was associated with increased levels of soluble E-selectin (p=8.7×10-12). According to the lipid phenotypes, the major rs644234*T allele was associated with decreased levels of apolipoproteins E (ApoE) (p=0.001) and low-density lipoprotein cholesterol (LDL-C) (p=0.032) but was associated with increased levels of high-density lipoprotein cholesterol (HDL-C) (p=0.013). The association of the HDL-C was especially significant in the male individuals (p=0.001). We confirmed that ABO is a major locus for serum soluble E-selectin levels variability, and we also correlated this gene with different lipid phenotypes. Furthermore, we demonstrated that this pleiotropic effect is independent. This is the first time that a correlation has been made between the ABO gene and the ApoE levels. According to these results, the major allele of this polymorphism may have a protective effect when it comes to cardiovascular related diseases, and more specifically when it comes to the lipid phenotypes.

  17. ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior.

    Science.gov (United States)

    Forni, Diego; Cleynen, Isabelle; Ferrante, Marc; Cassinotti, Andrea; Cagliani, Rachele; Ardizzone, Sandro; Vermeire, Severine; Fichera, Maria; Lombardini, Marta; Maconi, Giovanni; de Franchis, Roberto; Asselta, Rosanna; Biasin, Mara; Clerici, Mario; Sironi, Manuela

    2014-06-01

    ABO encodes a glycosyltranferase which determines the major human histo-blood group. The FUT2 fucosyltransferase allows expression of ABO antigens on the gastrointestinal mucosa and in bodily secretions (secretor phenotype). A nonsense allele in FUT2 represents a susceptibility variant for Crohn's disease, and both the secretor and ABO blood group status affect the composition of the gut microbiota. Thus, we evaluated if variants in ABO might represent good candidates as Crohn's disease susceptibility loci. We recruited two case-control cohorts, from Italy (n=1301) and Belgium (n=2331). Subjects were genotyped for one SNP in FUT2 and two variants in ABO. No effect on Crohn's disease risk was detected for ABO variants, whereas an association was observed between the FUT2 polymorphism and Crohn's disease susceptibility in the Belgian sample, but not in the Italian cohort. The effect of histo-blood groups was evaluated using group O as the reference. Most non-O groups had odds ratios (ORs) higher than 1 in both cohorts, and combined analysis of the two samples indicated a predisposing effect for the A and B groups (OR=1.17, 95% CI: 1.02-1.32 and OR=1.33, 95% CI: 1.09-1.58, respectively). In Crohn's disease patients, the non-O blood group and the non-secretor status were associated with higher risk of developing a stricturing or penetrating disease. ABO histo-blood group might confer susceptibility to Crohn's disease and modulate disease severity. Copyright © 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

  18. Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation

    Science.gov (United States)

    Solves, Pilar; Carpio, Nelly; Balaguer, Aitana; Romero, Samuel; Iacoboni, Gloria; Gómez, Inés; Lorenzo, Ignacio; Moscardó, Federico; Sanz, Jaime; Lopez, Francisca; Martin, Guillermo; Jarque, Isidro; Montesinos, Pau; de la Rubia, Javier; Sanz, Guillermo; Sanz, Miguel A.

    2015-01-01

    Background There are ABO antigens on the surface of platelets, but whether ABO compatible platelets are necessary for transfusions is a matter of ongoing debate. We retrospectively reviewed the ABO matching of platelet transfusions in a subset of patients undergoing autologous haematopoietic progenitor cell transplantation during a 14-year period. Our aim was to analyse the characteristics and outcomes of patients who received platelet transfusions that were or were not ABO identical. Material and methods We analysed 529 consecutive patients with various haematological and non-haematological diseases who underwent 553 autologous progenitor stem cell transplants at the University Hospital la Fe between January 2000 and December 2013. We retrospectively analysed and compared transfusion and clinical outcomes of patients according to the ABO match of the platelet transfusions received. The period analysed was the time from transplantation until discharge. Results The patients received a total of 2,772 platelet concentrates, of which 2,053 (74.0%) were ABO identical and 719 (26.0%) ABO non-identical; of these latter 309 were compatible and 410 incompatible with the patients’ plasma. Considering all transplants, 36 (6.5%) did not require any platelet transfusions, while in 246 (44.5%) cases, the patients were exclusively transfused with ABO identical platelets and in 47 (8.5%) cases they received only ABO non-identical platelet transfusions. The group of patients who received both ABO identical and ABO non-identical platelet transfusions had higher transfusion needs and worse clinical outcomes compared to patients who received only ABO identical or ABO non-identical platelets. Discussion In our hospital, patients undergoing autologous haematopoietic stem cell transplantation who received ABO identical or ABO non-identical platelet transfusions had similar transfusion and clinical outcomes. The isolated fact of receiving ABO non-identical platelets did not influence

  19. Psycholinguistics and Foreign Language Learning. Papers from a Conference (Stockholm, Sweden and Abo, Finland, October 25-26, 1982). Meddelanden fran Stiftelsens for Abo Akademi Forskningsinstitut Nr.86.

    Science.gov (United States)

    Ringbom, Hakan, Ed.

    At irregular intervals, beginning in 1977, Swedish-Finnish conferences on contrastive and applied linguistics have been arranged in Stockholm and Turko/Abo. This volume presents most of the papers given at the 1982 conference. Papers include: "Free Recall of Mixed Language Lists. Error Patterns in Bilingual Memory" (Karin Aronsson, Anja Metsola,…

  20. Renal radiopharmaceuticals

    International Nuclear Information System (INIS)

    Moretti, J.L.; Prevot, M.; Beco, V. de

    1995-01-01

    Renal tracers are classified according to their routes of excretion. Glomerular tracers most in use are 51 Cr EDTA and 99m Tc DTPA, the latter giving glomerular filtration values for each kidney with the help of scintigraphic imaging. Tubular tracers are a changing matter, 99m Tc MAG3 and 99m Tc EC would take the place of 123 I hippuran. Since 99m Tc glucoheptonate is not specific of the glomerular or tubular function and is a poor static imaging tracer, 99m Tc DMSA is the agent of choice for measuring the split functional renal mass. (authors). 16 refs., 5 figs

  1. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.

    Science.gov (United States)

    Albánez, S; Ogiwara, K; Michels, A; Hopman, W; Grabell, J; James, P; Lillicrap, D

    2016-05-01

    Essentials von Willebrand factor (VWF) and factor VIII (FVIII) levels are modulated by age and ABO status. The effect of aging and ABO blood type on VWF and FVIII was assessed in 207 normal individuals. Aging and ABO blood type showed combined and bidirectional influences on VWF and FVIII levels. Aging and ABO blood type influence VWF levels through both secretion and clearance mechanisms. Background The effect of aging and ABO blood type on plasma levels of von Willebrand factor (VWF) and factor VIII (FVIII) have been widely reported; however, a comprehensive analysis of their combined effect has not been performed and the mechanisms responsible for the age-related changes have not been determined. Objectives To assess the influence of aging and ABO blood type on VWF and FVIII levels, and to evaluate the contribution of VWF secretion and clearance to the age-related changes. Methods A cross-sectional observational study was performed in a cohort of 207 normal individuals, whose levels of VWF, FVIII, VWF propeptide (VWFpp), VWFpp/VWF:Ag ratio and blood type A antigen content on VWF (A-VWF) were quantified. Results Aging and ABO blood type exerted interrelated effects on VWF and FVIII plasma levels, because the age-related increase in both proteins was significantly higher in type non-O individuals (β = 0.011 vs. 0.005). This increase with age in non-O subjects drove the differences between blood types in VWF levels, as the mean difference increased from 0.13 U/mL in the young to 0.57 U/mL in the old. Moreover, A-VWF was associated with both VWF antigen (β = 0.29; 95% confidence interval [CI], 0.09, 0.50) and VWF clearance (β = -0.15; 95% CI, -0.25, -0.06). We also documented an effect of ABO blood type on VWF secretion with aging, as old individuals with blood type non-O showed higher levels of VWFpp (mean difference 0.29 U/mL). Conclusions Aging and ABO blood type have an interrelated effect on VWF and FVIII levels, where the effect of one is significantly

  2. ABO-Rh blood groups distribution in cardiac syndrome X patients.

    Science.gov (United States)

    Kheradmand, Fatemeh; Rasmi, Yousef; Nemati, Mohaddeseh; Mohammadzad, Mir Hossein Seyed

    2012-07-01

    Data on frequency distribution of ABO-Rh blood groups in cardiac syndrome X (CSX) patients are not available. We aimed to investigate the distribution of ABO-Rh blood groups in these patients. A total of 247 CSX patients' records were reviewed in a cross-sectional study from 2006 to 2010. One hundred forty six patients (59.1%) were female, and the mean patient age was 52 ± 11 years. The frequency of ABO-Rh blood groups was compared to the frequency of these blood groups in the West-Azerbaijan province, Iran; general population. Blood groups distribution among CSX patients showed phenotypes A, B, AB, O and Rh negative as 33.1%, 21.9%, 9.3%, 35.8%, and 7.9%, respectively. According to our results, there were no differences in ABO-Rh blood groups distribution between CSX patients and normal population. These data suggest that ABO-Rh blood groups might be unassociated with CSX.

  3. Association of ABO and Rh blood groups with type 2 diabetes mellitus.

    Science.gov (United States)

    Meo, S A; Rouq, F A; Suraya, F; Zaidi, S Z

    2016-01-01

    The phenotypic "ABO" blood groups are inherited antigenic substances which are found on the surface of red blood cells in addition to other tissues. Certain hypothesis advocates that genetic predisposition like "ABO" blood group would be associated with occurrence of diseases including type 2 diabetes. This study aimed to investigate the potential association between "ABO" and "Rhesus" blood groups with type 2 diabetes. We identified 47 research documents in a data based search including ISI-Web of Science, EMBASE and PubMed. Literature was explored using the key terms including "ABO blood groups" "type 2 diabetes". Studies in which "ABO" blood types and diabetes mellitus were discussed included without restrictions of research documents, types, status and language of the publications. Finally, 15 publications which matched our criteria were included, and remaining studies were excluded. Blood group "B" was associated with high incidence of type 2 diabetes and blood group "O" has a minimum association with type 2 diabetes. Blood group "A" and "AB" were almost equally distributed in both diabetic and non-diabetic population. However, we were unable to find an association between "Rh+ve" and "Rh-ve" blood groups with type 2 diabetes. Subjects with blood group "B" are at high risk while individuals with blood group "O" are at low peril of evolving type 2 diabetes. It is suggested that subjects with blood group "B" should be closely monitored by physicians as these subjects have an increased risk of type 2 diabetes.

  4. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].

    Science.gov (United States)

    Senterre, T; Minon, J-M; Rigo, J

    2011-03-01

    ABO allo-immunization is the most frequent hemolytic disease of the newborn and ABO incompatibility is present in 15-25 % of pregnancies. True ABO alloimmunization occurs in approximately one out of 150 births. Intensity is generally lower than in RhD allo-immunization. We report on three cases showing that ABO allo-immunization can lead to severe hemolytic disease of the newborn with potentially threatening hyperbilirubinemia and complications. Early diagnosis and adequate care are necessary to prevent complications in ABO incompatibility. A direct antiglobulin test is the cornerstone of diagnosis and should be performed at birth on cord blood sampling in all group infants born to O mothers, especially if of African origin. Risk factor analysis and attentive clinical monitoring during the first days of life are essential. Vigilance is even more important for infants discharged before the age of 72 h. Every newborn should be assessed for the risk of developing severe hyperbilirubinemia and should be examined by a qualified healthcare professional in the first days of life. Treatment depends on the total serum bilirubin level, which may increase very rapidly in the first 48 h of life in cases of hemolytic disease of the newborn. Phototherapy and, in severe cases, exchange transfusion are used to prevent hyperbilirubinemia encephalopathy. Intravenous immunoglobulins are used to reduce exchange transfusion. Treatments of severe hemolytic disease of the newborn should be provided and performed by trained personnel in neonatal intensive care units. Copyright © 2010 Elsevier Masson SAS. All rights reserved.

  5. Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?

    Science.gov (United States)

    Beken, Serdar; Hirfanoglu, Ibrahim; Turkyilmaz, Canan; Altuntas, Nilgun; Unal, Sezin; Turan, Ozden; Onal, Esra; Ergenekon, Ebru; Koc, Esin; Atalay, Yildiz

    2014-03-01

    Intravenous Immunoglobulin G (IVIG) therapy has been used as a component of the treatment of hemolytic disease of the newborn. There is still no consensus on its use in ABO hemolytic disease of the newborn routinely. The aim of this study is to determine whether administration of IVIG to newborns with ABO incompatibility is necessary. One hundred and seventeen patients with ABO hemolytic disease and positive Coombs test were enrolled into the study. The subjects were healthy except jaundice. Infants were divided into two groups: Group I (n = 71) received one dose of IVIG (1 g/kg) and LED phototherapy whereas Group II (n = 46) received only LED phototherapy. One patient received erythrocyte transfusion in Group I, no exchange transfusion was performed in both groups. Mean duration of phototherapy was 3.1 ± 1.3 days in Group I and 2.27 ± 0.7 days in Group II (p hemolytic disease. Meticulus follow-up of infants with ABO hemolytic disease and LED phototherapy decreases morbidity. IVIG failed to show preventing hemolysis in ABO hemolytic disease.

  6. Rapid ABO genotyping by high-speed droplet allele-specific PCR using crude samples.

    Science.gov (United States)

    Taira, Chiaki; Matsuda, Kazuyuki; Takeichi, Naoya; Furukawa, Satomi; Sugano, Mitsutoshi; Uehara, Takeshi; Okumura, Nobuo; Honda, Takayuki

    2018-01-01

    ABO genotyping has common tools for personal identification of forensic and transplantation field. We developed a new method based on a droplet allele-specific PCR (droplet-AS-PCR) that enabled rapid PCR amplification. We attempted rapid ABO genotyping using crude DNA isolated from dried blood and buccal cells. We designed allele-specific primers for three SNPs (at nucleotides 261, 526, and 803) in exons 6 and 7 of the ABO gene. We pretreated dried blood and buccal cells with proteinase K, and obtained crude DNAs without DNA purification. Droplet-AS-PCR allowed specific amplification of the SNPs at the three loci using crude DNA, with results similar to those for DNA extracted from fresh peripheral blood. The sensitivity of the methods was 5%-10%. The genotyping of extracted DNA and crude DNA were completed within 8 and 9 minutes, respectively. The genotypes determined by the droplet-AS-PCR method were always consistent with those obtained by direct sequencing. The droplet-AS-PCR method enabled rapid and specific amplification of three SNPs of the ABO gene from crude DNA treated with proteinase K. ABO genotyping by the droplet-AS-PCR has the potential to be applied to various fields including a forensic medicine and transplantation medical care. © 2017 Wiley Periodicals, Inc.

  7. Non-association between anti-Toxoplasma gondii antibodies and ABO blood group system

    Directory of Open Access Journals (Sweden)

    ACF Rodrigues

    2011-01-01

    Full Text Available Toxoplasma gondii infects humans through the gastrointestinal tract (GIT, which elicits humoral immune response with specific antibodies. The expression of the ABO blood group glycoconjugates also occurs in this same system and may influence the human susceptibility of infection by T. gondii. The aim of the present study was to investigate the association between ABO blood group phenotypes and the presence of anti-T. gondii antibodies. Data - including age, results of serology tests for T. gondii infection and ABO blood group phenotypes - were assembled from the medical records of 1,006 pregnant women attended in the Base Hospital of the Medical School of São José do Rio Preto, Brazil, between 2001 and 2004. The chi-square test was used to compare the results with the level of significance set at 5%. Of the studied cases, 64.1% (645/1006 and 35.9% (391/1006 presented respectively positive and negative serology tests for anti-T. gondii antibodies. The mean age of those who tested positive was higher than those with negative serology tests (p = 0.0004. The frequencies of ABO blood group phenotypes were similar in those with and without anti-T. gondii antibodies (p = 0.35. In conclusion, the ABO blood group system is not associated with the presence or absence of anti-T. gondii antibodies.

  8. Wear properties of hybrid ABO+BN+CNT/Al-Sn alloy matrix composites for engine bearing materials

    Science.gov (United States)

    Bak, Ji Hyeon; Cho, Dae Hyun; Shin, Sunmi; Park, Jin Young; Park, Ik Min

    2018-01-01

    Engine bearing materials need improved wear resistance to withstand high speeds and heavy loads. To meet the requirements of bearing materials, a new metal matrix composite (MMC) was designed. Here, the hybrid aluminum borate whisker (Al18B4O33, ABO) + hexagonal boron nitride (BN) + carbon nanotubes (CNTs)/Al-5Sn alloy MMCs were fabricated by squeeze infiltration. The wear properties of the hybrid MMCs were evaluated using a ball-on-disk tester. The effect of hybridization of ABO, BN, and CNTs on the wear properties of the Al-Sn MMCs was investigated. The microstructure of the hybrid MMCs showed a uniform distribution of the reinforcements. The wear resistance of the Al-5Sn alloy improved with the addition of ABO. The wear properties of the ABO+BN/ Al-Sn and ABO+CNT/Al-Sn MMCs were considerably enhanced compared to those of the ABO reinforced Al-Sn MMC because of the lubricating characteristic of BN and CNTs, and the CNTs were more effective than BN. The friction coefficient and wear rate of 20ABO+5BN+5CNT/Al-Sn MMC decreased by 1/4 and 1/20, respectively, compared to that of the ABO/Al-Sn MMC.

  9. Passenger Lymphocyte Syndrome (PLS): A Single-center Retrospective Analysis of Minor ABO-incompatible Liver Transplants

    NARCIS (Netherlands)

    Bruijn, S. de; Philipse, E.; Couttenye, M.M.; Bracke, B.; Ysebaert, D.; Michielsen, P.; Francque, S.; Vanwolleghem, T.; Verlinden, A.

    2017-01-01

    Background and Aims: Due to the shortage of donor livers, minor ABO-incompatible liver transplantations are commonly performed. Together with the allograft, immunocompetent B-lymphocytes, called passenger lymphocytes, are transplanted. In case of minor ABO-incompatibility, these passenger

  10. The investigation of ABO and Rh blood groups distribution in patients with endometriosis needs new project design.

    Science.gov (United States)

    Tabei, S M B; Daliri, K; Amini, A

    2012-05-01

    We carefully studied all the three published papers in your journal as "ABO and Rh Blood group distribution in patients with endometriosis" and "Associations of ABO blood groups with various gynecologic diseases" and would like to express our point of view about them.

  11. Renal denervation

    DEFF Research Database (Denmark)

    Olsen, Lene Kjær; Kamper, Anne-Lise; Svendsen, Jesper Hastrup

    2015-01-01

    PURPOSE OF REVIEW: Renal denervation (RDN) has, within recent years, been suggested as a novel treatment option for patients with resistant hypertension. This review summarizes the current knowledge on this procedure as well as limitations and questions that remain to be answered. RECENT FINDINGS...

  12. Glomerulopatí del trasplante. Resultados clínicos y seguimiento de casos.

    Science.gov (United States)

    Orizaga-de la Cruz, Citlalli; Parra-Michel, Renato; Chávez-Valencia, Venice; Fuentes-Ramírez, Francisco; Aragaki, Yuritomo; Márquez-Magaña, Isela; Villanueva-Pérez, Martha Arisbeth

    2017-01-01

    We describe the evolution of graft function in patients with transplant glomerulopathy measure by levels of serum creatinine, proteinuria and estimated glomerular filtration rate. Cross-sectional study conducted in the Regional General Hospital No. 46 IMSS. Included patients with kidney allograft and diagnosis of renal biopsy of transplant glomerulopathy grafting between January 1, 2006 to April 31, 2013 serum creatinine, proteinuria and estimated glomerular filtration rate at diagnosis, 6, 12 and 24 was recorded months. The results are shown with numbers, percentages and standard deviations. 42 patients were included. At 6 months of diagnosis, 14% decline in graft function and 7.1% graft loss. At 12 months, 17.9% graft loss, and at 24 months 36.3% had chronic graft dysfunction and graft loss as return to dialysis. Evolution in our patients seems to be better to other series of cases reported in the literature. Copyright: © 2017 SecretarÍa de Salud

  13. ABO blood groups and malaria related clinical outcome.

    Science.gov (United States)

    Deepa; Alwar, Vanamala A; Rameshkumar, Karuna; Ross, Cecil

    2011-03-01

    The study was undertaken to correlate the blood groups and clinical presentations in malaria patients and to understand the differential host susceptibility in malaria. From October 2007 to September 2008, malaria positive patients' samples were evaluated in this study. Hemoglobin, total leukocyte count, and platelet count of each patient were done on an automated cell counter. After determining the blood groups, malarial species and the severity of clinical course were correlated. A total of 100 patients were included in the study, of which 63 cases were positive for Plasmodium falciparum and 37 cases were positive for P. vivax infection and 11 patients had mixed infection. The results of the blood groups showed 22 - 'A' group, 42 - 'B' group, 35 - 'O' group and 1 was 'AB' group. When the clinical courses between different groups were compared using the following parameters for severe infection--a parasitic load of >10/1000 RBCs, severe anemia with hemoglobin 101°F and other organ involvement, it was observed that 'O' group had an advantage over other the groups. The difference in rosetting ability between red blood cells of different 'ABO' blood groups with a diminished rosetting potential in blood group 'O' red blood cells was due to the differential host susceptibility. 'O' group had an advantage over the other three blood groups. Based on literature and the results of this study, the diminished rosetting potential in blood group 'O' red blood cells is suggested as the basis for the differential host susceptibility.

  14. Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully with antigen-specific immunoadsorption

    DEFF Research Database (Denmark)

    Just, Søren Andreas; Marcussen, Niels; Sprogøe, Ulrik

    2010-01-01

    ABO-incompatible kidney transplantation is possible after pre-treatment with rituximab, intravenous immunoglobulin and basiliximab combined with tacrolimus, mycophenolate mofetil and prednisolone. We report on the first patient treated with this protocol who developed acute antibody-mediated reje......ABO-incompatible kidney transplantation is possible after pre-treatment with rituximab, intravenous immunoglobulin and basiliximab combined with tacrolimus, mycophenolate mofetil and prednisolone. We report on the first patient treated with this protocol who developed acute antibody......-mediated rejection (Banff grade II with IgG deposits) caused by ABO antibodies (anti-B). Anti-rejection treatment with anti-B-specific immunoadsorption, intravenous immunoglobulin and methylprednisolone efficiently cleared deposited IgG from the kidney allograft and re-established normal kidney function. We suggest...... that ABO-incompatible kidney transplantation complicated by acute antibody-mediated rejection, caused by ABO antibodies, may successfully be treated with this regime....

  15. Diagnóstico Precoz del Rechazo en el Trasplante Experimental de Páncreas Total con Duodeno en el Perro: Citología por Punción-Aspiración con Aguja Fina.

    OpenAIRE

    Rodríguez Abascal, Moisés

    2016-01-01

    El trasplante de páncreas está indicado fundamentalmente en los pacientes con diabetes mellitus tipo I. En la actualidad las soluciones terapéuticas ofertadas son: regímenes de insulina, bombas de infusión subcutánea de insulina, el páncreas artificial, y el trasplante de páncreas; este último sería la posibilidad que más fisiológicamente regularía el mecanismo de homostasis de la glucosa. Desde que...

  16. [Genotyping of ABO Blood Group in Partial Population of Yunnan Province by SNaPshot Technology].

    Science.gov (United States)

    Yu, S X; Zeng, F M; Jin, Y Z; Wan, H J; Zhai, D; Xing, Y M; Cheng, B W

    2017-06-01

    To detect the genotype of ABO blood group by SNaPshot technology. DNA were extracted from the peripheral blood samples with known blood groups (obtained by serology) of 107 unrelated individuals in Yunnan. Six SNP loci of the 261th, 297th, 681th, 703th, 802th, and 803th nucleotide positions were detected by SNaPshot Multiplex kit, and relevant genetics parameters were calculated. In 107 blood samples, the allele frequencies of types A, B, O A , and O G were 0.355 1, 0.168 2, 0.230 0 and 0.247 6, respectively, while that of types A G and cis AB were not detected. The genotyping results of ABO blood group were consistent with that of serologic testing. SNaPshot technology can be adapted for genotyping of ABO blood group. Copyright© by the Editorial Department of Journal of Forensic Medicine

  17. Frequency of ABO/Rhesus Blood Groups in Patients with Diabetes Mellitus.

    Science.gov (United States)

    Oner, Can; Dogan, Burcu; Telatar, Berrin; Celik Yagan, Canan Fidan; Oguz, Aytekin

    2016-01-01

    The correlation between ABO/Rh blood groups and diabetes mellitus is still controversial. The aim of this study was to determine the relationship between ABO/Rhesus blood groups and diabetes in Turkish population. This cross-sectional study was conducted in Istanbul Medeniyet University Göztepe Education and Training Hospital's Diabetes Units. The study group was composed of 421 patients with type-1 diabetes, 484 patients with type-2 diabetes and 432 controls. Blood samples were collected and tested for ABO/Rhesus blood groups. Data was analyzed by SPSS version 17.0. A significant association was found between blood groups and diabetes mellitus. The frequency of AB blood group was significantly higher in type-1 diabetics; and A blood group was significantly higher in type-2 diabetics. Furthermore, Rh negativity were significantly more frequent in type-2 diabetics.

  18. Relation of ABO blood groups to coronary lesion complexity in patients with stable coronary artery disease.

    Science.gov (United States)

    Kaya, Ahmet; Tanboğa, İbrahim Halil; Kurt, Mustafa; Işık, Turgay; Kaya, Yasemin; Günaydın, Zeki Yüksel; Aksakal, Enbiya

    2014-02-01

    We aimed to investigate the relationship between ABO blood groups and complexity of coronary lesions assessed by SYNTAX score (SS) in stable coronary artery disease (CAD) patients. Our cross-sectional and observational study population consisted of 559 stable CAD patients. From all patients, ABO blood group was determined and the SS was calculated as low SYNTAX score (0-22), intermediate SYNTAX (23-32) score and high SYNTAX score (>32). Statistical analysis was performed using Student's t-test or Mann-Whitney U test, ANOVA, or Kruskal-Wallis test and chi-square test. Multiple logistic regression analysis was used to identify the independent predictors of high SS. The analysis between the SS tertiles revealed that the frequency of non-O blood group was significantly higher in the upper SS tertiles (56.2% vs. 75.9 vs. 80.2%, pABO blood groups and complexity of angiographic CAD.

  19. ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis.

    Science.gov (United States)

    Zhong, Ming; Zhang, Hanrui; Reilly, John P; Chrisitie, Jason D; Ishihara, Mayumi; Kumagai, Tadahiro; Azadi, Parastoo; Reilly, Muredach P

    2015-07-01

    ABO blood groups have long been associated with cardiovascular disease, thrombosis, and acute coronary syndromes. Many studies over the years have shown type O blood group to be associated with lower risk of cardiovascular disease than non-type O blood groups. However, the mechanisms underlying this association remain unclear. Although ABO blood group is associated with variations in concentrations of circulating von Willebrand Factor and other endothelial cell adhesion molecules, ABO antigens are also present on several platelet surface glycoproteins and glycosphingolipids. As we highlight in this platelet-centric review, these glycomic modifications may affect platelet function in arterial thrombosis. More broadly, improving our understanding of the role of platelet glycan modifications in acute coronary syndromes may inform future diagnostics and therapeutics for cardiovascular diseases. © 2015 American Heart Association, Inc.

  20. The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer.

    Science.gov (United States)

    Franchini, Massimo; Lippi, Giuseppe

    2015-01-16

    Other than being present at the surface of red blood cells, the antigens of the ABO blood group system are efficiently expressed by a variety of human cells and tissues. Several studies recently described the involvement of the ABO blood group in the pathogenesis of many human disorders, including cardiovascular disease and cancer, so that its clinical significance extends now beyond the traditional boundaries of transfusion medicine. In a large cohort study recently published in BMC Medicine and including over 50,000 subjects, Etemadi and colleagues reported that nearly 6% of total deaths and as many as 9% of cardiovascular deaths could be attributed to having non-O blood groups, a condition that was also found to be associated with increased risk of gastric cancer. In this commentary, the clinical implications of ABO blood groups are critically discussed and a possible common pathogenic mechanism involving the von Willebrand factor is described.

  1. The effect of ABO blood incompatibility on corneal transplant failure in conditions with low-risk of graft rejection.

    Science.gov (United States)

    Dunn, Steven P; Stark, Walter J; Stulting, R Doyle; Lass, Jonathan H; Sugar, Alan; Pavilack, Mark A; Smith, Patricia W; Tanner, Jean Paul; Dontchev, Mariya; Gal, Robin L; Beck, Roy W; Kollman, Craig; Mannis, Mark J; Holland, Edward J

    2009-03-01

    To determine whether corneal graft survival over a 5-year follow-up period was affected by ABO blood type compatibility in participants in the Cornea Donor Study undergoing corneal transplantation principally for Fuchs dystrophy or pseudophakic corneal edema, conditions at low-risk for graft rejection. Multi-center prospective, double-masked, clinical trial. ABO blood group compatibility was determined for 1,002 donors and recipients. During a 5-year follow-up period, episodes of graft rejection were documented, and graft failures were classified as to whether or not they were attributable to immunologic rejection. Endothelial cell density was determined by a central reading center for a subset of subjects. ABO donor-recipient incompatibility was not associated with graft failure attributable to any cause including graft failure because of rejection, or with the occurrence of a rejection episode. The 5-year cumulative incidence of graft failure attributable to rejection was 32 (6%) for recipients with ABO recipient-donor compatibility and 12 (4%) for those with ABO incompatibility (hazard ratio, 0.65; 95% confidence interval, 0.33 to 1.25; P = .20). The 5-year incidence for a definite rejection episode, irrespective of whether graft failure ultimately occurred, was 64 (12%) for ABO compatible compared with 25 (8%) for ABO incompatible cases (P = .09). Among clear grafts at 5 years, percent loss of endothelial cells was similar in ABO compatible and incompatible cases. In patients undergoing penetrating keratoplasty for Fuchs dystrophy or pseudophakic corneal edema, ABO matching is not indicated since ABO incompatibility does not increase the risk of transplant failure attributable to graft rejection.

  2. Anemia y fiebre en el postrasplante renal: su relación con el parvovirus humano B19

    Directory of Open Access Journals (Sweden)

    Yanet Parodis López

    2017-03-01

    Presentamos el caso clínico de un varón de 65 años con trasplante renal de donante cadáver en septiembre de 2014. A los 38 días del trasplante comienza con anemia progresiva y resistente a los agentes estimulantes de la eritropoyesis. A los 64 días se produce hipertermia, con deterioro progresivo de su estado general. La serología vírica resultó negativa, al igual que la PCR inicial en sangre del parvovirus humano B19. A los 4 meses y 19 días se realiza una biopsia de médula ósea en la que se observan eritroblastos gigantes con inclusiones víricas nucleares compatibles con parvovirus, por lo que se realiza una PCR en dicho tejido que confirma el diagnóstico. Una segunda PCR en sangre resultó positiva. Tras el tratamiento con inmunoglobulinas intravenosas (IGIV y la suspensión temporal del micofenolato de mofetilo, se produce una remisión completa de la enfermedad, aunque persistía positiva la PCR para el parvovirus B19 en sangre, lo que hace necesario vigilar probables recidivas.

  3. Association of ABO blood groups and major ischaemic heart disease risk factors

    International Nuclear Information System (INIS)

    Lutf-Ullah, L.; Akhtar, B.; Noor-Us-Saba; Hanif, A.; Khan, B.Z.; Bukhshi, I.M.

    2010-01-01

    To study the association of ABO blood groups with major ischaemic heart disease risk factors. Setting: Department of Cardiology, Mayo hospital, Lahore over a period of two years from January 2008 to December 2009. Study Design: Analytic comparative study. Subjects and Methods: The study group included 907 patients of ischaemic heart disease (IHD). The distribution of ABO blood groups in IHD patients was compared for presence or absence of major IHD risk factors. Data was analyzed using SPSS 16. ANOVA and Chi-square tests for significance were used. P-value less than 0.05 was taken as significant. Results: In this study, the following pattern of ABO blood groups was observed in IHD patients : blood group A 251 (27.67%); blood group B 329 (36.27%); blood group O 235 (25.91%); blood group AB 92 (10.14%). We found no relation-ship of ABO blood groups with age (p-value = 0.234), gender (p-value = 0.093), hypertension (p-value = 0.230), diabetes mellitus (p-value = 0.801), family history of IHD (p-value = 0.277), transverse ear lobe crease (p-value = 0.231), total cholesterol (p-value = 0.797), triglycerides (p-value = 0.351), low density lipoprotein (p-value = 0.078), high density lipoprotein (p-value = 0.114). Similarly no relationship was found of smoking, weight, height and body mass index with ABO blood groups, p-values 0.428, 0.528, 0.908 and 0.455 respectively. Conclusion: There is no association of ABO blood groups and major ischaemic heart disease risk factors. (author)

  4. Relation of ABO blood groups to the severity of coronary atherosclerosis: an Gensini score assessment.

    Science.gov (United States)

    Gong, Ping; Luo, Song-Hui; Li, Xiao-Lin; Guo, Yuan-Lin; Zhu, Cheng-Gang; Xu, Rui-Xia; Li, Sha; Dong, Qian; Liu, Geng; Chen, Juan; Zeng, Rui-Xiang; Li, Jian-Jun

    2014-12-01

    Although the study on the relationship between ABO blood groups and coronary atherosclerosis has a long history, few data is available regarding ABO to severity of coronary atherosclerosis in a large cohort study. Therefore, the present study aimed to investigate the relation of the ABO blood groups to the severity of coronary atherosclerosis assessed by Gensini score (GS) in a large Chinese cohort undergoing coronary angiography. A total of 2919 consecutive patients undergoing coronary angiography were enrolled, and their baseline characteristics and ABO blood groups were collected. The GS was calculated as 1st tertile (0-10), 2nd tertile (11-36), 3rd tertile (>36) according to angiographic results. The relation of the ABO blood groups to GS was investigated. The frequency of blood group A was significantly higher in the upper GS tertiles (24.4% vs. 28.2% vs. 29.5%, p = 0.032). Multivariable linear regression analysis revealed that blood group A was independently associated with GS (β = 0.043, p = 0.017). Likewise, multivariable logistic regression analysis showed that group A remained significantly associated with mid-high GS (OR = 1.44, 95% CI 1.16-1.80, p = 0.001), and the group O was showed as a protective factor (OR = 0.77, 95% CI = 0.65-0.92, p = 0.004). In this large Chinese cohort study, the data indicated that there was an association between ABO blood groups and the severity of coronary atherosclerosis. Moreover, the blood group A was an independent risk factor for serious coronary atherosclerosis. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

  5. ABO blood groups and risk for obesity in Arar, Northern Saudi Arabia.

    Science.gov (United States)

    Aboel-Fetoh, Nagah M; Alanazi, Arwa R; Alanazi, Abdullah S; Alruwili, Asma N

    2016-12-01

    ABO blood groups are associated with some important chronic diseases. Previous studies have observed an association between ABO blood group and risk for obesity. This study aimed to determine whether there is an association between ABO blood groups and obesity in apparently healthy attendees of primary healthcare (PHC) centers in Arar city, Northern Saudi Arabia. This cross-sectional study included 401 participants aged 15 years and older attending three randomly selected PHC centers in Arar city. Data were collected by means of personal interview using a predesigned questionnaire. Anthropometric examination included height and weight measurements with calculation of BMI. ABO and Rh blood groups were determined. The majority of the participants were female (70.8%). The mean±SD age was 28.6±9.1 years. Only 5.7% were underweight. Both normal and overweight participants were equal in number and constituted 28.4%, whereas obese individuals constituted 37.4% with a mean BMI of 28.56±8.0. Blood group O was the most common (44.1%), followed by A (30.9%), B (18.7%), and AB (6.2%). Rh-positive cases constituted 87.0%. Blood group O was the most common type among the obese individuals (44.7%), followed by A, B, and AB groups (30, 20, and 5.3%, respectively). BMI was highest (28.8±9.2) in blood group O. There were no statistically significant differences between different ABO blood groups as regards BMI, Rh, and sex. Moreover, there was no statistically significant difference between Rh type and BMI. The prevalence of obesity and overweight is high in the population attending PHC centers of Arar city, Northern Saudi Arabia. There is no association between overweight, obesity, and ABO blood groups or Rh.

  6. Sensitive typing of reverse ABO blood groups with a waveguide-mode sensor.

    Science.gov (United States)

    Uno, Shigeyuki; Tanaka, Torahiko; Ashiba, Hiroki; Fujimaki, Makoto; Tanaka, Mutsuo; Hatta, Yoshihiro; Takei, Masami; Awazu, Koichi; Makishima, Makoto

    2018-02-27

    Portable, on-site blood typing methods will help provide life-saving blood transfusions to patients during an emergency or natural calamity, such as significant earthquakes. We have previously developed waveguide-mode (WM) sensors for forward ABO and Rh(D) blood typing and detection of antibodies against hepatitis B virus and hepatitis C virus. In this study, we evaluated a WM-sensor for reverse ABO blood typing. Since reverse ABO blood typing is a method for detection of antibodies against type A and type B oligosaccharide antigens on the surface of red blood cells (RBCs), we fixed a synthetic type A or type B trisaccharide antigen on the sensor chip of the WM sensor. We obtained significant changes in the reflectance spectra from a WM sensor on type A antigen with type B plasma and type O plasma and on type B antigen with type A plasma and type O plasma, and no spectrum changes on type A antigen or type B antigen with type AB plasma. Signal enhancement with the addition of a peroxidase reaction failed to increase the sensitivity for detection on oligosaccharide chips. By utilizing hemagglutination detection using regent type A and type B RBCs, we successfully determined reverse ABO blood groups with higher sensitivity compared to a method using oligosaccharide antigens. Thus, functionality of a portable device utilizing a WM sensor can be expanded to include reverse ABO blood typing and, in combination with forward ABO typing and antivirus antibody detection, may be useful for on-site blood testing in emergency settings. Copyright © 2018 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

  7. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.

    Science.gov (United States)

    Miqdad, A M; Abdelbasit, O B; Shaheed, M M; Seidahmed, M Z; Abomelha, A M; Arcala, O P

    2004-09-01

    Although intravenous immunoglobulin G (IVIG) therapy has been reported in hyperbilirubinemia of Rh hemolytic disease, its use in ABO hemolytic disease has been reported in only a few studies. In our institute we have observed that almost 30% of babies with hyperbilirubinemia due to ABO hemolytic disease required exchange transfusion. To determine whether administration of IVIG to newborns with significant hyperbilirubinemia due to ABO hemolytic disease would reduce the need for exchange transfusion as a primary goal in these babies. This was a prospective study involving all newborns with significant hyperbilirubinemia due to direct Coombs-positive ABO hemolytic disease. All healthy term babies with ABO hemolytic disease with positive direct Coombs test in the period between 2000 and 2002 were identified. Significant hyperbilirubinemia was defined as hyperbilirubinemia requiring phototherapy and/or rising by 8.5 micromol/l per h (0.5 mg/dl per h) or more to require exchange transfusion. Babies were randomly assigned into two groups: group 1 (study group) received phototherapy plus IVIG (500 mg/kg); and group 2 (control group) received phototherapy alone. Exchange transfusion was carried out in any group if at any time the bilirubin level reached 340 micromol/l (20 mg/dl) or more, or rose by 8.5 micromol/l per h (0.5 mg/dl per h) in group 2. A total of 112 babies were enrolled over 2 years, 56 in each group. Exchange transfusion was carried out in four babies in the study group, while 16 babies in the control group required exchange. Late anemia was not of concern in either group. No adverse effects related to IVIG administration were recorded. Administration of IVIG to newborns with significant hyperbilirubinemia due to ABO hemolytic disease with positive direct Coomb's test reduces the need for exchange transfusion without producing immediate adverse effects.

  8. Clinico-serologic co-relation in bi-directional ABO incompatible hemopoietic stem cell transplantation

    Directory of Open Access Journals (Sweden)

    Sabita Basu

    2015-01-01

    Full Text Available Background: The ABO blood group system is of prime significance in red cell transfusion and organ transplantation. However, ABO compatibility is not critical in allogenic hemopoietic stem cell transplantation (HSCT and approximately 40-50% of hemopoietic stem cell transplants are ABO incompatible. This incompatibility may be major, minor or bi-directional. Though there are descriptions of transfusion practice and protocols in ABO incompatible HSCT, there are considerable variations and transfusion support in these patients can be very challenging. Aims: The immunohematologic observations in two cases of bi-directional ABO incompatible HSCT have been described, and clinico-serologic correlation has been attempted. Materials and Methods: In both cases, peripheral blood stem cell harvests were obtained using the Cobe spectra cell separator. Immunohematologic assessments in the donor and recipient were done as a part of pre HSCT evaluation. Both the standard tube technique and column agglutination method (Ortho Biovue Micro Bead System was used. Antibody screen was done by column agglutination method using three cell panel (Surgiscreen cells. Isoagglutinin titration was done by the master dilution method and standard validated techniques were used. Results: The pattern of laboratory findings in the two cases was different and so were the clinical outcomes. Although there was early engraftment in the first case, the second case developed pure red cell aplasia and this was well-reflected in the immunohematologic assessments. Conclusion: Immunohematologic assessment correlated well with the clinical picture and could be used to predict clinical outcome and onset of complications in ABO incompatible HSCT.

  9. Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors.

    Science.gov (United States)

    Alharbi, Abdullah; Hassan, Salwa Bakr; Al-Momen, Abdul-Kareem; Al-Saleh, Khalid; Nasr, Rasheed; Kohgear, Haitham; Owaidah, Tarek

    2018-03-01

    : Von Willebrand disease is a common bleeding disorder. The wide variation in von Willebrand factor (VWF) levels between and within normal individuals highlights the clinical challenge of defining its cutoff value. Although studies on the influence of ethnicity on ABO phenotypes and the levels of VWF have been carried out on different ethnicities, there is a lack of such data among Arab population. We aimed to evaluate the correlation of ABO phenotypes with all the parameters of the minimal test panel of VWF including VWF antigen, VWF activity using the ristocetin cofactor and the collagen binding activity assays, and factor VIII coagulant activity (VWF:Ag, VWF:RCo, VWF:CB and FVIII:C) tested in a normal Arab population, and to estimate ABO-specific normal reference range. Blood samples were collected from 87 healthy donors in Riyadh to determine levels of factor VIII and VWF panel between the various ABO phenotypes. The highest mean values of factor VIII : C (128 U/dl), VWF : Ag (125 U/dl), VWF : RCo (109 U/dl) and VWF : CB (91 U/dl) were observed with type AB and the lowest mean values of factor VIII : C (81 U/dl), VWF : Ag (85 U/dl), VWF : RCo (73 U/dl) and VWF : CB (70 U/dl) corresponded to type O. ABO phenotypes significantly influence plasma levels of VWF parameters in Arab nations as seen with other ethnicity. Hence, ABO-specific normal ranges of the minimal test panel of VWF and factor VIII : C are essential for the appropriate prediction of mild von Willebrand disease. Further study including a larger categorized sample size is required to generalize the test panel on the Arab population.

  10. ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia.

    Science.gov (United States)

    Paquette, Martine; Dufour, Robert; Baass, Alexis

    2017-12-14

    The ABO blood group has been associated with cardiovascular disease (CVD) in observational studies. However, the effect of ABO blood group has never been studied in subjects affected by familial hypercholesterolemia (FH), a severe monogenic disease characterized by accelerated atherosclerotic plaque development. Our aim is to investigate the effect of the ABO blood group on CVD risk in FH patients. A total of 668 adult subjects with a heterozygous FH-causing mutation in the low density lipoprotein receptor (LDLR) gene were included in the present study. ABO blood group was determined using 2 functional single-nucleotide polymorphisms in the ABO gene (rs8176719 and rs8176746). Total cholesterol was significantly higher in non-O subjects compared to carriers of the O group (9.48 vs 9.14 mmol/L, P = .02). We observed a greater proportion of subjects carrying the non-O groups (73.4%) in patients with CVD compared to subjects without CVD (63.3%). In a regression model corrected for cardiovascular risk factors, the non-O group was significantly associated with an increased prevalence of CVD (odds ratio = 2.14, 95% confidence interval = 1.25-3.65, P = .005). In average, patients in the non-O blood group experienced more CVD events (0.88 per individual) than those in the O group (0.60 per individual), P = .008. Carrying a non-O blood group is associated with an independent twofold increased risk of CVD in FH patients. The ABO blood group represents a novel CVD risk factor in FH subjects that is often known by the patient and could be used to further stratify CVD risk in this population of patients. Copyright © 2017 National Lipid Association. Published by Elsevier Inc. All rights reserved.

  11. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.

    Science.gov (United States)

    Li, Sha; Xu, Rui-Xia; Guo, Yuan-Lin; Zhang, Yan; Zhu, Cheng-Gang; Sun, Jing; Li, Jian-Jun

    2015-04-01

    Proprotein convertase subtilisin/kexin type 9 (PCSK9), a newly-identified member that plays an essential role in cholesterol homeostasis and holds decent promise for hyperlipidemia and coronary artery disease (CAD) treatment. However, the determining factors of PCSK9 are not well-characterized. It is well established that ABO blood group is associated with cholesterol metabolism. Therefore, the relationship between ABO blood groups and plasma PCSK9 level was examined. A group of 507 consecutive patients undergoing diagnostic or interventional coronary angiography were enrolled in this cross-sectional study. The baseline clinical characteristics were collected, and the plasma PCSK9 levels were determined using ELISA. As a result, subjects of non-O type had higher levels of total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), non high density lipoprotein cholesterol (NHDL-C), apolipoprotein B (apo B), and PCSK9 compared with that of O type (p ABO group was significantly and independently associated with PCSK9 level (β = 7.91, p = 0.009). Additionally, mediation analysis indicated that ≈8%-19% of the effect of ABO blood group on PCSK9 levels was mediated by TC, LDL-C or NHDL-C levels. These data firstly suggested that the ABO blood group might be a significant determinant factor for plasma PCSK9 level. It is also possible that the observed association between PCSK9 and ABO blood group might be in part involved in their CAD susceptibility. Copyright © 2014 Elsevier B.V. All rights reserved.

  12. Conocimientos y actitudes de los médicos de instituciones hospitalarias en Barranquillla sobre donación y trasplante de órganos

    Directory of Open Access Journals (Sweden)

    Rafael Tuesca . M

    2003-01-01

    Full Text Available Objetivo: Identificar las actitudes y evaluar el conocimiento sobre donación y trasplante de órganos en médicos de instituciones hospitalarias en Barranquilla (Colombia. Métodos: Se diseñó un estudio observacional transversal. Muestra aleatoria estratificada de 305 médicos generales (MG y especialistas de instituciones hospitalarias de Barranquilla. Información de tipo primario, mediante encuestas autodiligenciadas. El cuestionario adaptado de Blanca, De Frutos y Rosel consta de 29 preguntas, divididas en tres capítulos. El primer capítulo: identificación personal (6 ítems; el segundo midió el conocimiento sobre donación y trasplante mediante preguntas de selección múltiple (11 ítems; y el tercero evaluó las actitudes con escala tipo likert (12 ítems. Se contó con el apoyo de los centros hospitalarios. Resultados: Se evaluaron 274 médicos (104 MG que presentaron una media de 48.7 años y desviación estándar de 6.37. La razón de médicos especialistas por médico general fue de 1.6:1. Con respectoalconocimientoteórico,seencontróun50.73%defrecuenciamodal derespuestasregulares y el 41.24% en el rango bueno. Al comparar el conocimiento con el área de trabajo se encontró una diferencia significativa respecto al grado de conocimiento entre médicos generales y especialistas, siendo (OR=2.37IC95%1.42–3.93.Losmédicosdesconocenelmarcolegalqueregulaladonación ytrasplantedeórganos.El72.3%delosencuestadosdesconocelaexistenciadelprogramadedonación y trasplante de órganos en Barranquilla. El 35% manifiestó que se actualiza al consultar libros o revistas especializadas. En cuanto al conocimiento general, existe diferencia significativa entre los médicos generales y especialistas, lo cual arrojó una prueba Z de diferencia de proporciones de 3.91 para una p= 0.00007. Conclusiones:Losinvestigadoressugierenentreotrosaspectos:promocionarydifundirlosprogramas de trasplante y donación de órganos para el público en general y

  13. Utilidad de las Troponinas Cardiacas en la Sangre del Donante como Predictores de Muerte por Fallo Precoz del Injerto en el Receptor de un Trasplante Cardiaco.

    OpenAIRE

    López Haldón, José Eduardo

    2017-01-01

    Se ha señalado que la muerte cerebral es capaz de provocar disfunción miocárdica en el potencial donante. No se conocen cuáles son los mecanismos por los que esto ocurre. La disfunción del ventrículo que aparece en el contexto de la muerte cerebral conduce a que un porcentaje nada despreciable de potenciales donantes hayan de ser rechazados para trasplante por mostrar injertos inadecuados. Esto agrava aún más el dramático proble...

  14. Enfermedad Granulomatosa Crónica en paciente pediátrico y trasplante de médula ósea como tratamiento curativo

    OpenAIRE

    Constanza Martínez R.; Valentina Ulloa P.; Claudio Mosso C.

    2016-01-01

    Introducción: La enfermedad granulomatosa crónica (EGC) es una inmunodeficiencia primaria, caracterizada por la incapacidad de células fagocíticas para producir sustancias necesarias para destruir microorganismos. Actualmente, el trasplante de médula ósea como tratamiento curativo de la EGC ha demostrado ser una prometedora alternativa terapéutica. Presentación del caso: Lactante menor de 8 meses, ingresa a Unidad de Cuidados Especiales Pediátricos por cuadro de nueve días de evolución caract...

  15. ABO Blood Group Genotyping by Real-time PCR in Kazakh Population

    Directory of Open Access Journals (Sweden)

    Pavel Tarlykov

    2014-12-01

    Full Text Available Introduction. ABO blood group genotyping is a new technology in hematology that helps prevent adverse transfusion reactions in patients. Identification of antigens on the surface of red blood cells is based on serology; however, genotyping employs a different strategy and is aimed directly at genes that determine the surface proteins. ABO blood group genotyping by real-time PCR has several crucial advantages over other PCR-based techniques, such as high rapidity and reliability of analysis. The purpose of this study was to examine nucleotide substitutions differences by blood types using a PCR-based method on Kazakh blood donors.Methods. The study was approved by the Ethics Committee of the National Center for Biotechnology. Venous blood samples from 369 healthy Kazakh blood donors, whose blood types had been determined by serological methods, were collected after obtaining informed consent. The phenotypes of the samples included blood group A (n = 99, B (n = 93, O (n = 132, and AB (n = 45. Genomic DNA was extracted using a salting-out method. PCR products of ABO gene were sequenced on an ABI 3730xl DNA analyzer (Applied Biosystems. The resulting nucleotide sequences were compared and aligned against reference sequence NM_020469.2. Real-time PCR analysis was performed on CFX96 Touch™ Real-Time PCR Detection System (BioRad.Results. Direct sequencing of ABO gene in 369 samples revealed that the vast majority of nucleotide substitutions that change the ABO phenotype were limited to exons 6 and 7 of the ABO gene at positions 261, 467, 657, 796, 803, 930 and 1,060. However, genotyping of only three of them (261, 796 and 803 resulted in identification of major ABO genotypes in the Kazakh population. As a result, TaqMan probe based real-time PCR assay for the specific detection of genotypes 261, 796 and 803 was developed. The assay did not take into account several other mutations that may affect the determination of blood group, because they have a

  16. Uremic Hemolitic Syndrome induced by Escherichia Coli producer of Shiga toxin in a pediatric patient with renal transplant

    Directory of Open Access Journals (Sweden)

    Ana Paula Ramírez

    2017-04-01

    Full Text Available El Síndrome Urémico Hemolítico (SUH secundario a la infección por Escherichia coli productora de toxina Shiga (STEC serotipo O157:H7 es una enfermedad endémica en Argentina según la Organización Panamericana de la Salud, siendo en nuestro país, y en los niños la primera causa de Injuria renal aguda (IRA y la segunda causa de Insuficiencia Renal Crónica (IRC. Esta entidad clínica y anátomo-patológica se caracteriza por presentación aguda de daño renal, anemia hemolítica microangiopática y trombocitopenia, que puede afectar otros parénquimas como intestino, sistema nervioso central, páncreas, corazón e hígado. Más del 90% de los pacientes afectados se recuperan en período agudo, aunque se han descrito secuelas renales a largo plazo hasta en el 25% de ellos. Según nuestro conocimiento aún no ha sido descrito en nuestro país casos de síndrome urémico hemolítico secundario a infección por Escherichia coli, productora de STEC luego del Trasplante Renal (TxR.

  17. Renal candidiasis

    International Nuclear Information System (INIS)

    Khanna, S.; Malik, N.; Khandelwal, N.

    1990-01-01

    Most fungal infections of the urinary tract are caused by Candida albicans, a yeast-like saprophytic fungus which may become apathogen under various conditions which lower the host resistance. The use of computed tomography in the diagnosis of renal fungus balls is the subject of this communication with emphasis on the radiologists role in the recognition of this entity. (H.W.). 6 refs.; 2 figs

  18. Hiperparatiroidismos renales

    Directory of Open Access Journals (Sweden)

    Valentín Malagón Castro

    1957-04-01

    Full Text Available En la presente monografía presentamos una síntesis, lo más completa posible, del gran problema de los Hiperparatirodismos secundarios a lesiones renales, enfocando su estudio con un criterio unicista, con el objeto de hacer más didáctico este amplio capítulo de la patología.

  19. Renal hemangioma

    Directory of Open Access Journals (Sweden)

    Theodorico F. da Costa Neto

    2004-06-01

    Full Text Available INTRODUCTION: Renal hemangioma is a relatively rare benign tumor, seldom diagnosed as a cause of hematuria. CASE REPORT: A female 40-year old patient presented with continuous gross hematuria, anemia and episodic right lumbar pain, with onset about 3 months previously. The patient underwent multiple blood transfusions during her hospital stay and extensive imaging propedeutics was performed. Semi-rigid ureterorenoscopy evidenced a bleeding focus in the upper calix of the right kidney, with endoscopic treatment being unfeasible. The patient underwent right upper pole nephrectomy and presented a favorable outcome. Histopathological analysis of the surgical specimen showed that it was a renal hemangioma. COMMENTS: Imaging methods usually employed for diagnostic investigation of hematuria do not have good sensitivity for renal hemangioma. However, they are important to exclude the most frequent differential diagnoses. The ureterorenoscopy is the diagnostic method of choice and endoscopic treatment can be feasible when the lesion is accessible and electrocautery or laser are available. We emphasize the open surgical treatment as a therapeutic option upon failure of less invasive methods.

  20. An ABO blood grouping discrepancy: Probable B(A) phenotype.

    Science.gov (United States)

    Jain, Ashish; Gupta, Anubhav; Malhotra, Sheetal; Marwaha, Neelam; Sharma, Ratti Ram

    2017-06-01

    In B(A) phenotype, an autosomal dominant phenotype, there is a weak A expression on group B RBCs. We herein report a case of a probable B(A) phenotype in a first time 20-year old male donor. The cell and serum grouping were done using tube technique and also with blood grouping gel card (Diaclone, ABD cards for donors, BioRad, Switzerland). The antisera used were commercial monoclonal IgM type. To check for the weak subgroup of A, cold adsorption and heat elution was performed. The cell grouping was A weak B RhD positive while the serum grouping was B. There was no agglutination with O cells and the autologous control was also negative. It was a group II ABO discrepancy with or without group IV discrepancy. Results for both the eluate and last wash were negative. Hence, the possibility of weak subgroup of A was unlikely. Blood grouping gel card also showed a negative reaction in the anti-A column. One lot of anti-A was showing 'weak +' agglutination while the other lot was showing 'negative' reaction with the donor RBCs by tube technique. There was no agglutination observed with anti-A1 lectin. Our case highlights the serological characteristics of a B(A) phenotype. This case emphasizes the vital role of cell and serum grouping in detecting such discrepancies especially in donors which can lead to mislabeling of the blood unit and may be a potential risk for the transfusion recipient if not resolved appropriately. Copyright © 2017 Elsevier Ltd. All rights reserved.

  1. Pabellón de trasplantes en el hospital general de Edimburgo, Gran Bretaña

    Directory of Open Access Journals (Sweden)

    Womersley, P.

    1970-11-01

    Full Text Available The set of buildings includes a medical wing, an administrative wing, and a slightly elevated passage, which connects the Nuffield Foundation with the Hospital, through which patients and donants are taken from the Hospital to the Pavillion. The body of the building, which is tower shaped, has stairs, a lift, water tanks; and in the semi-basement there are mechanical, sanitary, and air conditioning installations. This pavillion has been specially designed to carry out human transplants, mainly kidneys, and meets present complex technical needs in this branch of surgery. From the aesthetic aspect, the total designs gives the visitor the impression of safety and airiness, and induces a sensation of confidence.El conjunto construido consta de: un ala médica; un ala administrativa; y un paso ligeramente elevado, que une Nuffield con el Hospital, utilizado para el traslado de pacientes y donantes desde el Hospital al Pabellón. El cuerpo de edificio, con aspecto de «torre», contiene: la escalera, el ascensor, el depósito de agua, etc.; el semisótano alberga: los equipos mecánicos y los servicios de las instalaciones sanitarias, aire acondicionado, etc. Ha sido especialmente diseñado para realizar operaciones de trasplante de órganos humanos, en particular de riñon, y satisface adecuadamente las complejas exigencias técnicas que reclamaban los recientes avances en esta rama de la cirugía. Desde el punto de vista estético, el conjunto construido produce en el espectador una sensación segura y etérea, que lo hace sumamente atractivo.

  2. Enfermedad hemolítica del recién nacido por incompatibilidad ABO Hemolytic disease of the newborn due to ABO incompatibility

    OpenAIRE

    Débora Villegas Cruz; Raisa Durán Menéndez; Antonio Alfonso Dávila; María del Rosario López De Roux; Lázaro Cortina; Mirtha Vilar Carro; Lissette Orbeal Aldama

    2007-01-01

    La enfermedad hemolítica del recién nacido por incompatibilidad ABO es la más frecuente de todas las incompatibilidades de grupo sanguíneo entre la madre y el recién nacido. Se estudiaron 46 recién nacidos a término, afectos de esta enfermedad, que fueron diagnosticados en el Hospital General «Enrique Cabrera» entre junio de 2004 y marzo del 2006. El diagnóstico se realizó por examen físico, exámenes de laboratorio y exámenes inmunohematológicos: fenotipificación de grupo ABO, pru...

  3. The association of ABO blood groups with extent of coronary atherosclerosis in Croatian patients suffering from chronic coronary artery disease.

    Science.gov (United States)

    Karabuva, Svjetlana; Carević, Vedran; Radić, Mislav; Fabijanić, Damir

    2013-01-01

    The aim of study was to: 1) examine the relationship between ABO blood groups and extent of coronary atherosclerosis in patients with chronic coronary artery disease (CAD), 2) compare ABO blood groups distribution in CAD patients and general population, 3) examine possible differences in traditional risk factors frequency in CAD patients with different ABO blood groups. In the 646 chronic CAD patients (72.4% males) coronary angiograms were scored by quantitative assessment using multiple angiographic scoring system, Traditional risk factors were self reported or measured by standard methods. ABO blood distribution of patients was compared with group of 651 healthy blood donors (74.6% males). Among all ABO blood group patients there was no significant difference between the extent of coronary atherosclerosis with regard to all the three scoring systems: number of affected coronary arteries (P = 0.857), Gensini score (P = 0.818), and number of segments narrowed > 50% (P = 0.781). There was no significant difference in ABO blood group distribution between CAD patients and healthy blood donors. Among CAD patients, men with blood group AB were significantly younger than their pairs with non-AB blood groups (P = 0.008). Among CAD patients with AB blood group, males groups (P = 0.003). No association between ABO blood groups and the extent of coronary atherosclerosis in Croatian CAD patients is observed. Observation that AB blood group might possibly identify Croatian males at risk to develop the premature CAD has to be tested in larger cohort of patients.

  4. Association between ABO Blood Group and Risk of Congenital Heart Disease: A 6-year large cohort study.

    Science.gov (United States)

    Zu, Bailing; You, Guoling; Fu, Qihua; Wang, Jing

    2017-02-17

    ABO blood group, except its direct clinical implications for transfusion and organ transplantation, is generally accepted as an effect factor for coronary heart disease, but the associations between ABO blood group and congenital heart disease (CHD) are not coherent by previous reports. In this study, we evaluated the the potential relationship between ABO blood group and CHD risk. In 39,042 consecutive inpatients (19,795 CHD VS 19,247 controls), we used multivariable logistic regression to evaluate the roles of ABO blood group, gender, and RH for CHD. The associations between ABO blood group and CHD subgroups, were further evaluated using stratification analysis, adjusted by gender. A blood group demonstrated decreased risk for isolated CHD (OR 0.82; 95% CI, 0.78-0.87) in individuals with A blood group in the overall cohort analysis, and the finding was consistently replicated in independent subgroup analysis. ABO blood group may have a role for CHD, and this novel finding provides ABO blood group as a possible marker for CHD, but more studies need to be done.

  5. The potential association of the transcription levels of the ABO gene with the disease phases in AML patients.

    Science.gov (United States)

    Zhang, Wenjing; Liu, Jinling; Zhang, Wei; Zhuang, Yunlong

    2017-10-01

    Patients with AML may show ABO blood typing discrepancy, and the expression levels of the ABO antigens may show some alterations with the disease progression. To better understand this phenomenon, the blood samples of 25 AML patients and 25 healthy blood donors were examined. The serological ABO blood types of the patients were determined in different AML stages, and gene sequencing was performed to identify the precise ABO genotypes. Reverse transcription-polymerase chain reaction (RT-PCR) was carried out to detect the transcription levels of the antigens. The genotyping result showed that there were 4 patients with genotype A 1 O, 5 patients with B 1 O, and 16 patients with A 1 B 1 . RT-PCR results indicated that the transcription levels of the ABO gene in 76% (19/25) of the patients were significantly lower compared with those in controls (p ABO gene from those of controls. The data indicated that the transcription levels of the ABO gene changed with the disease progression, suggesting its potential role in the progression of AML disease. Copyright © 2017 Elsevier Ltd. All rights reserved.

  6. 148. Utilidad del sistema oxigenador de membrana extracorpórea como puente al trasplante pulmonar y como asistencia quirúrgica para la realización del mismo. una nueva indicación en nuestro centro

    Directory of Open Access Journals (Sweden)

    J.A. Sarralde

    2012-04-01

    Conclusiones: La ECMO es útil para pacientes con insuficiencia respiratoria refractaria a medidas convencionales incluidos en lista de espera, así como para aquellos que precisen circulación extracorpórea para realización del trasplante pulmonar, disminuyendo las posibles complicaciones y aumentando la supervivencia.

  7. Reconstitución inmune exitosa mediante trasplante de células madre hematopoyéticas en un paciente colombiano afectado con enfermedad granulomatosa crónica

    Directory of Open Access Journals (Sweden)

    Yermis Carolina Rocha

    2016-06-01

    Conclusión. El trasplante de células madre hematopoyéticas permite la reconstitución completa de la función inmunitaria relacionada con la actividad microbicida de las células fagocíticas de pacientes con enfermedad granulomatosa crónica ligada al cromosoma X.

  8. LA VISIÓN DEL PERSONAL DE SALUD SOBRE LA DONACIÓN Y EL TRASPLANTE DE ÓRGANOS: UNA REVISIÓN DE LA LITERATURA

    Directory of Open Access Journals (Sweden)

    Francisco Javier Mercado-Martínez

    2015-01-01

    Full Text Available El objetivo de este estudio fue revisar los estudios empíricos sobre la visión del personal de salud respecto a la donación y trasplante de órganos. Se hizo una revisión panorámica de la literatura en español, inglés y portugués; realizándose la búsqueda en dos buscadores y ocho bases de datos. El periodo abarca de 1985 al 2013. Se hizo análisis de contenido y frecuencias. De 316 artículos identificados, 248 fueron seleccionados. Según los hallazgos, los trabajos se concentraron en términos temporales y espaciales; predominando aquellos con metodologías cuantitativas. Las publicaciones priorizaron la perspectiva del personal médico y enfermería sobre las de otros actores, como directivos y coordinadores de donación. Las actitudes del personal sanitario hacia la donación de órganos de fallecido fue el tema más estudiado. Se concluye que una producción creciente de tipo cuantitativo analiza la perspectiva de médicos y enfermeras sobre la donación y trasplante de órganos de fallecido.

  9. Actitudes y conocimientos de Intensivistas colombianos sobre donación y trasplantes: Implicaciones para la nueva norma nacional de habilitación de servicios de salud.

    Directory of Open Access Journals (Sweden)

    David Andrés Castañeda Millán

    2015-01-01

    Full Text Available Introducción/Objetivo: Durante los últimos años Colombia se ha enfrentado a un descenso significativo en las tasas de donación de órganos, y por ende a una disminución en la cantidad de trasplantes realizados. En este contexto actualmente se implementa una nueva norma de habilitación para servicios de salud, que entre otras solicita al personal médico de cuidados intensivos capacitarse en gestión operativa de donación y trasplantes con el fin de optimizar la detección temprana y notificación de potenciales donantes; por lo tanto se pretende identificar las actitudes y conocimientos frente a la donación de órganos en médicos intensivistas de Colombia.  Materiales y Método: Estudio transversal descriptivo  realizado entre mayo y junio de 2013 a través de un formulario estructurado vía correo electrónico a los miembros de la Asociación Colombiana de Medicina Crítica y Cuidado Intensivo. Resultados: Se obtuvo un total de 48 participaciones efectivas. Del  total de participantes el 93,75% donaría sus órganos luego de morir, 97,91% donaría los órganos de un familiar fallecido, 95,83% donaría en vida uno de sus órganos para un familiar. El 83,33% ha manifestado a sus familiares la intención personal de donar; el 41,66% conoce alguna campaña de promoción sobre donación y el 12,5% tiene carné de donante. El 22,92% ha donado sangre en el último año; el 66,66% considera que se debe fortalecer la comunicación sobre donación en la unidad de cuidado intensivo, el 60,42% no aborda el tema de donación con  familias de pacientes neurocríticos con pobre pronóstico vital, el 54,17% no conoce la legislación colombiana sobre donación y trasplantes, el 18,75% califica como regular/mala la relación e interacción laboral con los coordinadores de trasplantes y el 43,75% tiene un concepto desfavorable sobre el modelo de trasplantes colombiano. Conclusiones: Los intensivistas colombianos tienen buena actitud  frente a la

  10. Stent liberadores de medicamento en enfermedad coronaria prematura en jóvenes con hipercolesterolemia familiar homocigota y trasplante hepático previo

    Directory of Open Access Journals (Sweden)

    Darío Echeverri

    2017-07-01

    Full Text Available La hipercolesterolemia familiar es una enfermedad genética que se caracteriza por niveles muy elevados de colesterol y lipoproteínas de baja densidad en suero, xantomas tendinosos y aterosclerosis prematura. La forma heterocigota es la más común; alcanza una prevalencia de aproximadamente 1 de cada 300 a 500 personas en el mundo, en tanto que la homocigota, autosómica dominante, es la forma más rara, con una prevalencia de 1 en 1 millón de personas. Esta se caracteriza por hipercolesterolemia severa, que conlleva enfermedad cardiovascular prematura y a menudo no responde al tratamiento tradicional por la falta de receptores para c-LDL funcionales. Los niveles de c-LDL pueden superar seis a diez veces los valores normales, en cuyo caso el trasplante de hígado se ha convertido en el tratamiento de elección para los pacientes que no responden a tratamientos farmacológicos de rutina. Se presentan dos casos con hipercolesterolemia familiar homocigota en jóvenes de 14 y 15 años, con antecedente de trasplante de hígado y enfermedad coronaria severa en vasos principales (descendente anterior y coronaria derecha a quienes se les hizo implante exitoso de stent liberador de medicamento.

  11. ABO blood group phenotypes influence parity specific immunity to Plasmodium falciparum malaria in Malawian women

    NARCIS (Netherlands)

    Senga, Edward; Loscertales, Maria-Paz; Makwakwa, K. E. B.; Liomba, George N.; Dzamalala, Charles; Kazembe, Peter N.; Brabin, Bernard J.

    2007-01-01

    BACKGROUND: Blood group O has been significantly associated with increased placental malaria infection in primiparae and reduced risk of infection in multiparae in the Gambia, an area with markedly seasonal malaria transmission. This study analyses the association between ABO blood group phenotypes

  12. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma

    DEFF Research Database (Denmark)

    Gao, Shan; Worm, Jesper; Guldberg, Per

    2004-01-01

    Loss of histo-blood group A and B antigen expression is a frequent event in oral carcinomas and is associated with decreased activity of glycosyltransferases encoded by the ABO gene. We examined 30 oral squamous cell carcinomas for expression of A and B antigens and glycosyltransferases. We also...

  13. The relationship between ABO/rhesus blood groups and type 2 ...

    African Journals Online (AJOL)

    Background: To determine the relationship between ABO/rhesus (Rh) blood groups and type 2 diabetes mellitus in a western Algerian population. Method: This case-control study was conducted at the Regional Hospital Centre of Maghnia, Tlemcen, from July 2008 to May 2009, involving 280 patients with type 2 diabetes ...

  14. Is there an association of ABO blood groups and Rhesus factor with alopecia areata?

    Science.gov (United States)

    İslamoğlu, Zeynep Gizem Kaya; Unal, Mehmet

    2018-01-15

    Alopecia areata (AA) is an autoimmune disease characterized by noncicatricial hair loss localized on hair, beard, mustache, eyebrow, eyelash, and sometimes on the body. Although etiopathogenesis is not fully understood, many studies show remarkable associations between various diseases and ABO blood groups. However, there is no study with AA and blood groups. Healthy people and patients with AA were included in this study. A total of 155 patients with AA and 299 healthy controls were included in the study. ABO blood group distribution in patients with AA and distribution of healthy donors were similar. However, Rhesus factor positivity in the AA group was significantly higher than in healthy donors. The relationship between stress and AA was high as known. But, ABO blood group and Rhesus factor were not in a significant connection with stress. We conclude that there was no association between ABO blood group and AA, but the observed distribution of Rhesus blood group differed slightly but significantly from that of the healthy population. The result of the study shows a small but statistically significant difference in the Rh blood group between patients with AA and the healthy population blood groups. This result is important because it suggests that genetic factors may influence the development of AA. The role of blood groups in the development of AA remains to be determined. We believe that the studies which will be carried out in other centers with wider series will be more valuable to support this hypothesis. © 2018 Wiley Periodicals, Inc.

  15. The relative incidence of diabetes mellitus in abo/rhesus blood ...

    African Journals Online (AJOL)

    A total of 224 diabetics and 221 non-diabetics (control) were involved in this study, to determine the relative incidence of diabetes mellitus in ABO/Rhesus blood group. The current criteria for the diagnosis f diabetes mellitus were applied in differentiating the diabetics from the non-diabetics. Blood group, fasting blood sugar ...

  16. The distribution of the ABO and Rhesus blood groups among an ...

    African Journals Online (AJOL)

    Background: In this study, the authors set out to find out the ABO-RhD blood group distribution among Idoma, an indigenous ethnic group in the middle belt of Nigeria in view of the paucity of such information about the ethnic group. Methodology: 2,000 blood donor volunteers were randomly selected from the Idoma ...

  17. A Study of Thumb Print Patterns and ABO Blood Group Distribution ...

    African Journals Online (AJOL)

    The aim of this study was to establish a possible relationship between thumb print pattern and ABO blood group distribution. The study involves two hundred and nine-two volunteers comprising 159 female and 133 male. The blood group and finger print patterns were determined using standard techniques. Results ...

  18. [Association between ABO blood groups and coronary heart disease in Chinese Guangxi Zhuang population].

    Science.gov (United States)

    Shi, Ying; Lin, Yingzhong; Liu, Hairun; Ji, Qingwei; Lu, Zhihong; Lu, Zhengde; Xu, Nengwen; Yuan, Jun; Liu, Ling

    2015-09-01

    To investigate this association between ABO blood groups and coronary heart disease (CHD) in the Chinese Guangxi Zhuang population. From August 2010 to April 2013, we performed a case-control study in a Chinese Zhuang population, which included 1 024 CHD cases and 1 024 age and gender-matched non-CHD controls. The ABO blood groups and biological variables were measured by standard laboratory procedures. The Gensini score was used to evaluate the severity of coronary artery stenosis. Compared to non-CHD control group, CHD group had higher levels of fasting blood glucose ((6.71 ± 6.72) mmol/L vs. (4.98 ± 1.55) mmol/L, P blood groups were associated with CHD risk in the Chinese Zhuang population. Compared with group O, the group B individuals had a higher risk of CHD (OR = 2.33, 95% CI 1.88-2.90, P group O subjects in the CHD group, and MACE at 1-year follow-up was similar between ABO blood groups of CHD individuals. ABO blood groups are associated with CHD risk in the Chinese Zhuang population.

  19. Distribution of ABO and Rh Blood Groups in Patients With Keratoconus: A Case-Control Study.

    Science.gov (United States)

    Naderan, Mohammad; Rajabi, Mohammad Taher; Shoar, Saeed; Kamaleddin, Mohammad Amin; Naderan, Morteza; Rezagholizadeh, Farzaneh; Zolfaghari, Masoome; Pahlevani, Rozhin

    2015-07-01

    Association of keratoconus (KC) with genetic predisposition and environmental factors has been well documented. However, no single study has investigated the possible relationship between ABO and Rh blood groups and KC. A case-control study was designed in a university hospital enrolling 214 patients with KC in the case group and equal number of age- and sex-matched healthy subjects in the control group. Primary characteristics, ABO blood group, and Rh factors were compared between the two groups. Topographic findings of KC eyes and the severity of the diseases were investigated according to the distribution of the blood groups. Blood group O and Rh(+) phenotype were most frequent in both groups. There was no significant difference between the two groups in terms of ABO blood groups or Rh factors. Mean keratometery (K), central corneal thickness, thinnest corneal thickness, flat K, steep K, sphere and cylinder, spherical equivalent, and uncorrected visual acuity were all similar between ABO blood groups and Rh(+) and Rh(-) groups. However, the best spectacle-corrected visual acuity (BCVA) had the highest value in AB blood group (0.35 ± 0.22 logMAR, P=0.005). Moreover, the blood group AB revealed the highest frequency for grade 3 KC, followed by grades 1, 2, and 4 (P=0.003). We observed no significant excess of any particular blood group among KC cases compared with healthy subjects. Except BCVA, none of the keratometric or topographic findings was significantly different between blood groups.

  20. The role of ABO blood groups in Crohn's disease and in monitoring response to infliximab treatment.

    Science.gov (United States)

    Yu, Qiao; Wang, Lingyun; Zhang, Shenghong; Feng, Ting; Li, Li; Chen, Baili; Chen, Minhu

    2016-09-01

    The variation in ABO blood groups is reported to be associated with multiple diseases. Infliximab (IFX) has been widely used in the treatment of Crohn's disease (CD). We aim to investigate the distribution of ABO blood groups in Chinese patients with CD and to explore its impact on response to IFX. Patients with CD were consecutively recruited to the study between 2007 and 2014. CD patients receiving IFX therapy were followed for at least two years. In 293 patients with CD, most patients (40.6%) had blood type O (119/293). The odds ratio (OR) of CD in blood type O patients was 1.06 (95%CI: 0.6-1.86; p=0.84) compared to all other blood types. Among those CD patients, 107 patients received IFX treatment. One year after the first course of IFX, a significant association was found between the overall ABO system and outcomes of IFX treatment (pblood type AB (OR=4.42, 95% CI: 1.04-18.76; p=0.044) were more likely to achieve mucosal healing, while CD patients with blood type A had a high risk of losing response (OR=0.38, 95% CI: 0.15-0.96; p=0.040). ABO blood groups are not associated with prevalence of CD. Patients with blood type AB had a better response to IFX while those with blood type A appeared to have a risk of losing response to IFX.

  1. Comparison of Lip Print Patterns in Two Indian Subpopulations and Its Correlation in ABO Blood Groups.

    Science.gov (United States)

    Sr, Ashwinirani; Suragimath, Girish; Sande, Abhijeet R; Kulkarni, Prasad; Nimbal, Anand; Shankar, T; Gowd, T Snigdha; Shetty, Prajwal K

    2014-10-01

    The study of lip-print pattern (cheiloscopy) is a scientific method for personal identification and plays a major role in forensic and criminal investigations. To compare the lip print patterns in Kerala and Maharashtra population and correlate between ABO blood groups. Two hundred subjects, 100 from Maharashtra and 100 from Kerala were considered for the study. Lip prints were recorded, analyzed according to Tsuchihashi classification. The lip print patterns were compared in the two populations, correlated in ABO blood groups. The data obtained was statistically analyzed with SPSS software using chi-square test. In our study, predominant lip print pattern observed in Kerala population was type IV (53%) and Maharashtra population was type II (42%). The difference between the two population was statistically significant (pblood groups had type II lip print predominance. Subjects with B+, AB+ and O+ blood groups had type IV predominance. The lip print patterns do not show any correlation in ABO blood groups. Lip prints are unique to each individual and are different even in two persons. Lip print patterns were different in the two sub populations studied, and they showed no correlation in ABO blood groups.

  2. Correlation of ABO blood groups with spontaneous recanalization in acute myocardial infarction.

    Science.gov (United States)

    Lin, Xian-Liang; Zhou, Bing-Yang; Li, Sha; Li, Xiao-Lin; Luo, Zhu-Rong; Li, Jian-Jun

    2017-08-01

    Although previous studies have demonstrated the relationship between ABO blood groups and cardiovascular disease, the association of ABO blood type with spontaneous recanalization (SR) in patients with acute myocardial infarction (AMI) has not been previously investigated. We performed an initial exploratory study on the association of ABO blood groups with the presence of SR in 1209 patients with AMI. They were divided into two groups according to the thrombolysis in myocardial infarction (TIMI) grades: no-SR group (TIMI 0-1, n = 442) and SR group (TIMI 2-3, n = 767). To confirm our primary findings, data from a second AMI population (n = 200) was analyzed. In the initial data, SR group had a significantly higher percentage of blood type O and a lower percentage of blood type A compared to the no-SR group. Multivariate logistic regression analysis showed that blood type O was positively associated with SR (odds ratio: 1.40, 95% confidence interval: 1.05-1.87, p = .02), and this finding was confirmed in our second population. The present study demonstrates that blood type O was independently and positively associated with an open culprit artery in patients with AMI, suggesting that the ABO blood type is not only associated with the susceptibility to coronary artery disease but also to spontaneous reperfusion in AMI patients.

  3. Relation between ABO blood groups and obesity in a Saudi Arabian population

    Directory of Open Access Journals (Sweden)

    Turki A. Alwasaidi, FRCPC

    2017-10-01

    Conclusion: Overall, our study did not show a significant relation between overweight and obesity and ABO blood groups. However, the elevation of the prevalence of overweight and obesity, mainly among the younger generations of the Saudi population, requires more awareness and educational programs.

  4. Effects of ABO/Rh blood groups, G-6-P-D enzyme activity and ...

    African Journals Online (AJOL)

    The main objective was to investigate the effects of ABO/Rh blood groups, haemoglobin genotype and G-6-P-D enzyme activity on malaria. The study was carried out in Buea, South West Province, Cameroon. Subjects consulting at health care facilities in Buea were randomly recruited into the study. A total of 121 febrile ...

  5. ABO (H) secretor status of sickle cell disease patients in Zaria ...

    African Journals Online (AJOL)

    Certain individuals secrete ABO blood group antigens in body fluids and secretions while others do not. In this study, the presence of water soluble agglutinogens in body fluids such as blood, saliva and urine of 64 sickle cell disease patients and 75 AA genotype subjects who served as control were taken and tested by ...

  6. Study of ABO blood types by combining membrane electrophoresis with surface-enhanced Raman spectroscopy

    Science.gov (United States)

    Wang, Jing; Lin, Juqiang; Huang, Zufang; Sun, Liqing; Shao, Yonghong; Lu, Peng; Shi, Wei; Lin, Jinyong; Chen, Rong

    2012-12-01

    The molecular characterization of ABO blood types, which is clinically significant in blood transfusion, has clinical and anthropological importance. Polymerase chain reaction sequence-based typing (PCR-SBT) is one of the most commonly used methods for the analysis of genetic bases of ABO blood types. However, such methods as PCR-SBT are time-consuming and are high in demand of equipments and manipulative skill. Here we showed that membrane electrophoresis based SERS method employed for studying the molecular bases of ABO blood types can provide rapidand easy-operation with high sensitivity and specificity. The plasma proteins were firstly purified by membrane electrophoresis and then mixed with silver nanoparticles to perform SERS detection. We use this method to classify different blood types, including blood type A (n=13), blood type B (n=9) and blood type O (n=10). Combination of principal component analysis (PCA) and liner discriminant analysis (LDA) was then performed on the SERS spectra of purified albumin, showing good classification results among different blood types. Our experimental outcomes represent a critical step towards the rapid, convenient and accurate identification of ABO blood types.

  7. ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.

    Science.gov (United States)

    Huang, Joyce Yongxu; Wang, Renwei; Gao, Yu-Tang; Yuan, Jian-Min

    2017-01-01

    ABO blood type is an inherited characteristic. The associations between ABO blood type and risk of all cancer and specific cancers were examined in a prospective cohort study of 18,244 Chinese men enrolled in 1986. During the 25 years of follow-up, 3,973 men developed cancer including 964 lung cancers, 624 colorectal cancers, 560 gastric cancers, 353 liver cancers, and 172 urinary bladder cancers. Hazard ratios (HR) for all cancer and specific cancers by ABO blood type were calculated using Cox proportional hazards models. Compared with blood type A, blood type B was associated with statistically significant reduced risk of all cancers (HR, 0.91, 95% CI:0.84, 0.99). Both blood types B and AB were associated with significantly lower risk of gastrointestinal cancer and colorectal cancer, respectively. Blood type B was also associated with significantly lower risk of stomach cancer and bladder cancer, while blood type AB was associated with significantly increased risk of liver cancer. By histological type, blood types B and AB were associated with lower risk of epidermoid carcinoma and adenocarcinoma, but were not associated with risk of sarcoma, lymphoma, leukemia or other cell types of cancer. The findings of this study support a role of genetic traits related to ABO blood type in the development of cancers in the gastrointestinal and urinary tracts.

  8. A Laboratory Exercise to Determine Human ABO Blood Type by Noninvasive Methods

    Science.gov (United States)

    Martin, Michael P.; Detzel, Stephen M.

    2008-01-01

    Analysis of single-nucleotide polymorphisms and their association with diseases and nondisease phenotypes is of growing importance in human biology studies. In this laboratory exercise, students determine the genetic basis for their ABO blood type; however, no blood is drawn. Students isolate genomic DNA from buccal mucosa cells that are present…

  9. ABO blood type and the risk of cancer – Findings from the Shanghai Cohort Study

    Science.gov (United States)

    Wang, Renwei; Gao, Yu-Tang

    2017-01-01

    ABO blood type is an inherited characteristic. The associations between ABO blood type and risk of all cancer and specific cancers were examined in a prospective cohort study of 18,244 Chinese men enrolled in 1986. During the 25 years of follow-up, 3,973 men developed cancer including 964 lung cancers, 624 colorectal cancers, 560 gastric cancers, 353 liver cancers, and 172 urinary bladder cancers. Hazard ratios (HR) for all cancer and specific cancers by ABO blood type were calculated using Cox proportional hazards models. Compared with blood type A, blood type B was associated with statistically significant reduced risk of all cancers (HR, 0.91, 95% CI:0.84, 0.99). Both blood types B and AB were associated with significantly lower risk of gastrointestinal cancer and colorectal cancer, respectively. Blood type B was also associated with significantly lower risk of stomach cancer and bladder cancer, while blood type AB was associated with significantly increased risk of liver cancer. By histological type, blood types B and AB were associated with lower risk of epidermoid carcinoma and adenocarcinoma, but were not associated with risk of sarcoma, lymphoma, leukemia or other cell types of cancer. The findings of this study support a role of genetic traits related to ABO blood type in the development of cancers in the gastrointestinal and urinary tracts. PMID:28880901

  10. Distribution of abo and rhesus (D) blood groups in Kano metropolis ...

    African Journals Online (AJOL)

    Background: To provide information in the distribution of ABO and Rhesus (D) blood groups since there has been no such study carried out in Kano. Study Population/Method: A total of 5,303 blood donors and pregnant women who came for antenatal care at Aminu Kano Teaching Hospital, Kano between January and ...

  11. Serum iron and total iron binding capacity levels among the abo ...

    African Journals Online (AJOL)

    Serum Iron, Total Iron Binding Capacity (TIBC) and Percentage Transferrin Saturation (%TS) levels were studied in 2260 apparently healthy Nigerian volunteers in Enugu, Eastern Nigeria. The ABO blood groups of the subjects were also determined. They were aged between 10 and 25 years, males were 1808 and females ...

  12. The Association Between Cancer Of The Breast And The Abo And ...

    African Journals Online (AJOL)

    Objective: To determine whether inheritance of ABO and Rhesus D antigen phenotypes constitute a risk factor for development of cancer of the breast. Design: A case-control study. Setting: Patients with histologically diagnosed cancer of the breast referred to Radiotherapy department of the Lagos University Teaching ...

  13. ABO genotyping of suspects from sperm DNA isolated from postcoital samples in sex crimes.

    Science.gov (United States)

    Sasaki, M; Shiono, H

    1996-03-01

    In sexual assaults against women, one key to identifying the suspect is ABO phenotyping or the typing of other polymorphic markers of the seminal fluid in the victim's vagina. However, ABO phenotyping is frequently unsuccessful, since mixtures of fluids cannot be separated to be subjected to conventional methods for the detection of antibody or antigen material. We therefore studied ABO blood group genotyping of sperm DNA isolated from contaminating vaginal fluid by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Seminal samples of genotypes OO, AO, BO and AB were experimentally mixed with vaginal fluid (OO, AO, BO and AB), and were successfully separated and genotyped by this method. In practice, we also separated and genotyped the seminal DNA of suspects from contaminated postcoital vaginal fluid obtained in 4 sexual assaults. These forensic samples were easily separated and completely genotyped. This reliable ABO genotyping method by PCR-RFLP, using separated sperm DNA, should be of value in forensic identification in sexual assaults.

  14. Frequency distribution of ABO and Rh (D) blood group alleles in ...

    African Journals Online (AJOL)

    Background: Frequency distribution of blood groups is important as it is used in modern medicine, genetic research, anthropology, and tracing ancestral relations of humans. The ABO and Rh blood groups are the most important blood groups despite the long list of several other blood groups discovered so far. Aim of the ...

  15. the distribution of abo and rhesus blood groups among indigenes of ...

    African Journals Online (AJOL)

    DJFLEX

    INTRODUCTION: The ABO and Rhesus blood group series is the commonest and most important blood groups series. It is of importance in blood transfusion services. (Molison,1979), in relation to diseases such as cardiovascular diseases (Shamim et al, 2002), diabetes mellitus (Nwafor and Onugha,2001), erythroblastosis.

  16. ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism

    NARCIS (Netherlands)

    Loscertales, María-Paz; Owens, Stephen; O'Donnell, James; Bunn, James; Bosch-Capblanch, Xavier; Brabin, Bernard J.

    2007-01-01

    Host susceptibility to Plasmodium falciparum infection is central for improved understanding of malaria in human populations. Red blood cell (RBC) polymorphisms have been proposed as factors associated with malaria infection or its severity, although no systematic appraisal of ABO phenotypes and

  17. Correlation of ABO Blood Group Phenotype and Rhesus Factor with Periodontal Disease: An Observational Study.

    Science.gov (United States)

    Gautam, Anju; Mittal, Neelam; Singh, T B; Srivastava, Ruchi; Verma, Pushpendra Kumar

    2017-01-01

    The knowledge of the ABO blood group phenotype of the patients and their correlation with the periodontal disease maybe important in the development of early treatment strategies, and it would be helpful to target non-responding areas to periodontal therapy of the susceptible individuals. The present study was conducted to determine whether there was any correlation between periodontal diseases and ABO blood groups and Rh factor. This study was carried out on 537 subjects attending Faculty of Dental Sciences OPD in BHU. Subjects were divided into three groups: group I (healthy subjects), group II (subjects with gingivitis), and group III (subjects with periodontitis) based on periodontal examination (Gingival index, Bleeding Index, Probing pocket depth and clinical attachment level). ABO Blood grouping were done and correlated with the periodontal status of study subjects. Statistical Analysis: Data was analyzed using the statistical software namely Statistical Package for the Social Sciences (SPSS, Version 16, IBM Analytics) and Systat 8.0. In this study, there was a greater prevalence of gingivitis in blood group O and periodontitis in blood group B. The blood group AB showed the least prevalence of periodontal diseases. Similarly gingivitis and peridontitis were significantly higher among Rhesus positive groups when compared with Rhesus negative groups. Considering the results of this study, it can be concluded that ABO blood groups and Rh factor could be a risk factor for the development of periodontal disease.

  18. Association of ABO Blood Group Phenotype and Allele Frequency with Chikungunya Fever

    Directory of Open Access Journals (Sweden)

    Pairaya Rujirojindakul

    2015-01-01

    Full Text Available Background. The objective of this study was to investigate the association of the ABO blood group phenotype and allele frequency with CHIK fever. Methods. A rural community survey in Southern Thailand was conducted in August and September 2010. A total of 506 villagers were enrolled. Cases were defined as individuals having anti-CHIK IgG by hemagglutination ≥1 : 10. Results. There were 314 cases (62.1% with CHIK seropositivity. Females were less likely to have positive anti-CHIK IgG with odds ratio (OR (95% CI of 0.63 (0.43, 0.93. All samples tested were Rh positive. Distribution of CHIK seropositivity versus seronegativity (P value in A, B, AB, and O blood groups was 80 versus 46 (0.003, 80 versus 48 (0.005, 24 versus 20 (0.55, and 130 versus 78 (<0.001, respectively. However, chi-square test between ABO and CHIK infection showed no statistical significance P=0.76. Comparison of the ABO blood group allele frequency between CHIK seropositivity and seronegativity was not statistically significant. Conclusion. This finding demonstrated no association of the ABO blood group phenotypes and allele frequencies with CHIK infection.

  19. Clinical use of the ABO-Scoring Index: reliability and subtraction frequency.

    Science.gov (United States)

    Lieber, William S; Carlson, Sean K; Baumrind, Sheldon; Poulton, Donald R

    2003-10-01

    This study tested the reliability and subtraction frequency of the study model-scoring system of the American Board of Orthodontists (ABO). We used a sample of 36 posttreatment study models that were selected randomly from six different orthodontic offices. Intrajudge and interjudge reliability was calculated using nonparametric statistics (Spearman rank coefficient, Wilcoxon, Kruskal-Wallis, and Mann-Whitney tests). We found differences ranging from 3 to 6 subtraction points (total score) for intrajudge scoring between two sessions. For overall total ABO score, the average correlation was .77. Intrajudge correlation was greatest for occlusal relationships and least for interproximal contacts. Interjudge correlation for ABO score averaged r = .85. Correlation was greatest for buccolingual inclination and least for overjet. The data show that some judges, on average, were much more lenient than others and that this resulted in a range of total scores between 19.7 and 27.5. Most of the deductions were found in the buccal segments and most were related to the second molars. We present these findings in the context of clinicians preparing for the ABO phase III examination and for orthodontists in their ongoing evaluation of clinical results.

  20. Renal tuberculosis

    Directory of Open Access Journals (Sweden)

    Džamić Zoran

    2016-01-01

    Full Text Available Tuberculosis is still a significant health problem in the world, mostly in developing countries. The special significance lies in immunocompromised patients, particularly those suffering from the HIV. Urogenital tuberculosis is one of the most common forms of extrapulmonary tuberculosis, while the most commonly involved organ is the kidney. Renal tuberculosis occurs by hematogenous dissemination of mycobacterium tuberculosis from a primary tuberculosis foci in the body. Tuberculosis is characterized by the formation of pathognomonic lesions in the tissues - granulomata. These granulomata may heal spontaneously or remain stable for years. In certain circumstances in the body associated with immunosuppression, the disease may be activated. Central caseous necrosis occurs within tuberculoma, leading to formation of cavities that destroy renal parenchyma. The process may gain access to the collecting system, forming the caverns. In this way, infection can be spread distally to renal pelvis, ureter and bladder. Scaring of tissue by tuberculosis process may lead to development of strictures of the urinary tract. The clinical manifestations are presented by nonspecific symptoms and signs, so tuberculosis can often be overlooked. Sterile pyuria is characteristic for urinary tuberculosis. Dysuric complaints, flank pain or hematuria may be presented in patients. Constitutional symptoms of fever, weight loss and night sweats are presented in some severe cases. Diagnosis is made by isolation of mycobacterium tuberculosis in urine samples, by cultures carried out on standard solid media optimized for mycobacterial growth. Different imaging studies are used in diagnostics - IVU, CT and NMR are the most important. Medical therapy is the main modality of tuberculosis treatment. The first line anti-tuberculosis drugs include isoniazid, rifampicin, pyrazinamide and ethambutol. Surgical treatment is required in some cases, to remove severely damaged kidney, if

  1. Drug-induced renal injury

    African Journals Online (AJOL)

    induced renal toxicity into four major renal syndromes: • acute renal failure. • chronic renal failure. • glomerulonephritis. • tubulopathies. These major renal syndromes are discussed in further detail below (see summary in Table I). Acute renal failure. Drugs can cause acute renal failure by causing pre-renal, intrinsic or.

  2. Studies of the ABO and FORS Histo-Blood Group Systems: Focus on Flow Cytometric and Genetic Analysis

    OpenAIRE

    Hult, Annika

    2013-01-01

    ABO is the clinically most important blood group system and its antigens are carbohydrate moieties present on the surface of the red blood cell (RBC) but also on other tissues throughout the body. The ABO gene encodes an enzyme, a glycosyltransferase (GT),that adds a terminal monosaccharide to the precursor structure, H antigen, to define the A or B antigens. Blood group O is due to a non-functional GT that leaves the precursor unchanged. Weak expression of ABO antigens can be acquired or be ...

  3. Risk Factors for Graft Failure and Death following Geriatric Renal Transplantation.

    Directory of Open Access Journals (Sweden)

    Hyungjin Cho

    Full Text Available Population aging is a major health concern in Asian countries and it has affected the age distribution of patients with end-stage renal disease (ESRD. As a consequence, the need for kidney transplantation in the geriatric population has increased, but the shortage of donors is an obstacle for geriatric renal transplantation. The aim of this study was to evaluate risk factors for graft failure and death in geriatric renal transplantation.Kidney transplantations performed in a tertiary hospital in South Korea from May 1995 to December 2014 were retrospectively reviewed. Recipients younger than 60 years of age or who underwent other organ transplantations were excluded. The Kaplan-Meier method was used to assess patient and graft survival. A Cox regression analysis was used to evaluate risk factors for graft failure and patient death.A total of 229 kidney transplantation patients were included. Graft survival at 1, 5, and 10 years were 93.2%, 82.9%, and 61.2% respectively. Patient survival at 1, 5, and 10 years were 94.6%, 86.9%, and 68.8%, respectively. According to the Cox multivariate analysis, ABO incompatibility (hazard ratio [HR] 3.91, p < 0.002, DGF (HR 3.544, p < 0.004, CMV infection (HR 2.244, p < 0.011, and HBV infection (HR 6.349, p < 0.015 were independent risk factors for graft survival. Recipient age (HR 1.128, p < 0.024, ABO incompatibility (HR 3.014, p < 0.025, CMV infection (HR 2.532, p < 0.010, and the number of HLA mismatches (HR 1.425, p < 0.007 were independent risk factors for patient death.Kidney transplantation in the geriatric population showed good clinical outcomes. ABO incompatibility, DGF, CMV infection, and HBV infection were risk factors for graft failure and the recipient age, ABO incompatibility, CMV infection, and the number of HLA mismatches were risk factors for patient death in geriatric renal transplantation.

  4. PP13, Maternal ABO Blood Groups and the Risk Assessment of Pregnancy Complications

    Science.gov (United States)

    Than, Nandor Gabor; Romero, Roberto; Meiri, Hamutal; Erez, Offer; Xu, Yi; Tarquini, Federica; Barna, Laszlo; Szilagyi, Andras; Ackerman, Ron; Sammar, Marei; Fule, Tibor; Karaszi, Katalin; Kovalszky, Ilona; Dong, Zhong; Kim, Chong Jai; Zavodszky, Peter; Papp, Zoltan; Gonen, Ron

    2011-01-01

    Background Placental Protein 13 (PP13), an early biomarker of preeclampsia, is a placenta-specific galectin that binds beta-galactosides, building-blocks of ABO blood-group antigens, possibly affecting its bioavailability in blood. Methods and Findings We studied PP13-binding to erythrocytes, maternal blood-group effect on serum PP13 and its performance as a predictor of preeclampsia and intrauterine growth restriction (IUGR). Datasets of maternal serum PP13 in Caucasian (n = 1078) and Hispanic (n = 242) women were analyzed according to blood groups. In vivo, in vitro and in silico PP13-binding to ABO blood-group antigens and erythrocytes were studied by PP13-immunostainings of placental tissue-microarrays, flow-cytometry of erythrocyte-bound PP13, and model-building of PP13 - blood-group H antigen complex, respectively. Women with blood group AB had the lowest serum PP13 in the first trimester, while those with blood group B had the highest PP13 throughout pregnancy. In accordance, PP13-binding was the strongest to blood-group AB erythrocytes and weakest to blood-group B erythrocytes. PP13-staining of maternal and fetal erythrocytes was revealed, and a plausible molecular model of PP13 complexed with blood-group H antigen was built. Adjustment of PP13 MoMs to maternal ABO blood group improved the prediction accuracy of first trimester maternal serum PP13 MoMs for preeclampsia and IUGR. Conclusions ABO blood group can alter PP13-bioavailability in blood, and it may also be a key determinant for other lectins' bioavailability in the circulation. The adjustment of PP13 MoMs to ABO blood group improves the predictive accuracy of this test. PMID:21799738

  5. ABO and Rh blood groups frequency in women with HER2 positive breast cancer.

    Science.gov (United States)

    Urun, Y; Utkan, G; Altundag, K; Arslan, O; Onur, H; Arslan, U Y; Kocer, M; Dogan, I; Senler, F C; Yalcin, B; Demirkazik, A; Akbulut, H; Icli, F

    2012-01-01

    The role of genetic factors in the development of cancer is widely accepted. Data on the role of ABO blood group and Rh factor in breast cancer is inconclusive. The aim of this study was to investigate the presence of a possible association between HER2 (+) breast cancer in Turkish women and ABO blood groups and Rh factor. In 294 female patients with HER2 (+) breast cancer, ABO blood groups and Rh factor were examined. The relationship of blood groups with age, menopausal status, and family history of cancer, estrogen receptor (ER), progesterone receptor (PR) and HER2 status of these patients was evaluated. Blood groups distribution of 22,821 healthy blood donors was also assessed and compared with the patients' blood groups distribution. The median patient age was 47 years (range 20-80) and 56% of the patients were premenopausal. ER and PR were positive in 50 and 60% of the patients, respectively. Overall, the ABO blood group distribution of the 294 HER2 (+) breast cancer patients was similar to that of the healthy blood donors (p=0.36). Likewise there was no correlation between blood type and ER, PR and menopausal status. Rh (-) patients had more frequent family cancer history and this difference was significant for patients with blood group B Rh (-) and O Rh (-) (p = 0.04). In the present study we didn't find any relationship between HER2 status and ABO blood group and Rh factor. However, further studies with larger number of patients are needed to establish the role (if any) of blood groups in patients with breast cancer.

  6. Associations between ABO blood groups and biochemical recurrence after radical prostatectomy.

    Science.gov (United States)

    Ohno, Yoshio; Ohori, Makoto; Nakashima, Jun; Okubo, Hidenori; Satake, Naoya; Takizawa, Issei; Hashimoto, Takeshi; Hamada, Riu; Nakagami, Yoshihiro; Yoshioka, Kunihiko; Tachibana, Masaaki

    2015-01-01

    Recent studies have demonstrated associations between ABO blood groups and prognosis in various types of cancers. The aim of this study was to investigate the association between ABO blood groups and biochemical recurrence (BCR) after radical prostatectomy (RP). A total of 555 patients with prostate cancer who underwent RP were included in the study. No patients received neoadjuvant and/or adjuvant therapy. The effect of ABO blood groups on BCR was examined using univariate and multivariate analyses. During the follow-up period (mean, 52.0 months), 166 patients (29.9%) experienced BCR, with a 5-year BCR-free rate of 67.3%. Although the ABO blood group was not a significantly associated with BCR in the univariate analysis, it was an independent predictor of BCR in the multivariate analysis: blood type O patients had a significantly lower risk of BCR compared to type A patients (Hazard ratio, 0.608; 95% confidence interval, 0.410-0.902; P = 0.014). Further analyses revealed that surgical margin status confounded the assessment of the association between the ABO blood group and BCR. In the analyses of patients with a negative surgical margin, the 5-year BCR-free rate in blood type O patients was a significantly higher than that in type A patients (91.2% vs. 71.0%; P = 0.026). Blood type O is significantly associated with a decreased risk of biochemical recurrence after radical prostatectomy. Further studies are needed to clarify the nature of this association.

  7. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years.

    Science.gov (United States)

    Matteocci, A; De Rosa, A; Buffone, E; Pierelli, L

    2018-01-25

    To study the rate of ABO haemolytic anaemia of fetus and newborn (HDFN) in one institution over 6 years. ABO major incompatibility between mothers and their newborns occurs in about 10% of births. So, mothers with an O blood group may form IgG-class antibodies against A and B antigens, which could pass across the placenta and lead to a variable degree of HDFN in the newborn. At our institution, we have reviewed data regarding ABO-based HDFN in the last 6 years. We found that, in 28 089 deliveries, an ABO major incompatibility between mothers and newborns occurs in 11% of cases, with 72% of O/A and 28% of O/B incompatibility. In turn, 23% of these newborns had an eluate-confirmed positive direct antiglobulin test [DAT; 74% (511) were due to anti-A and 26% (179) to anti-B], with 1·0% requiring invasive treatments (exchange transfusion or intravenous immunoglobulin). Overall, 2·5% of the total newborns had a positive DAT for an anti-A or anti-B antibody, and 0·11% required invasive treatment in addition to phototherapy for their HDFN. Serological ABO HDFN is a relatively frequent event when an O-A/O-B incompatibility between mothers and their newborn occurs and, in most cases, translates into a self-limiting disease, with a small number of newborns requiring invasive treatments. The DAT test, although not predictive of disease severity, appears to be a useful tool to monitor babies born from O-A/O-B-incompatible pregnancies and to identify those who may require treatment. © 2018 British Blood Transfusion Society.

  8. Renal calculus

    CERN Document Server

    Pyrah, Leslie N

    1979-01-01

    Stone in the urinary tract has fascinated the medical profession from the earliest times and has played an important part in the development of surgery. The earliest major planned operations were for the removal of vesical calculus; renal and ureteric calculi provided the first stimulus for the radiological investigation of the viscera, and the biochemical investigation of the causes of calculus formation has been the training ground for surgeons interested in metabolic disorders. It is therefore no surprise that stone has been the subject of a number of monographs by eminent urologists, but the rapid development of knowledge has made it possible for each one of these authors to produce something new. There is still a technical challenge to the surgeon in the removal of renal calculi, and on this topic we are always glad to have the advice of a master craftsman; but inevitably much of the interest centres on the elucidation of the causes of stone formation and its prevention. Professor Pyrah has had a long an...

  9. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.

    Science.gov (United States)

    Canaani, Jonathan; Savani, Bipin N; Labopin, Myriam; Huang, Xiao-Jun; Ciceri, Fabio; Arcese, William; Tischer, Johanna; Koc, Yener; Bruno, Benedetto; Gülbas, Zafer; Blaise, Didier; Maertens, Johan; Ehninger, Gerhard; Mohty, Mohamad; Nagler, Arnon

    2017-06-01

    A significant proportion of hematopoietic stem cell transplants are performed with ABO-mismatched donors. The impact of ABO mismatch on outcome following transplantation remains controversial and there are no published data regarding the impact of ABO mismatch in acute myeloid leukemia patients receiving haploidentical transplants. Using the European Blood and Marrow Transplant Acute Leukemia Working Group registry we identified 837 patients who underwent haploidentical transplantation. Comparative analysis was performed between patients who received ABO-matched versus ABO-mismatched haploidentical transplants for common clinical outcome variables. Our cohort consisted of 522 ABO-matched patients and 315 ABO-mismatched patients including 150 with minor, 127 with major, and 38 with bi-directional ABO mismatching. There were no significant differences between ABO matched and mismatched patients in terms of baseline disease and clinical characteristics. Major ABO mismatching was associated with inferior day 100 engraftment rate whereas multivariate analysis showed that bi-directional mismatching was associated with increased risk of grade II-IV acute graft- versus -host disease [hazard ratio (HR) 2.387; 95% confidence interval (CI): 1.22-4.66; P =0.01). Non-relapse mortality, relapse incidence, leukemia-free survival, overall survival, and chronic graft- versus -host disease rates were comparable between ABO-matched and -mismatched patients. Focused analysis on stem cell source showed that patients with minor mismatching transplanted with bone marrow grafts experienced increased grade II-IV acute graft- versus -host disease rates (HR 2.03; 95% CI: 1.00-4.10; P =0.04). Patients with major ABO mismatching and bone marrow grafts had decreased survival (HR=1.82; CI 95%: 1.048 - 3.18; P =0.033). In conclusion, ABO incompatibility has a marginal but significant clinical effect in acute myeloid leukemia patients undergoing haploidentical transplantation. Copyright© Ferrata

  10. [Survival in renal transplant recipients in Colombia, 2008-2012].

    Science.gov (United States)

    Osorio-Arango, Karime; Beltrán-Durán, Mauricio; Arias-Murillo, Yazmín; Prieto, Franklyn; Robayo, Adriana

    2017-06-01

    The Red Nacional de Donación y Trasplantes of the Colombian Instituto Nacional de Salud reported that in 2014, 1,059 organ transplants were performed, of which 761 were kidney transplants, and 643 (84.5%) of these were from cadaveric organ donors. To describe the socio-demographic characteristics of patients who received renal transplants, as well as their outcomes in terms of survival. National kidney transplants were analyzed through an observational retrospective cohort study. Overall survival was estimated using the Kaplan-Meier method. The survival curves by sex, age, type of donor, type of insurance, and time on the waiting list were compared utilizing the log rank hypothesis and a Cox regression. A total of 3,980 patients were included, of whom 338 died according to the Registry of Affiliates. The median follow-up time was 49 months, overall survival was 6.35 years (95% CI: 6.30 to 6.40), the one-year survival following transplantation was 97.2%, the three-year survival, 93.2%, and the five-year survival, 90.8%. The survival rate was higher in patients under 50 years of age, receptors of living donor transplants, and with less than six months on the waiting list. The results obtained serve as the basis for future studies with strict monitoring of survival among kidney transplant recipients in Colombia.

  11. Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning.

    Science.gov (United States)

    Konuma, Takaaki; Kato, Seiko; Ooi, Jun; Oiwa-Monna, Maki; Ebihara, Yasuhiro; Mochizuki, Shinji; Yuji, Koichiro; Ohno, Nobuhiro; Kawamata, Toyotaka; Jo, Norihide; Yokoyama, Kazuaki; Uchimaru, Kaoru; Tojo, Arinobu; Takahashi, Satoshi

    2014-04-01

    ABO blood group incompatibility between donor and recipient has been associated with poor transplant outcomes in allogeneic hematopoietic stem cell transplantation. However, its effect on the outcome of cord blood transplantation (CBT) has yet to be clarified. We retrospectively analyzed 191 adult patients who received single-unit CBT after myeloablative conditioning for malignant disease in our institute. Major mismatch showed a significantly lower incidence of platelet engraftment compared with ABO match as a reference (hazard ratio, .57; P = .01). Nevertheless, there was no increase in graft-versus-host disease, transplant-related mortality, and overall mortality after ABO-incompatible CBT. These data suggested that donor-recipient ABO incompatibility does not have a significant impact on outcome after myeloablative CBT for hematological malignancies. Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

  12. Prevalencia de enfermedad de Fabry en pacientes en lista de trasplante y posttrasplante renal en fundación cardioinfantil Bogotá

    OpenAIRE

    Saravia Bermeo, Isabel Cristina; Ducuara Rodriguez, Daniel Humberto

    2015-01-01

    Introducción: La Enfermedad de Fabry (EF), es una enfermedad multisistémica de almacenamiento lisosomal ligada al cromosoma X que afecta principalmente a hombres, pero también puede causar significativa morbilidad en las mujeres heterocigotas (1–5). La deficiencia de la enzyma α-galactosidaseA (α-Gal A,) provoca acumulación de glicosfingolipidos que afectan diferentes tipos celulares entre ellos el endotelio vascular en vasos de pequeño calibre, células epiteliales y Músculo liso en el sistem...

  13. [Hypertension and renal disease

    DEFF Research Database (Denmark)

    Kamper, A.L.; Pedersen, E.B.; Strandgaard, S.

    2009-01-01

    Renal mechanisms, in particular the renin-angiotensin system and renal salt handling, are of major importance in blood pressure regulation. Co-existence of hypertension and decreased renal function may be due to nephrosclerosis secondary to hypertension, or primary renal disease with secondary...

  14. Soluble type A substance in fresh-frozen plasma as a function of ABO and Secretor genotypes and Lewis phenotype.

    Science.gov (United States)

    Achermann, F J; Julmy, F; Gilliver, L G; Carrel, T P; Nydegger, U E

    2005-06-01

    Soluble ABO blood group substance (SAS) in fresh-frozen plasma (FFP) and its cognate alloantibody titer reduction capacity (TRC) are not considered when prescribing this product for plasma exchange (PEX) therapy of ABO incompatible transplant recipients. SAS was quantified in 250 single FFPs using ELISA. Total and IgG class-specific anti-A TRCs of FFPs were measured using a microhemagglutination inhibition assay. SAS level depended not only on the A subtype (p p p p = 0.0003).

  15. Comparative Analysis of Clinical Samples Showing Weak Serum Reaction on AutoVue System Causing ABO Blood Typing Discrepancies

    OpenAIRE

    Jo, Su Yeon; Lee, Ju Mi; Kim, Hye Lim; Sin, Kyeong Hwa; Lee, Hyeon Ji; Chang, Chulhun Ludgerus; Kim, Hyung-Hoi

    2016-01-01

    Background ABO blood typing in pre-transfusion testing is a major component of the high workload in blood banks that therefore requires automation. We often experienced discrepant results from an automated system, especially weak serum reactions. We evaluated the discrepant results by the reference manual method to confirm ABO blood typing. Methods In total, 13,113 blood samples were tested with the AutoVue system; all samples were run in parallel with the reference manual method according to...

  16. [Impacts of ABO incompatibility on early outcome after single unit unrelated cord blood transplantation: a retrospective single center experience].

    Science.gov (United States)

    Yan, Jiawei; Sun, Guangyu; Zhang, Lei; Yao, Wen; Zhu, Xiaoyu; Tang, Baolin; Zheng, Changcheng; Liu, Huilan; Sun, Zimin

    2015-12-01

    To retrospectively study the impacts of ABO incompatibility on early outcome after single unit unrelated cord blood transplantation(UCBT), such as cumulative incidence of engraftment, incidence of acute graft- versus- host disease (aGVHD) and 180- day transplant- related mortality(TRM). 208 patients underwent single unit UCBT from April 2008 to October 2014 were analyzed, included 99 ABO- identical, 60 minor, 38 major and 11 bidirectional ABO- incompatible recipients. All the patients received intensified myeloablative conditioning, and a combination of cyclosporine A and mycophenolate mofetil was given for GVHD prophylaxis. Cumulative incidences of neutrophil engraftment, platelet recovery, erythroid lineage reconstitution, Ⅱ-Ⅳ aGVHD, Ⅲ-Ⅳ aGVHD and 180- day TRM showed no significant difference among the patients receiving ABOidentical, minor, major, and bidirectional UCBT(all P>0.05, respectively). What's more, none of the patients developed pure red- cell aplasia(PRCA)after UCBT. Group A donor and a group O recipient patients didn't appeared to influence the clinical results when compared with others(all P>0.05, respectively). Patients receive ABO- incompatible UCBT may not develop PRCA. The presence of ABO- incompatibility did not influence the hematopoietic reconstitution, the incidence of aGVHD and 180-day TRM in this cohort. There is not support for the need to regard ABO-compatibility as an UCB-graft selection criterion.

  17. Histopathological Study of Central Nervous System Lesions: Emphasizing Association of Neoplasms with ABO Blood Groups.

    Science.gov (United States)

    Kumarguru, B N; Pallavi, P; Sunila; Manjunath, G V; Vasan, T S; Rajalakshmi, B R

    2017-04-01

    The Central Nervous System (CNS) lesions show considerable geographic and racial variations with respect to the incidence and the pattern of distribution of lesions. The ABO blood status is a readily accessible factor in genetic constitution of the patients. It has been shown to be associated with many diseases. But the influence of blood group status on the pathogenesis of brain tumours is still unclear. To study various histopathological patterns of CNS lesions and to evaluate the association of CNS tumours with the distribution of ABO blood groups in documented cases. In the present study, 147 cases were analyzed. It was an analytical type of study, done at JSS Medical College, Mysore, over a period of 2 years and 8 months from January 2009 to August 2011. Histopathology slides were routinely stained by Haematoxylin and Eosin (H&E) stain. Special stains were performed in selected cases. Blood group of the patients and the control group were documented. Blood group distribution pattern was assessed in relation to histopathological diagnosis of various CNS tumours. Histopathological diagnosis of 147 cases included neoplastic lesions (84.35%) and non-neoplastic lesions (15.64%). Neoplastic lesions (84.35%) constituted the majority, which included neuroepithelial tumours (29.25%) as predominant pattern. Non-neoplastic lesions constituted only 15.64%, which included inflammatory lesion (8.16%) as the predominant pattern. ABO blood group data was available in 92 cases (84.4%) of neoplastic lesions, which included 71 cases (48.29%) of primary CNS neoplasms categorized according to WHO grades. The control group constituted 21,067 healthy voluntary donors. Blood group O was the most frequent blood group in neoplastic lesions (40.21%) and primary CNS neoplasms categorized according to WHO grades (45.07%). The association between the CNS neoplasms and ABO blood groups was not statistically significant (p = 0.055). But a definite change in the pattern of distribution of ABO

  18. Transplante cardíaco: complicações apresentadas por pacientes durante a internação Trasplante de corazón: complicaciones que presentan los pacientes durante la hospitalización Heart Transplantation: complications presented by patients during the hospitalization

    Directory of Open Access Journals (Sweden)

    Elaine Araújo da Silva

    2012-12-01

    Full Text Available Com o avanço da ciência, a insuficiência cardíaca tem como possibilidade de intervenção o transplante cardíaco. Este trabalho teve como objetivos traçar o perfil demográfico dos pacientes submetidos ao transplante cardíaco e identificar as complicações apresentadas durante a internação. Trata-se de um estudo descritivo, quantitativo, realizado com 44 prontuários de pacientes submetidos a transplante de junho/2006 a julho/2009 em um Hospital Universitário de Belo Horizonte, Minas Gerais, Brasil. O projeto atendeu às recomendações da Resolução 196/96. Pelos resultados, a maioria dos pacientes era do sexo masculino, casada, escolaridade de nível fundamental e idade média de 45,2 anos. A miocardiopatia chagásica foi a principal causa de insuficiência cardíaca. As complicações predominantes foram alteração da glicemia, insuficiência renal e infecções. A taxa de mortalidade na internação foi de 20,4%. Além das complicações biológicas só foram registradas ansiedade e depressão. São necessárias pesquisas sobre o tema nos âmbitos psicossociais e espirituais, contribuindo para o desenvolvimento científico.Hoy día, con los avances de la medicina y de la tecnología para el tratamiento de la insuficiencia cardiaca irreversible, se ha utilizado como última intervención el trasplante cardíaco. Este trabajo se desarrolló con los objetivos de delinear el perfil demográfico de los pacientes sometidos a trasplante cardíaco e identificar las complicaciones presentadas por ellos después del trasplante de corazón. Estudio descriptivo y cuantitativo, realizado en conjunto con los registros de 44 pacientes sometidos a trasplante de corazón desde Jun/2006 hasta Jul/2009, en un Hospital Universitario de Belo Horizonte, Minas Gerais, Brasil. El proyecto cumplió con las recomendaciones de la Resolución 196/96. Los resultados mostraron que la mayoría de los pacientes eran del sexo masculino, casados, con educaci

  19. Costos de intervenciones para pacientes con insuficiencia renal crónica Costs of intervention for patients with chronic renal disease

    Directory of Open Access Journals (Sweden)

    Armando Arredondo

    1998-06-01

    Full Text Available INTRODUCCIÓN: Se presentan resultados sobre un estudio que pretendió identificar los costos de intervenciones en salud en el manejo de pacientes con insuficiencia renal crónica. MATERIAL Y MÉTODO: El método de costeo se basó en técnicas de consenso y de instrumentación de manejo de caso a través de la identificación de insumos y funciones de producción para la demanda de cada servicio solicitado. Las intervenciones costeadas incluyeron: diálisis peritoneal, hemodiálisis y trasplante renal. RESULTADOS: El costo por evento en US dóllares fué de $3.71, $57.95 y $ 8,778.32 respectivamente. En cuanto al costo de manejo anual de caso los resultados fueron: diálisis peritoneal $5,643.07, hemodiálisis $9,631.60 y trasplante $3,021.67. CONCLUSIONES: La información generada a partir de los costos de eventos difiere considerablemente de la información generada a partir del costo de manejo anual de caso. Estas diferencias resultan significativas para el diseño y evaluación de patrones de asignación de recursosINTRODUÇÃO: Apresentam-se os resultados sobre estudo que pretendeu identificar os custos de intervenções em saúde no manejo de pacientes com insuficiência renal crônica. MATERIAL E MÉTODO: O método de custeio teve como base técnicas de consenso e de instrumentação de manejo de caso a partir da identificação de insumos e funções de produção na demanda de cada serviço solicitado. As intervenções avaliadas nos seus custos foram: diálise peritoneal, hemodiálise e transplate renal. RESULTADOS: O custo por evento (diálise, hemodiálise e transplante em dólares foi de US$3.71, US$57.95 e US$8,778.32, respectivamente. Quanto ao custo do manejo anual de caso os resultados foram: diálise peritoneal US$5,643.07, hemodiálise US$9,631.60 e transplate renal de US$3,021.63. CONCLUSÕES: A informação gerada a partir dos custos de eventos difere consideravelmente do custo de manejo anual de caso.. Essas diferen

  20. Enfermedad hemolítica del recién nacido por incompatibilidad ABO Hemolytic disease of the newborn due to ABO incompatibility

    Directory of Open Access Journals (Sweden)

    Débora Villegas Cruz

    2007-12-01

    Full Text Available La enfermedad hemolítica del recién nacido por incompatibilidad ABO es la más frecuente de todas las incompatibilidades de grupo sanguíneo entre la madre y el recién nacido. Se estudiaron 46 recién nacidos a término, afectos de esta enfermedad, que fueron diagnosticados en el Hospital General «Enrique Cabrera» entre junio de 2004 y marzo del 2006. El diagnóstico se realizó por examen físico, exámenes de laboratorio y exámenes inmunohematológicos: fenotipificación de grupo ABO, prueba de Coombs directa y el título de IgG anti-A/B materno. El 60,8 % de los 46 recién nacidos afectados fueron de fenotipo A y procedían de madres de fenotipo O. El Coombs directo fue positivo en 2 casos y el título de IgG materno en estos casos fue mayor o igual a 1024. La fototerapia fue la modalidad de tratamiento más empleada. Aunque esta entidad es la menos grave de todos los conflictos de grupo sanguíneo entre la madre y el recién nacido, se debe estar alerta ante un curso inusual para poder brindar el tratamiento óptimo en el momento adecuado y disminuir la morbilidad.The hemolytic disease of the newborn due to ABO incompatibility is the most frequent of all the blood group incompatibilities between the mother and the infant. 46 infants at term, who were diagnosed this disease at Enrique CabreraNational Hospital from June 2004 to March 2006, were studied. The diagnosis was made by physical examination, lab tests and immunohematological tests: ABO phenotyping, direct Coombstest, and the maternal IgG anti-A/B titer. 60.8 % of the newborn infants affected were phenotype A and their mothers were phenotype O. the direct Coombstest yielded positive in 2 cases. The maternal IgG titer in these cases was higher than or equal to 1024. Phototherapy was the most used treatment modality. Although this entity is the least severe of all the blood grouping conflicts between the mother and the infant, one should be alert before an unusual course to apply

  1. Perspectivas futuras de tratamiento en la insuficiencia cardíaca: del trasplante de células a la regeneración cardíaca

    OpenAIRE

    Prosper, F. (Felipe); Herreros, J. (Jesús); Barba, J. (Joaquín)

    2004-01-01

    En los últimos años hemos asistido a un interés creciente por el tratamiento de la insuficiencia cardíaca mediante el trasplante de células madre. Mientras que los estudios con células madre de músculo (mioblastos) se iniciaron hace más de 10 años, la posibilidad de que las células madre de la médula ósea tengan un enorme potencial de diferenciación y proliferación ha estimulado la investigación con otros tipos de células madre. Estos estudios experimentales han demost...

  2. Relation of ABO Blood Groups to the Plaque Characteristic of Coronary Atherosclerosis.

    Science.gov (United States)

    Huang, Xingtao; Zou, Yongpeng; Li, Lulu; Chen, Shuyuan; Hou, Jingbo; Yu, Bo

    2017-01-01

    The ABO blood types related to morphological characteristics of atherosclerosis plaque are not clear. We aimed to evaluate the relationship between ABO blood groups and the coronary plaque characteristic. We retrospectively identified the target lesions in 392 acute coronary syndrome patients who underwent optical coherence tomography examination before stenting. Subjects were divided into different groups according to different blood types. The fibrous cap thickness was significantly thicker in O type compared with non-O type (0.075 ± 0.033 mm versus 0.061 ± 0.024, p blood type groups even between O type and non-O type group ( p > 0.05). The plaques of O type blood group were exhibited more stably compared with non-O type blood group. Moreover, the non-O type blood group have more serious coronary artery stenosis than O type blood group.

  3. Relationship between ABO blood groups and head and neck cancer among Greek patients.

    Science.gov (United States)

    Kakava, Kassiani; Karelas, Ioannis; Koutrafouris, Ioannis; Damianidis, Savvas; Stampouloglou, Paulos; Papadakis, Georgios; Xenos, Antonios; Krania, Foteini; Sarof, Paulos; Tasopoulos, Georgios; Petridis, Nikolaos

    2016-01-01

    We examined the association of ABO blood groups with the different types of head and neck cancers. 195 diagnosed cases and 801 controls were selected from a Greek tertiary cancer center. Information regarding type of head and neck cancer and ABO blood group was collected and registered. The O blood group was found to be most prevalent followed by A, B and AB among the controls, whereas blood group A followed by O, B and AB was most prevalent among cancer patients. The difference among the distribution between the cases and controls was statistically significant in blood group A (pblood group A had 1.52-fold higher risk of developing head and neck cancer compared to people of other blood groups. Blood group A was found to be a potential risk factor for the development of head and neck cancers.

  4. Effect of ABO blood group and secretor status on the frequency of Helicobacter pylori antibodies.

    Science.gov (United States)

    Höök-Nikanne, J; Sistonen, P; Kosunen, T U

    1990-08-01

    Duodenal ulcer is associated with such genetic characteristics as blood group O and secretor status. Since Helicobacter pylori has been proved to be an important factor in the pathogenesis of duodenal ulcer, we wanted to study whether the frequency of H. pylori antibodies would vary in individuals with different blood group antigens. Antibodies against H. pylori were determined in 271 blood donors. Acid glycine extract from an H. pylori strain was used as antigen in enzyme immunoassay. Our results suggested no significant association of increased level of H. pylori antibodies with ABO blood group and secretor status, which implies that H. pylori infection is not associated with the ABO group and secretor status. Thus H. pylori and blood group antigens seem to be independently linked to duodenal ulcer.

  5. Structural diversity and biological importance of ABO, H, Lewis and secretor histo-blood group carbohydrates

    Directory of Open Access Journals (Sweden)

    Luiz Carlos de Mattos

    Full Text Available ABSTRACT ABO, H, secretor and Lewis histo-blood system genes control the expression of part of the carbohydrate repertoire present in areas of the body occupied by microorganisms. These carbohydrates, besides having great structural diversity, act as potential receptors for pathogenic and non-pathogenic microorganisms influencing susceptibility and resistance to infection and illness. Despite the knowledge of some structural variability of these carbohydrate antigens and their polymorphic levels of expression in tissue and exocrine secretions, little is known about their biological importance and potential applications in medicine. This review highlights the structural diversity, the biological importance and potential applications of ABO, H, Lewis and secretor histo-blood carbohydrates.

  6. Protocolos de selección y estudio del donante y receptor aplicables a la práctica chilena, en trasplante cardiaco

    Directory of Open Access Journals (Sweden)

    V. Marcelo Llancaqueo, Dr.

    2010-03-01

    Full Text Available La terapia actual de la insuficiencia cardiaca (IC logra disminuir la morbilidad y la mortalidad, ésta persiste siendo elevada en etapas avanzadas, por lo que el trasplante cardiaco (TC constituye la mejor alternativa terapéutica en la fase terminal de la enfermedad. Como todo procedimiento quirúrgico, una adecuada selección de los candidatos, tanto receptor como donante, es fundamental para el éxito de un programa de trasplante cardíaco, más aún cuando constituye un procedimiento electivo. La indicación de TC está dada por la presencia de una cardiopatía con severa limitación de la capacidad funcional (CF III o IV sin otra alternativa de terapia médica y/o quirúrgica. La evaluación del receptor se basa en el descarte de enfermedades sistémicas, infecciones o neoplasias activas, así como de hipertensión pulmonar no reversible, y de cualquiera otra condición que comprometa la expectativa de vida del paciente. El estudio del donante se base en descartar una cardiopatía estructural o disfunción sistólica y enfermedades trasmisibles. En suma la morbilidad y mortalidad en un programa de TC depende la adecuada selección de los candidatos a receptor y el donante, así como del delicado equilibrio entre el nivel de la terapia inmuno-supresora necesaria para controlar el rechazo y los efectos secundarios de la misma, como el aumento de la susceptibilidad a las infecciones.

  7. ABO Blood Group and Dementia Risk ? A Scandinavian Record-Linkage Study

    OpenAIRE

    Vasan, Senthil K; Rostgaard, Klaus; Ullum, Henrik; Melbye, Mads; Hjalgrim, Henrik; Edgren, Gustaf

    2015-01-01

    Background Dementia includes a group of neuro-degenerative disorders characterized by varying degrees of cognitive impairment. Recent data indicates that blood group AB is associated with impaired cognition in elderly patients. To date there are no large-scale studies that have examined the relationship between ABO blood group and dementia-related disorders in detail. Methods We used data from the SCANDAT2 database that contains information on over 1.6 million blood donors from 1968 in Sweden...

  8. Heterogeneity and diversity of ABO and Rh blood group genes in select Saudi Arabian populations.

    Science.gov (United States)

    AlSuhaibani, E S; Kizilbash, N A; Malik, S

    2015-07-14

    In order to investigate the diversity of ABO and Rh blood group genes in the Saudi Arabian population, we assembled the phenotypic data of approximately 66,000 subjects from ten representative Saudi populations: Al-Khobar, Riyadh, Tabuk/Madina Al-Munawaara, Jeddah, Abha, South region, Sakaka, Domah, Al-Qurayat, and Sweer. The frequencies of p[A], q[B], and r[O] alleles at the ABO locus were observed to be 0.1688, 0.1242, and 0.7070, respectively, and the frequency of the D allele at the Rh locus was 0.7138. The heterozygosities at the ABO and Rh loci were 0.4563 and 0.4086, respectively, while the combined heterozygosity was 0.4324. Homogeneity tests revealed the population of Abha to be the most heterogeneous while that of Tabuk/Madina was found to be the least heterogeneous. Homogeneity was higher among the Northern populations while Southern populations demonstrated subdivisions and stratification. Gene diversity analyses yielded a total heterozygosity value of 0.4449. The coefficient of gene differentiation was 0.0090. Nei's genetic distance analyses showed that there was close affinity between the populations of Al-Khobar and Riyadh. The largest differences were observed between the populations of Sakaka and Domah. Furthermore, negative correlations were found between p[A] and r[O] alleles, and between q[B] and r[O] alleles at the ABO locus. Clinal analyses revealed that the r[O] allele showed an increasing trend from North-East to South-West, and conversely the q[B] allele exhibited a decreasing trend at these coordinates. These analyses present interesting aspects of the blood group allele distribution across the geography of Saudi Arabia.

  9. An integrated system of ABO typing and multiplex STR testing for forensic DNA analysis.

    Science.gov (United States)

    Jiang, Xianhua; He, Juan; Jia, Fei; Shen, Hongying; Zhao, Jinling; Chen, Chuguang; Bai, Liping; Liu, Feng; Hou, Guangwei; Guo, Faye

    2012-12-01

    A new amplification system for ABO and STR genotyping in a single reaction has been successfully developed. Two types of information can be obtained from a biological sample at one time. One is the classical information of ABO blood group typing for screening suspects and the other is STR information for individual identification. The system allows for the simultaneous detection of 15 autosomal STR loci (containing all CODIS STR loci as well as Penta D and Penta E), six ABO genotypes (O/O, B/B, A/A, A/O, A/B, and B/O) and the gender-determining locus Amelogenin. Primers are designed so that the amplicons are distributed ranging from 75bp to 500bp within a four-dye fluorescent design, leaving a fourth dye for the internal size standard. With 30 cycles, the results showed that the optimal amount of DNA template for this multiplex ranges from 250pg to 2ng and the lowest detection threshold is 125pg (as low as 63pg for ABO loci). For the DNA template outside the optimal detection range, we could adjust the number of cycles to obtain the robust profiles. Mixture studies showed that over 83% of minor alleles were detected at 1:9 ratios. The full profiles were still observed when 4ng of degraded DNA was digested by DNase I and 1ng undegraded DNA was added to 40μM haematin. Polymerase chain reaction (PCR)-based conditions including the concentrations of primers, magnesium and the Taq polymerase as well as volume, cycle numbers and annealing temperature were examined and optimised. In addition, the system was validated by 364 bloodstain samples and 32 common casework samples. According to the Chinese National Standards and Scientific Working Group on DNA Analysis Methods (SWGDAM) guidelines, our system demonstrates good detection performance and is an ideal tool for forensic DNA typing with potential application. Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

  10. Helicobacter pylori Infection in Various ABO Blood Groups of Kashmiri Population

    OpenAIRE

    Romshoo, Gh. Jeelani; Bhat, Md. Youssuf; Malik, G. M.; Rather, Ab. Rasheed; Naikoo, B. A.; Basu, Javaid A.; Hussain, Tajamul; Rashid, Samia

    1997-01-01

    Aim: This study was carried out to assess the prevalence of Helicobacter pylori infection in various ABO blood groups of people of Kashmir. Method: The study comprised 80 individuals – 50 peptic ulcer patients (whose disease was diagnosed by endoscopy) and 30 asymptomatic volunteers. Every subject's blood group and Rhesus status was determined by standard serological tests. Helicobacter pylori infection was diagnosed by three different methods viz., one minute endoscopy room test (urease test...

  11. ABO blood group and risk of coronary heart disease in two prospective cohort studies.

    Science.gov (United States)

    He, Meian; Wolpin, Brian; Rexrode, Kathy; Manson, Joann E; Rimm, Eric; Hu, Frank B; Qi, Lu

    2012-09-01

    Epidemiological data regarding the association between ABO blood groups and risk of coronary heart disease (CHD) have been inconsistent. We sought to investigate the associations between ABO blood group and CHD risk in prospective cohort studies. Two large, prospective cohort studies (the Nurses' Health Study [NHS] including 62 073 women and the Health Professionals Follow-up Study [HPFS] including 27 428 men) were conducted with more than 20 years of follow-up (26 years in NHS and 24 years in HPFS). A meta-analysis was performed to summarize the associations from the present study and previous studies. In NHS, during 1 567 144 person-years of follow-up, 2055 participants developed CHD; in HPFS, 2015 participants developed CHD during 517 312 person-years of follow-up. ABO blood group was significantly associated with the risk of developing CHD in both women and men (log-rank test; P=0.0048 and 0.0002, respectively). In the combined analysis adjusted for cardiovascular risk factors, compared with participants with blood group O, those with blood groups A, B, or AB were more likely to develop CHD (adjusted hazard ratios [95% CI] for incident CHD were 1.06 [0.99-1.15], 1.15 [1.04-1.26], and 1.23 [1.11-1.36], respectively). Overall, 6.27% of the CHD cases were attributable to inheriting a non-O blood group. Meta-analysis indicated that non-O blood group had higher risk of CHD (relative risk =1.11; 95% CI, 1.05-1.18; P=0.001) compared with O blood group. These data suggest that ABO blood group is significantly associated with CHD risk. Compared with other blood groups, those with the blood type O have moderately lower risk of developing CHD.

  12. Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation.

    Science.gov (United States)

    Uchida, J; Machida, Y; Iwai, T; Naganuma, T; Kitamoto, K; Iguchi, T; Maeda, S; Kamada, Y; Kuwabara, N; Kim, T; Nakatani, T

    2010-12-01

    A positive crossmatch indicates the presence of donor-specific alloantibodies and is associated with a graft loss rate of >80%; anti-ABO blood group antibodies develop in response to exposure to foreign blood groups, resulting in immediate graft loss. However, a desensitization protocol for highly HLA-sensitized and ABO-incompatible high-titer kidney transplantation has not yet been established. We treated 6 patients with high (≥1:512) anti-A/B antibody titers and 2 highly HLA-sensitized patients. Our immunosuppression protocol was initiated 1 month before surgery and included mycophenolate mofetil (1 g/d) and/or low-dose steroid (methylprednisolone 8 mg/d). Two doses of the anti-CD20 antibody rituximab (150 mg/m(2)) were administered 2 weeks before and on the day of transplantation. We performed antibody removal with 6-12 sessions of plasmapheresis (plasma exchange or double-filtration plasmapheresis) before transplantation. Splenectomy was also performed on the day of transplantation. Postoperative immunosuppression followed the same regimen as ABO-compatible cases, in which calcineurin inhibitors were initiated 3 days before transplantation, combined with 2 doses of basiliximab. Of the 8 patients, 7 subsequently underwent successful living-donor kidney transplantation. Follow-up of our recipients showed that the patient and graft survival rates were 100%. Acute cellular rejection and antibody-mediated rejection episodes occurred in 1 of the 7 recipients. These findings suggest that our immunosuppression regimen consisting of rituximab infusions, splenectomy, plasmapheresis, and pharmacologic immunosuppression may prove to be effective as a desensitization protocol for highly HLA-sensitized and ABO-incompatible high-titer kidney transplantation. Copyright © 2010 Elsevier Inc. All rights reserved.

  13. Effect of Helicobacter pylori Eradication and ABO Genotype on Gastric Cancer Development.

    Science.gov (United States)

    Oh, Sooyeon; Kim, Nayoung; Kwon, Jin-Won; Shin, Cheol Min; Choi, Yoon Jin; Lee, Dong Ho; Jung, Hyun Chae

    2016-12-01

    Evidence is lacking regarding how Helicobacter pylori infection status, eradication history, and ABO blood type affect the development of gastric cancer (GC) given the multifactorial and distinctive etiology according to cancer location (noncardia vs cardia) and histologic type (intestinal vs diffuse-type). We evaluated the effect of H. pylori infection status incorporated with H. pylori eradication history and ABO genotype on GC development according to cancer location and histologic type. A case-control study of 997 patients with noncardia GC (NCGC) and 1147 control subjects was performed using risk analyses with 14 factors including H. pylori infection with eradication history and ABO genotype. As final analyses, multivariable logistic regression models were fitted. Additionally, H. pylori infection status with eradication history was tested for its association with age, atrophic gastritis (AG), and intestinal metaplasia (IM). The ABO genotype with the B allele was associated with a significantly lower risk of NCGC of both histologic types. The reduction in risk for NCGC by adding the B allele was more prominent in diffuse-type than that in the intestinal-type. H. pylori infection with eradication history was associated with a significantly lower risk of NCGC of both histologic types, compared with those without eradication history (odds ratio (OR), 0.22; 95% confidence interval (CI), 0.14-0.34) approaching that of uninfected subjects. Past infection status without an eradication history was associated with older age, AG, and IM. H. pylori eradication and the B allele decreased the risks of the intestinal and diffuse-types of NCGC. H. pylori eradication revealed a strong association against developing NCGC. Therefore, it should be considered as a primary measure in NCGC prevention. © 2016 John Wiley & Sons Ltd.

  14. A-site hybridization wave induced Mott transition in ABO$_3$ perovskites

    OpenAIRE

    Paul, Atanu; Mukherjee, Anamitra; Dasgupta, Indra; Paramekanti, Arun; Saha-Dasgupta, Tanusri

    2018-01-01

    Correlated insulators in quantum materials including ABO$_3$ perovskites are traditionally classified as Mott-Hubbard or charge-transfer insulators, focussing exclusively on the B-site cation and the ligand (oxygen). In this work, we propose a unique kind of {\\it hybridization wave} induced Mott insulator, where a spatial modulation in the hybridization between the ligand and the A-site cation triggers a Mott transition on the correlated B-site transition metal cation. Our work is relevant to...

  15. Impact of dietary intake and nutritional status on outcomes after liver transplantation Efecto de la ingesta y del estado nutricional en el trasplante hepático

    Directory of Open Access Journals (Sweden)

    D. A. de Luis

    2006-01-01

    nutritional status and dietary intake. Nutritional parameters showed no association with outcomes after liver transplantation. Liver transplantation improved serum protein levels and did not modify weight or dietary intake. Further studies are needed to clarify the role of liver transplantation on nutritional status and of nutritional status on liver transplantation outcomes, considering different populations of patients.Objetivo: el objetivo de nuestro estudio fue examinar de una manera prospectiva si la situación nutricional y la ingesta dietética pueden influir en los resultados del postrasplante hepático. Material y pacientes: se realizó una valoración nutricional basal y a los 6 meses en 31 pacientes consecutivos que fueron sometidos a trasplante hepático ortotópico (THO, en el Hospital U. Río Hortega. La evaluación nutricional incluyó el test de valoración subjetiva global (VSG, el test mininutritional assessment (MNA, antropometría convencional, analítica sérica y una encuesta nutricional de 3 días. Resultados: los pacientes tuvieron una edad media de 56,2 ± 8,11 años, peso (72,9 ± 15,3 kg e índice de masa corporal de (26,6 ± 4,1. La valoración antropométrica mostró los siguientes datos: pliegue tricipital 12,2 ± 6,1 mm, circunferencia muscular del brazo 24,5 ± 4,1 cm, masa libre de grasa 54,5 ± 10,9 kg, masa grasa 18,4 ± 6,5 mm y agua corporal 41,4 ± 9,1 kg. Tras seis meses del trasplante estos parámetros permanecieron inalterados. La ingesta calórica fue similar en el pre- y post-trasplante (28.1 ± 6 vs. 27,5 ± 5,8 kcal/kg: ns. Los niveles séricos de albúmina, prealbúmina y transferrina mejoraron a los 6 meses. La estancia media hospitalaria fue de 22,4 ± 14,9 días y la estancia en cuidados intensivos de 0,7 ± 1,7 días. EL estado nutricional determinado por los tests VSG y MNA no influyó en las estancias. Dos pacientes fallecieron tras el trasplante hepático (6,5% y 3 tuvieron rechazo agudo (9,6%. El estado nutricional

  16. ABO blood groups and oral premalignancies: A clinical study in selected Indian population.

    Science.gov (United States)

    Bhateja, S; Arora, G

    2014-01-01

    Background: The ABO blood group antigens are present on the surface of red blood cells and various epithelial cells. As the majority of human cancers are derived from epithelial cells, changes in blood group antigens constitute an important aspect of human cancers. The aim of the study was to establish clinical usefulness of ABO blood group as a predisposing factor in early diagnosis and management of patients with oral precancerous lesions/conditions. Materials and Methods: The study sample consisted of 50 control and 50 oral precancer (25 leukoplakia and 25 Oral Submucous Fibrosis) confirmed by histopathologic examination. All samples were subjected to blood group testing and their prevalence was compared by Z-test using STATA version 8. Results: The "A" blood group was prevalent among the precancerous group. Significant differences on prevalences of blood groups were found (P blood group. Conclusion: Blood group type should be considered along with other risk factors to understand the individual patient's risk and further studies in larger samples with inclusion of Rh factor is needed to elucidate the relationship with ABO blood group types.

  17. ABO Blood Group and Dementia Risk--A Scandinavian Record-Linkage Study.

    Science.gov (United States)

    Vasan, Senthil K; Rostgaard, Klaus; Ullum, Henrik; Melbye, Mads; Hjalgrim, Henrik; Edgren, Gustaf

    2015-01-01

    Dementia includes a group of neuro-degenerative disorders characterized by varying degrees of cognitive impairment. Recent data indicates that blood group AB is associated with impaired cognition in elderly patients. To date there are no large-scale studies that have examined the relationship between ABO blood group and dementia-related disorders in detail. We used data from the SCANDAT2 database that contains information on over 1.6 million blood donors from 1968 in Sweden and 1981 from Denmark. The database was linked with health outcomes data from nationwide patient and cause of death registers to investigate the relationship between blood groups and risk of different types of dementia. The incident rate ratios were estimated using log-linear Poisson regression models. Among 1,598,294 donors followed over 24 million person-years of observation we ascertained 3,615 cases of Alzheimer's disease, 1,842 cases of vascular dementia, and 9,091 cases of unspecified dementia. Overall, our study showed no association between ABO blood group and risk of Alzheimer's disease, vascular dementia or unspecified dementia. This was also true when analyses were restricted to donors aged 70 years or older except for a slight, but significantly decreased risk of all dementia combined in subjects with blood group A (IRR, 0.93; 95% confidence interval [CI], 0.88-0.98), compared to those with blood group O. Our results provide no evidence that ABO blood group influences the risk of dementia.

  18. [Errors in detection of subgroups in the ABO blood group system].

    Science.gov (United States)

    Sato, C; Maeda, H

    1997-09-01

    In the ABO blood group system, several subgroups have been described based on: 1) the difference of reactivities of the red cells with anti-A, anti-B, anti-A1, and anti-H, 2) the presence or absence of anti-A, anti-B, anti-A1, anti-H, and anti-HI in serum, and 3) the presence of A, B, H substances in the saliva of ABH secretors. Subgroups of A are more frequent in Caucasians than in Japanese, while those of B are more frequent in Japanese. Both the red cell typing (testing red cells for A and B antigens) and serum typing (testing the antibodies in the serum against red cells of known ABO groups) are important to identify and not to overlook these ABO subgroups. When transfusion is required in individuals with these subgroups, compatible blood products must be selected according to the presence or absence of antibodies active at 37 degrees C.

  19. ABO blood type is associated with ovarian reserve in Chinese women with subfertility.

    Science.gov (United States)

    Mu, Liangshan; Jin, Wumin; Yang, Haiyan; Chen, Xia; Pan, Jiexue; Lin, Jia; Wang, Peiyu; Huang, Xuefeng

    2016-08-09

    Ovarian reserve reflects both the quantity and quality of oocytes available for procreation, and is affected by many known and unknown factors. ABO blood type is related to a number of infertility processes, but it is unclear whether and how ABO blood type affects ovarian reserve. Here, we explored the relationship between ABO blood type and ovarian reserve in Chinese women with subfertility. Day-3 serum follicle-stimulating hormone (FSH) levels and blood type were examined in 14,875 women who underwent IVF or ICSI treatment. Blood type proportions in the patient population were as follows: 30.98% type A, 24.54% type B, 7.57% type AB, and 36.91% type O. A higher percentage of women with diminished ovarian reserve (DOR) were blood type O, while a lower percentage had the B antigen (B and AB). Multiple logistic regression analysis revealed that blood type O was associated with a greater risk of DOR than blood type B and B antigen-positive types. By contrast, the B antigen (B and AB) was associated with a lower incidence of DOR than blood type O. These results suggest that blood type O is a risk factor for DOR while the B antigen (blood type B or AB) is a protective factor for ovarian reserve in Chinese women with subfertility. Further studies are needed to confirm this effect and identify the underlying mechanisms.

  20. Influence of ABO blood type on the outcome after non-aneurysmal subarachnoid hemorrhage.

    Science.gov (United States)

    Dubinski, Daniel; Won, Sae-Yeon; Behmanesh, Bedjan; Kashefiolasl, Sepide; Geisen, Christof; Seifert, Volker; Senft, Christian; Konczalla, Juergen

    2018-04-01

    In patients with non-aneurysmal subarachnoid hemorrhage (NA-SAH), the etiology is unknown and the bleeding source remains unidentified. However, the ABO blood type system has a profound role in patient's hemostasis and thrombosis. To date, the aspect of ABO blood type in incidence, clinical course, and outcome after NA-SAH has not been investigated. In this retrospective analysis, 81 patients with non-traumatic and non-aneurysmal subarachnoid hemorrhage treated between 2010 and 2014 at the author's institution were included. WFNS admission status, cerebral vasospasm, delayed infarction, ventriculoperitoneal shunt necessity, the Fisher grade, and the modified Rankin Scale were analyzed for their association with ABO blood type. Four hundred seventy patients with aneurysmal subarachnoid hemorrhage served as a control group. The AB blood type is more frequent in NA-SAH compared to aneurysmal patients and the German population (OR 2.45, p ≤ 0.05). Furthermore, NA-SAH with AB blood type showed a similar sequelae compared to aneurysmal patients in terms of shunt necessity (OR 2.00, p ≥ 0.05), cerebral vasospasm (OR 1.66, p ≥ 0.05), and delayed infarctions (OR 1.07, p ≥ 0.05). The clinical course of NA-SAH AB blood type patients shows similar severity as of aneurysmal subarachnoid hemorrhage. Therefore, patients with AB blood type should be under intensified observation.

  1. A Dermatoglyphic Study: Association of Fingerprint Patterns Among ABO Blood Groups

    Directory of Open Access Journals (Sweden)

    Tri Panjiasih Susmiarsih

    2016-12-01

    Full Text Available Fingerprints are probably the most common biometric technique used in personal identification. The potential of fingerprints to determine sex and human identification has been well exhibited. However, very few studies have been conducted correlating finger prints with blood groups. The aim of this study was to investigate the distribution of fingerprint patterns based on ABO blood groups. The total sample consisted of 302 medical students of YARSI University Jakarta comprising of 187 females and 115 males. The fingerprint patterns were classified into arches, loops (ulnar and radial, whorls. counted and comprised triradius and total ridge count. The data analysis used Chi Square and Student-T test.The study results indicated that there were fourth especially pattern type. Significantly (p<0.05, frequency of loop types (60.36% was highest in B blood, whorl type was highest in O blood (40.45% and arches in AB blood was higher (5.12% as compared to other groups. Dankmeijer indices of O and AB blood were 3.78 and 11.34, respectively. There were indicated significantly (p<0.05 difference of average ridge count total among ABO blood groups. This study implied an association between dermatoglyphics and blood groups.How to CiteSusmiarsih, T. P., Mustofa, M. S., & Mirfat, M. (2016. A Dermatoglyphic Study: Association of Fingerprint Patterns Among ABO Blood Groups. Biosaintifika: Journal of Biology & Biology Education, 8(3, 294-300. 

  2. A case of ABO-incompatible blood transfusion treated by plasma exchange therapy and continuous hemodiafiltration.

    Science.gov (United States)

    Namikawa, Akio; Shibuya, Yuko; Ouchi, Haruki; Takahashi, Hiroko; Furuto, Yoshitaka

    2018-05-01

    ABO-incompatible blood transfusion is potentially a life-threatening event. A 74-year-old type O Rh-positive male was accidentally transfused with 280 mL type B Rh-positive red blood cells during open right hemicolectomy, causing ABO-incompatible blood transfusion. Immediately after the transfusion, the patient experienced a hypotension episode followed by acute hemolytic reaction, disseminated intravascular coagulation and acute kidney injury. Plasma exchange therapy was performed to remove anti-B antibody and free hemoglobin because they caused acute hemolytic reaction, disseminated intravascular coagulation, and acute kidney injury. Free hemoglobin levels decreased from 13 to 2 mg/dL for 2 h. Continuous hemodiafiltration was used to stabilize hemodynamics. The patient was successfully treated for acute hemolytic reaction, disseminated intravascular coagulation, and acute kidney injury. Plasma exchange therapy and continuous hemodiafiltration are likely to be effective treatments for ABO-incompatible blood transfusion, and further studies are required to assess this effectiveness in future.

  3. Molecular polymorphisms of the ABO locus as informative markers of ancestry in Central Argentina.

    Science.gov (United States)

    Tavella, María Pía; García, Angelina; Pauro, Maia; Demarchi, Darío A; Nores, Rodrigo

    2017-07-08

    The aim of this study was to investigate the distribution of molecular polymorphisms of the ABO gene in four population samples from the province of Córdoba, in Central Argentina, and to compare them with other worldwide populations. A total of 110 buccal swab samples from autochthonous individuals of Córdoba were typified. Molecular characterization of the allelic variants was performed by the analysis of exons 6 and 7 of the ABO gene using PCR-RFLP analysis. Additionally, the Native American AIM O1v542 was characterized by direct sequencing. The four Córdoba populations did not show significant geographic structure, although the frequency of the O1v542 haplotype, detected in all the populations studied, ranged from 0.019 to 0.222. The principal component analysis based on O allele distribution showed that the populations from Córdoba clustered close to the admixed populations of Santiago and Mexico City, and at intermediate distances between European and Native American populations, while being distant from the African population. The results demonstrate that the analysis of the ABO system constitutes a useful tool for the study of the genetic structure and evolutionary history of human populations, reflecting accurately the relative contribution of parental continental contribution to the gene pool of admixed populations. © 2017 Wiley Periodicals, Inc.

  4. A correlation between severe haemolytic disease of the fetus and newborn and maternal ABO blood group.

    Science.gov (United States)

    Doyle, B; Quigley, J; Lambert, M; Crumlish, J; Walsh, C; McParland, P; Culliton, M; Murphy, K; Fitzgerald, J

    2014-08-01

    To analyse anti-D quantification levels and frequency of intrauterine transfusion (IUT), per maternal ABO blood group. Maternally derived red cell allo-antibodies can target fetal red cell antigens in utero leading to haemolytic disease and fetal anaemia. When a clinically significant allo-antibody is formed the priority is ascertaining the risk to the fetus and maternal ABO blood groups are not considered relevant. This was a 10-year retrospective, observational study carried out on women referred for anti-D quantification (n = 1106), and women whose fetuses required an IUT to treat fetal anaemia (n = 62) due to anti-D, in the Republic of Ireland. Relative to the overall incidence of RhD allo-immunisation by blood group, women of blood group A were more likely to require IUT compared with those who were blood group O (P = 0.002). It is known that ABO feto-maternal compatibility can influence the incidence and level of red cell allo-antibodies in pregnancy; however, it does not account for the significantly high rate of severe haemolytic disease requiring IUT seen in blood group A women. © 2014 The Authors. Transfusion Medicine © 2014 British Blood Transfusion Society.

  5. Genetic Analysis of ABO and Rh Blood Groups in Backward Caste Population of Uttar Pradesh, India

    Directory of Open Access Journals (Sweden)

    Vandana RAI

    2011-08-01

    Full Text Available A series of glycoproteins and glycolipids on red blood cell surface constitute blood group antigens. These are AB, A, B and O in ABO blood group system and Rh in rhesus blood group system. A total of 1065 unrelated Backward Caste (OBC individuals from Uttar Pradesh were studied for the phenotype and allele frequency distribution of ABO and Rh (D blood groups. Total 1065 samples analyzed, phenotype B blood type has the highest frequency 36.81% (n=392, followed by O (32.68%; n=348, A (23.66%; n=252 and AB (6.85%; n=73. The overall phenotypic frequencies of ABO blood groups were B>O>A>AB. The allelic frequencies of O, A, and B alleles were 0.5819, 0.1674 and 0.2506 respectively. Out of total 1065 samples, 1018 (95.59% samples were Rh-positive and 47 (4.41% were Rh-negative. Phenotypic frequency of Rh-negative in Koari, Yadav, Kurmi and Maurya samples were 0.99%, 4%, 1.4% and 7.6% respectively.

  6. ABO and D typing and alloantibody screening in marrow samples: relevance to intraosseous blood transfusion.

    Science.gov (United States)

    Bäckman, Sari; Ångerman-Haasmaa, Susanne; Jousi, Milla; Siitonen, Sanna; Salmela, Katja

    2018-03-01

    Blood transfusion through the intraosseous route is gaining popularity in emergency medicine. Pretransfusion peripheral blood (PB) samples are usually not available in these patients, leading to discrepancies in blood group typing and a possible delay in transferring to group-specific blood products. The aim of this study was to assess the feasibility of ABO and D typing and red blood cell alloantibody screening in marrow (BM) samples. Direct and reverse ABO typing, D typing, and a two-cell alloantibody screen were performed in EDTA-anticoagulated BM samples with standard manual column agglutination techniques. EDTA-anticoagulated PB samples were used as controls. The mean age of the study subjects (n = 71) was 47 years (range, 1-82 years). All ABO groups and both D+ and D- types were represented. In all subjects, concordant results were observed for all analyses in BM and PB samples. In 15 (21%) of the samples, a discrepancy of one reaction strength step (1+) was observed in at least one of the analyses (Cohen's weighted κ = 0.993); this did not affect interpretation of the results. Blood group typing and alloantibody screening are feasible in BM samples, providing proof-of-concept that intraosseous samples for blood group serologic analyses can be collected from emergency patients before intraosseous blood transfusion. This will enable a timely transfer to group-specific blood products and enable conservation of the valuable universal-donor blood products. © 2018 AABB.

  7. ABO, Secretor and Lewis histo-blood group systems influence the digestive form of Chagas disease.

    Science.gov (United States)

    Bernardo, Cássia Rubia; Camargo, Ana Vitória Silveira; Ronchi, Luís Sérgio; de Oliveira, Amanda Priscila; de Campos Júnior, Eumildo; Borim, Aldenis Albaneze; Brandão de Mattos, Cinara Cássia; Bestetti, Reinaldo Bulgarelli; de Mattos, Luiz Carlos

    2016-11-01

    Chagas disease, caused by Trypanosoma cruzi, can affect the heart, esophagus and colon. The reasons that some patients develop different clinical forms or remain asymptomatic are unclear. It is believed that tissue immunogenetic markers influence the tropism of T. cruzi for different organs. ABO, Secretor and Lewis histo-blood group systems express a variety of tissue carbohydrate antigens that influence the susceptibility or resistance to diseases. This study aimed to examine the association of ABO, secretor and Lewis histo-blood systems with the clinical forms of Chagas disease. We enrolled 339 consecutive adult patients with chronic Chagas disease regardless of gender (cardiomyopathy: n=154; megaesophagus: n=119; megacolon: n=66). The control group was composed by 488 healthy blood donors. IgG anti-T. cruzi antibodies were detected by ELISA. ABO and Lewis phenotypes were defined by standard hemagglutination tests. Secretor (FUT2) and Lewis (FUT3) genotypes, determined by Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), were used to infer the correct histo-blood group antigens expressed in the gastrointestinal tract. The proportions between groups were compared using the χ2 test with Yates correction and Fisher's exact test and the Odds Ratio (OR) and 95% Confidence Interval (95% CI) were calculated. An alpha error of 5% was considered significant with p-values Chagas disease. Copyright © 2016 Elsevier B.V. All rights reserved.

  8. Renal cell cancer without a renal primary

    Directory of Open Access Journals (Sweden)

    Cumani B

    2010-03-01

    Full Text Available Abstract Renal cell carcinoma has been increasing in incidence over the past two decades. Men are affected more than women and metastatic disease at presentation occurs in up to one third of patients. Metastasis can occur to virtually any organ, and involvement of multiple organs is not uncommon. To date, no reports have been found of metastatic disease without a renal primary. We present a case of renal cell cancer initially presenting as a subcutaneous mass with subsequent pancreatic and parotid gland metastases in absence of a primary renal source.

  9. Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility

    Directory of Open Access Journals (Sweden)

    Serena Valsami

    2015-01-01

    Full Text Available Platelet transfusions have contributed to the revolutionary modern treatment of hypoproliferative thrombocytopenia. Despite the long-term application of platelet transfusion in therapeutics, all aspects of their optimal use (i.e., in cases of ABO and/or Rh (D incompatibility have not been definitively determined yet. We reviewed the available data on transfusion practices and outcome in ABO and RhD incompatibility and platelet refractoriness due to anti-human leukocyte antigen (HLA antibodies. Transfusion of platelets with major ABO-incompatibility is related to reduced posttransfusion platelet (PLT count increments, compared to ABO-identical and minor, but still are equally effective in preventing clinical bleeding. ABO-minor incompatible transfusions pose the risk of an acute hemolytic reaction of the recipient that is not always related to high anti-A, B donor titers. ABO-identical PLT transfusion seems to be the most effective and safest therapeutic strategy. Exclusive ABO-identical platelet transfusion policy could be feasible, but alternative approaches could facilitate platelet inventory management. Transfusion of platelets from RhD positive donors to RhD negative patients is considered to be effective and safe though is associated with low rate of anti-D alloimmunization due to contaminating red blood cells. The prevention of D alloimmunization is recommended only for women of childbearing age. HLA alloimmunization is a major cause of platelet refractoriness. Managing patients with refractoriness with cross-matched or HLA-matched platelets is the current practice although data are still lacking for the efficacy of this practice in terms of clinical outcome. Leukoreduction contributes to the reduction of both HLA and anti-D alloimmunization.

  10. Diagnóstico precoz del rechazo en el trasplante experimental de páncreas total con duodeno en el perro: citología por punción-aspiración con aguja fina

    OpenAIRE

    Rodríguez Abascal, Moisés

    1993-01-01

    El trasplante de páncreas está indicado fundamentalmente en los pacientes con diabetes mellitus tipo I. En la actualidad las soluciones terapéuticas ofertadas son: regímenes de insulina, bombas de infusión subcutánea de insulina, el páncreas artificial, y el trasplante de páncreas; este último sería la posibilidad que más fisiológicamente regularía el mecanismo de homostasis de la glucosa. Desde que se descubrió la insulina hace ya más de 70 años, ha cambiado poco el tratamiento del enferm...

  11. Radionuclide evaluation of renal transplants

    International Nuclear Information System (INIS)

    Yang Hong; Zhao Deshan

    2000-01-01

    Radionuclide renal imaging and plasma clearance methods can quickly quantitate renal blood flow and function in renal transplants. They can diagnose acute tubular necrosis and rejection, renal scar, surgical complications such as urine leaks, obstruction and renal artery stenosis after renal transplants. At the same time they can assess the therapy effect of renal transplant complications and can also predict renal transplant survival from early post-operative function studies

  12. Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients

    Directory of Open Access Journals (Sweden)

    Jaff MS

    2011-09-01

    Full Text Available Mohamad Salih Jaff Pathology Department, College of Medicine, Hawler Medical University (formerly Salahuddin University, Erbil, Kurdistan Region, Iraq Abstract: Epidemiological studies have demonstrated higher frequencies of the O blood group and the nonsecretor phenotype of ABH antigens among patients suffering from peptic ulcers. Since Helicobacter pylori has been established as the main etiological factor in this disease, controversies about the associations of the ABO and Lewis blood group phenotypes and secretor and nonsecretor phenotypes in relation to susceptibility towards infection by this bacillus have been presented. The aim of this study was to verify the frequencies of ABO and Rhesus (Rh blood groups in H. pylori seropositive symptomatic patients. The study included (n = 1108 patients with dyspepsia symptoms referred from an outpatient clinic in Erbil city for investigation. Age, sex, and residency were recorded as a routine laboratory framework. Patients underwent SD Bioline (Standard Diagnostics Inc, Kyonggi-do, South Korea and enzyme-linked immunosorbent assay serologic tests for H. pylori. ABO blood group phenotypes were determined by a standard hemagglutination test. Results showed that 64.8% of patients (n = 718/1108 were seropositive for H. pylori infection, and (35.2% (n = 390/1108 were seronegative. Of the seropositive patients, 40.8% (n = 293/718 were male and 59.2% (n = 425/718 were female; while of the seronegative patients, 46.7% (n = 182/390 were male and 53.3% (n = 208/390 were female. The mean age for seropositives and seronegatives was (38.0 ± 14.6 years and (37.6 ± 15.7 years respectively. The frequency of the ABO and Rh-positive (Rh+ blood groups among seropositive patients was (A = 32.0%, B = 19.5%, AB = 6.7%, O = 41.8%, and Rh+ = 92.5% and was (A = 32.3%, B = 28.2%, AB = 8.0%, O = 31.5%, and Rh+ = 92.5% in seronegatives. The results of this study suggest that ABO blood groups, age, and gender influence

  13. Occurrence of ABO And RhD Incompatibility with Rh Negative Mothers.

    Science.gov (United States)

    Izetbegovic, Sebija

    2013-12-01

    Hemolytic disease of the newborn was first described in the medical literature 1609, when it was diagnosed in one French housewife. In 1932 Diamond and colleagues described the mutual relationship of fetal hydrops, jaundice, anemia and erythoblastosis, which was later called fetal erytroblastosis. Hemolytic disease of the newborn (HDN) in the strict sense is considered disease whose basis is accelerated immune destruction of fetal/child erythrocytes that are bound to IgG antibodies of maternal origin. These antibodies are directed against antigens of father's origin, which are present in the fetal/children's erythrocytes and that the mother's immune system recognizes them as foreign antigens. The goal is that in the period from January 1(st) 2011 to October 23(st) 2013 determine the frequency of ABO and Rh D incompatibilities in our sample of pregnant women/mothers, and to underscore the importance of regular check of ABO Rh D negative pregnant women and application specific Rh D protection. In the General Hospital "Prim. Dr. Abdulah Nakas" in Sarajevo by retrospective study are followed several relevant variables. Immune alloantibodies were detected in vivo by indirect Coombs test (ICT) with serum mother and O test erythrocytes, by direct Coombs test (DCT) with erythrocytes of a newborn. The total number of births ABO Rh D negative was 596 (14%) and ABO Rh D positive mothers 4261 (86%). Of the total number of Rh D negative mothers there was A Rh D: negative mothers 42%; O Rh D negative 33%; B Rh D: negative 17% and AB Rh D: negative 8%. Most of immune antibodies appear in mothers with O Rh D: negative blood type. The emergence of immune antibodies in the Rh D negative mothers was 1%, the appearance of ABO incompatibilities amounted to 2.3% of our sample. IN ORDER TO REDUCE THE OCCURRENCE OF ALLOIMMUNIZATION OF THE MOTHER TO ERYTHROCYTE ANTIGENS OF THE NEWBORN THAT CAN LEAD TO MAJOR COMPLICATIONS IN SUBSEQUENT PREGNANCIES OF RH D: negative mothers and HDN constant

  14. Kidney (Renal) Failure

    Science.gov (United States)

    ... Physician Resources Professions Site Index A-Z Kidney Failure Kidney failure, also known as renal failure, is ... is kidney failure treated? What is kidney (renal) failure? The kidneys are designed to maintain proper fluid ...

  15. Linfangioleiomiomatosis y trasplante pulmonar

    OpenAIRE

    Ansótegui Barrera, Emilio

    2012-01-01

    La linfangioleiomiomatosis (LAM) es una enfermedad rara que afecta predominantemente a la mujer, sobre todo en edad fértil. Se caracteriza por una proliferación anormal de células musculares lisas inmaduras, células LAM, que crecen de una manera aberrante en la vía aérea, parénquima, linfáticos y vasos sanguíneos pulmonares, lo que determina una evolución progresiva hacia la insuficiencia respiratoria que condiciona el fallecimiento de las pacientes. Tiene carácter multisistémico afectando as...

  16. Autoanticuerpos frente a proteínas de la vía alternativa del complemento en enfermedad renal

    Directory of Open Access Journals (Sweden)

    Pilar Nozal

    2016-09-01

    Full Text Available La activación del sistema del complemento interviene en el desarrollo de varias enfermedades renales, como las glomerulonefritis mediadas por anticuerpos, el daño por isquemia-reperfusión en los trasplantes renales o el rechazo de los injertos. Además, alteraciones en la vía alternativa están directamente implicadas en la patogénesis de las glomerulopatías C3 y del síndrome hemolítico urémico atípico. Estas alteraciones pueden ser congénitas o adquiridas; estas últimas en forma de autoanticuerpos dirigidos contra los diversos componentes y reguladores de la vía alternativa del complemento. Las consecuencias funcionales de algunos de estos anticuerpos y su asociación con estas enfermedades se conocen desde hace tiempo, pero de otros solo existen descripciones de casos aislados. En este artículo, se describen los autoanticuerpos frente a proteínas de la vía alternativa del complemento, sus características y su implicación en la enfermedad renal.

  17. Genetic Distance and Genetic Identity between Hindu and Muslim populations of Barak Valley for ABO and Rh genes

    Directory of Open Access Journals (Sweden)

    Supriyo CHAKRABORTY

    2010-09-01

    Full Text Available A genetic study was carried out in two endogamous populations namely Hindus and Muslims in the Barak Valley Zone of Assam in India. Nei�s genetic distance and genetic identity between two populations were calculated on the basis of estimated allele frequencies of ABO and Rh blood group genes. The genetic distance between Hindus and Muslims was 0.12% for ABO gene and 0.10% for Rh gene. The genetic identity between two populations was estimated as 99.88% for ABO gene and 99.90% for Rh gene suggesting very high genetic similarity between these two populations. Observed heterozygosity estimate was higher in Hindus (0.5598 for ABO gene and 0.2822 for Rh gene than Muslims (0.5346 for ABO gene and 0.2408 for Rh gene indicating lesser inbreeding in Hindus than Muslims. Fixation index was lower in Hindus (16.02% for ABO gene and 43.56% for Rh gene than Muslims (19.80% for ABO gene and 51.84% for Rh gene. Panmictic index was higher in Hindus than Muslims for both the genes. Fixation and panmictic indices revealed that during evolutionary process the Hindus maintained more outbreeding feature than the Muslims in the valley. In this study, the concepts of genetic load of a population and genotype fitness were extended to alleles to estimate the magnitude of allele genetic load (GL and allele fitness for 3 alleles in ABO gene and for 2 alleles in Rh gene in two populations. The genetic load for O, A and B alleles were lower in Hindus than Muslims. Similar results for genetic load were found for the alleles of Rh gene in the comparison of two populations. The fitness estimates of O, A and B alleles for ABO gene and D and d alleles for Rh gene were higher in Hindus than Muslims. A population with low allele genetic load (GL and high allele fitness (AF might have greater survival advantage in nature in the absence of heterozygote advantage and higher adaptive value of the allele with increased frequency.

  18. Inclusión diferencial de extranjeros/migrantes a trasplantes de órganos: dilemas éticos frente a "prácticas no éticas"

    Directory of Open Access Journals (Sweden)

    Lourdes Basualdo

    Full Text Available Resumen Este artículo aborda el modo en que ciertos dilemas éticos vinculados al trasplante de órganos a extranjeros "no residentes", son movilizados por el Estado argentino en las normativas que definen un tratamiento diferenciado entre nacionales y no-nacionales en materia de trasplante, y cómo son puestos en relación con la política migratoria. Se muestra que existen mecanismos de inclusión diferencial que garantizan la inscripción a lista de espera sólo a nacionales y extranjeros "residentes" y permiten el trasplante con donante vivo a extranjeros "no residentes". Estos procesos de apertura y cierre de fronteras son posibles porque en el contexto actual coexisten la preocupación estatal en resguardar los bienes sociales proporcionados por el Estado (una de las funciones constitutivas del control migratorio y la obligación moral de los Estados-nación por el cuidado de la vida en el marco del gobierno humanitario.

  19. Renal inflammatory myofibroblastic tumor

    DEFF Research Database (Denmark)

    Heerwagen, S T; Jensen, C; Bagi, P

    2007-01-01

    Renal inflammatory myofibroblastic tumor (IMT) is a rare soft-tissue tumor of controversial etiology with a potential for local recurrence after incomplete surgical resection. The radiological findings in renal IMT are not well described. We report two cases in adults with a renal mass treated...

  20. Significance of prenatal joint detection of ABO antibody titers and irregular antibodies in pregnant women with type O blood.

    Science.gov (United States)

    Zhu, W Y; Li, H X; Liang, Y

    2014-01-01

    To investigate the effects of blood transfusion and number of pregnancies on ABO antibody titers and irregular antibodies in pregnant women with type O blood. The study included 4,200 pregnant women with type O blood (their husbands were with non-O type blood) that were divided into transfusion group and non-transfusion group, according to whether they had a history of blood transfusion. The both groups were respectively divided into three subgroups (the number of pregnancies was one, two, and > or = three). The ABO antibody titers and irregular antibodies were detected at the same time. The effects ofABO antibody titers and irregular antibodies on hemolytic disease of the newborn (HDN) were discussed. There was no consistency of ABO antibody titers and existence of irregular antibody. The positive rates of irregular antibody of transfusion group and of the subgroup (number of pregnancies > or = three) were far higher than that of non-transfusion group and of the subgroups (number of pregnancies pregnant women with positive irregular antibody in non-transfusion group were with HDN. For pregnant women with number of pregnancies > or = three or with history of blood transfusion, the prenatal joint detection of ABO antibody titers and irregular antibodies is helpful for accurately reflecting the in vivo antibody type and level.

  1. Assessment of ABO blood grouping and secretor status in the saliva of the patients with oral potentially malignant disorders.

    Science.gov (United States)

    Rai, Pragati; Acharya, Swetha; Hallikeri, Kaveri

    2015-01-01

    Secretor status may possibly be one of the factors in the etiopathogenesis of oral precancerous lesions and subsequently cancer. Studies have shown the relationship between the pathogenesis of disease and secretor status. They have made known that secretor status is a possible factor influencing disease status. Studies have revealed the association between blood groups and specific diseases. To assess any association of ABO blood grouping with oral potentially malignant disorders (OPMDs) and to examine whether there is any difference in the saliva secretor status in the patients with OPMDs and healthy controls. The study consisted of 90 subjects, with 45 patients assigned to two groups (a) Patients with potentially malignant disorders and (b) healthy controls. ABO blood grouping was done and 1 ml of unstimulated saliva was collected in a sterile test tube. The Wiener agglutination test was performed to analyze the secretor status in both the groups. Chi-square test and odd ratio were used to assess the relationship between ABO blood group and OPMDs. Chi-square test was performed to assess the relationship between secretor status and OPMDs. Probability level was fixed at ABO blood groups and OPMDs (P > 0.05). The study confirms the inability to secrete blood group antigens in the saliva of patients with OPMDs which could be regarded as a host risk factor. Results could not propose a relationship between ABO blood group and OPMDs.

  2. Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.

    Science.gov (United States)

    Kudek, Matthew R; Shanley, Ryan; Zantek, Nicole D; McKenna, David H; Smith, Angela R; Miller, Weston P

    2016-11-01

    Existing literature shows mixed conclusions regarding the impact of ABO incompatibility on outcomes after hematopoietic stem cell transplantation. Because the future for umbilical cord blood (UCB) expansion technologies is bright, we assessed whether this typically overlooked graft characteristic impacted various outcomes after UCB transplantation (UCBT) for nonmalignant disorders (NMDs). A prospectively maintained institutional blood and marrow transplant program database was queried for all patients undergoing first UCBT for NMDs. UCB and recipient ABO compatibility was considered as matched, major mismatched, minor mismatched, or bidirectional mismatched. The impact of ABO incompatibility was assessed on overall survival, graft failure, acute and chronic graft-versus-host disease (GVHD), time to neutrophil and platelet recovery, day 0 to day 100 RBC transfusion burden, and donor hematopoietic chimerism. Through December 2014, 270 patients have undergone first UCBT for various NMDs. In both univariable and multivariable analyses, ABO compatibility status did not appear to impact any outcomes assessed, although a trend toward increased grades III to IV acute GVHD was seen in recipients of major mismatched units. When considering UCBT for treatment of NMDs, ABO compatibility between the donor unit and intended recipient does not appear to be an important consideration in the UCB unit choice. Copyright © 2016 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

  3. The role of carboxyhemoglobin measured with CO-oximetry in the detection of hemolysis in newborns with ABO alloimmunization.

    Science.gov (United States)

    Lozar-Krivec, Jana; Bratanic, Borut; Paro-Panjan, Darja

    2016-01-01

    To evaluate carboxyhemoglobin (COHb) values measured with a CO-oximeter (Roche-cobas b 221) in jaundiced newborns with or without hemolysis and healthy controls in order to assess whether COHb measurement determined with a CO-oximeter could be used as an indicator of hemolysis in newborns with ABO alloimmunization. A total of 86 term newborn infants were prospectively studied. The study cohort consisted of three subgroups: 18 infants with ABO HDN, 21 infants with hyperbilirubinemia without hemolytic disease who required phototherapy, and 47 healthy controls. The COHb, bilirubin, and Hb levels were measured. The three subgroups did not differ significantly with respect to birth weight, gestational age, gender, Apgar score, or mode of delivery. The ABO HDN infants had significantly higher COHb values than the healthy controls (median 2.4% versus 1.3%, p disease (median 2.4% versus 1.3%, p disease did not have significantly higher COHb values compared with the healthy controls. The cut-off value of 1.7% COHb had 72% sensitivity and 97% specificity for confirming hemolysis in ABO alloimmunization. Our data show that COHb values determined with CO-oximeters are higher in newborns with hemolysis than in those without hemolysis. COHb measured with CO-oximeters could be used to confirm hemolysis in infants with ABO alloimmunization.

  4. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population

    NARCIS (Netherlands)

    Duell, E.J.; Bonet, C.; Munoz, X.; Lujan-Barroso, L.; Weiderpass, E.; Boutron-Ruault, M.C.; Racine, A.; Severi, G.; Canzian, F.; Rizzato, C.; Boeing, H.; Overvad, K.; Tjonneland, A.; Arguelles, M.; Sanchez-Cantalejo, E.; Chamosa, S.; Huerta, J.M.; Barricarte, A.; Khaw, K.T.; Wareham, N.; Travis, R.C.; Trichopoulou, A.; Trichopoulos, D.; Yiannakouris, N.; Palli, D.; Agnoli, C.; Tumino, R.; Naccarati, A.; Panico, S.; Bueno-de-Mesquita, H.B.; Siersema, P.D.; Peeters, P.H.M.; Ohlsson, B.; Lindkvist, B.; Johansson, I.; Ye, W.; Johansson, M.; Fenger, C.; Riboli, E.; Sala, N.; Gonzalez, C.A.

    2015-01-01

    ABO blood serotype A is known to be associated with risk of gastric cancer (GC), but little is known how ABO alleles and the fucosyltransferase (FUT) enzymes and genes which are involved in Lewis antigen formation [and in Helicobacter pylori (H. pylori) binding and pathogenicity] may be related to

  5. A transição no transplante hepático: um estudo de caso La transición en el trasplante: un estudio de caso The transition in liver trasplantation: a case study

    Directory of Open Access Journals (Sweden)

    Liliana Andreia Neves da Mota

    2011-12-01

    Full Text Available Contexto: as transições de saúde/doença são uma dimensão importante da prática de enfermagem. É com a ajuda à pessoa na vivência de transições saudáveis que os enfermeiros podem ser verdadeiramente significativos. O doente transplantado hepático vive, durante o período pós-transplante, uma enorme necessidade de adaptação à nova condição. Objetivos:operacionalizar a teoria de Médio alcance de Meleis à vivência de uma transição saúde/doença de um doente numa situação de transplante hepático, em contexto de hepatite fulminante. Metodologia: estudo de caso operacionalizando a teoria de Médio alcance de Meleis a uma situação concreta. Neste sentido, foi efetuada uma análise aos registos eletrónicos de enfermagem, assim como uma entrevista semiestruturada ao doente selecionado por conveniência para o estudo de caso. Discussão: a teoria de médio alcance de Meleis é uma teoria exequível na área da transplantação hepática. Com base nesta teoria é possível implementar um processo de Enfermagem individualizado, uma vez que é possível precaver o sentido da transição do doente. Conclusão: é fundamental que os enfermeiros alicercem a sua prática na evidência, para que tenham práticas mais sustentadas.Contexto: las transiciones entre la salud y la enfermedad son una importante dimensión de la práctica de Enfermería. Es con la ayuda a la persona en la vivencia de transiciones saludables que los enfermeros pueden ser verdaderamente significativos. El paciente trasplantado hepático vive durante el postrasplante una enorme necesidad de adaptación a la nueva condición. Objetivos: aplicar la teoría de Medio alcance de Meleis a la vivencia de una transición salud/enfermedad de un paciente en una situación de trasplante hepático, en contexto de hepatitis fulminante. Metodología: se realizó un estudio de caso aplicando la teoría de Medio alcance de Meleis a una situación concreta. En este sentido, se

  6. Renal insufficiency and failure.

    Science.gov (United States)

    Dimopoulos, Meletios A; Terpos, Evangelos

    2010-01-01

    Renal impairment is a common complication of multiple myeloma. Chronic renal failure is classified according to glomerular filtration rate as estimated by the MDRD (modification of diet in renal disease) formula, while RIFLE (risk, injury, failure, loss and end-stage renal disease) and AKIN (acute renal injury network) criteria may be used for the definition of the severity of acute renal injury. Novel criteria based on estimated glomerular filtration rate measurements are proposed for the definition of the reversibility of renal impairment. Renal complete response (CRrenal) is defined as sustained (i.e., lasting at least 2 months) improvement of creatinine clearance (CRCL) from under 50 mL/min at baseline to 60 mL/min or above. Renal partial response (PRrenal) is defined as sustained improvement of CRCL from under 15 mL/min at baseline to 30 to 59 mL/min. Renal minor response (MRrenal) is defined as sustained improvement of the baseline CRCL of under 15 mL/min to 15 to 29 mL/min or, if baseline CRCL was 15 to 29 mL/min, improvement to 30 to 59 mL/min. Bortezomib with high-dose dexamethasone is considered the treatment of choice for myeloma patients with renal impairment and improves renal function in most patients. Although there is limited experience with thalidomide, this agent can be administered at the standard dosage to patients with renal failure. Lenalidomide, when administered at reduced doses according to renal function, is effective and can reverse renal impairment in a subset of myeloma patients.

  7. Cooperación jurídica internacional en materia de donación y trasplante de organos: hacia un nuevo paradigma

    Directory of Open Access Journals (Sweden)

    Joaquín Cayón de las CUEVAS

    2013-04-01

    Full Text Available RESUMEN El trasplante de órganos puede contribuir decisivamente no sólo a salvar vidas sino también a mejorar la calidad de las mismas. Sin embargo, el problema fundamental al que se enfrenta este tipo de terapias es la desproporción entre la oferta y la demanda. El número de donantes es, por definición, muy limitado y la donación puede no resultar posible por motivos diversos tales como la falta de autorización familiar o la ausencia de condiciones necesarias. Así las cosas, la dificultad en el acceso a las terapias de trasplante constituye el reflejo de una de las desigualdades en salud. Por otra parte, la escasez de órganos hace pervivir el indeseable fenómeno de la comercialización internacional. Resulta evidente que el problema de la insuficiencia de donantes afecta a toda la comunidad trasplantadora internacional dado que las necesidades de trasplantes son equivalentes en las diferentes regiones del mundo. En este sentido, el futuro pasa por propiciar una progresiva integración de las políticas públicas en materia de donación y trasplantes de órganos, superando el actual estadio de cooperación intergubernamental, loable pero insuficiente, para adentrarnos gradualmente en un nuevo paradigma de coordinación internacional de ámbito regional, condicionado a la previa armonización de la legislación de las naciones afectadas, que permita cifras homologables de donantes. Este nuevo paradigma de coordinación debe instrumentar mecanismos de prevención del fenómeno del turismo de trasplantes pero también facilitar y potenciar el intercambio internacional de órganos, removiendo desigualdades en el acceso al tratamiento trasplantador. RESUMO O transplante de órgãos pode ser valiosa não só para salvar vidas, mas também para melhorar a qualidade dos pacientes. No entanto, o problema fundamental dessas terapias é o desequilíbrio entre oferta e demanda. O número de doadores é muito limitado e a doação pode não ser

  8. Crecimiento de Morus alba L. durante la etapa de establecimiento, a partir del trasplante de posturas Growth of Morus alba L. during the establishment stage, since seedling transplant

    Directory of Open Access Journals (Sweden)

    Gertrudis Pentón

    2012-06-01

    Full Text Available El objetivo de este estudio fue evaluar el comportamiento morfoagronómico de la especie Morus alba L. var.Tigreada durante la primera etapa de establecimiento, a partir del trasplante de posturas. Para ello, se determinó la respuesta del cultivo al manejo de estas para el trasplante, se caracterizó el crecimiento y se determinaron las variables lineales que permiten cuantificar el área foliar de dicha variedad. Las posturas se mantuvieron en el vivero durante 120 días y se trasplantaron en el período lluvioso. Los surcos se orientaron de este a oeste, con un marco de siembra de 1,0 x 0,5 m. Se mantuvo un adecuado control de las malezas, las plagas y las enfermedades. No se regó y se aplicó materia orgánica en el momento del trasplante. Se establecieron dos formas de manejo de las posturas para el trasplante: deshoje total, y corte a la altura de 50 cm y deshoje total. Durante la etapa inicial de crecimiento posterior al trasplante, se obtuvo un ligero aumento en la capacidad de rebrote de las posturas cortadas y deshojadas. Ello no afectó el establecimiento de la especie, pues a los 135 días la producción de biomasa foliar varió entre 100 y 116 g/planta. El crecimiento en los primeros 155 días describió una curva sigmoidea, caracterizada por un ritmo lento durante los primeros 21 días; a ello le siguió un crecimiento intenso entre los 30 y 135 días, el cual se tornó nuevamente lento con el inicio de la época seca o invernal. Se demostró que la medición del largo de la hoja y su ajuste a través de los modelos no lineales Y = B0+B1X+B2X2 y Y = B0+B1X+B2X2+B3X3 permiten estimar el área foliar, y ello se cumple para la condición de que el largo del óvalo foliar mida entre 1,3 y 20,4 cm. La alta correlación encontrada hace apropiado este procedimiento de estimación.The objective of this study was to evaluate the morphoagronomic performance of the specie Morus alba L. var. Tigreada during the first establishment stage

  9. Citoquinas reguladoras de la respuesta al transplante renal alogénico Regulatory cytokines in the response to the allogeneic renal transplant

    Directory of Open Access Journals (Sweden)

    Rita L. Cardoni

    2005-03-01

    Full Text Available La aceptación o el rechazo del riñón alogénico dependen principalmente de la respuesta inmune y de su compleja regulación en la cual la red de citoquinas y otros mediadores juegan un importante papel. Actualmente, la biopsia renal es, a pesar de lo invasor del procedimiento, la herramienta de mayor utilidad para el control del rechazo al trasplante y el diagnóstico de las nefropatías asociadas. Por ello, es de gran interés encontrar métodos alternativos para el diagnóstico. La evaluación de citoquinas reguladoras de la respuesta inmune es un procedimiento sencillo y de bajo costo que podría ser de utilidad para incrementar la sensibilidad de la detección de diferencias polimórficas, para pronosticar la aceptación del trasplante y para la detección precoz del rechazo. Los estudios recientes sugieren que la producción exagerada de mediadores pro-inflamatorios, incluyendo a citoquinas Th1, sería desventajosa para la sobrevida del trasplante, mientras que la producción de citoquinas reguladoras anti-inflamatorias, como la interleuquina (IL-10 y el factor de crecimiento tumoral (TGF-b, sería beneficiosa. En las primeras etapas, la respuesta Th1 puede incrementar la actividad citotóxica y la detección de moléculas citotóxicas está asociada al rechazo agudo. Luego podría ser más importante considerar el balance entre la producción de mediadores pro- y anti-inflamatorios y la regulación de sus niveles. Así, el TGF-b es también fibrogénico y su excesiva producción local puede contribuir al daño renal. Por otro lado, el incremento de la producción de IL-10 en respuesta al estímulo alogénico sería, en la mayoría de los casos, un marcador importante para pronosticar la aceptación prolongada.The outcome of the kidney allograft mainly depends on the immune response and on its complex regulation, where the cytokine network and other mediators play an important role. At present, kidney biopsy is the most useful tool for

  10. [Hypertension and renal disease

    DEFF Research Database (Denmark)

    Kamper, A.L.; Pedersen, E.B.; Strandgaard, S.

    2009-01-01

    hypertension. Mild degrees of chronic kidney disease (CKD) can be detected in around 10% of the population, and detection is important as CKD is an important risk factor for atherosclerotic cardiovascular disease. Conversely, heart failure may cause an impairment of renal function. In chronic progressive......Renal mechanisms, in particular the renin-angiotensin system and renal salt handling, are of major importance in blood pressure regulation. Co-existence of hypertension and decreased renal function may be due to nephrosclerosis secondary to hypertension, or primary renal disease with secondary...

  11. Insuficiencia renal aguda

    Directory of Open Access Journals (Sweden)

    Juan Manuel Miyahira Arakaki

    2003-01-01

    Full Text Available Acute renal failure (ARF is a clinic syndrome characterized by decline in renal function occurring over a short time period. Is a relatively common complication in hospitalized critically ill patients and is associated with high morbidity and mortality. ARF has often a multi-factorial etiology syndrome usually approached diagnostically as pre-renal, post-renal, or intrinsic ARF. Most intrinsic ARF is caused by ischemia or nephrotoxins and is classically associated with acute tubular necrosis (ATN. High mortality is associated with severity of ARF, age more than 60 years old and presence of pulmonar and cardiovascular complications. Most patients who survive an episode of ARF recover sufficient renal function; however, 50% have subclinical functional defects in renal function or scarring on renal biopsy. ARF is irreversible in approximately 5% of patients, usually as a consequence of complete cortical necrosis. ( Rev Med Hered 2003; 14: 36-43.

  12. The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 Transplants

    Directory of Open Access Journals (Sweden)

    Laura Pankhurst, MSc

    2017-07-01

    Conclusions. Results of AIT were acceptable, certainly in the context of a choice between living donor AIT and an antibody compatible deceased donor transplant. Several factors were associated with increased chance of transplant loss, and these can lead to testable hypotheses for further improving therapy.

  13. Liver transplantation in patients with hepatocellular carcinoma: factors implicated in tumor relapse Trasplante hepático en pacientes con hepatocarcinoma: factores implicados en la recidiva tumoral

    Directory of Open Access Journals (Sweden)

    D. Martínez Ares

    2004-01-01

    Full Text Available Introduction: liver segmental resection and liver transplantation are both treatments intended for healing liver cancer. An adequate selection of patients eligible for transplantation is crucial, since organs available for transplants are usually scarce. For this reason, awareness of the prognostic factors of relapse is of great importance. We present a comprehensive review of our series in order to better understand these prognostic factors. Material and methods: we revised the cases of patients with hepatocellular carcinoma who underwent liver transplantation during the period 1994-2000, and present a detailed analysis of a series of variables which may be probably implicated in the appear-ance of relapse and which have an effect on survival. Results: after a mean follow-up of 33 months, the mortality rate was 27.5% and relapse occurred in 18.75% of cases. No history of alcohol abuse, the number and size of the nodules, the presence of macro and microscopic vascular invasion, and pTNM stage T4 were all factors associated with a significantly increased risk of relapse (pIntroducción: tanto la resección hepática segmentaria como el trasplante hepático son tratamientos con intención curativa para el hepatocarcinoma. La adecuada selección de los pacientes para el trasplante es de vital importancia dada la escasa disponibilidad de órganos. Por ello resulta fundamental el conocer los factores predictivos de recidiva tumoral, motivo por el que hacemos una exhaustiva revisión de nuestra serie. Material y métodos: revisamos los pacientes con hepatocarcinoma trasplantados en el periodo 1994-2000, y analizamos detalladamente una serie de variables con probable implicación en la recidiva tumoral y repercusión sobre la supervivencia. Resultados: tras un seguimiento medio de 33 meses, la mortalidad fue del 27,5% y la tasa de recidiva del 18,75%. La ausencia de alcoholismo, el número y el tamaño de nódulos, la invasión vascular macro y microsc

  14. Allelic variance among ABO blood group genotypes in a population from the western region of Saudi Arabia.

    Science.gov (United States)

    Mohamed, Abdularahman B O; Hindawi, Salwa Ibrahim; Al-Harthi, Sameer; Alam, Qamre; Alam, Mohammad Zubair; Haque, Absarul; Ahmad, Waseem; Damanhouri, Ghazi A

    2016-12-01

    Characterization of the ABO blood group at the phenotype and genotype levels is clinically essential for transfusion, forensics, and population studies. This study elucidated ABO phenotypes and genotypes, and performed an evaluation of their distribution in individuals from the western region of Saudi Arabia. One-hundred and seven samples underwent standard serological techniques for ABO blood group phenotype analysis. ABO alleles and genotypes were identified using multiplex polymerase chain reaction, and electrophoretic analysis was performed to evaluate the highly polymorphic ABO locus. A phenotype distribution of 37.4%, 30.8%, 24.3%, and 7.5% was found for blood groups O, A, B, and AB respectively in our study cohort. Genotype analysis identified 10 genotype combinations with the O01/O02 and A102/O02 genotypes being the most frequent with frequencies of 33.6% and 14.95%, respectively. Common genotypes such as A101/A101 , A101/A102 , A101/B101 , B101/B101 , and O01/O01 were not detected. Similarly, the rare genotypes, cis-AB01/O02 , cis-AB01/O01 , and cis-AB01/A102 were not found in our cohort. The most frequently observed allele was O02 (35.98%) followed by the A102 allele (17.76%). Furthermore, our findings are discussed in reference to ABO allele and genotype frequencies found in other ethnic groups. The study has a significant implication on the management of blood bank and transfusion services in Saudi Arabian patients.

  15. ABO blood type/Rh factor and the incidence and outcomes for patients with triple-negative breast cancer.

    Science.gov (United States)

    Yu, Jennifer; Gao, Feng; Klimberg, V Suzanne; Margenthaler, Julie A

    2012-10-01

    Triple-negative breast cancer (TNBC) has a poorer prognosis; the factors that contribute to this remain unclear. We hypothesized that TNBC is associated with ABO blood type/Rh factors that account for differences in survival. We identified 468 patients with stage I-III TNBC [estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2 nonamplified]. Patient/tumor characteristics, treatments, and outcomes were obtained. Data were examined for associations with specific ABO blood type/Rh factors. Descriptive statistics and χ (2) analysis were utilized for data summary and comparisons. Of 468 TNBC patients, 283 had known ABO blood type [122 (43 %) O, 108 (38 %) A, 39 (14 %) B, and 14 (5 %) AB] and Rh factor [253 (89 %) positive and 30 (11 %) negative]. Mean patient age was 53.7 ± 12.5 years, and median follow-up was 30.2 ± 20.5 months. The incidence of each ABO blood type/Rh factor in our TNBC cohort was not different from the general population or a cohort of ER-positive breast cancers (P > 0.05). Compared with patients with blood type O, there was no difference in breast cancer-specific mortality for type A [hazard ratio (HR) 0.906; 95 % confidence interval (CI) 0.554-1.481], type B (HR 1.534; 95 % CI 0.792-2.972), or type AB (HR 0.488; 95 % CI 0.113-2.106). Compared with women with negative Rh, there was no difference in breast cancer-specific mortality for women with positive Rh (HR 1.161; 95 % CI 0.568-2.374). TNBC was not associated with a specific ABO blood type or Rh factor. Our results failed to demonstrate an association between ABO blood type/Rh factor and breast cancer mortality in patients with TNBC.

  16. Evolucion de niños post-trasplante hepático luego del primer año de sobrevida Evolution of children one year post liver transplant

    Directory of Open Access Journals (Sweden)

    Miriam Cuarterolo

    2005-10-01

    Full Text Available El trasplante hepático constituye la única alternativa terapéutica para numerosas enfermedades hepáticas avanzadas. En el seguimiento post-trasplante pueden observarse complicaciones de diversa gravedad. El objetivo de este estudio fue analizar la evolución a largo plazo de los pacientes trasplantados con un seguimiento mayor de un año post quirúrgico. En el período 11/92-11/01 se realizaron 264 trasplantes en 238 pacientes; incluyéndose en este trabajo 143 niños con más de un año post-trasplante. La mediana de edad ± DS fue de 5.41 ± 5.26 años (r: 0.58-21.7 años. Catorce (9.79% fueron retrasplantados. Todos los pacientes recibieron ciclosporina (inmunosupresión primaria. Las indicaciones de trasplante fueron: falla hepática fulminante (n: 50; atresia de vías biliares (n: 38; cirrosis (n: 37; colestasis crónica (n: 13 y otras (n: 5. Las indicaciones de retrasplante fueron: cirrosis biliar (n: 7; trombosis de la arteria hepática (n: 4 y rechazo crónico (n: 3. Fueron utilizados injertos reducidos en 73/157 trasplantes(14 donantes vivos relacionados y 11 biparticiones hepáticas. La sobrevida global fue de 93%, paciente y 86%, injerto. El retrasplante y el injerto reducido fueron las variables de mayor significación para el aumento del riesgo de muerte. El déficit de talla y masa ósea se recuperó antes de los 3años post-trasplante. La incidencia de síndrome linfoproliferativo fue del 7.69%. Se diagnosticó hepatitis B de novo en 7 pacientes (4.8%. El riesgo social no afectó la sobrevida. La prevención, detección y tratamiento precoz de las complicaciones en el seguimiento a largo plazo permitió mejorar la evolución de los pacientes.Orthotopic liver transplantation is the only definitive mode of therapy for children with end-stage liver disease. However, it remains challenging because of the necessity to prevent long-term complications. The aim of this study was to analyze the evolution of transplanted patients with

  17. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma--genotypic and phenotypic characterization

    DEFF Research Database (Denmark)

    Gao, Shan; Bennett, Erik Paul; Reibel, Jesper

    2004-01-01

    Loss of histo-blood group A/B antigens is frequent in oral cancer. It is unclear whether this alteration is due to loss of the chromosomal region encoding the genes. The aim was to investigate genotypic alterations in the ABO locus in oral potentially malignant lesions and carcinomas. Seventy...... to establish the ABO genotype. Total and patchy loss of A/B antigen expression was found in 24/32 carcinomas, 6/7 leukoplakias with severe dysplasia, 12/17 leukoplakias with mild and moderate dysplasia, and 6/17 leukoplakias without dysplasia. Specific A/B allele loss was found in 8/24 cases with carcinoma...

  18. [Analysis of the curative effect of ABO-incompatible liver transplantation in the treatment in patients with acute severe liver disease].

    Science.gov (United States)

    Shen, Zhongyang; Deng, Yonglin; Zheng, Hong; Pan, Cheng; Zhang, Yamin; Jiang, Wentao; Zhang, Jianjun; Gao, Wei; Huai, Mingsheng; Shi, Rui

    2014-08-01

    To analyze and evaluate the clinical effect of ABO-incompatible liver transplantation in the treatment of acute severe liver disease. A retrospective clinical study was conducted. The clinical data of 4 136 patients undergoing orthotopic liver transplantation in Organ Transplantation Center of Tianjin First Center Hospital from September 1999 to December 2013 were analyzed. The criteria of patients enrolled were as following: model for end-stage liver disease (MELD) score ≥ 20, the donor's and recipient's blood types were different, age 18-70 years, and undergone primary non-bypass orthotopic liver transplantation. According to the rate of compliance with the principles of blood transfusion, the cases were divided into two groups: ABO-compatible group (ABO-C group, n=41), ABO-incompatible group (ABO-I group, n=22). The patients in ABO-I group received basiliximab + methylprednisolone for immune induction therapy during operation, basiliximab + tacrolimus + mycophenolate + cortisol as quadruple immunosuppressive regimen after operation. They also received subcutaneous injection of low molecular heparin for anticoagulant therapy after operation, and oral warfarin or aspirin and clopidogrel bisulfate instead after 7 days. They also received routine alprostadil after operation. The remaining treatment was the same as that of ABO-C group. The clinical data, postoperative complications, rejection and survival rates of two groups were statistically analyzed. There were no significant differences in gender, age, MELD score, complicated with tumor, quality of donor liver, length of cold preservation of donor liver, duration of operation, and blood loss during operation between ABO-C and ABO-I groups. Number of splenectomy during operation was significantly higher in ABO-I group than that in ABO-C group (5 cases vs. 1 case, χ² = 4.687, P=0.030). The 3-month, 6-month, 1-year, 3-year and 5-year survival rates of ABO-C group were 89.5%, 78.3%, 72.5%, 69.1% and 61

  19. Association between Cheiloscopic Patterns and ABO Blood Groups among South Indian Population.

    Science.gov (United States)

    Khanapure, Sneha; Suhas, H G; Potdar, Shrudha; Sam, George; Sudeep, C B; Arjun, M R

    2017-07-01

    Human beings have few characteristics that are unique from others. Lip prints are one of such feature. They are not changed throughout the life and are not influenced by injuries, diseases, or environmental changes. According to the various antigen-antibody reactions in the bloodstream, different individuals have specific blood groups. To study the distribution of lip print patterns among individuals with different ABO and Rh blood groups and also to know the relation between their characters and blood groups. In the present study, lip prints were collected randomly from 85 individuals, and their blood group matching was performed. This is to identify the most common lip print type and to know any association between lip print types and blood groups. Tsuchihashi's classification of lip prints was used to compare with the ABO and Rh blood grouping systems. It was observed that in individuals with B+, A+, and O- blood groups, predominant pattern was Type IV and individuals having blood group O+ and AB+ common lip print pattern was Type II. This study showed strong association between lip print patterns and ABO blood groups as some blood groups were not included in statistical analysis; further studies including larger sample are essential to substantiate the results. Correlating lip print with blood group helps in identification of the suspects. Along with lip prints, another biological record that remains unchanged throughout the lifetime of a person is the blood group. Determining the blood group of a person from the samples obtained at the site of crime and also recovering lip prints from site can help identify a person.

  20. ABO Blood Group and Dementia Risk--A Scandinavian Record-Linkage Study.

    Directory of Open Access Journals (Sweden)

    Senthil K Vasan

    Full Text Available Dementia includes a group of neuro-degenerative disorders characterized by varying degrees of cognitive impairment. Recent data indicates that blood group AB is associated with impaired cognition in elderly patients. To date there are no large-scale studies that have examined the relationship between ABO blood group and dementia-related disorders in detail.We used data from the SCANDAT2 database that contains information on over 1.6 million blood donors from 1968 in Sweden and 1981 from Denmark. The database was linked with health outcomes data from nationwide patient and cause of death registers to investigate the relationship between blood groups and risk of different types of dementia. The incident rate ratios were estimated using log-linear Poisson regression models.Among 1,598,294 donors followed over 24 million person-years of observation we ascertained 3,615 cases of Alzheimer's disease, 1,842 cases of vascular dementia, and 9,091 cases of unspecified dementia. Overall, our study showed no association between ABO blood group and risk of Alzheimer's disease, vascular dementia or unspecified dementia. This was also true when analyses were restricted to donors aged 70 years or older except for a slight, but significantly decreased risk of all dementia combined in subjects with blood group A (IRR, 0.93; 95% confidence interval [CI], 0.88-0.98, compared to those with blood group O.Our results provide no evidence that ABO blood group influences the risk of dementia.

  1. Fingerprints as an Alternative Method to Determine ABO and Rh Blood Groups.

    Science.gov (United States)

    Chaudhary, Sonam; Deuja, Sajana; Alam, Munna; Karmacharya, Poonam; Mondal, Monami

    2017-01-01

    Blood grouping is conventionally done with invasive method by taking blood samples. The objective of this study is to determine blood group with uninvasive procedure by taking fingerprints of the participants and know the associations between their fingerprints and blood groups. Seven hundred participants of both genders with no any age limitation from Manipal Teaching Hospital and Manipal College of Medical Sciences were randomly selected. The blood grouping was done by cross reacting blood sample with the antibodies. The fingerprints were taken with the help of stamp pad imprinting the finger ridges over A4 size white papers. The loop, whorl and arch patterns were studied. O+ve blood group 224 (32%) was most prevalent among 700 participants. The loop pattern was highly distributed 3708 (53%) in all blood groups except in A-ve blood group with highest distribution of whorl 20 (40%). The mean comparisons of specific fingerprint in total and also in individual fingers with different ABO and ABO-Rh blood groups showed no any statistical association with P>0.05. However, the loop distribution in individual finger was highest in right middle finger (M) of B-ve blood group 5 (10%). The whorl distribution in individual finger was highest in right index (I), left thumb (T) and left ring (R) fingers of AB+ve blood group 20 (5.5% each). Similarly, the arch distribution was highest in right index fingers of A-ve blood group 3 (6%). The mean comparison of different fingerprints with ABO and Rh blood groups showed no significant statistical association concluding fingerprints cannot be used for blood grouping.

  2. ABO Blood Group and Dementia Risk – A Scandinavian Record-Linkage Study

    Science.gov (United States)

    Vasan, Senthil K; Rostgaard, Klaus; Ullum, Henrik; Melbye, Mads; Hjalgrim, Henrik; Edgren, Gustaf

    2015-01-01

    Background Dementia includes a group of neuro-degenerative disorders characterized by varying degrees of cognitive impairment. Recent data indicates that blood group AB is associated with impaired cognition in elderly patients. To date there are no large-scale studies that have examined the relationship between ABO blood group and dementia-related disorders in detail. Methods We used data from the SCANDAT2 database that contains information on over 1.6 million blood donors from 1968 in Sweden and 1981 from Denmark. The database was linked with health outcomes data from nationwide patient and cause of death registers to investigate the relationship between blood groups and risk of different types of dementia. The incident rate ratios were estimated using log-linear Poisson regression models. Results Among 1,598,294 donors followed over 24 million person-years of observation we ascertained 3,615 cases of Alzheimer’s disease, 1,842 cases of vascular dementia, and 9,091 cases of unspecified dementia. Overall, our study showed no association between ABO blood group and risk of Alzheimer’s disease, vascular dementia or unspecified dementia. This was also true when analyses were restricted to donors aged 70 years or older except for a slight, but significantly decreased risk of all dementia combined in subjects with blood group A (IRR, 0.93; 95% confidence interval [CI], 0.88-0.98), compared to those with blood group O. Conclusions Our results provide no evidence that ABO blood group influences the risk of dementia. PMID:26042891

  3. Structural Basis for the ABO Blood-Group Dependence of Plasmodium falciparum Rosetting

    Science.gov (United States)

    Hessel, Audrey; Raynal, Bertrand; England, Patrick; Cohen, Jacques H.; Bertrand, Olivier; Peyrard, Thierry; Bentley, Graham A.; Lewit-Bentley, Anita; Mercereau-Puijalon, Odile

    2012-01-01

    The ABO blood group influences susceptibility to severe Plasmodium falciparum malaria. Recent evidence indicates that the protective effect of group O operates by virtue of reduced rosetting of infected red blood cells (iRBCs) with uninfected RBCs. Rosetting is mediated by a subgroup of PfEMP1 adhesins, with RBC binding being assigned to the N-terminal DBL1α1 domain. Here, we identify the ABO blood group as the main receptor for VarO rosetting, with a marked preference for group A over group B, which in turn is preferred to group O RBCs. We show that recombinant NTS-DBL1α1 and NTS-DBL1α1-CIDR1γ reproduce the VarO-iRBC blood group preference and document direct binding to blood group trisaccharides by surface plasmon resonance. More detailed RBC subgroup analysis showed preferred binding to group A1, weaker binding to groups A2 and B, and least binding to groups Ax and O. The 2.8 Å resolution crystal structure of the PfEMP1-VarO Head region, NTS-DBL1α1-CIDR1γ, reveals extensive contacts between the DBL1α1 and CIDR1γ and shows that the NTS-DBL1α1 hinge region is essential for RBC binding. Computer docking of the blood group trisaccharides and subsequent site-directed mutagenesis localized the RBC-binding site to the face opposite to the heparin-binding site of NTS-DBLα1. RBC binding involves residues that are conserved between rosette-forming PfEMP1 adhesins, opening novel opportunities for intervention against severe malaria. By deciphering the structural basis of blood group preferences in rosetting, we provide a link between ABO blood grouppolymorphisms and rosette-forming adhesins, consistent with the selective role of falciparum malaria on human genetic makeup. PMID:22807674

  4. ABO and Rh (D group distribution and gene frequency; the first multicentric study in India

    Directory of Open Access Journals (Sweden)

    Amit Agrawal

    2014-01-01

    Full Text Available Background and Objectives: The study was undertaken with the objective to provide data on the ABO and Rh(D blood group distribution and gene frequency across India. Materials and Methods: A total of 10,000 healthy blood donors donating in blood banks situated in five different geographical regions of the country (North, South, East and Center were included in the study. ABO and Rh (D grouping was performed on all these samples. Data on the frequency of ABO and Rh(D blood groups was reported in simple numbers and percentages. Results: The study showed that O was the most common blood group (37.12% in the country closely followed by B at 32.26%, followed by A at 22.88% while AB was the least prevalent group at 7.74%. 94.61% of the donor population was Rh positive and the rest were Rh negative. Regional variations were observed in the distribution. Using the maximum likelihood method, the frequencies of the I A , I B and I O alleles were calculated and tested according to the Hardy Weinberg law of Equilibrium. The calculated gene frequencies are 0.1653 for I A (p, 0.2254 for I B (q and 0.6093 for I O (r. In Indian Population, O (r records the highest value followed by B (q and A (p; O > B > A. Conclusion: The study provides information about the relative distribution of various alleles in the Indian population both on a pan-India basis as well as region-wise. This vital information may be helpful in planning for future health challenges, particularly planning with regards to blood transfusion services.

  5. Effect of ABO blood type on ovarian reserve in Chinese women.

    Science.gov (United States)

    Lin, Shengli; Li, Rong; Chi, Hongbin; Huang, Shuo; Zhang, Hua; Zheng, Xiaoying; Liu, Ping; Qiao, Jie

    2014-12-01

    To explore the effect of ABO blood type on ovarian reserve in Chinese women. Retrospective analysis. University-affiliated IVF center. The retrospective analysis involved 35,479 women who underwent in vitro fertilization and embryo transfer (IVF-ET) cycles between 2006 and 2012. None. The association between ABO blood types and diminished ovarian reserve (DOR). Among 35,479 Chinese women, 11,395 (32.12%) had blood type B, 10,583 (29.83%) had blood type O, 9,861 (27.79%) had blood type A, and 3,640 (10.26%) had blood type AB. There was a statistically significantly higher percentage of blood type O among those with follicle-stimulating hormone (FSH) levels ≤10 IU/L compared with those with FSH levels >10 IU/L. Conversely, among the women with DOR, there was statistically significantly higher percentage of those with blood types B and AB. Blood type A was not associated with DOR occurrence. Multivariate logistic regression analysis showed that blood type O was statistically significantly less often associated with DOR occurrence, whereas the B antigen (blood type B or AB) was statistically significantly associated with an increased risk of DOR. Our results have shown that there is an association between ABO blood type and DOR occurrence in Chinese women. Women with blood type O were statistically significantly less likely to have DOR, whereas those with B antigen (blood type B or AB) were statistically significantly more likely to have DOR. Blood type A was not associated with ovarian reserve. Copyright © 2014. Published by Elsevier Inc.

  6. Characterizing vertical heterogeneity of permafrost soils in support of ABoVE radar retrievals

    Science.gov (United States)

    Tabatabaeenejad, A.; Chen, R. H.; Silva, A.; Schaefer, K. M.; Moghaddam, M.

    2017-12-01

    Permafrost-affected soils, including the top active layer and underlying permafrost, have unique seasonal variations in terms of soil temperature, soil moisture, and freeze/thaw-state profiles. The presence of a perennially frozen and impermeable substrate maintains the required temperature gradient for the descending thawing front, and causes meltwater to accumulate and form the saturated zone in the active layer. Radar backscattering measurements are sensitive to dielectric properties of subsurface soils, which are strongly correlated with unfrozen water content and soil texture/composition. To enable accurate radar retrievals, we need to properly characterize soil profile heterogeneity, which can be modeled with layered soil or depth-dependent functions. To this end, we first cross compare the measured radar backscatter and model-predicted radar backscatter using in-situ dielectric profile measurements as well as mathematical or hydrologic-based profile functions. Since radar signal's backscatter has limited penetration, to fully capture the true heterogeneity profile, we determine the optimal profile function by minimizing the error between predicted and measured radar backscatter signals as well as between in-situ and fitted profiles. The in-situ soil profile data (temperature, dielectric constant, unfrozen water content, organic/mineral soils) are collected from the Soil Moisture Sensing Controller And oPtimal Estimator (SoilSCAPE) sensor networks and from the Arctic-Boreal Vulnerability Experiment (ABoVE) field campaign in August 2017 (concurrent with the ABoVE August flights over Alaska North Slope) while the radar data are acquired by NASA's P-band AirMOSS and L-band UAVSAR as part of the ABoVE airborne campaign. The retrieval results using our new heterogeneity model will be compared with the results from retrievals that model soil as a layered medium. This analysis can advance the accuracy of retrieval of active layer properties using low-frequency SAR

  7. A CORRELATION BETWEEN ABO BLOOD GROUPS AND BODY MASS INDEX AMONG MEDICAL STUDENTS

    Directory of Open Access Journals (Sweden)

    Sarbjit Singh

    2017-11-01

    Full Text Available BACKGROUND ABO blood groups are associated with some important chronic diseases, obesity being the major risk factor is rising rapidly globally. The present study seeks to determine if there is any association between ABO blood groups and body mass index. MATERIALS AND METHODS The present study involve 200 medical students, 102 boys and 98 girls in the age group of 18-23 years in the Government Medical College, Amritsar. Weight, height for BMI and blood groups were determined in order to find any association between ABO blood group and BMI. RESULTS Overweight and obesity was found more prevalent in boys than girls, 22.5% students were overweight and 15.5% were obese. The prevalence of overweight was (24.52% boys and 20.40% girls and prevalence of obesity was (25.49% boys and 5.10% girls. Blood group B was reported the most common blood groups (37.5% followed by blood group O (32.0%, while blood groups A and AB were found 19.5% and 11% of participants, respectively. The prevalence of overweight (BMI 25-29.9 among participants based on blood group O, A, AB and B was 29.69%, 25.64%, 18.18%, 16.00%, while obesity (BMI >30 among participants based on blood groups B, O, A and AB was 24.00%, 10.94%, 10.26% and 9.09%. CONCLUSION Prevalence of overweight and obesity was more in blood group O and B respectively and was more in males than females

  8. The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.

    Science.gov (United States)

    Capuzzo, Enrico; Bonfanti, Carlo; Frattini, Francesco; Montorsi, Paolo; Turdo, Rosalia; Previdi, Maria Grazia; Turrini, Elisa; Franchini, Massimo

    2016-05-01

    The ABO blood group exerts a profound influence on hemostasis, and it has hence been associated with the development of thrombotic cardiovascular adverse events. In this study, we evaluated the relationship between the ABO blood group and the risk of cardiovascular disease assessed with the Cardiorisk score. All blood donors aged between 35 and 65 years were enrolled in the Cardiorisk program, which included the assessment of 8 variables (sex, age, total cholesterol, high-density lipoprotein (HDL) cholesterol, plasma glucose, arterial blood pressure, anti-hypertensive therapy and smoking) which were used to generate a score. Individuals with a resulting score ≥20, considered at high cardiovascular risk, underwent additional instrumental tests (chest X-ray, stress electrocardiogram and Doppler ultrasound of supra-aortic trunks) and were closely clinically monitored. Between January 2005 and December 2015, 289 blood donors with Cardiorisk ≥20 were identified, 249 of whom were included in the study with at least 2 years of follow-up. Among these, 36 (14.5%) had instrumental abnormality tests and developed adverse cardiovascular events (10 acute coronary syndrome, 2 cerebral ischemia, 3 cardiac arrhythmia, 8 stenosis of supra-aortic trunks or iliac arteries) during a median follow-up of 5.3 years. In this group of 249 high risk individuals, a statistically significant association (P=0.02) was found between the non-O blood type and the risk of developing subclinical or clinical cardiovascular events (odds ratio, 3.3; 95% CI, 1.1-10.1; P=0.033). The results of this study underline the both key role of ABO blood group for the risk of developing arterial thrombotic events and the need for including such unmodifiable variable on the scores assessing the thrombotic risk.

  9. Refractory anemia leading to renal hemosiderosis and renal failure.

    Science.gov (United States)

    Siddappa, Sujatha; Mythri, K M; Kowsalya, R; Parekh, Ashish

    2011-01-01

    Renal hemosiderosis is a rare cause of renal failure and, as a result, may not be diagnosed unless a detailed history, careful interpretation of blood parameters and renal biopsy with special staining is done. Here, we present a rare case of renal hemosiderosis presenting with renal failure.

  10. Refractory anemia leading to renal hemosiderosis and renal failure

    Directory of Open Access Journals (Sweden)

    Sujatha Siddappa

    2011-01-01

    Full Text Available Renal hemosiderosis is a rare cause of renal failure and, as a result, may not be diagnosed unless a detailed history, careful interpretation of blood parameters and renal biopsy with special staining is done. Here, we present a rare case of renal hemosiderosis presenting with renal failure.

  11. Phenotypic and allelic distribution of the ABO and Rhesus (D) blood groups in the Cameroonian population.

    Science.gov (United States)

    Ndoula, S T; Noubiap, J J N; Nansseu, J R N; Wonkam, A

    2014-06-01

    Data on blood group phenotypes are important for blood transfusion programs, for disease association and population genetics studies. This study aimed at reporting the phenotypic and allelic distribution of ABO and Rhesus (Rh) groups in various ethnolinguistic groups in the Cameroonians. We obtained ABO and Rhesus blood groups and self-identified ethnicity from 14,546 Cameroonian students. Ethnicity was classified in seven major ethnolinguistic groups: Afro-Asiatic, Nilo-Saharan, Niger-Kordofanian/West Atlantic, Niger-Kordofanian/Adamawa-Ubangui, Niger-Kordofanian/Benue-Congo/Bantu/Grassfield, Niger-Kordofanian/Benue-Congo/Bantu/Mbam and Niger-Kordofanian/Benue-Congo/Bantu/Equatorial. ABO allelic frequencies were determined using the Bernstein method. Differences in phenotypic distribution of blood groups were assessed using the chi-square test; a P value blood groups O, A, B and AB were 48.62%, 25.07%, 21.86% and 4.45%, respectively. Rhesus-positive was 96.32%. The allelic frequencies of O, A and B genes were 0.6978, 0.1605 and 0.1416, respectively. Phenotypic frequencies of the blood groups in the general study population and in the different ethnolinguistic groups were in agreement with Hardy-Weinberg equilibrium expectations (P > 0.05). The frequencies of O, A, and B blood phenotypes were significantly lower, respectively, in the Nilo-Saharan group (P = 0.009), the Niger-Kordofanian/Benue-Congo/Bantu groups (P = 0.021) and the Niger-Kordofanian/West-Atlantic group. AB blood group was most frequent in the Niger-Kordofanian/Adamawa-Ubangui group (P = 0.024). Our study provides the first data on ethnic distribution of ABO and Rhesus blood groups in the Cameroonian population and suggests that its general profile is similar to those of several sub-Saharan African populations. We found some significant differences in phenotypic distribution amongst major ethnolinguistic groups. These data may be important for blood donor recruitment policy and blood transfusion

  12. MAPEAMENTO DO SISTEMA DE GRUPOS SANGUÍNEOS ABO EM RONDONÓPOLIS – MT

    OpenAIRE

    Neves, Dannyara Rodrigues; Vieira, Elizete Cavalcante Souza; Carvalho, Eslany Moraes; Silva, Rodrigo Andrade da; Mendes, Simone de Oliveira; Medeiros, Mauro Osvaldo

    2014-01-01

    O conhecimento da frequência fenotípica dos vários grupos sanguíneos da nossa população é essencial para estimar a disponibilidade de sangue compatível para pacientes que apresentem anticorpos antieritrocitários. Dessa forma, o objetivo do trabalho foi mapear os tipos sanguíneos de doadores voluntários de sangue do Departamento de Hemoterapia do Hospital Regional de Rondonópolis "Irmã Elza Giovanella", para detectar a distribuição da frequência quanto ao sistema ABO, para a formação de um ban...

  13. sup(99m)Tc-DMSA renal scintigraphy in renal failure due to various renal diseases

    International Nuclear Information System (INIS)

    Hosokawa, Shin-ichi; Daijo, Kazuyuki; Okabe, Tatsushiro; Kawamura, Juichi; Hara, Akira

    1979-01-01

    Renal contours in renal failure were studied by means of sup(99m)Tc-dimercaptosuccinic acid (DMSA) renoscintigraphy. Renal cortical images were obtained even in renal failure cases. Causes of renal failure were chronic glomerulonephritis in 7, bilateral renal tuberculosis in 2, chronic pyelonephritis in 3, bilateral renal calculi in 3, diabetic nephropathy in 2, polycystic kidney disease in 2 and stomach cancer in 1. (author)

  14. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?

    Science.gov (United States)

    Gutiérrez-Aguirre, Cesar Homero; Gómez-De-León, Andrés; Alatorre-Ricardo, Julio; Cantú-Rodríguez, Olga Graciela; González-Llano, Oscar; Jaime-Pérez, José Carlos; Mancías-Guerra, Consuelo; Flores-Jiménez, Juan Antonio; Gómez-Almaguer, David

    2014-05-01

    Graft-versus-host disease (GVHD) is a major cause of morbimortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Minor ABO incompatibility has been associated with an increased risk of GVHD. We analyzed the impact of ABO matching on patient outcome after peripheral blood, reduced-intensity allo-HSCT in an outpatient setting, and its relationship with GVHD. Data of 121 patients were included. All patients received allo-HSCT from HLA-identical siblings as outpatients using a reduced-intensity conditioning regimen. Influence of ABO matching as a risk factor for the development of GVHD and survival was analyzed using logistic regression and Cox proportional hazards regression, respectively. Median age was 36 years (range, 1-71 years); 88 patients were ABO identical: 13 presented major mismatch and 20 minor mismatch, with an ABO incompatibility rate of 27.3%. The median follow-up period was 54 months (range, 0.3-120 months). Minor ABO incompatibility patients presented the highest rate of acute GVHD (aGVHD; 25%), in comparison with ABO-identical (20.5%) and major ABO incompatibility patients (15.4%; p = 0.79). The highest incidence of chronic GVHD (cGVHD) occurred in the context of minor ABO incompatibility (35%), in contrast to ABO-identical (30.8%) and major ABO incompatibility (15.4%). Survival was higher for patients in the minor ABO mismatch group; however, there was no significant correlation between ABO matching status and survival (p = 0.45). Using this type of peripheral blood stem cell transplantation, minor ABO-mismatched allo-HSCT was associated with a higher incidence of aGVHD and cGVHD and with increased survival, albeit with no significance. © 2013 American Association of Blood Banks.

  15. Imaging of renal osteodystrophy

    Energy Technology Data Exchange (ETDEWEB)

    Jevtic, V. E-mail: vladimir.jevtic@mf.uni-lj.si

    2003-05-01

    Chronic renal insufficiency, hemodialysis, peritoneal dialysis, renal transplantation and administration of different medications provoke complex biochemical disturbances of the calcium-phosphate metabolism with wide spectrum of bone and soft tissue abnormalities termed renal osteodystrophy. Clinically most important manifestation of renal bone disease includes secondary hyperparathyroidism, osteomalacia/rickets, osteoporosis, adynamic bone disease and soft tissue calcification. As a complication of long-term hemodialysis and renal transplantation amyloid deposition, destructive spondyloarthropathy, osteonecrosis, and musculoskeletal infections may occur. Due to more sophisticated diagnostic methods and more efficient treatment classical radiographic features of secondary hyperparathyroidism and osteomalacia/rickets are now less frequently seen. Radiological investigations play an important role in early diagnosis and follow-up of the renal bone disease. Although numerous new imaging modalities have been introduced in clinical practice (scintigraphy, CT, MRI, quantitative imaging), plain film radiography, especially fine quality hand radiograph, still represents most widely used examination.

  16. Imaging of renal osteodystrophy

    International Nuclear Information System (INIS)

    Jevtic, V.

    2003-01-01

    Chronic renal insufficiency, hemodialysis, peritoneal dialysis, renal transplantation and administration of different medications provoke complex biochemical disturbances of the calcium-phosphate metabolism with wide spectrum of bone and soft tissue abnormalities termed renal osteodystrophy. Clinically most important manifestation of renal bone disease includes secondary hyperparathyroidism, osteomalacia/rickets, osteoporosis, adynamic bone disease and soft tissue calcification. As a complication of long-term hemodialysis and renal transplantation amyloid deposition, destructive spondyloarthropathy, osteonecrosis, and musculoskeletal infections may occur. Due to more sophisticated diagnostic methods and more efficient treatment classical radiographic features of secondary hyperparathyroidism and osteomalacia/rickets are now less frequently seen. Radiological investigations play an important role in early diagnosis and follow-up of the renal bone disease. Although numerous new imaging modalities have been introduced in clinical practice (scintigraphy, CT, MRI, quantitative imaging), plain film radiography, especially fine quality hand radiograph, still represents most widely used examination

  17. Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma.

    Science.gov (United States)

    Ko, Kyungtae; Park, Young Hyun; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyeon Hoe; Kwak, Cheol

    2016-08-25

    In this study, we evaluated the prognostic significance of the ABO blood type in patients with renal cell carcinoma (RCC) who had undergone partial or radical nephrectomy. Information on the ABO blood type was obtained from 1750 patients with RCC. A total of 1243 men and 507 women (mean age, 55.41 ± 12.43 years) with RCC who had undergone partial or radical nephrectomy were enrolled in this study. The median follow-up duration was 35.0 months (interquartile range [IQR], 16.0-67.0). During the follow-up period, 271 patients experienced RCC recurrence, and 137 patients died from RCC. Type A was the most common blood type (568, 32.5%), followed by type O (525, 30.0%), type B (464, 26.5%), and type AB (193, 11.0%). Generally, blood type was not associated with any clinicopathological factors. Unlike blood type O, the multivariate analysis of progression-free survival (PFS) showed that blood type non-O (A, B, and AB) was an independent prognostic factor for a worse outcome (95% confidence interval [CI]: 1.24- 2.37, hazard ratio [HR] = 1.71, P = .001; 95% CI: 1.08-2.13, HR = 1.51, P = .016; 95% CI: 1.03-2.43, HR = 1.58, P = .037, respectively). Cancer-specific survival (CSS) analysis showed that blood type A was an independent factor associated with a worse prognosis for CSS (95% CI: 1.05-2.64, HR 1.66, P = .031, respectively). The ABO blood type is significantly associated with PFS and CSS in patients with RCC following partial or radical nephrectomy. Blood type non-O (A, B, and AB) is an independent prognostic factor for a worse PFS outcome, and blood type A is an independent factor associated with a worse CSS prognosis. .

  18. Trasplante de mucosa oral en la reconstrucción de las vías lagrimales Oral mucosa transplants in restoration of lacrimal canaliculi

    Directory of Open Access Journals (Sweden)

    Bernardo Canto Vidal

    2000-06-01

    Full Text Available Se realizaron 143 intervenciones de las vías lagrimales, mediante la técnica quirúrgica de trasplante de mucosa oral con 55 injertos libres y 88 tubulares, a partir del año 1995. Para ello se tuvo en cuenta el examen clínico y radiológico y el tipo de afectación. Con la utilización de las técnicas de injerto libre o tubular de la mucosa se puede restablecer la fisiología lagrimal en los pacientes con mutilaciones por traumatismos o presencia de tumores con disminución del riesgo quirúrgico; además se recomienda por novedosa, práctica y por los buenos resultados obtenidos.143 interventions of lacrimal canaliculi were carried out, throgh surgical technique of oral mucosa transplant (55 free grafts and 88 tutular ones since 1995, bearing in min radiological and clinical examination and type of invelvement. Using technique of free or tubular graft, it is possible restore lacrimal physiology in patients with mutilations from trauma or prevence of tumors thus decreasing surgical risk; this tachnique is recommended by its novelty, usefulness . and by good results obtained.

  19. Cistitis hemorrágica relacionada al trasplante de médula ósea: primer reporte de casos en el país

    Directory of Open Access Journals (Sweden)

    Juan Nunura

    2004-06-01

    Full Text Available Objetivo: Determinar la incidencia, características clínicas y complicaciones de la cistitis hemorrágica (CH. Material y Métodos: Estudio descriptivo sobre pacientes transplantados de médula ósea en la Unidad de Trasplante de Médula Ósea del Hospital Nacional Edgardo Rebagliati Martins, desde noviembre 1994 hasta octubre 2003, y que desarrollaron cistitis hemorrágica. Resultados: En 9 años fueron transplantados 170 pacientes, desarrollando cistitis hemorrágica 8 de ellos (incidencia acumulada 4,7%. El cuadro clínico se caracterizó por disuria más hematuria macroscópica o microscópica. La presentación tardía fue la más frecuente. En 4 pacientes, la cistitis hemorrágica fue severa. Dos de los tres pacientes que desarrollaron el cuadro de cistitis hemorrágica en dos oportunidades, fallecieron. Conclusiones: La mitad de los pocos pacientes que desarrollan CH en la Unidad, lo hacen bajo la forma severa y, si presentan la CH por segunda vez, su pronóstico se complica.

  20. Trasplante de Médula Ósea 10 Años de Experiencia en la Clínica de Marly”.

    Directory of Open Access Journals (Sweden)

    Enrique Pedraza Mesa

    2004-03-01

    El desarrollo del programa necesitó implementar muchísimos aspectos tanto científicos como de enfermería, protocolos, mejorar el banco de sangre y el laboratorio clínico, la farmacia, ya que el trasplante utiliza una gran cantidad de medicamentos sumamente sofisticados y costosos que inicialmente tuvimos que importar directamente, tuvimos que mejorar el área física, hacer un laboratorio de criopreservación. Las células que se utilizan se obtienen de la sangre periférica de los propios pacientes que van a ser trasplantados o de un donante, en ese caso de un hermano idéntico, y estas células se llevan al laboratorio, se mezclan con un medio de cultivo y con un agente criopreservante y se congelan en nitrógeno líquido; por eso es necesario utilizar unas máquinas que llevan estas células a una temperatura de -170ºC...

  1. Incidental renal neoplasms

    DEFF Research Database (Denmark)

    Rabjerg, Maj; Mikkelsen, Minne Nedergaard; Walter, Steen

    2014-01-01

    On the basis of associations between tumor size, pathological stage, histological subtype and tumor grade in incidentally detected renal cell carcinoma vs symptomatic renal cell carcinoma, we discussed the need for a screening program of renal cell carcinoma in Denmark. We analyzed a consecutive...... series of 204 patients with renal tumors in 2011 and 2012. The tumors were classified according to detection mode: symptomatic and incidental and compared to pathological parameters. Eighty-nine patients (44%) were symptomatic, 113 (55%) were incidental. Information was not available in two patients...

  2. Novel association of soluble intercellular adhesion molecule 1 and soluble P-selectin with the ABO blood group in a Chinese population.

    Science.gov (United States)

    Zhang, Wenjing; Xu, Qun; Zhuang, Yunlong; Chen, Yuanfeng

    2016-08-01

    Recent studies have reported that the ABO gene can affect circulating expression levels of soluble intercellular adhesion molecule 1 (sICAM-1) and soluble P-selectin (sP-selectin) in Caucasians. However, several factors may affect the association, including the distribution and variations of the ABO gene, ethnic diversity and the inflammatory response status. The aim of the present study was to investigate this issue in Asian subjects of various blood groups. A total of 800 blood samples were randomly selected from healthy blood donors. The ABO blood groups were examined using standard serological tests, and ABO genotypes of group A and group AB specimens were analyzed. Plasma concentrations of sICAM-1 and sP-selectin were detected by standard enzyme-linked immunosorbent assays. In healthy Chinese individuals, blood group A was detected to be significantly associated with lower circulating expression levels of sICAM-1 and sP-selectin, compared with group O. Individuals with ≥1 A1 allele had significantly lower expression levels of sICAM-1 and sP-selectin compared with all other ABO groups. The data indicate the significant association of ABO blood group antigens with sICAM-1 and sP-selectin expression levels in a healthy Chinese population, independent of the specific variations and distributions of ABO blood groups among ethnic populations. This result provides evidence for the previously unidentified role of ABO blood group antigens in the regulation of the inflammatory adhesion process. Accordingly, it can be proposed that ABO blood groups may require consideration when soluble adhesion molecules are identified as predictors for cardiovascular disease.

  3. Relative Susceptibilities of ABO Blood Groups to Plasmodium falciparum Malaria in Ghana.

    Science.gov (United States)

    Afoakwah, Richmond; Aubyn, Edmond; Prah, James; Nwaefuna, Ekene Kwabena; Boampong, Johnson N

    2016-01-01

    The clinical outcome of falciparum malaria in endemic areas is influenced by erythrocyte polymorphisms including the ABO blood groups. Studies have reported association of ABO blood group to resistance, susceptibility, and severity of P. falciparum malaria infection. Individuals with blood group "A" have been found to be highly susceptible to falciparum malaria whereas blood group "O" is said to confer protection against complicated cases. We analyzed samples from 293 young children less than six years old with malaria in the Korle-Bu Teaching Hospital in Accra, Ghana. It was observed that group O was present in about 16.1% of complicated cases weighed against 40.9% of uncomplicated controls. Individuals with complicated malaria were about twice likely to be of blood groups A and B compared to group O (A versus O, OR = 1.90, 95% CI = 1.59-2.26, P Blood group O participants with complicated diseases had low parasitaemia compared to the other blood groups (P blood group O individuals a survival advantage over the other groups in complicated malaria as suggested. Participants with complicated falciparum malaria were generally anaemic and younger than those with uncomplicated disease.

  4. ABO Blood Groups Influence Macrophage-mediated Phagocytosis of Plasmodium falciparum-infected Erythrocytes

    Science.gov (United States)

    Branch, Donald R.; Hult, Annika K.; Olsson, Martin L.; Liles, W. Conrad; Cserti-Gazdewich, Christine M.; Kain, Kevin C.

    2012-01-01

    Erythrocyte polymorphisms associated with a survival advantage to Plasmodium falciparum infection have undergone positive selection. There is a predominance of blood group O in malaria-endemic regions, and several lines of evidence suggest that ABO blood groups may influence the outcome of P. falciparum infection. Based on the hypothesis that enhanced innate clearance of infected polymorphic erythrocytes is associated with protection from severe malaria, we investigated whether P. falciparum-infected O erythrocytes are more efficiently cleared by macrophages than infected A and B erythrocytes. We show that human macrophages in vitro and mouse monocytes in vivo phagocytose P. falciparum-infected O erythrocytes more avidly than infected A and B erythrocytes and that uptake is associated with increased hemichrome deposition and high molecular weight band 3 aggregates in infected O erythrocytes. Using infected A1, A2, and O erythrocytes, we demonstrate an inverse association of phagocytic capacity with the amount of A antigen on the surface of infected erythrocytes. Finally, we report that enzymatic conversion of B erythrocytes to type as O before infection significantly enhances their uptake by macrophages to observed level comparable to that with infected O wild-type erythrocytes. These data provide the first evidence that ABO blood group antigens influence macrophage clearance of P. falciparum-infected erythrocytes and suggest an additional mechanism by which blood group O may confer resistance to severe malaria. PMID:23071435

  5. ABO blood groups and Helicobacter pylori cagA infection: evidence of an association

    Directory of Open Access Journals (Sweden)

    DE Mattos

    2010-01-01

    Full Text Available Diseases resulting from Helicobacter pylori infection appear to be dependent on a host of genetic traits and virulence factors possessed by this microorganism. This paper aimed to investigate the association between the ABO histo-blood groups and H. pylori cagA infections. Genomic DNA samples (n = 110 of gastric biopsies obtained from patients with endoscopic diagnosis of peptic ulcers (n = 25 and chronic active gastritis (n = 85 were analyzed by PCR using specific primers for the cagA gene. Of the samples, 66.4% (n = 73 tested positive and 33.6% (n = 37 negative for the gene. The cagA strain was predominant in peptic ulcers (n = 21; 84.0% compared with chronic active gastritis (n = 52; 61.2% (p = 0.05; OR 3.332; 95% CI: 1.050-10.576. Additionally, the cagA strain was prevalent in the type O blood (48/63; 76.2% compared with other ABO phenotypes (25/47; 53.2% (p = 0.01; OR 2.816; 95% CI: 1.246-6.364. These results suggest that H. pylori cagA infection is associated with the O blood group in Brazilian patients suffering from chronic active gastritis and peptic ulcers.

  6. The ABO blood group is a trans-species polymorphism in primates.

    Science.gov (United States)

    Ségurel, Laure; Thompson, Emma E; Flutre, Timothée; Lovstad, Jessica; Venkat, Aarti; Margulis, Susan W; Moyse, Jill; Ross, Steve; Gamble, Kathryn; Sella, Guy; Ober, Carole; Przeworski, Molly

    2012-11-06

    The ABO histo-blood group, the critical determinant of transfusion incompatibility, was the first genetic polymorphism discovered in humans. Remarkably, ABO antigens are also polymorphic in many other primates, with the same two amino acid changes responsible for A and B specificity in all species sequenced to date. Whether this recurrence of A and B antigens is the result of an ancient polymorphism maintained across species or due to numerous, more recent instances of convergent evolution has been debated for decades, with a current consensus in support of convergent evolution. We show instead that genetic variation data in humans and gibbons as well as in Old World monkeys are inconsistent with a model of convergent evolution and support the hypothesis of an ancient, multiallelic polymorphism of which some alleles are shared by descent among species. These results demonstrate that the A and B blood groups result from a trans-species polymorphism among distantly related species and has remained under balancing selection for tens of millions of years-to date, the only such example in hominoids and Old World monkeys outside of the major histocompatibility complex.

  7. ABO blood groups and Rhesus factor: an exploring link to periodontal diseases.

    Science.gov (United States)

    Koregol, Arati C; Raghavendra, M; Nainegali, Sangamesh; Kalburgi, Nagaraj; Varma, Siddharth

    2010-01-01

    The presence or absence of blood group antigens has been associated with various diseases, with antigens also acting as receptors for infectious agents. Scanty literature is available in assessing the relative liability of blood group phenotypes to periodontal diseases. This research was conducted to determine the association of the ABO blood group and Rhesus (Rh) factor to periodontal diseases to assess whether they could be the predictors of periodontal diseases. A total of 1,220 subjects aged between 20 and 55 years were selected on a random basis. The study populations were segregated into three groups according to Ramfjord's periodontal disease index: Healthy, Gingivitis and Periodontitis. Blood samples were collected to identify the ABO blood groups and the Rh factor by the slide method. Blood group A showed a significantly higher percentage in the gingivitis group and blood group O showed a higher percentage in the periodontitis group. The blood group AB showed the least percentage of periodontal diseases. The distribution of Rh factor in all groups showed a significantly higher distribution of Rh-positive. The genetic factors may alter the oral ecology and the process of periodontal disease. These data are suggestive of a broad correlation between periodontal diseases and blood groups, which may act as risk predictors for periodontal diseases. This will make it possible to better-understand the risk factors of diseases of the periodontal tissues and to predict the effective methods of prevention and treatment of periodontal diseases.

  8. Relative Susceptibilities of ABO Blood Groups to Plasmodium falciparum Malaria in Ghana

    Directory of Open Access Journals (Sweden)

    Richmond Afoakwah

    2016-01-01

    Full Text Available The clinical outcome of falciparum malaria in endemic areas is influenced by erythrocyte polymorphisms including the ABO blood groups. Studies have reported association of ABO blood group to resistance, susceptibility, and severity of P. falciparum malaria infection. Individuals with blood group “A” have been found to be highly susceptible to falciparum malaria whereas blood group “O” is said to confer protection against complicated cases. We analyzed samples from 293 young children less than six years old with malaria in the Korle-Bu Teaching Hospital in Accra, Ghana. It was observed that group O was present in about 16.1% of complicated cases weighed against 40.9% of uncomplicated controls. Individuals with complicated malaria were about twice likely to be of blood groups A and B compared to group O (A versus O, OR = 1.90, 95% CI = 1.59–2.26, P<0.0001; B versus O, OR = 1.82. 95% CI = 1.57–2.23, P<0.0001. Blood group O participants with complicated diseases had low parasitaemia compared to the other blood groups (P<0.0001. This may give blood group O individuals a survival advantage over the other groups in complicated malaria as suggested. Participants with complicated falciparum malaria were generally anaemic and younger than those with uncomplicated disease.

  9. Distal renal tubular acidosis in recurrent renal stone formers

    DEFF Research Database (Denmark)

    Osther, P J; Hansen, A B; Røhl, H F

    1989-01-01

    (1.1%) had complete distal renal tubular acidosis and 14 (15.5%) incomplete distal renal tubular acidosis. Our results confirm that distal renal tubular acidification defects are associated with a more severe form of stone disease and make distal renal tubular acidosis one of the most frequent...... metabolic disturbances in renal stone formers. Distal renal tubular acidosis (dRTA) was relatively more common in female stone formers and most often found in patients with bilateral stone disease (36%). Since prophylactic treatment in renal stone formers with renal acidification defects is available...

  10. Renal pelvis or ureter cancer

    Science.gov (United States)

    Transitional cell cancer of the renal pelvis or ureter; Kidney cancer - renal pelvis; Ureter cancer ... system, but it is uncommon. Renal pelvis and ureter cancers affect men more often than women. These ...

  11. Bilateral papillary renal cell carcinoma

    International Nuclear Information System (INIS)

    Gossios, K.; Vazakas, P.; Argyropoulou, M.; Stefanaki, S.; Stavropoulos, N.E.

    2001-01-01

    Papillary renal cell carcinoma is a subgroup of malignant renal epithelial neoplasms. We report the clinical and imaging findings of a case with multifocal and bilateral renal cell carcinoma which are nonspecific. (orig.)

  12. Genetics Home Reference: renal hypouricemia

    Science.gov (United States)

    ... expand/collapse boxes. Description Renal hypouricemia is a kidney (renal) disorder that results in a reduced amount of ... Causes of Kidney Stones National Kidney Foundation: Acute Kidney Injury Orphanet: Hereditary renal hypouricemia Patient Support and Advocacy Resources (2 links) ...

  13. Correlation of ABO and Rh blood groups with transfusion administration and fever onset after hip surgery in children.

    Science.gov (United States)

    Brdar, Radivoj; Petronic, Ivana; Nikolic, Dejan; Golubovic, Zoran; Bukva, Bojan; Radlovic, Vladimir; Abramovic, Dusan; Ducic, Sinisa; Colovic, Hristina

    2012-01-01

    Aim of our study was to evaluate distribution of ABO and Rh blood type groups in children after hip surgery regarding transfusion administration and fever presence. Four types of ABO blood groups (A; B; AB; O) and 2 types of Rh blood groups (Rh+; Rh-) were evaluated in group with administered transfusion (tr+) and without given transfusion (tr-); and in group with fever (fev+) and without fever (fev-), in 146 children after hip surgery. Tr+ and fev+ groups were divided into 3 groups (0-24h; 25-48h; 49-72h): for tr+ group (Group 1, Group 2, Group 3), and for fev+ group (Group A, Group B, Group C). AB blood group significantly decreased in Group 1 (χ2= 6.44; pblood group in Group 3 in tr+ group (χ2= 7.68; pblood group significantly increased in Group 3 in tr+ group (χ2= 9.96; pblood group significantly decreased in Groups B (χ2= 12.2; pblood group significantly increased in Group C (χ2= 34.4; pgroup. Administration of transfusion and fever onset in pediatric patients undergoing surgical correction of the hip is not influenced by the ABO and Rh blood groups system in humans. There is correlation between distribution of ABO blood groups with the time of transfusion administration and fever onset in children after hip surgery.

  14. Association of ABO Blood Group and Body Mass Index: A Cross-Sectional Study from a Ghanaian Population

    Directory of Open Access Journals (Sweden)

    Samuel Smith

    2018-01-01

    Full Text Available ABO blood group and body mass index (BMI have individually been appraised as risk factors for certain diseases. From statistical perspective, it may be important to examine the relationship between the ABO blood antigen and BMI. This cross-sectional study involved 412 participants aged 18 to 46 at the Kwame Nkrumah University of Science and Technology (KNUST, Kumasi. Weight and height of participants were measured for BMI calculation; blood group determination was done using antisera. Blood group O was the most prevalent (51.2%, while Rhesus-positive individuals constituted 90.3%. 6.3% of the participants were obese, while 18.7% were overweight. There was significant (p=0.006 higher prevalence of obesity in females (10.3% than in males (3.4%. The study did not observe any significant difference by association of ABO blood group with gender (p=0.973, BMI (p=0.307, or Rhesus status (p=0.723. Regarding gender (p=0.400 and BMI (p=0.197, no statistically significant difference was observed between Rhesus blood groups. The prevalence of overweight, obesity, blood type O, and rhesus positive observed among students in this study is largely similar to what has been reported in published studies in Ghana and from other countries. Overweight and obesity were not associated with ABO blood groups or Rhesus in this study.

  15. Association Between ABO Blood Type and Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Unilateral Total Hip Arthroplasty Surgery in China.

    Science.gov (United States)

    Li, Jie; Zhou, Jun; Wan, Yunqiang; Liu, Li; Ou, Cehua

    2017-05-28

    BACKGROUND Postoperative cognitive dysfunction (POCD) is a postoperative complication after surgery and anesthesia. Whether ABO blood types are associated with POCD in elderly patients undergoing unilateral total hip arthroplasty surgery in China is unclear. MATERIAL AND METHODS Firstly, 142 elderly patients were divided into a POCD group and a non-POCD group according to the Mini Mental State Examination (MMSE) scores and ABO blood types were analyzed. Secondly, according to ABO blood type, the selected 226 patients were divided into 4 groups: type A group, type B group, type AB group, and type O group. Then, all patients completed the MMSE before and after surgery. Finally, the occurrence of POCD was recorded and related data were analyzed. RESULTS Firstly, there was a significant difference in both groups in terms of distribution of ABO blood types, and elderly patients who developed POCD were more likely to have type A blood and less likely to have type O blood. Secondly, compared with elderly patients with type A blood, those with type O had higher MMSE scores on the first day and the seventh day after surgery. Finally, the risk of developing POCD was significantly higher in patients with type A blood and on the first day and the seventh day after surgery the risk of developing POCD was significantly lower in patients with type O blood. CONCLUSIONS Elderly patients with type A blood have higher risk of developing early POCD and those with type O blood have less risk of developing early POCD.

  16. Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation.

    Science.gov (United States)

    Ishida, Hideki; Kondo, Tsunenori; Shimizu, Tomokazu; Nozaki, Taiji; Tanabe, Kazunari

    2015-03-01

    The purpose of this study is to examine whether postoperative antiblood type antibody rebound is attributed to kidney allograft rejection in ABO blood type-incompatible (ABO-I) living-related kidney transplantation (KTx). A total of 191 ABO-I recipients who received ABO-I living-related KTx between 2001 and 2013 were divided into two groups: Group 1 consisted of low rebound [(≦1:32), N = 170] and Group 2 consisted of high rebound [(≧1:64), N = 21], according to the levels of the rebounded antiblood type antibodies within 1 year after transplantation. No prophylactic treatment for rejection was administered for elevated antiblood type antibodies, regardless of the levels of the rebounded antibodies. Within 1 year after transplantation, T-cell-mediated rejection was observed in 13 of 170 recipients (13/170, 8%) in Group 1 and in 2 of 21 recipients (2/21, 10%) in Group 2 (Groups 1 vs. 2, P = 0.432). Antibody-mediated rejection was observed in 15 of 170 recipients (15/170, 9%) and 2 of 21 recipients (2/21, 10%) in Groups 1 and 2, respectively (P = 0.898). In this study, we found no correlation between the postoperative antiblood type antibody rebound and the incidence of acute rejection. We concluded that no treatment is necessary for rebounded antiblood type antibodies. © 2014 Steunstichting ESOT.

  17. High rhesus (Rh(D)) negative frequency and ethnic-group based ABO blood group distribution in Ethiopia.

    Science.gov (United States)

    Golassa, Lemu; Tsegaye, Arega; Erko, Berhanu; Mamo, Hassen

    2017-07-26

    Knowledge of the distribution of ABO-Rh(D) blood groups in a locality is vital for safe blood services. However, the distribution of these blood systems among Ethiopians in general is little explored. This study was, therefore, designed to determine the ABO-Rh(D) blood group distribution among patients attending Gambella hospital, southwestern Ethiopia. A cross-sectional study was conducted between November and December 2013 (N = 449). The patients were grouped into two broad categories. Those who originally moved from different parts of Ethiopia and currently residing in Gambella are named 'highlanders' (n = 211). The other group consisted of natives (Nilotics) to the locality (n = 238). ABO-Rh(D) blood groups were typed by agglutination, open-slide test method, using commercial antisera (Biotech laboratories Ltd, Ipswich, Suffolk, UK). Overall, majority of the participants (41.20%) had blood type 'O' followed by types 'A' (34.96%), 'B' (20.48%) and 'AB' (3.34%). However, blood type 'A' was the most frequent (44.07%) blood group among the 'highlanders' and 50.42% of Nilotic natives had type 'O'. The proportion of participants devoid of the Rh factor was 19.37%. While the ABO blood group distribution is similar to previous reports, the Rh(D) frequency is much higher than what was reported so far for Ethiopia and continental Africa.

  18. ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis.

    Science.gov (United States)

    Chen, Zhuo; Yang, Sheng-Hua; Xu, Hao; Li, Jian-Jun

    2016-03-18

    ABO blood group system, a well-known genetic risk factor, has clinically been demonstrated to be linked with thrombotic vascular diseases. However, the relationship between ABO blood group and coronary artery disease (CAD) is still controversial. We here performed an updated meta-analysis of the related studies and tried to elucidate the potential role of ABO blood group as a risk factor for CAD. All detectable case-control and cohort studies comparing the risk of CAD in different ABO blood groups were collected for this analysis through searching PubMed, Embase, and the Cochrane Library. Ultimately, 17 studies covering 225,810 participants were included. The combined results showed that the risk of CAD was significantly higher in blood group A (OR = 1.14, 95% CI = 1.03 to 1.26, p = 0.01) and lower in blood group O (OR = 0.85, 95% CI = 0.78 to 0.94, p = 0.0008). Even when studies merely about myocardial infarction (MI) were removed, the risk of CAD was still significantly higher in blood group A (OR = 1.05, 95% CI = 1.00 to 1.10, p = 0.03) and lower in blood group O (OR = 0.89, 95% CI = 0.85 to 0.93, p < 0.00001). This updated systematic review and meta-analysis indicated that both blood group A and non-O were the risk factors of CAD.

  19. Genetic of the ABO blood system and its link with the immune system A genética do sistema ABO e sua relação com o sistema imune

    Directory of Open Access Journals (Sweden)

    Luiz C. de Mattos

    2004-03-01

    Full Text Available In the book "Eat Right For Your Type" the author Peter J. D'Adamo writes that the O blood type was the first blood type to appear in humans and affirms that the blood groups are the key to the immune system. Some recent phylogenetic network studies in humans and non-human primates implies that the A gene represents an ancient form of the ABO genes. Relationships between blood groups and infectious and noninfectious diseases and immunodeficiency abnormalities have also been reported in the literature. As D'Adamo's propositions seem to be in opposition with the current knowledge, we present in this paper some comments about the genetics and the evolution of the ABO blood group genes and some links between this blood system and the functioning of the immune system.Peter J. D'Adamo, autor do livro "Eat Right For Your Type", escreve que o grupo O representa o primeiro tipo sangüíneo que surgiu nos humanos e também afirma que os grupos sangüíneos constituem as bases do sistema imune. Recentes estudos filogenéticos realizados em primatas humanos e não humanos estabeleceram que o gene A representa a forma ancestral dos genes que ocupam o locus ABO. Associações entre os grupos sangüíneos ABO, doenças infecciosas, não infecciosas e imunodeficiências também foram relatadas. Diante das proposições do autor, as quais se opõem às informações resultantes de recentes estudos moleculares e filogenéticos, nossa intenção é apresentar algumas reflexões sobre a genética e a evolução dos genes do sistema ABO e as conexões deste sistema com o sistema imune.

  20. MAPEAMENTO DOS SISTEMAS DE GRUPOS SANGÜÍNEOS ABO E RH DOS DOADORES DE SANGUE EM PRIMAVERA DO LESTE – MT

    OpenAIRE

    Silva, Rodrigo Andrade da; Mendes, Simone de Oliveira; Souza, André Vinicius Valuz de; Luz, Paulo Roberto Gomes; Medeiros, Mauro Osvaldo

    2011-01-01

     No Brasil, existem poucos trabalhos que avaliam a predominância dos grupos sangüíneos que compõem os sistemas ABO e RH. Estudos dessa natureza podem contribuir para um melhor planejamento das demandas de derivados sangüíneos, considerando as necessidades da população. Assim, o objetivo do trabalho foi mapear os tipos sanguíneos do sistema ABO e o fator RH dos doadores de sangue. Para determinar a ocorrência das classes fenotípicas dos sistemas sangüíneos ABO e RH, foram coletados dados de 27...